<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/"><channel><title>GNews Health</title><link>https://news.google.com/</link><description></description><generator>rfeed v1.1.1</generator><docs>https://github.com/svpino/rfeed/blob/master/README.md</docs><item><title>意见|不接种疫苗代价高昂--《华盛顿邮报》</title><link>https://www.washingtonpost.com/opinions/2025/09/11/vaccines-skipping-cost/</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="wpds-c-PJLV article-body type-text grid-center grid-body" data-qa="article-body"&gt;&lt;p data-apitype="text" data-contentid="6VMV3H2DPBGP3OUUU7RU2SI7C4" data-el="text" class="wpds-c-heFNVF wpds-c-heFNVF-iPJLV-css overrideStyles font-copy" dir="null"&gt;&lt;i&gt;Donald G. McNeil Jr., a former global health reporter for the New York Times, is the author of “The Wisdom of Plagues: Lessons From 25 Years of Covering Pandemics.”&lt;/i&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="wpds-c-PJLV article-body type-text grid-center grid-body" data-qa="article-body"&gt;&lt;p data-apitype="text" data-contentid="ESKLBY6OXJGZZDU4JNE4ODBHNU" data-el="text" class="wpds-c-heFNVF wpds-c-heFNVF-iPJLV-css overrideStyles font-copy" dir="null"&gt;Robert F. Kennedy Jr.’s efforts to undermine vaccines in America are not just scientifically absurd. They’re also financially ruinous. The costs of medical care in the United States have been skyrocketing for years, forcing health insurers to raise their premiums faster than overall inflation and pushing the Medicare’s trust fund ever &lt;a href="https://www.kff.org/medicare/faqs-on-medicare-financing-and-trust-fund-solvency/"&gt;deeper into trouble&lt;/a&gt;.&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>The Washington Post</author><pubDate>Thu, 11 Sep 2025 15:01:48 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMif0FVX3lxTFA2cWFadFJ5QkJfejNCLWhvR3otUWk2cTFZSFNrd2VpaDI3b1d2bDJpZlg4a3ZXd0Q2TURENVNreWt4MFdRbFFlckhSRTJuX3Q0cU5nWTFxdmttRUNZNEJLOUhvMFdxclpfWUZjVVZkTXNPWXJZWXdsMmdZbzJEWDg</guid></item><item><title>一项新的研究显示，单次运动可能会减缓癌细胞的生长-《华盛顿邮报》</title><link>https://www.washingtonpost.com/wellness/2025/09/11/exercise-cancer-benefits-prevention-recurrence/</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="wpds-c-PJLV article-body type-text" data-qa="article-body"&gt;&lt;p data-apitype="text" data-contentid="QYKJEJKTLNBRTEPDKY2CIZKWSE" data-el="text" class="wpds-c-heFNVF wpds-c-heFNVF-iPJLV-css overrideStyles font-copy" dir="null"&gt;Exercising muscles pumps out substances that can suppress&lt;b&gt; &lt;/b&gt;the growth of breast cancer cells, according to an important new study of exercise and cancer.&lt;/p&gt;&lt;/div&gt;&lt;div class="wpds-c-PJLV article-body type-text" data-qa="article-body"&gt;&lt;p data-apitype="text" data-contentid="IJRARYDOWVETDGV4IB7IIXU2KA" data-el="text" class="wpds-c-heFNVF wpds-c-heFNVF-iPJLV-css overrideStyles font-copy" dir="null"&gt;The &lt;a href="https://pubmed.ncbi.nlm.nih.gov/40608178/" target="_blank"&gt;study&lt;/a&gt;, published last month, involved 32 women who’d survived breast cancer. After a single session of interval training or weightlifting, their blood contained higher levels of certain molecules, and those factors helped put the brakes on laboratory-grown breast cancer cells.&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>The Washington Post</author><pubDate>Thu, 11 Sep 2025 12:40:06 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMinwFBVV95cUxQUW9qdU5ydHhrQzdFa09MclpmclFMMk1aSHdRam05Z0dFN0RQZGR6YlRHSHk2bEpCZTUxM0hmZTBjSUhOSzRycnVRVUw4WjdoZHhrOGtuVEZka1NNanVvaDEtclFucWM1Nk92ZTdyb3RXejljQVlQSkxnLThCbzB1MjZUN0JFQmxySVJiazZzSGlpS1NzZkFlM3NBanVEREk</guid></item><item><title>希腊酸奶有多健康？ -《西雅图时报》</title><link>https://www.seattletimes.com/nation-world/how-healthy-is-greek-yogurt/</link><description>&lt;a href="https://news.google.com/rss/articles/CBMiekFVX3lxTE45UXQ4ZUNVZFNLS1F5SWVjQmxYMGkyNkRhSEFPQzJwbkhyYms1THFENGpST1hxaTRqYkN0VVZ0bjlQRHJrVEtoUzhiVjA0dXlpTFV0Nl8taUNBMnNXMXloUjZpUU11TGNtWmF6ZDNBaVRzN0hnZ1RlVzRB?oc=5" target="_blank"&gt;How healthy is Greek yogurt?&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;The Seattle Times&lt;/font&gt;</description><author>The Seattle Times</author><pubDate>Thu, 11 Sep 2025 11:22:01 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMiekFVX3lxTE45UXQ4ZUNVZFNLS1F5SWVjQmxYMGkyNkRhSEFPQzJwbkhyYms1THFENGpST1hxaTRqYkN0VVZ0bjlQRHJrVEtoUzhiVjA0dXlpTFV0Nl8taUNBMnNXMXloUjZpUU11TGNtWmF6ZDNBaVRzN0hnZ1RlVzRB</guid></item><item><title>爱情、毒品和安全套：艾滋病毒感染者身份不同的夫妇面临新的现实-美国国家公共广播电台</title><link>https://www.npr.org/sections/goats-and-soda/2025/09/11/g-s1-77007/hiv-condoms-hiv-positive-u-s-aid-cuts</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div id="storytext" class="storytext storylocation linkLocation"&gt;
      &lt;div id="resg-s1-82264" class="bucketwrap image x-large"&gt;
            
&lt;div class="credit-caption"&gt;
    &lt;div class="caption-wrap"&gt;
        &lt;div class="caption" aria-label="Image caption"&gt;
            &lt;p&gt;
                Robert Ochweda and Millicent Akoth is HIV positive — she caught the virus from her former husband. She is now married to Robert Ochweda, a fisherman who is HIV negative. After the two of them fell in love, he says he was afraid to marry her lest he contract the virus. "I have been able to stay safe by using condoms and PrEP," Ochweda explains, referring to a pill that prevents infection. In the wake of U.S. foreign aid cuts, they say it's become harder to find the pills and condoms that keep them safe.
                &lt;b class="credit" aria-label="Image credit"&gt;
                    
                    Julia Gunther for NPR
                    
                &lt;/b&gt;
                &lt;b class="hide-caption"&gt;&lt;b&gt;hide caption&lt;/b&gt;&lt;/b&gt;
            &lt;/p&gt;
        &lt;/div&gt;


            &lt;b class="toggle-caption"&gt;&lt;b&gt;toggle caption&lt;/b&gt;&lt;/b&gt;
    &lt;/div&gt;

    &lt;span class="credit" aria-label="Image credit"&gt;
        
        Julia Gunther for NPR
        
    &lt;/span&gt;
&lt;/div&gt;
   &lt;/div&gt;
   &lt;p&gt;Let's say you fall in love with someone harboring a deadly -- and highly infectious -- virus. And you think … is it crazy to get married?&lt;/p&gt;   &lt;p&gt;Sometimes love conquers all — with the help of modern medicine.&lt;/p&gt;   &lt;p&gt;That's the story of serodiscordant couples — the term used when one partner is HIV positive and the other is HIV negative.&lt;/p&gt;   &lt;p&gt;Robert Ochweda and Millicent Akoth of Kenya are one such couple. She is HIV positive — she caught the virus from her former husband. He is a fisherman who is HIV negative. After the two of them fell in love, he says he was afraid to marry her lest he contract the virus.&lt;/p&gt;   
   &lt;p&gt;He was able to overcome his fears.&lt;/p&gt;   &lt;p&gt;"I have been able to stay safe by using condoms and PrEP," Ochweda explains, referring to a pill that prevents infection. And The Centers for Disease Control and Prevention writes: "Most condoms are highly effective in preventing HIV."&lt;/p&gt;   &lt;p&gt;His wife takes antiretroviral pills that reduce her viral load, so she does not face the risk of death from AIDS. Those pills also reduce the risk that she will infect her husband.&lt;/p&gt;   &lt;p&gt;This year, couples in this category are especially anxious. They say that, in the wake of the Trump administration's dramatic foreign aid cuts and dismantling of USAID, the agency that supported health-related programs, it's become harder to find the pills and condoms that keep them safe.&lt;/p&gt;   &lt;div id="resg-s1-82272" class="bucketwrap image x-large"&gt;
            
&lt;div class="credit-caption"&gt;
    &lt;div class="caption-wrap"&gt;
        &lt;div class="caption" aria-label="Image caption"&gt;
            &lt;p&gt;
                Caleb Ochieng, who is HIV negative, has been married to DIana Odhiambo, who is HIV positive, for eight years. They have two children. On a recent visit to pick up his PrEP drugs that reduce his risk of infection, he says, "I was told the supply that was available has been reserved for pregnant women."
                &lt;b class="credit" aria-label="Image credit"&gt;
                    
                    Julia Gunther for NPR
                    
                &lt;/b&gt;
                &lt;b class="hide-caption"&gt;&lt;b&gt;hide caption&lt;/b&gt;&lt;/b&gt;
            &lt;/p&gt;
        &lt;/div&gt;


            &lt;b class="toggle-caption"&gt;&lt;b&gt;toggle caption&lt;/b&gt;&lt;/b&gt;
    &lt;/div&gt;

    &lt;span class="credit" aria-label="Image credit"&gt;
        
        Julia Gunther for NPR
        
    &lt;/span&gt;
&lt;/div&gt;
   &lt;/div&gt;
   &lt;p&gt;Caleb Ochieng, who is HIV negative, has been married to Diana Odhiambo, who is HIV positive, for eight years. &lt;/p&gt;   &lt;p&gt;Ochieng learned of Odhiambo's HIV status when they went to do an HIV test as they made plans to tie the knot after several years of cohabiting. She believes she contracted the disease from a previous relationship.&lt;/p&gt;   &lt;p&gt;"We were shocked because at that time we had two children and wanted others. We were advised on preventive measures like condom use and voluntary male circumcision as a way of preventing HIV infection," he says.&lt;/p&gt;   
   &lt;p&gt;"I wondered how we would manage," he recalls. "It's not been easy but with love, we have been taking care of ourselves." &lt;/p&gt;   &lt;p&gt;Odhiambo takes pills to suppress the virus; he takes pre-exposure prophylaxis (PrEP) to stay safe. He is tested for HIV every three months. &lt;/p&gt;   &lt;p&gt;Taking these precautions, the couple has had two children who are HIV negative. After counseling, Odhiambo has become a peer educator who talks to other couples in the same situation.  The partner who is positive, he reflects, "has a lot of emotions. AS a partner, you should be there for them and support them well."&lt;/p&gt;   &lt;p&gt;On a recent visit to the clinic where he picks up his PrEP drugs, he says, "I was told the supply that was available has been reserved for pregnant women. I traveled to neighboring Busia county and managed to get a small dose that could last a month and a half."&lt;/p&gt;   &lt;p&gt;His experience echoes a memo from the State Department that NPR obtained, stating that if a clinic receives funding through the U.S. program PEPFAR, this preventative medication can "only" be given to "pregnant and breastfeeding women" during the 90-day freeze on foreign aid that the Trump administration instituted — and that is still in effect.&lt;/p&gt;   &lt;p&gt;A senior health official with the Kenyan Ministry of Health told NPR that clinics have been rationing medications and other supplies because of the uncertainties about donor funds.&lt;/p&gt;   &lt;p&gt;"We acquire most of the HIV medication through partners and donors. The exit of U.S. funding means that there is a gap, and until that gap is filled, there is always bound to be friction but the government has done everything to keep operations going," says the official, who asked not to be identified by name because he did not have permission to speak to the press.&lt;/p&gt;   
   &lt;p&gt;Joywine Adek, a programs officer at &lt;a href="https://www.mildmay.org/kenya" target="_blank"&gt;Mildmay Kenya&lt;/a&gt;, an organization that supports HIV patients, is seeing this gap.&lt;/p&gt;   &lt;p&gt;Mildmay Kenya is among the organizations that was receiving funding from the U.S. government to support HIV interventions in Kenya, including screening services, distribution of antiretroviral drugs and condoms, and counseling for serodiscordant couples.&lt;/p&gt;   &lt;p&gt;"In the current grant that is available after the reduction in funding, there is no support for discordant couples," Adek says, adding that the charity has had to halt many of its services because of the loss of U.S. aid.&lt;/p&gt;   &lt;p&gt;"We are trying to sort this out by doing what we call integration of HIV care into routine health care," says Fredrick Oluoch, the director of public health in Kenya's Kisumu County.&lt;/p&gt;   &lt;p&gt;The lack of condoms is evident. This reporter saw empty dispensers where co Kndoms were once stocked and made available in clinics.&lt;/p&gt;   &lt;div id="resg-s1-82267" class="bucketwrap image large"&gt;
            
&lt;div class="credit-caption"&gt;
    &lt;div class="caption-wrap"&gt;
        &lt;div class="caption" aria-label="Image caption"&gt;
            &lt;p&gt;
                Empty condom dispensers at a charity called Mildmay Kenya, which supports people who are HIV positive. According to the United Nations Population Fund, the U.S. cuts in foreign aid have had an impact on the supply of free condoms for those in need.
                &lt;b class="credit" aria-label="Image credit"&gt;
                    
                    Julia Gunther for NPR
                    
                &lt;/b&gt;
                &lt;b class="hide-caption"&gt;&lt;b&gt;hide caption&lt;/b&gt;&lt;/b&gt;
            &lt;/p&gt;
        &lt;/div&gt;


            &lt;b class="toggle-caption"&gt;&lt;b&gt;toggle caption&lt;/b&gt;&lt;/b&gt;
    &lt;/div&gt;

    &lt;span class="credit" aria-label="Image credit"&gt;
        
        Julia Gunther for NPR
        
    &lt;/span&gt;
&lt;/div&gt;
   &lt;/div&gt;
   &lt;p&gt;And even though condoms are inexpensive — as little as $1 or $2 each in the U.S., even less in Kenya — that price could still be daunting in a country where a third of the population lives below the poverty line of about $2 a day in income.&lt;/p&gt;   &lt;p&gt;Kenya has previously reported that the supply of condoms was not equal to the demand. But this year, officials say, things are worse than ever in the wake of the U.S. foreign aid shakeup, which has affected some of the suppliers, like the United Nations Population Fund (UNFPA).&lt;/p&gt;   &lt;p&gt;In a statement to NPR, UNFPA noted: "Kenya has historically relied heavily on USAID for its free condom distribution programs. Kenya's annual condom requirement is estimated at 400–450 million units. Condom procurement by UNFPA has been affected indirectly — but nonetheless significantly - by U.S. funding cuts. While UNFPA continues its role in condom programming through funding from other global partners, the U.S. stop work order has contributed to shortfalls in supply, putting more pressure on UNFPA and other providers. Some 9.8 million UNFPA-procured condoms were received at the Kenya Central Stores on August 13, 2025, but funding restrictions from the U.S. and other donors mean there is uncertainty as to whether UNFPA will be able to meet projected condom procurement needs for 2026 and beyond."&lt;/p&gt;   
   &lt;p&gt;NPR asked the State Department to respond to these points about U.S. funding and free condom programs but did not receive a response.&lt;/p&gt;   &lt;p&gt;The result of this altered aid landscape is that partners with different HIV status are living with newfound uncertainty.&lt;/p&gt;   &lt;div id="resg-s1-82273" class="bucketwrap image x-large"&gt;
            
&lt;div class="credit-caption"&gt;
    &lt;div class="caption-wrap"&gt;
        &lt;div class="caption" aria-label="Image caption"&gt;
            &lt;p&gt;
                "The shortage of the drugs and condoms is a major concern for us, and the government is yet to address our concerns," says Erastus Ng'uono, who is HIV positive and married to Winnie Auma Miyare, who is HIV negative. The couple is standing in front of their home with two of their children, a boy named Rain and a baby girl named Rose. Says Ng'uono: "I don't know what the future holds."
                &lt;b class="credit" aria-label="Image credit"&gt;
                    
                    Julia Gunther for NPR
                    
                &lt;/b&gt;
                &lt;b class="hide-caption"&gt;&lt;b&gt;hide caption&lt;/b&gt;&lt;/b&gt;
            &lt;/p&gt;
        &lt;/div&gt;


            &lt;b class="toggle-caption"&gt;&lt;b&gt;toggle caption&lt;/b&gt;&lt;/b&gt;
    &lt;/div&gt;

    &lt;span class="credit" aria-label="Image credit"&gt;
        
        Julia Gunther for NPR
        
    &lt;/span&gt;
&lt;/div&gt;
   &lt;/div&gt;
   &lt;p&gt;Erastus Ng'uono was born with HIV positive status. When he met Winnie Auma Miyare and wanted to start a relationship with her, he asked her if she could love someone who is HIV positive and using ARVs. A few days later, he told her about his HIV status. &lt;/p&gt;   &lt;p&gt;At first she did not want to have anything to do with him. But when he explained how medications could help her ward off infection, she changed her mind. She takes PrEP pills. They have four children who are all HIV negative. Their youngest is six months old. &lt;/p&gt;   &lt;p&gt;The news of U.S. aid cuts that could affect the strategies they use has hit them hard. "I encouraged him to have courage and not to worry," she says. "I know the government will intervene." &lt;/p&gt;   &lt;p&gt;"I was very afraid," he says. "I even prayed over it and I know God will see us through."&lt;/p&gt;   &lt;p&gt;Still he worries. "The shortage of the drugs and condoms is a major concern for us and the government is yet to address our concerns," says Ng'uono. "I don't know what the future holds."&lt;/p&gt;   &lt;p&gt;&lt;em&gt;Viola Kosome is a Kenyan journalist. See more of photojournalist Julia Gunther's work on &lt;/em&gt;&lt;a href="https://urldefense.com/v3/__https:/juliagunther.com/__;!!Iwwt!U8T0yz2hwgnmX_1m42aPsJ22zA2gPchXvncsvL95H7Bz6veQvg35xeVEGgzaX6K1_v9bFlEPLbL4VLU$" target="_blank"&gt;&lt;em&gt;her website&lt;/em&gt;&lt;/a&gt;&lt;em&gt; or follow her on Instagram: &lt;/em&gt;&lt;a href="https://urldefense.com/v3/__https:/www.instagram.com/juliagunther_photography/__;!!Iwwt!U8T0yz2hwgnmX_1m42aPsJ22zA2gPchXvncsvL95H7Bz6veQvg35xeVEGgzaX6K1_v9bFlEPZJnKJmA$" target="_blank"&gt;&lt;em&gt;@juliagunther_photography&lt;/em&gt;&lt;/a&gt;&lt;em&gt;.&lt;/em&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>NPR</author><pubDate>Thu, 11 Sep 2025 10:56:59 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMipgFBVV95cUxNZ3BVeURqYnlYTHplbGVnY1F6d2tpSUFNaUliYm13MFl5WjZ4VWNjX0UwSV9IYkMtbFE1eDhaRXA0aGtwR3ZVeHEzRHJXSnUtcG5ITmxFQWFEeGpuODZBOW5lNTd3bXVWdU41MnhOYnZqX0lUR05TNFFLZHA0NVhvQWJsY2VmcURzRG1TOElyRXhBN0paVFVXdDUyYk1XazlsemFUTFNn</guid></item><item><title>“混乱是重点” ：在RFK Jr下部署新冠疫苗助推器的动荡-卫报</title><link>https://www.theguardian.com/world/2025/sep/11/covid-vaccine-boosters-rfk</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="article-body-commercial-selector article-body-viewer-selector dcr-11jq3zt"&gt;&lt;p class="dcr-130mj7b"&gt;The first deployment of updated Covid shots under the &lt;a href="https://www.theguardian.com/us-news/trump-administration" data-link-name="in body link"&gt;Trump administration&lt;/a&gt; has been plagued by access issues and misinformation amid confusion and chaos at US health agencies.&lt;/p&gt;&lt;p class="dcr-130mj7b"&gt;People attempting to get the &lt;a href="https://www.theguardian.com/society/vaccines" data-link-name="in body link"&gt;vaccines&lt;/a&gt; say they have struggled to understand eligibility requirements, book appointments, process insurance claims, battle misinformation from pharmacists and obtain prescriptions from their doctors in some states. Such hurdles will disproportionately affect people of color and low-income people, experts say.&lt;/p&gt;&lt;p id="sign-in-gate"&gt;&lt;gu-island name="SignInGateSelector" priority="feature" deferuntil="visible" props='{"contentType":"Article","sectionId":"world","tags":[{"id":"world/coronavirus-outbreak","type":"Keyword","title":"Coronavirus"},{"id":"society/vaccines","type":"Keyword","title":"Vaccines and immunisation"},{"id":"us-news/robert-f-kennedy-jr","type":"Keyword","title":"Robert F Kennedy Jr"},{"id":"science/infectiousdiseases","type":"Keyword","title":"Infectious diseases"},{"id":"us-news/healthcare","type":"Keyword","title":"US healthcare"},{"id":"society/health","type":"Keyword","title":"Health"},{"id":"science/science","type":"Keyword","title":"Science"},{"id":"us-news/us-news","type":"Keyword","title":"US news"},{"id":"world/world","type":"Keyword","title":"World news"},{"id":"campaign/email/the-stakes-us-election-edition","type":"Campaign","title":"This Week in Trumpland"},{"id":"type/article","type":"Type","title":"Article"},{"id":"tone/news","type":"Tone","title":"News"},{"id":"tone/features","type":"Tone","title":"Features"},{"id":"profile/melody-schreiber","type":"Contributor","title":"Melody Schreiber"},{"id":"tracking/commissioningdesk/us-news","type":"Tracking","title":"US News"}],"isPaidContent":false,"isPreview":false,"host":"https://www.theguardian.com","pageId":"world/2025/sep/11/covid-vaccine-boosters-rfk","idUrl":"https://profile.theguardian.com","contributionsServiceUrl":"https://contributions.guardianapis.com","editionId":"US"}'&gt;&lt;/gu-island&gt;&lt;/p&gt;&lt;p class="dcr-130mj7b"&gt;These problems come amid turmoil at US health agencies, with top leaders of the Centers for Disease Control and Prevention (CDC) quitting because of reported pressure from the Trump administration to approve unscientific vaccine policies and new limitations placed on the Covid vaccines.&lt;/p&gt;&lt;figure id="a7ab4d7a-20d2-4cf8-b2fa-b858d7baf041" data-spacefinder-role="richLink" data-spacefinder-type="model.dotcomrendering.pageElements.RichLinkBlockElement" class="dcr-47fhrn"&gt;&lt;gu-island name="RichLinkComponent" priority="feature" deferuntil="idle" props='{"richLinkIndex":3,"element":{"_type":"model.dotcomrendering.pageElements.RichLinkBlockElement","prefix":"Related: ","text":"As Covid surges in the US, Americans can’t get vaccinated: ‘terrified I might kill somebody’","elementId":"a7ab4d7a-20d2-4cf8-b2fa-b858d7baf041","role":"richLink","url":"https://www.theguardian.com/us-news/2025/sep/08/covid-surge-vaccine-restrictions"},"ajaxUrl":"https://api.nextgen.guardianapps.co.uk","format":{"design":10,"display":0,"theme":0}}'&gt;&lt;/gu-island&gt;&lt;/figure&gt;&lt;p class="dcr-130mj7b"&gt;“Anybody can get the booster,” Robert F Kennedy Jr, secretary of the US Department of Health and Human Services (HHS), said at a hearing before a US Senate committee last week – before adding: “It’s not recommended for healthy people.” In an August &lt;a href="https://x.com/SecKennedy/status/1960742897201872969" data-link-name="in body link"&gt;post&lt;/a&gt; on X, Kennedy said the updated Covid vaccine was approved only for people “at higher risk”.&lt;/p&gt;&lt;p class="dcr-130mj7b"&gt;Matt Shipman, a health writer in North Carolina, was eager to receive an updated shot to protect himself against the acute and &lt;a href="https://academic.oup.com/ofid/advance-article/doi/10.1093/ofid/ofaf533/8244677" data-link-name="in body link"&gt;long-term&lt;/a&gt; risks of a Covid infection, especially as the late-summer &lt;a href="https://www.cdc.gov/cfa-modeling-and-forecasting/rt-estimates/index.html#:~:text=As%20of%20July%2022%2C%202025,not%20changing%20in%2019%20states." data-link-name="in body link"&gt;Covid wave&lt;/a&gt; appears to be reaching its peak.&lt;/p&gt;&lt;p class="dcr-130mj7b"&gt;It used to be easy to schedule an appointment at a pharmacy, but now he received a message saying the vaccines will hopefully be available in a few weeks. He had heard some people were getting prescriptions for the shots, but when he called his doctor’s office, they wouldn’t even make an appointment for a prescription.&lt;/p&gt;&lt;p class="dcr-130mj7b"&gt;North Carolina is one of several states where pharmacists are requiring prescriptions before administering any shots.&lt;/p&gt;&lt;p class="dcr-130mj7b"&gt;In some states, pharmacists are prevented by law from administering vaccines that are not recommended by the CDC’s advisory committee on immunization practices (ACIP). While doctors have liability protections for Covid vaccines under the Public Readiness and Emergency Preparedness (Prep) Act, pharmacists may not if the vaccines are not approved by the advisory committee.&lt;/p&gt;&lt;p class="dcr-130mj7b"&gt;Some insurers might also opt not to cover the shots until they are recommended.&lt;/p&gt;&lt;p class="dcr-130mj7b"&gt;The independent advisers are expected to take up Covid recommendations at the next meeting in mid-September, but that meeting has been embroiled in controversy. Senator Bill Cassidy, a Republican from Louisiana, called for an &lt;a href="https://www.help.senate.gov/rep/newsroom/press/cassidy-calls-for-vaccine-committee-meeting-to-be-postponed-following-cdc-departures" data-link-name="in body link"&gt;indefinite postponement&lt;/a&gt; given the recent upheaval at health agencies.&lt;/p&gt;&lt;p class="dcr-130mj7b"&gt;Shipman said: “It’s incredibly frustrating, because this has significant consequences for public health, and there is no reason in the world for this to be happening.&lt;/p&gt;&lt;p class="dcr-130mj7b"&gt;“It is an entirely manufactured problem that is going to cost people their health and wellbeing and possibly their lives. It is manifestly clear that people who would like the Covid vaccine are not able to access it.”&lt;/p&gt;&lt;p class="dcr-130mj7b"&gt;Changing the rules to make vaccination easier will depend on the state, said Lindsay Wiley, a professor of law and faculty director of the health law and policy program at UCLA Law.&lt;/p&gt;&lt;p class="dcr-130mj7b"&gt;“In several states, governors and health officials are solving the prescription problem pretty swiftly, so it’s a rapidly evolving situation right now. In other states, the legislature may need to take action to fix the problem,” Wiley said.&lt;/p&gt;&lt;p class="dcr-130mj7b"&gt;Even states that have tried to combat the confusion still have vaccine challenges. The state of Maryland released &lt;a href="https://governor.maryland.gov/news/press/pages/Maryland-Protects-Access-to-Vaccines-for-All-Marylanders.aspx" data-link-name="in body link"&gt;guidance&lt;/a&gt; last week for all residents to access vaccines – without specifying the need to disclose qualifying conditions. Maryland’s governor, Wes Moore, called the federal changes to vaccine policy “harmful for Marylanders and all Americans”.&lt;/p&gt;&lt;p class="dcr-130mj7b"&gt;Yet when Ian Morgan tried to obtain the vaccine in Maryland, the pharmacist said it could only be administered to those over the age of 65 or people with at least one underlying health condition. Morgan tried to make an appointment online, but was told CVS couldn’t schedule his appointment because he did not qualify.&lt;/p&gt;&lt;p class="dcr-130mj7b"&gt;Morgan, a postdoctoral fellow at the National Institutes of &lt;a href="https://www.theguardian.com/society/health" data-link-name="in body link" data-component="auto-linked-tag"&gt;Health&lt;/a&gt; and a union steward of NIH Fellows United-UAW 2750, said the tumult has been caused by Kennedy’s messaging on vaccines.&lt;/p&gt;&lt;p class="dcr-130mj7b"&gt;“I think the chaos is the point, and that chaos has consequences,” Morgan said. “Creating this confusion, creating this chaos, trying to discredit scientific experts – and we see that every time [Kennedy] goes out there – that in and of itself is causing problems, and that in itself is harming the American people.”&lt;/p&gt;&lt;figure id="f1f7cf35-b4f9-47ab-aad7-e55e9cb97247" data-spacefinder-role="inline" data-spacefinder-type="model.dotcomrendering.pageElements.ImageBlockElement" class="dcr-173mewl"&gt;&lt;figcaption data-spacefinder-role="inline" class="dcr-fd61eq"&gt;&lt;span class="dcr-1inf02i"&gt;&lt;svg viewbox="0 0 18 13"&gt;&lt;path d="M18 3.5v8l-1.5 1.5h-15l-1.5-1.5v-8l1.5-1.5h3.5l2-2h4l2 2h3.5l1.5 1.5zm-9 7.5c1.9 0 3.5-1.6 3.5-3.5s-1.6-3.5-3.5-3.5-3.5 1.6-3.5 3.5 1.6 3.5 3.5 3.5z"&gt;&lt;/path&gt;&lt;/svg&gt;&lt;/span&gt;&lt;span class="dcr-1qvd3m6"&gt;Workers log a shipment of Covid vaccines in Horsham, Pennsylvania.&lt;/span&gt; Photograph: Matt Rourke/AP&lt;/figcaption&gt;&lt;/figure&gt;&lt;p class="dcr-130mj7b"&gt;Morgan is one of 1,000 current and former HHS employees who signed a &lt;a href="https://www.savehhs.org/" data-link-name="in body link"&gt;letter&lt;/a&gt; calling for Kennedy’s resignation.&lt;/p&gt;&lt;p class="dcr-130mj7b"&gt;Vaccine availability for children, especially for those under the age of five, has lagged even further behind adults as pediatricians struggle to understand new limitations and potential legal risks.&lt;/p&gt;&lt;p class="dcr-130mj7b"&gt;Joanne Hilden, a retired physician, has been searching for the updated vaccines for her four grandchildren, who are between the ages three and 12, in Minnesota. The local health department, where the youngest two kids were vaccinated in 2021, is only offering vaccines for adults over the age of 65. Pharmacies have not received the pediatric doses yet.&lt;/p&gt;&lt;p class="dcr-130mj7b"&gt;There are also immense structural barriers that make it harder for marginalized people to access the shots.&lt;/p&gt;&lt;p class="dcr-130mj7b"&gt;Julia Lynch, a professor of political science at the University of Pennsylvania, first made plans to get vaccinated in Oakland, New Jersey, a 45-minute drive from her home in Philadelphia, before the state board of pharmacy gave pharmacies the go-ahead to vaccinate Pennsylvanians.&lt;/p&gt;&lt;p class="dcr-130mj7b"&gt;The CVS pharmacies near her home had no appointments, so she ended up driving to a predominantly white suburb.&lt;/p&gt;&lt;p class="dcr-130mj7b"&gt;“I don’t know why it is that the vaccines are getting to those CVSes first,” she said. But that means “if you’re Black or Latino, you are less likely than if you’re white to live close to someplace where you can get a vaccine”.&lt;/p&gt;&lt;figure data-spacefinder-role="inline" data-spacefinder-type="model.dotcomrendering.pageElements.NewsletterSignupBlockElement" class="dcr-173mewl"&gt;&lt;a data-ignore="global-link-styling" href="#EmailSignup-skip-link-27" class="dcr-jzxpee"&gt;skip past newsletter promotion&lt;/a&gt;&lt;aside aria-label="newsletter promotion" class="dcr-av5vqf"&gt;&lt;div class="dcr-10et71f"&gt;&lt;p class="dcr-rsfwa"&gt;Sign up to &lt;span&gt;This Week in Trumpland&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p class="dcr-1xjndtj"&gt;A deep dive into the policies, controversies and oddities surrounding the Trump administration&lt;/p&gt;&lt;gu-island name="SecureSignup" priority="feature" deferuntil="visible" props='{"newsletterId":"the-stakes-us-election-edition","successDescription":"A deep dive into the policies, controversies and oddities surrounding the Trump administration"}'&gt;&lt;/gu-island&gt;&lt;span class="dcr-1eusqlu"&gt;&lt;strong&gt;Privacy Notice: &lt;/strong&gt;Newsletters may contain information about charities, online ads, and content funded by outside parties. If you do not have an account, we will create a guest account for you on &lt;a data-ignore="global-link-styling" href="https://www.theguardian.com" rel="noreferrer" class="dcr-1rjy2q9"&gt;theguardian.com&lt;/a&gt; to send you this newsletter. You can complete full registration at any time. For more information about how we use your data see our &lt;a data-ignore="global-link-styling" href="https://www.theguardian.com/help/privacy-policy" rel="noreferrer" class="dcr-1rjy2q9"&gt;Privacy Policy&lt;/a&gt;. We use Google reCaptcha to protect our website and the Google &lt;a data-ignore="global-link-styling" href="https://policies.google.com/privacy" rel="noreferrer" class="dcr-1rjy2q9"&gt;Privacy Policy&lt;/a&gt; and &lt;a data-ignore="global-link-styling" href="https://policies.google.com/terms" rel="noreferrer" class="dcr-1rjy2q9"&gt;Terms of Service&lt;/a&gt; apply.&lt;/span&gt;&lt;/aside&gt;&lt;p id="EmailSignup-skip-link-27" tabindex="0" aria-label="after newsletter promotion" role="note" class="dcr-jzxpee"&gt;after newsletter promotion&lt;/p&gt;&lt;/figure&gt;&lt;p class="dcr-130mj7b"&gt;The population of Oakland, for example, is 80% white and had appointments – but neighboring Camden, New Jersey, had no appointments, and its population is 3.5% white.&lt;/p&gt;&lt;p class="dcr-130mj7b"&gt;Transportation is another major issue. Traveling to Oakland by public transit would have taken more than two hours on three buses and one regional train.&lt;/p&gt;&lt;p class="dcr-130mj7b"&gt;“Eligibility right now is obviously limited to people who are over 65 or who have at least one medical condition that puts them at high risk,” Lynch said. “These are exactly the people who are most likely to have trouble traveling four-plus hours on a multimodal public transit journey to get their Covid shot.”&lt;/p&gt;&lt;p class="dcr-130mj7b"&gt;Not everyone has reliable internet access, the technological knowledge to book appointments, or the ability to take time off work or find childcare to locate and travel to appointments.&lt;/p&gt;&lt;p class="dcr-130mj7b"&gt;“For people who are not chronically online, it’s a major undertaking to do all this,” Lynch said.&lt;/p&gt;&lt;p class="dcr-130mj7b"&gt;Fighting to have the shots covered by insurance, or paying out of pocket for the uninsured, is another major hurdle, she said.&lt;/p&gt;&lt;p class="dcr-130mj7b"&gt;Rachel, who lives in Pittsburgh and asked to be identified by her first name to protect her health history, has two autoimmune disorders and a genetic blood clotting disorder that puts her at high risk if she gets sick with Covid. She said she would like to get the latest Covid shot, but is planning to wait for a few weeks.&lt;/p&gt;&lt;p class="dcr-130mj7b"&gt;“The challenges right now for me are just around information, and actually knowing what is the truth and what is going to happen if I try to get it,” she said. She said she had heard of people being turned away from pharmacies even after the Pennsylvania vaccine announcement.&lt;/p&gt;&lt;p class="dcr-130mj7b"&gt;“It just sounds like it’s still a shitshow. It’s still challenging to make an appointment here, so I’m going to wait a little bit.”&lt;/p&gt;&lt;p class="dcr-130mj7b"&gt;Rachel said it reminded her of 2021, when many people scrambled to get their first Covid shots.&lt;/p&gt;&lt;p class="dcr-130mj7b"&gt;“It’s just frustrating to me that based on absolutely zero evidence, and in some cases, just making up lies about evidence, [the] HHS has just decided these are so dangerous that we need to limit them,” she said.&lt;/p&gt;&lt;p class="dcr-130mj7b"&gt;Sarah, who lives in Westchester county, New York, and asked to be identified by her first name so she is not harassed by anti-vaccine activists, said she was finally able to get the shot after days of effort.&lt;/p&gt;&lt;p class="dcr-130mj7b"&gt;In New York, she needed a prescription. That later changed when Kathy Hochul, the governor, &lt;a href="https://www.governor.ny.gov/news/governor-hochul-signs-executive-order-expanding-access-vaccines-amid-uncertainty-washington" data-link-name="in body link"&gt;opened&lt;/a&gt; up access to all New Yorkers.&lt;/p&gt;&lt;p class="dcr-130mj7b"&gt;The faxed prescription never went through, so her health system had to set up an electronic prescription system. Sarah asked that her doctor prescribe any Covid vaccine; she said she overheard the pharmacist denying one prescription because it was for the Pfizer vaccine and they only had Moderna.&lt;/p&gt;&lt;p class="dcr-130mj7b"&gt;Even after the prescription was received, the pharmacist said he needed verbal confirmation from the doctor by phone as well.&lt;/p&gt;&lt;p class="dcr-130mj7b"&gt;Sarah said she paid $250 out of pocket, and has since spent hours on the phone with her insurance company to be reimbursed. After she paid, the pharmacist tried to dissuade her from getting the shot, Sarah said.&lt;/p&gt;&lt;p class="dcr-130mj7b"&gt;“Do you really know what you’re getting into? This is brand new,” she recalls him saying. She responded: “I know – that’s why I want it.” But he told her they “don’t know anything” about the updated vaccines and “we don’t know what’s gonna happen” to her once she received it, she said.&lt;/p&gt;&lt;p class="dcr-130mj7b"&gt;The roadblocks were “wearing me down”, Sarah said. “It’s trying to make it inaccessible, impossible, confusing.”&lt;/p&gt;&lt;p class="dcr-130mj7b"&gt;Shipman in North Carolina was dogged in his search, even looking at appointments in other states. Eventually, he was able to receive the vaccine at an urgent care center.&lt;/p&gt;&lt;p class="dcr-130mj7b"&gt;But not everyone is able to track down the vaccine and overcome these obstacles, Lynch said. “It’s really hard for ordinary people who are very busy and not necessarily paying close attention to this to know what they’re supposed to do to keep themselves or their loved ones safe.”&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>The Guardian</author><pubDate>Thu, 11 Sep 2025 10:04:00 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMifEFVX3lxTE5aenlhSG9hSV8zOW5oSWpzUmdXZW9xeGxnRWowV0dieGRicEY0NXhfMk01aEdfSUxqLXVqTUtrXzh1Y2hRWmlEbUs2a2lKaGpVRGJVSDdRTXZQY2JPYlRjcEdkSTlPdnJVVDlwa01fM09URGRhQlRna0NnaDc</guid></item><item><title>Dropping hepatitis B shots for newborns would ignore history and endanger children, scientists warn - statnews.com</title><link>https://www.statnews.com/2025/09/11/newborn-hep-b-vaccine-debate-how-it-started/</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="entry-content the-content wp-block-post-content is-layout-flow wp-block-post-content-is-layout-flow"&gt;&lt;p&gt;It was the late 1980s and the American plan to combat hepatitis B wasn’t working. A vaccine had been available since 1982 and recommended for those deemed to be at highest risk, such as health care workers and men who have sex with men. But the infection rates had gone up, not down. When epidemiologists at the Centers for Disease Control and Prevention dug into the data, they noticed one figure that had stayed alarmingly stable: Between 30% and 40% of hepatitis B patients had no identifiable risk factors at all.&lt;/p&gt;



&lt;p&gt;When they published &lt;a href="https://jamanetwork.com/journals/jama/article-abstract/380888" target="_blank" rel="noopener"&gt;their paper&lt;/a&gt; in 1990, it was subtitled, “Need for Alternative Vaccination Strategies.” The next year, the Advisory Committee on Immunization Practices — the CDC body that sets such guidelines — recommended vaccinating all infants. Over the next two decades, case numbers &lt;a href="https://journals.sagepub.com/doi/10.1177/00333549231175548" target="_blank" rel="noopener"&gt;plummeted&lt;/a&gt; by 99% among children and teens. &lt;/p&gt;



&lt;p&gt;Now, under the Trump administration, some members of the ACIP have hinted at a desire to reverse course when the committee &lt;a href="https://www.cdc.gov/acip/meetings/index.html" target="_blank" rel="noopener"&gt;next&lt;/a&gt; convenes on Sept. 18 and 19, as part of a broader review of childhood vaccines.&lt;/p&gt;



&lt;p&gt;At the last meeting in June, after health secretary Robert F. Kennedy Jr. abruptly &lt;a href="https://www.statnews.com/2025/06/09/rfk-jr-fires-every-member-of-cdc-vaccine-expert-panel-acip/"&gt;fired&lt;/a&gt; all 17 experts who sat on the committee and &lt;a href="https://www.statnews.com/2025/06/11/rfk-jr-names-new-acip-members-replaces-cdc-vaccine-experts-he-just-fired/"&gt;replaced&lt;/a&gt; them with his own picks, the new chair, Martin Kulldorff, expressed doubts about the current advice. “Is it wise to administer a birth dose of hepatitis B vaccine to every newborn before leaving the hospital? That’s the question,” he said. “Unless the mother is hepatitis B positive, an argument could be made to delay the vaccine for this infection, which is primarily spread by sexual activity and intravenous drug use.”&lt;/p&gt;



&lt;p&gt;To people who study, treat, or have hepatitis B, that argument is dangerously misguided, and if adopted, they warn it could lead to a resurgence of the virus as well as the liver disease and cancer it causes. &lt;/p&gt;



&lt;p&gt;“I’m speechless. It’s a failure to recognize why that strategy was put into place,” said Miriam Alter, the first author of that 1990 study, now retired from the CDC and the University of Texas Medical Branch at Galveston. If that argument is taken up by the committee, she went on, “the virus, because it still circulates in the population, will rear its ugly head. We’ll be back in the same situation we were in when we depended upon risk-factor-based screening.”&lt;/p&gt;





&lt;p&gt;One reason for giving the first vaccine dose on the first day of life, and the next doses soon after, is that infants are exquisitely vulnerable. A newly minted immune system — still learning what’s foreign and what’s self, not yet able to muster certain protective white blood cells — can allow hepatitis B to run amok, replicating continuously. That &lt;a href="https://www.mdpi.com/2076-393X/12/4/439" target="_blank" rel="noopener"&gt;happens&lt;/a&gt; to fewer than 10% of people who get infected as adults, to 30% of those who get infected between the ages of 1 and 4, and to a whopping 90% of babies who get infected in the first year. If they’re vaccinated, though, that rate nosedives into the single digits. &lt;/p&gt;



&lt;p&gt;“What you need to do is get their bodies the tools they need for the babies to start fighting the virus as soon as they are exposed,” said Chari Cohen, president of the Hepatitis B Foundation.&lt;/p&gt;



&lt;p&gt;That exposure can take place before an infant has fully entered the world. Hepatitis B is a blood-borne pathogen, and childbirth, be it vaginal or cesarean, is bloody, with a possibility of mother-to-child transmission. While Sen. Rand Paul (R.-Ky.) &lt;a href="https://x.com/RandPaul/status/1962223758896173407" target="_blank" rel="noopener"&gt;recently claimed on X&lt;/a&gt; that there is “no medical need to give newborns Hep B vaccine if mother is not infected” because “all mothers who deliver in a hospital are tested,” he was quickly corrected by his Senate colleague Bill Cassidy (R.-La.), who &lt;a href="https://x.com/SenBillCassidy/status/1962269409642197050" target="_blank" rel="noopener"&gt;posted, “Empirically, this is not true.&lt;/a&gt; Not all mothers have prenatal care. Some get infected between testing in the first trimester and delivery. In some cases, the test is overlooked.”&lt;/p&gt;



&lt;p&gt;If infection occurs at birth, there’s a 24-hour window of opportunity. “The vaccine needs to be given immediately to help the newborn develop antibodies to fight off that infection they have just been exposed to,” said John Ward, director of the Coalition for Global Hepatitis Elimination, who led the CDC’s viral hepatitis division from 2005 to 2018. “The longer you wait, then the longer that virus has time to set up shop and resist those antibodies.”&lt;/p&gt;



&lt;p&gt;But early immunization isn’t only helpful in cases of maternal infection. Hepatitis B is extremely infectious, some 50-to-100 times more easily transmissible than HIV, with more of it typically present in blood, meaning that a smaller speck may suffice for the pathogen to be passed on. Su Wang, a New Jersey physician specializing in hepatitis B, has seen young people with so much virus per milliliter of blood that “the lab test couldn’t even quantify it,” and technicians had to dilute the specimen in order to get a read. &lt;/p&gt;



&lt;p&gt;That means that a child’s risk doesn’t end once they come home from the hospital: Transmission can happen in the household or at day care, in the infinitesimal-seeming blood exposure that might stem from a razor nick or shared toothbrush, a bite or scratch from another kid. &lt;/p&gt;





&lt;p&gt;Wang is a case in point. She was diagnosed with hepatitis B in her first year of college, when she signed up to donate blood, and she assumed she’d gotten it from her mom. But when her mom got tested, it came back negative. Her maternal grandparents, on the other hand, tested positive. They’d lived with Wang’s family when she was little, and Wang imagines that they may have been her source of exposure, but can’t be sure. &lt;/p&gt;



&lt;p&gt;Those cases of early-childhood transmission are rare in the United States, but the consequences can be dire. Often, the virus lurks silently in the liver. It triggers inflammation that kills cells, which means someone may end up needing a transplant. But it also hijacks the genetic machinery and increases the likelihood of mutations. “We hear these stories all the time. Someone wakes up with tremendous pain in their side, they go to the emergency room, and by the end of the day, they’re told they have liver cancer,” Cohen said. “They don’t find out they have hep B until after they’re diagnosed with liver cancer, and they live for six weeks.” &lt;/p&gt;



&lt;p&gt;Such horrible outcomes are part of the calculus behind a “birth dose.” While critics of the strategy point out that some countries such as Denmark don’t vaccinate against hepatitis B until later in infancy, American researchers respond that the setting is quite different: Unlike European countries with smaller populations and universal health care systems, the United States has no unified public health apparatus that tracks every baby born and every intervention they receive. Prenatal care falls through the cracks; childhood visits fall through the cracks.&lt;/p&gt;



&lt;p&gt;Other issues emerge when trying to screen or vaccinate adults based on their risk, as was recommended in the 1980s. If patients get to the doctor’s office at all, doctors may not think to ask about risk factors. Even if they do, patients might not feel comfortable disclosing their histories of sexual encounters and drug use, for instance, given the potential for stigma. Plus, by then, it might be too late.&lt;/p&gt;



&lt;p&gt;“How do you identify individuals before they become ‘at risk’? You can’t,” said Alter. “That’s why immunizing young children was such a successful strategy. Because, by doing that, you immunize the population before they develop risk factors, whatever those risk factors might be.”&lt;/p&gt;



&lt;p&gt;Plus, hundreds of millions of people have received the hepatitis B vaccine worldwide, and follow-up studies have shown that it is remarkably safe, with the most common side effects being fever, redness and soreness at the injection site, and vomiting. &lt;/p&gt;



&lt;p&gt;It’s easy to forget, when discussing statistics and stratifications of risk, that real people’s lives are at stake. There are antivirals that can help control hepatitis B, but there is no cure. Once people have it, they have it for life. If their immune systems become suppressed, it can roar out of hiding. &lt;/p&gt;



&lt;p&gt;After she was diagnosed at 21, during a routine screening before a college semester abroad, Wendy Lo sometimes couldn’t bring herself to go to her appointments. She’d likely been infected from her mom at birth; every visit was a painful reminder of the stigma she’d inherited. “Monitoring was doing a number to my psychology,” said Lo, 52, a former tech professional who now works as a fitness coach and hepatitis B advocate. “It’s just telling me I have this blemish. It’s kind of like a scarlet letter, this stain.”&lt;/p&gt;



&lt;p&gt;She eventually did seek care, but at every stage, the virus shadowed her life. She canceled her study abroad program. The need to disclose her status made dating a minefield. Even the mildest of social drinking was off limits, given her elevated risk of liver failure. When she got married, her husband was protected by vaccines but she was terrified of giving the disease to her children. When doctors reassured her, saying that her babies would be safe with the administration of vaccines and other protective proteins, she worried that she might leave them without a mom. “Premature death, that is a very real and perpetual anxiety,” she said.&lt;/p&gt;



&lt;p&gt;The fear was heightened as her uncle died of liver failure caused by hepatitis B. There were jobs and promotions Lo didn’t accept because she worried the stress might be too much for her health, or because the new health insurance wouldn’t cover the hepatitis drugs she needed. There are all sorts of medications she’s avoided so as not to burden her liver. In her 40s, when she was diagnosed with scarring of the liver, she became so anxious she couldn’t eat or sleep or make even the most quotidian decision. &lt;/p&gt;



&lt;p&gt;She’d been born years too early. But she can’t help but splice those two time frames together, and imagine what might’ve happened if she hadn’t gotten the virus, if she’d gone to do that semester abroad in Nanjing, if she’d stayed in China to start her career as planned — all of the worries and complications and curveballs she could have sidestepped with a vaccine. &lt;/p&gt;
&lt;/div&gt;

		&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>statnews.com</author><pubDate>Thu, 11 Sep 2025 08:34:09 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMihwFBVV95cUxOVlhwOGJXdkxWeDFieWY2Z0t2Q0NkWlBuVGdFWnB5LWdHdVFYWDZRMGZINlBCLVYzdmdiUmZoU0ZVTktUR3NoNmlDZEpqSlc4eTRfR3FWX0FKSjFHWDBiaGdzX3ZmSXZEb3ZXR2c1bk5ORWkwRFhBcUNxcGswOC1DQVhLVTRYTEU</guid></item><item><title>简单的维生素可以逆转世界上最常见的肝病吗？ - SciTechDaily</title><link>https://scitechdaily.com/could-a-simple-vitamin-reverse-the-worlds-most-common-liver-disease/</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="post-content cf entry-content content-spacious"&gt;

		
				
		&lt;figure id="attachment_493743" aria-describedby="caption-attachment-493743" class="wp-caption aligncenter"&gt;&lt;a href="https://scitechdaily.com/images/Liver-Human-Body.jpg"&gt;&lt;img fetchpriority="high" decoding="async" class="size-large wp-image-493743" src="https://scitechdaily.com/images/Liver-Human-Body-777x437.jpg" alt="Liver Human Body" srcset="https://scitechdaily.com/images/Liver-Human-Body-777x437.jpg 777w, https://scitechdaily.com/images/Liver-Human-Body-400x225.jpg 400w, https://scitechdaily.com/images/Liver-Human-Body-768x432.jpg 768w, https://scitechdaily.com/images/Liver-Human-Body-1536x864.jpg 1536w, https://scitechdaily.com/images/Liver-Human-Body-150x84.jpg 150w, https://scitechdaily.com/images/Liver-Human-Body-450x253.jpg 450w, https://scitechdaily.com/images/Liver-Human-Body-1200x675.jpg 1200w, https://scitechdaily.com/images/Liver-Human-Body.jpg 2000w" sizes="(max-width: 777px) 100vw, 777px"&gt;&lt;/a&gt;&lt;figcaption id="caption-attachment-493743" class="wp-caption-text"&gt;Researchers have identified a genetic trigger of fatty liver disease and found that vitamin B3 may hold the key to suppressing it. The discovery offers a promising pathway toward targeted therapies using a familiar, already approved drug. Credit: Shutterstock&lt;/figcaption&gt;&lt;/figure&gt;
&lt;p&gt;&lt;strong&gt;MiR-93 promotes fatty liver disease, but vitamin B3 can counteract its effects. This discovery suggests a new treatment approach.&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Roughly 30% of people worldwide are affected by metabolic-associated fatty liver disease (MASLD), a condition that until recently lacked targeted therapies. In an important breakthrough, scientists have identified a genetic factor that worsens the disease, and notably, the FDA-approved compound shown to be most effective against this factor is vitamin B3.&lt;/p&gt;
&lt;p&gt;A global first was achieved by a collaborative research group led by Professor Jang Hyun Choi of the Department of Life Sciences at UNIST, together with Professor Hwayoung Yun from the College of Pharmacy and Research Institute for Drug Development at Pusan National University (PNU) and Professor Neung Hwa Park from Ulsan University Hospital (UUH). Their work revealed the critical role of microRNA-93 (miR-93), a molecule expressed in the liver, as a genetic regulator influencing the onset and progression of MASLD.&lt;/p&gt;
&lt;h4&gt;Role of miR-93 in liver function&lt;/h4&gt;
&lt;p&gt;MiR-93 is a type of &lt;span class="glossaryLink" aria-describedby="tt" data-cmtooltip="&amp;lt;div class=glossaryItemTitle&amp;gt;RNA&amp;lt;/div&amp;gt;&amp;lt;div class=glossaryItemBody&amp;gt;RNA, or ribonucleic acid, is a single-stranded molecule involved in coding, decoding, and regulating gene expression. It acts as a messenger between DNA and protein synthesis and plays crucial roles in both genetic function and viral replication. Variants like mRNA, tRNA, and rRNA support different stages of protein assembly.&amp;lt;/div&amp;gt;" data-gt-translate-attributes='[{"attribute":"data-cmtooltip", "format":"html"}]' tabindex="0" role="link"&gt;RNA&lt;/span&gt; found in hepatocytes that suppresses the activity of specific target genes. Researchers detected unusually high levels of miR-93 in both human patients with fatty liver disease and in experimental animal models. Molecular studies showed that miR-93 drives lipid buildup, inflammation, and fibrosis by blocking the expression of SIRT1, a gene essential for regulating lipid metabolism in liver cells.&lt;/p&gt;
&lt;p&gt;When scientists used gene-editing techniques to block miR-93 production in mice, they observed major reductions in liver fat accumulation, along with improved &lt;span class="glossaryLink" aria-describedby="tt" data-cmtooltip="&amp;lt;div class=glossaryItemTitle&amp;gt;insulin&amp;lt;/div&amp;gt;&amp;lt;div class=glossaryItemBody&amp;gt;Insulin is a hormone produced by the pancreas, crucial for regulating blood glucose levels. It helps cells in the body absorb glucose from the bloodstream and convert it into energy or store it for future use. Insulin production and action are essential for maintaining stable blood sugar levels. In people with diabetes, the body either does not produce enough insulin (Type 1 diabetes) or cannot effectively use the insulin it does produce (Type 2 diabetes), leading to elevated levels of glucose in the blood. This can cause various health complications over time, including heart disease, kidney damage, and nerve dysfunction. Insulin therapy, where insulin is administered through injections or an insulin pump, is a common treatment for managing diabetes, particularly Type 1. The discovery of insulin in 1921 by Frederick Banting and Charles Best was a landmark in medical science, transforming diabetes from a fatal disease to a manageable condition.&amp;lt;/div&amp;gt;" data-gt-translate-attributes='[{"attribute":"data-cmtooltip", "format":"html"}]' tabindex="0" role="link"&gt;insulin&lt;/span&gt; sensitivity and liver function markers. In contrast, mice engineered to overexpress miR-93 displayed more severe impairments in liver metabolism.&lt;/p&gt;
&lt;h4&gt;Vitamin B3 as a therapeutic candidate&lt;/h4&gt;
&lt;p&gt;Furthermore, screening 150 FDA-approved drugs revealed that niacin (vitamin B3) most effectively suppresses miR-93. Mice treated with niacin showed a significant decrease in hepatic miR-93 levels and a notable increase in SIRT1 activity. The activated SIRT1 restored disrupted lipid metabolism pathways, thereby normalizing liver lipid homeostasis.&lt;/p&gt;
&lt;p&gt;The research team explained, “This study precisely elucidates the molecular origin of MASLD and demonstrates the potential for repurposing an already approved vitamin compound to modulate this pathway, which has high translational clinical relevance.”&lt;/p&gt;
&lt;p&gt;They added, “Given that niacin is a well-established and safe medication used to treat hyperlipidemia, it holds promise as a candidate for combination therapies targeting miRNA pathways in MASLD.”&lt;/p&gt;
&lt;p&gt;Reference: “Hepatic miR-93 promotes the pathogenesis of metabolic dysfunction-associated steatotic liver disease by suppressing SIRT1” by Yo Han Lee, Jinyoung Lee, Joonho Jeong, Kieun Park, Bukyung Baik, Yuseong Kwon, Kimyeong Kim, Keon Woo Khim, Haneul Ji, Ji Young Lee, Kwangho Kim, Ji Won Kim, Tam Dao, Misung Kim, Tae Young Lee, Yong Ryoul Yang, Haejin Yoon, Dongryeol Ryu, Seonghwan Hwang, Haeseung Lee and Jang Hyun Choi, 12 April 2025, &lt;i&gt;Metabolism&lt;/i&gt;.&lt;br&gt;
&lt;a href="https://doi.org/10.1016/j.metabol.2025.156266"&gt;DOI: 10.1016/j.metabol.2025.156266&lt;/a&gt;&lt;/p&gt;
&lt;p&gt;This research was supported by various including the National Research Foundation of Korea (NRF) and the Korea Research Institute of Bioscience and Biotechnology (KRIBB).&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Never miss a breakthrough: &lt;a href="https://scitechdaily.com/newsletter/"&gt;Join the SciTechDaily newsletter.&lt;/a&gt;&lt;/b&gt;&lt;/p&gt;
				
		
		
		
	&lt;/div&gt;
&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>SciTechDaily</author><pubDate>Thu, 11 Sep 2025 08:16:28 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMimAFBVV95cUxPUm5BNUJ4U3lycmh3MjFHOTVPQjhLaFhhSU1nUFlQNG1CNWZxTW9QaGY5dHFKMTRnczJLYTdDdDVhVm9QdWVTT1dOcjJUemgtOXlEZU01SGZuc0dycDcwdDRZLWRvakhvT0p1cExxZFc0SzRoR0tqaUozRUZQZkhkWko1UVJRZHc0c0hYcE1SY1BCWjc1MzJ3eg</guid></item><item><title>致命真菌在医院蔓延引发欧洲警报- Bloomberg.com</title><link>https://www.bloomberg.com/news/articles/2025-09-11/candidozyma-auris-warning-as-deadly-fungus-spreads-in-europe-hospitals</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;section class="box main"&gt;
                &lt;h2 class="main__heading"&gt;We've detected unusual activity from your computer network&lt;/h2&gt;
                &lt;p class="continue"&gt;To continue, please click the box below to let us know you're not a robot.&lt;/p&gt;
                &lt;p id="px-captcha"&gt;&lt;/p&gt;
            &lt;/section&gt;
            &lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Bloomberg.com</author><pubDate>Thu, 11 Sep 2025 08:00:00 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMivgFBVV95cUxPVmExTXRwY2RUOXNuS0ZIc3FMelRpb2dRNEtMUFZRMkduQ25fNGZLM1RpWEpNdFFPOGZzTjhTRy1URVZmTDdtR3BINnI5TmxyT3MzdmdvbFR5Z2VOX3hhRm5xWXIzMmRyNHNBVTB0Zjh0V19jUmRma1plTXBzTU5fbmMyb3gxdGN4TU1VQTdaeU9WMTRaU0V4RThGWjNEcHBnLWFGa0lCeUlOeTJxUzBSV3lYX2FkVFgyMlM1OUpn</guid></item><item><title>言论自由和医疗错误信息之间的界限模糊不清-《金融时报》</title><link>https://www.ft.com/content/0be45570-a889-44f4-a2e2-e099b8e1d15d</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="card-content css-1onnxdk"&gt;&lt;p class="o-grid-row o3-type-body-highlight css-1rea6b9"&gt;&lt;span&gt;&lt;span class="o3-visually-hidden"&gt;was &lt;/span&gt;&lt;span class="crossed-out-price css-lhfuqt"&gt;$540&lt;/span&gt;&lt;span&gt; &lt;/span&gt;&lt;span class="o3-visually-hidden"&gt;now &lt;/span&gt;&lt;span class="price css-79fz17"&gt;$319&lt;/span&gt;&lt;span&gt; for your first year&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div class="o-grid-row details-section o3-type-body-base css-pmzbjb"&gt;&lt;p&gt;&lt;span&gt;&lt;span&gt;Save now on essential digltal access to quality FT journalism on any device. Saving based on monthly annualised price.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div id="expander-content-recommendedOffers-Recommended Offers-standard" class="expander__content css-1n99znb" aria-hidden="true" data-offer-type="standard"&gt;&lt;ul&gt;&lt;li class="css-i7yamd"&gt;&lt;span src="https://www.ft.com/__origami/service/image/v2/images/raw/https://barrier-page-components.s3.eu-west-1.amazonaws.com/assets/icons/global_news.svg?source=next-barrier-page&amp;amp;format=svg" alt="" class="css-5w798v"&gt;&lt;/span&gt;&lt;span class="o3-type-body-base"&gt;Global news &amp;amp; analysis&lt;/span&gt;&lt;/li&gt;&lt;li class="css-i7yamd"&gt;&lt;span src="https://www.ft.com/__origami/service/image/v2/images/raw/https://barrier-page-components.s3.eu-west-1.amazonaws.com/assets/icons/expert_opinion.svg?source=next-barrier-page&amp;amp;format=svg" alt="" class="css-gai379"&gt;&lt;/span&gt;&lt;span class="o3-type-body-base"&gt;Expert opinion&lt;/span&gt;&lt;/li&gt;&lt;li class="css-i7yamd"&gt;&lt;span src="https://www.ft.com/__origami/service/image/v2/images/raw/https://barrier-page-components.s3.eu-west-1.amazonaws.com/assets/icons/ft_logo_android_ios.svg?source=next-barrier-page&amp;amp;format=svg" alt="" class="css-koy9w6"&gt;&lt;/span&gt;&lt;span class="o3-type-body-base"&gt;FT App on Android &amp;amp; iOS&lt;/span&gt;&lt;/li&gt;&lt;li class="css-i7yamd"&gt;&lt;span src="https://www.ft.com/__origami/service/image/v2/images/raw/https://barrier-page-components.s3.eu-west-1.amazonaws.com/assets/icons/ft_edit_app.svg?source=next-barrier-page&amp;amp;format=svg" alt="" class="css-1ki4xuj"&gt;&lt;/span&gt;&lt;span class="o3-type-body-base"&gt;FT Edit: Access on iOS and web&lt;/span&gt;&lt;/li&gt;&lt;li class="css-i7yamd"&gt;&lt;span src="https://www.ft.com/__origami/service/image/v2/images/raw/https://barrier-page-components.s3.eu-west-1.amazonaws.com/assets/icons/first_ft.svg?source=next-barrier-page&amp;amp;format=svg" alt="" class="css-hdxmz4"&gt;&lt;/span&gt;&lt;span class="o3-type-body-base"&gt;FirstFT: the day's biggest stories&lt;/span&gt;&lt;/li&gt;&lt;li class="css-i7yamd"&gt;&lt;span src="https://www.ft.com/__origami/service/image/v2/images/raw/https://barrier-page-components.s3.eu-west-1.amazonaws.com/assets/icons/mail_icon.svg?source=next-barrier-page&amp;amp;format=svg" alt="" class="css-1f3rsb0"&gt;&lt;/span&gt;&lt;span class="o3-type-body-base"&gt;20+ curated newsletters&lt;/span&gt;&lt;/li&gt;&lt;li class="css-i7yamd"&gt;&lt;span src="https://www.ft.com/__origami/service/image/v2/images/raw/https://barrier-page-components.s3.eu-west-1.amazonaws.com/assets/icons/my_ft.svg?source=next-barrier-page&amp;amp;format=svg" alt="" class="css-ziqj0d"&gt;&lt;/span&gt;&lt;span class="o3-type-body-base"&gt;Follow topics &amp;amp; set alerts with myFT&lt;/span&gt;&lt;/li&gt;&lt;li class="css-i7yamd"&gt;&lt;span src="https://www.ft.com/__origami/service/image/v2/images/raw/https://barrier-page-components.s3.eu-west-1.amazonaws.com/assets/icons/videos_and_podcasts.svg?source=next-barrier-page&amp;amp;format=svg" alt="" class="css-sqib2a"&gt;&lt;/span&gt;&lt;span class="o3-type-body-base"&gt;FT Videos &amp;amp; Podcasts&lt;/span&gt;&lt;/li&gt;&lt;li class="css-i7yamd"&gt;&lt;span src="https://www.ft.com/__origami/service/image/v2/images/raw/https://barrier-page-components.s3.eu-west-1.amazonaws.com/assets/icons/additional_articles.svg?source=next-barrier-page&amp;amp;format=svg" alt="" class="css-96k0qz"&gt;&lt;/span&gt;&lt;span class="o3-type-body-base"&gt;10 monthly gift articles to share&lt;/span&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Financial Times</author><pubDate>Thu, 11 Sep 2025 04:00:18 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMicEFVX3lxTE9rZmRHRHBZS2VJX1hkbTA4N01KdzZITmRSME93QnN2dXc4VTAtemFsZG5WYjEzZmVZWURIQUNYdTlxb3I3WkJTcllXWmdfMXlMQkpKMlM2WHhnVFRCQXM3RUpNSDZlLWF6bjNFOVMxNlo</guid></item><item><title>全球慢性病死亡人数下降，但美国的进展停滞不前-《纽约时报》</title><link>https://www.nytimes.com/2025/09/10/well/chronic-disease-deaths.html</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;body id="readabilityBody"&gt;&lt;p id="cmsg"&gt;Please enable JS and disable any ad blocker&lt;/p&gt;&lt;/body&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>The New York Times</author><pubDate>Thu, 11 Sep 2025 01:29:07 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMidkFVX3lxTFBaamU1VU90VHd6MW94S0lJaERVd3MyMFBDV1FEbHBEcnZHcnJsVFAxWl94MDdwc0VrZTgyZ19KZXhfNjBlUnA0eXlDNnEwLXdNMk15c291cUo3SlRtVnA4RW82TENRVXhnWGQ4V1pnVE5FbVU5VXc</guid></item><item><title>压力以及如何管理： Xand van Tulleken博士的五个关键提示- BBC</title><link>https://www.bbc.com/news/articles/cg42zq7nqxwo</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;article&gt;&lt;p data-component="headline-block" class="sc-3b6b161a-0 bPbmDW"&gt;&lt;h1 class="sc-f98b1ad2-0 jRDKjj"&gt;Dr Xand: Stress is normal. Here's how to manage it better&lt;/h1&gt;&lt;/p&gt;&lt;div data-component="byline-block" class="sc-3b6b161a-0 jdlrvG"&gt;&lt;div data-testid="byline-new" class="sc-c4820dd1-0 cYDsPh"&gt;&lt;span data-testid="byline-new-contributors" class="sc-c4820dd1-11 bxdaHR"&gt;&lt;p class="sc-c4820dd1-5 iYeVyy"&gt;&lt;span class="sc-c4820dd1-7 dbQBRo"&gt;Dr Xand van Tulleken&lt;/span&gt;&lt;span data-testid="undefined-role-location" class="sc-c4820dd1-8 evcqcz"&gt;Morning Live expert&lt;/span&gt;&lt;/p&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;figure&gt;&lt;div data-component="image-block" class="sc-3b6b161a-0 kSquvq"&gt;&lt;div data-testid="hero-image" class="sc-86c96223-1 evkFpM"&gt;&lt;img src="https://static.files.bbci.co.uk/bbcdotcom/web/20250905-110137-f27f908f49-web-2.29.1-3/grey-placeholder.png" class="sc-86c96223-0 iMuqLZ hide-when-no-script" aria-label="image unavailable"&gt;&lt;img sizes="(min-width: 1280px) 50vw, (min-width: 1008px) 66vw, 96vw" srcset="https://ichef.bbci.co.uk/news/240/cpsprodpb/b1af/live/0dcd84d0-8d78-11f0-a337-d7a51974c55f.jpg.webp 240w,https://ichef.bbci.co.uk/news/320/cpsprodpb/b1af/live/0dcd84d0-8d78-11f0-a337-d7a51974c55f.jpg.webp 320w,https://ichef.bbci.co.uk/news/480/cpsprodpb/b1af/live/0dcd84d0-8d78-11f0-a337-d7a51974c55f.jpg.webp 480w,https://ichef.bbci.co.uk/news/640/cpsprodpb/b1af/live/0dcd84d0-8d78-11f0-a337-d7a51974c55f.jpg.webp 640w,https://ichef.bbci.co.uk/news/800/cpsprodpb/b1af/live/0dcd84d0-8d78-11f0-a337-d7a51974c55f.jpg.webp 800w,https://ichef.bbci.co.uk/news/1024/cpsprodpb/b1af/live/0dcd84d0-8d78-11f0-a337-d7a51974c55f.jpg.webp 1024w,https://ichef.bbci.co.uk/news/1536/cpsprodpb/b1af/live/0dcd84d0-8d78-11f0-a337-d7a51974c55f.jpg.webp 1536w" src="https://ichef.bbci.co.uk/news/480/cpsprodpb/b1af/live/0dcd84d0-8d78-11f0-a337-d7a51974c55f.jpg.webp" loading="eager" alt="Getty Images Shot of a stressed out businesswoman surrounded by colleagues needing help. Businesswoman feeling stressed out in a demanding office environment at work. Photo of businesswoman under strain as colleagues request various things from her. Businesswoman feeling overwhelmed by her colleagues in the office. Frustrated businesswoman having a headache while her colleagues are demanding her to work on many things in the office. Stress, anxiety and multitasking businesswoman with headache from workload and laptop deadline in office." class="sc-86c96223-0 fHZDyi"&gt;&lt;span class="sc-86c96223-2 hqrvRC"&gt;Getty Images&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;p data-component="caption-block" class="sc-3b6b161a-0 etSgSK"&gt;&lt;figcaption class="sc-536eff7b-0 jFVvLh"&gt;September's back-to-it energy can leave us feeling overwhelmed and stressed&lt;/figcaption&gt;&lt;/p&gt;&lt;/figure&gt;&lt;div data-component="text-block" class="sc-3b6b161a-0 jdlrvG"&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;Summer's over, the holidays feel like a distant memory and suddenly the world is back at full speed. &lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;And that back-to-it energy can leave many of us feeling stretched thin. &lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;Stress, in small doses, can help us stay sharp but left unchecked, it can chip away at our health, mood and relationships.&lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;Cortisol, often labelled as the stress hormone has become a bit of a wellness buzzword but it's worth remembering that it isn't the enemy - it's what helps us wake up, stay alert, and handle challenges. &lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;The trick is keeping it in balance, not eliminating it.&lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;Here are five simple, science-backed ways to manage stress and get back in control.&lt;/p&gt;&lt;/div&gt;&lt;p data-component="subheadline-block" class="sc-3b6b161a-0 bPbmDW"&gt;&lt;h2 class="sc-f98b1ad2-0 fsBZby"&gt;1. Stop stressing about it&lt;/h2&gt;&lt;/p&gt;&lt;figure&gt;&lt;div data-component="image-block" class="sc-3b6b161a-0 geRyoc"&gt;&lt;div data-testid="image" class="sc-86c96223-1 evkFpM"&gt;&lt;img src="https://static.files.bbci.co.uk/bbcdotcom/web/20250905-110137-f27f908f49-web-2.29.1-3/grey-placeholder.png" class="sc-86c96223-0 iMuqLZ hide-when-no-script" aria-label="image unavailable"&gt;&lt;img sizes="(min-width: 1280px) 50vw, (min-width: 1008px) 66vw, 96vw" srcset="https://ichef.bbci.co.uk/news/240/cpsprodpb/73d8/live/34a6bd60-8d78-11f0-a337-d7a51974c55f.jpg.webp 240w,https://ichef.bbci.co.uk/news/320/cpsprodpb/73d8/live/34a6bd60-8d78-11f0-a337-d7a51974c55f.jpg.webp 320w,https://ichef.bbci.co.uk/news/480/cpsprodpb/73d8/live/34a6bd60-8d78-11f0-a337-d7a51974c55f.jpg.webp 480w,https://ichef.bbci.co.uk/news/640/cpsprodpb/73d8/live/34a6bd60-8d78-11f0-a337-d7a51974c55f.jpg.webp 640w,https://ichef.bbci.co.uk/news/800/cpsprodpb/73d8/live/34a6bd60-8d78-11f0-a337-d7a51974c55f.jpg.webp 800w,https://ichef.bbci.co.uk/news/1024/cpsprodpb/73d8/live/34a6bd60-8d78-11f0-a337-d7a51974c55f.jpg.webp 1024w,https://ichef.bbci.co.uk/news/1536/cpsprodpb/73d8/live/34a6bd60-8d78-11f0-a337-d7a51974c55f.jpg.webp 1536w" src="https://ichef.bbci.co.uk/news/480/cpsprodpb/73d8/live/34a6bd60-8d78-11f0-a337-d7a51974c55f.jpg.webp" loading="lazy" alt="Getty Images A young woman is sitting on the sofa at home with her head in her hands" class="sc-86c96223-0 fHZDyi"&gt;&lt;span class="sc-86c96223-2 hqrvRC"&gt;Getty Images&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/figure&gt;&lt;div data-component="text-block" class="sc-3b6b161a-0 jdlrvG"&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;Ironically, worrying about the effects of stress can make it worse.&lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;The more we talk about how much harm stress does, we start to think 'agh now I'm stressed and I know it's doing me lots of harm', so try not to worry about how you're feeling. &lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;Stress is a normal part of life and is unavoidable especially during major challenges like grief, caring for loved ones, looking after young children or navigating job uncertainties. &lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;Instead of panicking about being stressed, accept that it happens and remind yourself it won't last forever.&lt;/p&gt;&lt;/div&gt;&lt;p data-component="subheadline-block" class="sc-3b6b161a-0 bPbmDW"&gt;&lt;h2 class="sc-f98b1ad2-0 fsBZby"&gt;2. Move your body&lt;/h2&gt;&lt;/p&gt;&lt;figure&gt;&lt;div data-component="image-block" class="sc-3b6b161a-0 geRyoc"&gt;&lt;div data-testid="image" class="sc-86c96223-1 evkFpM"&gt;&lt;img src="https://static.files.bbci.co.uk/bbcdotcom/web/20250905-110137-f27f908f49-web-2.29.1-3/grey-placeholder.png" class="sc-86c96223-0 iMuqLZ hide-when-no-script" aria-label="image unavailable"&gt;&lt;img sizes="(min-width: 1280px) 50vw, (min-width: 1008px) 66vw, 96vw" srcset="https://ichef.bbci.co.uk/news/240/cpsprodpb/04e4/live/608b1e40-8d77-11f0-a337-d7a51974c55f.jpg.webp 240w,https://ichef.bbci.co.uk/news/320/cpsprodpb/04e4/live/608b1e40-8d77-11f0-a337-d7a51974c55f.jpg.webp 320w,https://ichef.bbci.co.uk/news/480/cpsprodpb/04e4/live/608b1e40-8d77-11f0-a337-d7a51974c55f.jpg.webp 480w,https://ichef.bbci.co.uk/news/640/cpsprodpb/04e4/live/608b1e40-8d77-11f0-a337-d7a51974c55f.jpg.webp 640w,https://ichef.bbci.co.uk/news/800/cpsprodpb/04e4/live/608b1e40-8d77-11f0-a337-d7a51974c55f.jpg.webp 800w,https://ichef.bbci.co.uk/news/1024/cpsprodpb/04e4/live/608b1e40-8d77-11f0-a337-d7a51974c55f.jpg.webp 1024w,https://ichef.bbci.co.uk/news/1536/cpsprodpb/04e4/live/608b1e40-8d77-11f0-a337-d7a51974c55f.jpg.webp 1536w" src="https://ichef.bbci.co.uk/news/480/cpsprodpb/04e4/live/608b1e40-8d77-11f0-a337-d7a51974c55f.jpg.webp" loading="lazy" alt="Getty Images Mature Man Exercising in a Park in the Morning " class="sc-86c96223-0 fHZDyi"&gt;&lt;span class="sc-86c96223-2 hqrvRC"&gt;Getty Images&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/figure&gt;&lt;div data-component="text-block" class="sc-3b6b161a-0 jdlrvG"&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;The best way to physically manage stress is to exercise. &lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;Exercise does the same thing to your body as stress does - it raises your heart rate, puts your blood pressure up, makes you breather faster and releases adrenaline and cortisol. &lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;By exercising, your body is learning to manage the cortisol spikes and handle those surges so you're better equipped to manage life's bigger stresses. &lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;If you're getting stressed thinking about what exercise you're going to do or what gym to join, remember that any form of exercise is great. &lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;It doesn't have to be anything too time consuming or high pressured - a simple walk, jog or any activity you enjoy will do the trick. &lt;/p&gt;&lt;/div&gt;&lt;p data-component="subheadline-block" class="sc-3b6b161a-0 bPbmDW"&gt;&lt;h2 class="sc-f98b1ad2-0 fsBZby"&gt;3. Prioritise sleep&lt;/h2&gt;&lt;/p&gt;&lt;figure&gt;&lt;div data-component="image-block" class="sc-3b6b161a-0 geRyoc"&gt;&lt;div data-testid="image" class="sc-86c96223-1 evkFpM"&gt;&lt;img src="https://static.files.bbci.co.uk/bbcdotcom/web/20250905-110137-f27f908f49-web-2.29.1-3/grey-placeholder.png" class="sc-86c96223-0 iMuqLZ hide-when-no-script" aria-label="image unavailable"&gt;&lt;img sizes="(min-width: 1280px) 50vw, (min-width: 1008px) 66vw, 96vw" srcset="https://ichef.bbci.co.uk/news/240/cpsprodpb/0b9e/live/2fb39bd0-8d77-11f0-a337-d7a51974c55f.jpg.webp 240w,https://ichef.bbci.co.uk/news/320/cpsprodpb/0b9e/live/2fb39bd0-8d77-11f0-a337-d7a51974c55f.jpg.webp 320w,https://ichef.bbci.co.uk/news/480/cpsprodpb/0b9e/live/2fb39bd0-8d77-11f0-a337-d7a51974c55f.jpg.webp 480w,https://ichef.bbci.co.uk/news/640/cpsprodpb/0b9e/live/2fb39bd0-8d77-11f0-a337-d7a51974c55f.jpg.webp 640w,https://ichef.bbci.co.uk/news/800/cpsprodpb/0b9e/live/2fb39bd0-8d77-11f0-a337-d7a51974c55f.jpg.webp 800w,https://ichef.bbci.co.uk/news/1024/cpsprodpb/0b9e/live/2fb39bd0-8d77-11f0-a337-d7a51974c55f.jpg.webp 1024w,https://ichef.bbci.co.uk/news/1536/cpsprodpb/0b9e/live/2fb39bd0-8d77-11f0-a337-d7a51974c55f.jpg.webp 1536w" src="https://ichef.bbci.co.uk/news/480/cpsprodpb/0b9e/live/2fb39bd0-8d77-11f0-a337-d7a51974c55f.jpg.webp" loading="lazy" alt="Getty Images Woman in depression closed face with hands and crying in bed." class="sc-86c96223-0 fHZDyi"&gt;&lt;span class="sc-86c96223-2 hqrvRC"&gt;Getty Images&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/figure&gt;&lt;div data-component="text-block" class="sc-3b6b161a-0 jdlrvG"&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;Try and get into bed earlier and wake up at roughly the same time in the morning so your body gets into a routine. &lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;If you find yourself tossing and turning at night and not being able to fall asleep, don't worry. &lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;Your body can function on less sleep occasionally and over time your natural rhythms will recalibrate.&lt;/p&gt;&lt;/div&gt;&lt;p data-component="subheadline-block" class="sc-3b6b161a-0 bPbmDW"&gt;&lt;h2 class="sc-f98b1ad2-0 fsBZby"&gt;4. Focus on yourself&lt;/h2&gt;&lt;/p&gt;&lt;figure&gt;&lt;div data-component="image-block" class="sc-3b6b161a-0 geRyoc"&gt;&lt;div data-testid="image" class="sc-86c96223-1 evkFpM"&gt;&lt;img src="https://static.files.bbci.co.uk/bbcdotcom/web/20250905-110137-f27f908f49-web-2.29.1-3/grey-placeholder.png" class="sc-86c96223-0 iMuqLZ hide-when-no-script" aria-label="image unavailable"&gt;&lt;img sizes="(min-width: 1280px) 50vw, (min-width: 1008px) 66vw, 96vw" srcset="https://ichef.bbci.co.uk/news/240/cpsprodpb/76bb/live/ed13a3b0-8d76-11f0-a337-d7a51974c55f.jpg.webp 240w,https://ichef.bbci.co.uk/news/320/cpsprodpb/76bb/live/ed13a3b0-8d76-11f0-a337-d7a51974c55f.jpg.webp 320w,https://ichef.bbci.co.uk/news/480/cpsprodpb/76bb/live/ed13a3b0-8d76-11f0-a337-d7a51974c55f.jpg.webp 480w,https://ichef.bbci.co.uk/news/640/cpsprodpb/76bb/live/ed13a3b0-8d76-11f0-a337-d7a51974c55f.jpg.webp 640w,https://ichef.bbci.co.uk/news/800/cpsprodpb/76bb/live/ed13a3b0-8d76-11f0-a337-d7a51974c55f.jpg.webp 800w,https://ichef.bbci.co.uk/news/1024/cpsprodpb/76bb/live/ed13a3b0-8d76-11f0-a337-d7a51974c55f.jpg.webp 1024w,https://ichef.bbci.co.uk/news/1536/cpsprodpb/76bb/live/ed13a3b0-8d76-11f0-a337-d7a51974c55f.jpg.webp 1536w" src="https://ichef.bbci.co.uk/news/480/cpsprodpb/76bb/live/ed13a3b0-8d76-11f0-a337-d7a51974c55f.jpg.webp" loading="lazy" alt="Getty Images Happy young woman mixing bowl of fresh salad." class="sc-86c96223-0 fHZDyi"&gt;&lt;span class="sc-86c96223-2 hqrvRC"&gt;Getty Images&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/figure&gt;&lt;div data-component="text-block" class="sc-3b6b161a-0 jdlrvG"&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;Managing stress isn't just about avoiding the negatives, it's also about actively building yourself up.  &lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;Make sure you're eating well with plenty of fruits, vegetables, whole foods and good-quality proteins to fuel your body. &lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;Try and also carve out some quality alone time where you can relax and recharge. &lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;Mindfulness can also help - it's not about using a meditation app or sitting in silence, it's about being intentional in how you approach your life. &lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;Take a few minutes to think about the day or week ahead of you, what might be challenging and how you can pace yourself. &lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;For me, it's about planning ahead with batch cooking as that can relieve some stress in the evening after work.&lt;/p&gt;&lt;/div&gt;&lt;p data-component="subheadline-block" class="sc-3b6b161a-0 bPbmDW"&gt;&lt;h2 class="sc-f98b1ad2-0 fsBZby"&gt;5. Talk it out&lt;/h2&gt;&lt;/p&gt;&lt;figure&gt;&lt;div data-component="image-block" class="sc-3b6b161a-0 geRyoc"&gt;&lt;div data-testid="image" class="sc-86c96223-1 evkFpM"&gt;&lt;img src="https://static.files.bbci.co.uk/bbcdotcom/web/20250905-110137-f27f908f49-web-2.29.1-3/grey-placeholder.png" class="sc-86c96223-0 iMuqLZ hide-when-no-script" aria-label="image unavailable"&gt;&lt;img sizes="(min-width: 1280px) 50vw, (min-width: 1008px) 66vw, 96vw" srcset="https://ichef.bbci.co.uk/news/240/cpsprodpb/3dff/live/f2eb2740-8d76-11f0-a337-d7a51974c55f.jpg.webp 240w,https://ichef.bbci.co.uk/news/320/cpsprodpb/3dff/live/f2eb2740-8d76-11f0-a337-d7a51974c55f.jpg.webp 320w,https://ichef.bbci.co.uk/news/480/cpsprodpb/3dff/live/f2eb2740-8d76-11f0-a337-d7a51974c55f.jpg.webp 480w,https://ichef.bbci.co.uk/news/640/cpsprodpb/3dff/live/f2eb2740-8d76-11f0-a337-d7a51974c55f.jpg.webp 640w,https://ichef.bbci.co.uk/news/800/cpsprodpb/3dff/live/f2eb2740-8d76-11f0-a337-d7a51974c55f.jpg.webp 800w,https://ichef.bbci.co.uk/news/1024/cpsprodpb/3dff/live/f2eb2740-8d76-11f0-a337-d7a51974c55f.jpg.webp 1024w,https://ichef.bbci.co.uk/news/1536/cpsprodpb/3dff/live/f2eb2740-8d76-11f0-a337-d7a51974c55f.jpg.webp 1536w" src="https://ichef.bbci.co.uk/news/480/cpsprodpb/3dff/live/f2eb2740-8d76-11f0-a337-d7a51974c55f.jpg.webp" loading="lazy" alt="Getty Images Two women sitting in armchairs and talking. Female coach, psychotherapist, psychologist, advisor and patient, client " class="sc-86c96223-0 fHZDyi"&gt;&lt;span class="sc-86c96223-2 hqrvRC"&gt;Getty Images&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/figure&gt;&lt;div data-component="text-block" class="sc-3b6b161a-0 jdlrvG"&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;I get terribly anxious about all kinds of things and everyone worries about money, jobs and families. &lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;Those worries can quickly spiral when kept bottled up so sharing your concerns with someone you trust lightens the load and gives perspective, even if they can't solve the problem for you.&lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;Sometimes just saying it out loud makes the problem feel more manageable.&lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;&lt;i id="additional-reporting-by-yasmin-rufo" class="sc-d16436d-0 gbdkAi"&gt;Additional reporting by Yasmin Rufo&lt;/i&gt;&lt;/p&gt;&lt;/div&gt;&lt;/article&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>BBC</author><pubDate>Thu, 11 Sep 2025 00:30:06 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMiWkFVX3lxTE9JQ0dNR2tGSTdCQUd0TUVnTjJvWkdhYmlQNlYxV0VoSzkxejVRWGtTYkNxMGd0OS1OOTBvRzVzRjEzaHFNb1Z6VFhqT0JxbU5uckJ1MXBzQ0lOUQ</guid></item><item><title>压力以及如何管理： Xand van Tulleken博士的五个关键提示- BBC</title><link>https://www.bbc.com/news/articles/cg42zq7nqxwo</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;article&gt;&lt;p data-component="headline-block" class="sc-3b6b161a-0 bPbmDW"&gt;&lt;h1 class="sc-f98b1ad2-0 jRDKjj"&gt;Dr Xand: Stress is normal. Here's how to manage it better&lt;/h1&gt;&lt;/p&gt;&lt;div data-component="byline-block" class="sc-3b6b161a-0 jdlrvG"&gt;&lt;div data-testid="byline-new" class="sc-c4820dd1-0 cYDsPh"&gt;&lt;span data-testid="byline-new-contributors" class="sc-c4820dd1-11 bxdaHR"&gt;&lt;p class="sc-c4820dd1-5 iYeVyy"&gt;&lt;span class="sc-c4820dd1-7 dbQBRo"&gt;Dr Xand van Tulleken&lt;/span&gt;&lt;span data-testid="undefined-role-location" class="sc-c4820dd1-8 evcqcz"&gt;Morning Live expert&lt;/span&gt;&lt;/p&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;figure&gt;&lt;div data-component="image-block" class="sc-3b6b161a-0 kSquvq"&gt;&lt;div data-testid="hero-image" class="sc-86c96223-1 evkFpM"&gt;&lt;img src="https://static.files.bbci.co.uk/bbcdotcom/web/20250905-110137-f27f908f49-web-2.29.1-3/grey-placeholder.png" class="sc-86c96223-0 iMuqLZ hide-when-no-script" aria-label="image unavailable"&gt;&lt;img sizes="(min-width: 1280px) 50vw, (min-width: 1008px) 66vw, 96vw" srcset="https://ichef.bbci.co.uk/news/240/cpsprodpb/b1af/live/0dcd84d0-8d78-11f0-a337-d7a51974c55f.jpg.webp 240w,https://ichef.bbci.co.uk/news/320/cpsprodpb/b1af/live/0dcd84d0-8d78-11f0-a337-d7a51974c55f.jpg.webp 320w,https://ichef.bbci.co.uk/news/480/cpsprodpb/b1af/live/0dcd84d0-8d78-11f0-a337-d7a51974c55f.jpg.webp 480w,https://ichef.bbci.co.uk/news/640/cpsprodpb/b1af/live/0dcd84d0-8d78-11f0-a337-d7a51974c55f.jpg.webp 640w,https://ichef.bbci.co.uk/news/800/cpsprodpb/b1af/live/0dcd84d0-8d78-11f0-a337-d7a51974c55f.jpg.webp 800w,https://ichef.bbci.co.uk/news/1024/cpsprodpb/b1af/live/0dcd84d0-8d78-11f0-a337-d7a51974c55f.jpg.webp 1024w,https://ichef.bbci.co.uk/news/1536/cpsprodpb/b1af/live/0dcd84d0-8d78-11f0-a337-d7a51974c55f.jpg.webp 1536w" src="https://ichef.bbci.co.uk/news/480/cpsprodpb/b1af/live/0dcd84d0-8d78-11f0-a337-d7a51974c55f.jpg.webp" loading="eager" alt="Getty Images Shot of a stressed out businesswoman surrounded by colleagues needing help. Businesswoman feeling stressed out in a demanding office environment at work. Photo of businesswoman under strain as colleagues request various things from her. Businesswoman feeling overwhelmed by her colleagues in the office. Frustrated businesswoman having a headache while her colleagues are demanding her to work on many things in the office. Stress, anxiety and multitasking businesswoman with headache from workload and laptop deadline in office." class="sc-86c96223-0 fHZDyi"&gt;&lt;span class="sc-86c96223-2 hqrvRC"&gt;Getty Images&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;p data-component="caption-block" class="sc-3b6b161a-0 etSgSK"&gt;&lt;figcaption class="sc-536eff7b-0 jFVvLh"&gt;September's back-to-it energy can leave us feeling overwhelmed and stressed&lt;/figcaption&gt;&lt;/p&gt;&lt;/figure&gt;&lt;div data-component="text-block" class="sc-3b6b161a-0 jdlrvG"&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;Summer's over, the holidays feel like a distant memory and suddenly the world is back at full speed. &lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;And that back-to-it energy can leave many of us feeling stretched thin. &lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;Stress, in small doses, can help us stay sharp but left unchecked, it can chip away at our health, mood and relationships.&lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;Cortisol, often labelled as the stress hormone has become a bit of a wellness buzzword but it's worth remembering that it isn't the enemy - it's what helps us wake up, stay alert, and handle challenges. &lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;The trick is keeping it in balance, not eliminating it.&lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;Here are five simple, science-backed ways to manage stress and get back in control.&lt;/p&gt;&lt;/div&gt;&lt;p data-component="subheadline-block" class="sc-3b6b161a-0 bPbmDW"&gt;&lt;h2 class="sc-f98b1ad2-0 fsBZby"&gt;1. Stop stressing about it&lt;/h2&gt;&lt;/p&gt;&lt;figure&gt;&lt;div data-component="image-block" class="sc-3b6b161a-0 geRyoc"&gt;&lt;div data-testid="image" class="sc-86c96223-1 evkFpM"&gt;&lt;img src="https://static.files.bbci.co.uk/bbcdotcom/web/20250905-110137-f27f908f49-web-2.29.1-3/grey-placeholder.png" class="sc-86c96223-0 iMuqLZ hide-when-no-script" aria-label="image unavailable"&gt;&lt;img sizes="(min-width: 1280px) 50vw, (min-width: 1008px) 66vw, 96vw" srcset="https://ichef.bbci.co.uk/news/240/cpsprodpb/73d8/live/34a6bd60-8d78-11f0-a337-d7a51974c55f.jpg.webp 240w,https://ichef.bbci.co.uk/news/320/cpsprodpb/73d8/live/34a6bd60-8d78-11f0-a337-d7a51974c55f.jpg.webp 320w,https://ichef.bbci.co.uk/news/480/cpsprodpb/73d8/live/34a6bd60-8d78-11f0-a337-d7a51974c55f.jpg.webp 480w,https://ichef.bbci.co.uk/news/640/cpsprodpb/73d8/live/34a6bd60-8d78-11f0-a337-d7a51974c55f.jpg.webp 640w,https://ichef.bbci.co.uk/news/800/cpsprodpb/73d8/live/34a6bd60-8d78-11f0-a337-d7a51974c55f.jpg.webp 800w,https://ichef.bbci.co.uk/news/1024/cpsprodpb/73d8/live/34a6bd60-8d78-11f0-a337-d7a51974c55f.jpg.webp 1024w,https://ichef.bbci.co.uk/news/1536/cpsprodpb/73d8/live/34a6bd60-8d78-11f0-a337-d7a51974c55f.jpg.webp 1536w" src="https://ichef.bbci.co.uk/news/480/cpsprodpb/73d8/live/34a6bd60-8d78-11f0-a337-d7a51974c55f.jpg.webp" loading="lazy" alt="Getty Images A young woman is sitting on the sofa at home with her head in her hands" class="sc-86c96223-0 fHZDyi"&gt;&lt;span class="sc-86c96223-2 hqrvRC"&gt;Getty Images&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/figure&gt;&lt;div data-component="text-block" class="sc-3b6b161a-0 jdlrvG"&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;Ironically, worrying about the effects of stress can make it worse.&lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;The more we talk about how much harm stress does, we start to think 'agh now I'm stressed and I know it's doing me lots of harm', so try not to worry about how you're feeling. &lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;Stress is a normal part of life and is unavoidable especially during major challenges like grief, caring for loved ones, looking after young children or navigating job uncertainties. &lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;Instead of panicking about being stressed, accept that it happens and remind yourself it won't last forever.&lt;/p&gt;&lt;/div&gt;&lt;p data-component="subheadline-block" class="sc-3b6b161a-0 bPbmDW"&gt;&lt;h2 class="sc-f98b1ad2-0 fsBZby"&gt;2. Move your body&lt;/h2&gt;&lt;/p&gt;&lt;figure&gt;&lt;div data-component="image-block" class="sc-3b6b161a-0 geRyoc"&gt;&lt;div data-testid="image" class="sc-86c96223-1 evkFpM"&gt;&lt;img src="https://static.files.bbci.co.uk/bbcdotcom/web/20250905-110137-f27f908f49-web-2.29.1-3/grey-placeholder.png" class="sc-86c96223-0 iMuqLZ hide-when-no-script" aria-label="image unavailable"&gt;&lt;img sizes="(min-width: 1280px) 50vw, (min-width: 1008px) 66vw, 96vw" srcset="https://ichef.bbci.co.uk/news/240/cpsprodpb/04e4/live/608b1e40-8d77-11f0-a337-d7a51974c55f.jpg.webp 240w,https://ichef.bbci.co.uk/news/320/cpsprodpb/04e4/live/608b1e40-8d77-11f0-a337-d7a51974c55f.jpg.webp 320w,https://ichef.bbci.co.uk/news/480/cpsprodpb/04e4/live/608b1e40-8d77-11f0-a337-d7a51974c55f.jpg.webp 480w,https://ichef.bbci.co.uk/news/640/cpsprodpb/04e4/live/608b1e40-8d77-11f0-a337-d7a51974c55f.jpg.webp 640w,https://ichef.bbci.co.uk/news/800/cpsprodpb/04e4/live/608b1e40-8d77-11f0-a337-d7a51974c55f.jpg.webp 800w,https://ichef.bbci.co.uk/news/1024/cpsprodpb/04e4/live/608b1e40-8d77-11f0-a337-d7a51974c55f.jpg.webp 1024w,https://ichef.bbci.co.uk/news/1536/cpsprodpb/04e4/live/608b1e40-8d77-11f0-a337-d7a51974c55f.jpg.webp 1536w" src="https://ichef.bbci.co.uk/news/480/cpsprodpb/04e4/live/608b1e40-8d77-11f0-a337-d7a51974c55f.jpg.webp" loading="lazy" alt="Getty Images Mature Man Exercising in a Park in the Morning " class="sc-86c96223-0 fHZDyi"&gt;&lt;span class="sc-86c96223-2 hqrvRC"&gt;Getty Images&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/figure&gt;&lt;div data-component="text-block" class="sc-3b6b161a-0 jdlrvG"&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;The best way to physically manage stress is to exercise. &lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;Exercise does the same thing to your body as stress does - it raises your heart rate, puts your blood pressure up, makes you breather faster and releases adrenaline and cortisol. &lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;By exercising, your body is learning to manage the cortisol spikes and handle those surges so you're better equipped to manage life's bigger stresses. &lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;If you're getting stressed thinking about what exercise you're going to do or what gym to join, remember that any form of exercise is great. &lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;It doesn't have to be anything too time consuming or high pressured - a simple walk, jog or any activity you enjoy will do the trick. &lt;/p&gt;&lt;/div&gt;&lt;p data-component="subheadline-block" class="sc-3b6b161a-0 bPbmDW"&gt;&lt;h2 class="sc-f98b1ad2-0 fsBZby"&gt;3. Prioritise sleep&lt;/h2&gt;&lt;/p&gt;&lt;figure&gt;&lt;div data-component="image-block" class="sc-3b6b161a-0 geRyoc"&gt;&lt;div data-testid="image" class="sc-86c96223-1 evkFpM"&gt;&lt;img src="https://static.files.bbci.co.uk/bbcdotcom/web/20250905-110137-f27f908f49-web-2.29.1-3/grey-placeholder.png" class="sc-86c96223-0 iMuqLZ hide-when-no-script" aria-label="image unavailable"&gt;&lt;img sizes="(min-width: 1280px) 50vw, (min-width: 1008px) 66vw, 96vw" srcset="https://ichef.bbci.co.uk/news/240/cpsprodpb/0b9e/live/2fb39bd0-8d77-11f0-a337-d7a51974c55f.jpg.webp 240w,https://ichef.bbci.co.uk/news/320/cpsprodpb/0b9e/live/2fb39bd0-8d77-11f0-a337-d7a51974c55f.jpg.webp 320w,https://ichef.bbci.co.uk/news/480/cpsprodpb/0b9e/live/2fb39bd0-8d77-11f0-a337-d7a51974c55f.jpg.webp 480w,https://ichef.bbci.co.uk/news/640/cpsprodpb/0b9e/live/2fb39bd0-8d77-11f0-a337-d7a51974c55f.jpg.webp 640w,https://ichef.bbci.co.uk/news/800/cpsprodpb/0b9e/live/2fb39bd0-8d77-11f0-a337-d7a51974c55f.jpg.webp 800w,https://ichef.bbci.co.uk/news/1024/cpsprodpb/0b9e/live/2fb39bd0-8d77-11f0-a337-d7a51974c55f.jpg.webp 1024w,https://ichef.bbci.co.uk/news/1536/cpsprodpb/0b9e/live/2fb39bd0-8d77-11f0-a337-d7a51974c55f.jpg.webp 1536w" src="https://ichef.bbci.co.uk/news/480/cpsprodpb/0b9e/live/2fb39bd0-8d77-11f0-a337-d7a51974c55f.jpg.webp" loading="lazy" alt="Getty Images Woman in depression closed face with hands and crying in bed." class="sc-86c96223-0 fHZDyi"&gt;&lt;span class="sc-86c96223-2 hqrvRC"&gt;Getty Images&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/figure&gt;&lt;div data-component="text-block" class="sc-3b6b161a-0 jdlrvG"&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;Try and get into bed earlier and wake up at roughly the same time in the morning so your body gets into a routine. &lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;If you find yourself tossing and turning at night and not being able to fall asleep, don't worry. &lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;Your body can function on less sleep occasionally and over time your natural rhythms will recalibrate.&lt;/p&gt;&lt;/div&gt;&lt;p data-component="subheadline-block" class="sc-3b6b161a-0 bPbmDW"&gt;&lt;h2 class="sc-f98b1ad2-0 fsBZby"&gt;4. Focus on yourself&lt;/h2&gt;&lt;/p&gt;&lt;figure&gt;&lt;div data-component="image-block" class="sc-3b6b161a-0 geRyoc"&gt;&lt;div data-testid="image" class="sc-86c96223-1 evkFpM"&gt;&lt;img src="https://static.files.bbci.co.uk/bbcdotcom/web/20250905-110137-f27f908f49-web-2.29.1-3/grey-placeholder.png" class="sc-86c96223-0 iMuqLZ hide-when-no-script" aria-label="image unavailable"&gt;&lt;img sizes="(min-width: 1280px) 50vw, (min-width: 1008px) 66vw, 96vw" srcset="https://ichef.bbci.co.uk/news/240/cpsprodpb/76bb/live/ed13a3b0-8d76-11f0-a337-d7a51974c55f.jpg.webp 240w,https://ichef.bbci.co.uk/news/320/cpsprodpb/76bb/live/ed13a3b0-8d76-11f0-a337-d7a51974c55f.jpg.webp 320w,https://ichef.bbci.co.uk/news/480/cpsprodpb/76bb/live/ed13a3b0-8d76-11f0-a337-d7a51974c55f.jpg.webp 480w,https://ichef.bbci.co.uk/news/640/cpsprodpb/76bb/live/ed13a3b0-8d76-11f0-a337-d7a51974c55f.jpg.webp 640w,https://ichef.bbci.co.uk/news/800/cpsprodpb/76bb/live/ed13a3b0-8d76-11f0-a337-d7a51974c55f.jpg.webp 800w,https://ichef.bbci.co.uk/news/1024/cpsprodpb/76bb/live/ed13a3b0-8d76-11f0-a337-d7a51974c55f.jpg.webp 1024w,https://ichef.bbci.co.uk/news/1536/cpsprodpb/76bb/live/ed13a3b0-8d76-11f0-a337-d7a51974c55f.jpg.webp 1536w" src="https://ichef.bbci.co.uk/news/480/cpsprodpb/76bb/live/ed13a3b0-8d76-11f0-a337-d7a51974c55f.jpg.webp" loading="lazy" alt="Getty Images Happy young woman mixing bowl of fresh salad." class="sc-86c96223-0 fHZDyi"&gt;&lt;span class="sc-86c96223-2 hqrvRC"&gt;Getty Images&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/figure&gt;&lt;div data-component="text-block" class="sc-3b6b161a-0 jdlrvG"&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;Managing stress isn't just about avoiding the negatives, it's also about actively building yourself up.  &lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;Make sure you're eating well with plenty of fruits, vegetables, whole foods and good-quality proteins to fuel your body. &lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;Try and also carve out some quality alone time where you can relax and recharge. &lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;Mindfulness can also help - it's not about using a meditation app or sitting in silence, it's about being intentional in how you approach your life. &lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;Take a few minutes to think about the day or week ahead of you, what might be challenging and how you can pace yourself. &lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;For me, it's about planning ahead with batch cooking as that can relieve some stress in the evening after work.&lt;/p&gt;&lt;/div&gt;&lt;p data-component="subheadline-block" class="sc-3b6b161a-0 bPbmDW"&gt;&lt;h2 class="sc-f98b1ad2-0 fsBZby"&gt;5. Talk it out&lt;/h2&gt;&lt;/p&gt;&lt;figure&gt;&lt;div data-component="image-block" class="sc-3b6b161a-0 geRyoc"&gt;&lt;div data-testid="image" class="sc-86c96223-1 evkFpM"&gt;&lt;img src="https://static.files.bbci.co.uk/bbcdotcom/web/20250905-110137-f27f908f49-web-2.29.1-3/grey-placeholder.png" class="sc-86c96223-0 iMuqLZ hide-when-no-script" aria-label="image unavailable"&gt;&lt;img sizes="(min-width: 1280px) 50vw, (min-width: 1008px) 66vw, 96vw" srcset="https://ichef.bbci.co.uk/news/240/cpsprodpb/3dff/live/f2eb2740-8d76-11f0-a337-d7a51974c55f.jpg.webp 240w,https://ichef.bbci.co.uk/news/320/cpsprodpb/3dff/live/f2eb2740-8d76-11f0-a337-d7a51974c55f.jpg.webp 320w,https://ichef.bbci.co.uk/news/480/cpsprodpb/3dff/live/f2eb2740-8d76-11f0-a337-d7a51974c55f.jpg.webp 480w,https://ichef.bbci.co.uk/news/640/cpsprodpb/3dff/live/f2eb2740-8d76-11f0-a337-d7a51974c55f.jpg.webp 640w,https://ichef.bbci.co.uk/news/800/cpsprodpb/3dff/live/f2eb2740-8d76-11f0-a337-d7a51974c55f.jpg.webp 800w,https://ichef.bbci.co.uk/news/1024/cpsprodpb/3dff/live/f2eb2740-8d76-11f0-a337-d7a51974c55f.jpg.webp 1024w,https://ichef.bbci.co.uk/news/1536/cpsprodpb/3dff/live/f2eb2740-8d76-11f0-a337-d7a51974c55f.jpg.webp 1536w" src="https://ichef.bbci.co.uk/news/480/cpsprodpb/3dff/live/f2eb2740-8d76-11f0-a337-d7a51974c55f.jpg.webp" loading="lazy" alt="Getty Images Two women sitting in armchairs and talking. Female coach, psychotherapist, psychologist, advisor and patient, client " class="sc-86c96223-0 fHZDyi"&gt;&lt;span class="sc-86c96223-2 hqrvRC"&gt;Getty Images&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/figure&gt;&lt;div data-component="text-block" class="sc-3b6b161a-0 jdlrvG"&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;I get terribly anxious about all kinds of things and everyone worries about money, jobs and families. &lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;Those worries can quickly spiral when kept bottled up so sharing your concerns with someone you trust lightens the load and gives perspective, even if they can't solve the problem for you.&lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;Sometimes just saying it out loud makes the problem feel more manageable.&lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;&lt;i id="additional-reporting-by-yasmin-rufo" class="sc-d16436d-0 gbdkAi"&gt;Additional reporting by Yasmin Rufo&lt;/i&gt;&lt;/p&gt;&lt;/div&gt;&lt;/article&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>BBC</author><pubDate>Thu, 11 Sep 2025 00:30:06 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMiWkFVX3lxTE9JQ0dNR2tGSTdCQUd0TUVnTjJvWkdhYmlQNlYxV0VoSzkxejVRWGtTYkNxMGd0OS1OOTBvRzVzRjEzaHFNb1Z6VFhqT0JxbU5uckJ1MXBzQ0lOUdIBX0FVX3lxTE1jUUF4c1YzWUxsQndZdlM1Ykh4SmtDUXZqbU1Ob0hfeW5ZaFkzS09lMjVNdUFTUnduSk1FWVgteTZwRHdhVHV3WC1EMm8xbWx0RFVxTWVFcGtXQnFLZjZj</guid></item><item><title>如果您居住在这些国家，您死于慢性病的风险已经下降—自然</title><link>https://www.nature.com/articles/d41586-025-02905-z</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="article__teaser" data-test="access-teaser"&gt; &lt;figure class="figure"&gt;&lt;picture class="embed intensity--high"&gt;&lt;source type="image/webp" srcset="//media.nature.com/lw767/magazine-assets/d41586-025-02905-z/d41586-025-02905-z_51434352.jpg?as=webp 767w, //media.nature.com/lw319/magazine-assets/d41586-025-02905-z/d41586-025-02905-z_51434352.jpg?as=webp 319w" sizes="(max-width: 319px) 319px, (min-width: 1023px) 100vw,  767px"&gt;&lt;/source&gt;&lt;img class="figure__image" alt="Sign attached to a street post indicating a no smoking district in a downtown area in California." loading="lazy" src="//media.nature.com/lw767/magazine-assets/d41586-025-02905-z/d41586-025-02905-z_51434352.jpg"&gt;&lt;figcaption&gt;&lt;p class="figure__caption u-sans-serif"&gt;&lt;span class="mr10"&gt;Public-health policies that restrict smoking have helped to reduce the chance of people dying from non-communicable diseases such as lung cancer.&lt;/span&gt;&lt;span&gt;Credit: Smith Collection/Gado/Getty&lt;/span&gt;&lt;/p&gt;&lt;/figcaption&gt;&lt;/picture&gt;&lt;/figure&gt;&lt;p&gt;The chance of dying from chronic illnesses such as heart disease, &lt;a href="https://www.nature.com/articles/d41586-023-02075-w" data-track="click" data-label="https://www.nature.com/articles/d41586-023-02075-w" data-track-category="body text link"&gt;cancer &lt;/a&gt;and &lt;a href="https://www.nature.com/articles/d41586-023-00676-z" data-track="click" data-label="https://www.nature.com/articles/d41586-023-00676-z" data-track-category="body text link"&gt;diabetes&lt;/a&gt; declined in four out of five countries between 2010 and 2019, finds a study of 185 countries published in &lt;i&gt;The Lancet&lt;/i&gt; today&lt;sup&gt;&lt;a href="#ref-CR1" data-track="click" data-action="anchor-link" data-track-label="go to reference" data-track-category="references"&gt;1&lt;/a&gt;&lt;/sup&gt;.&lt;/p&gt;&lt;p&gt;&lt;a href="https://www.nature.com/articles/nindia.2019.60" data-track="click" data-label="https://www.nature.com/articles/nindia.2019.60" data-track-category="body text link"&gt;Non-communicable diseases&lt;/a&gt; (NCDs) are the leading cause of death globally. The United Nations has set the goal of reducing deaths from these diseases by one-third by 2030.&lt;/p&gt;&lt;p&gt;&lt;article class="recommended pull pull--left u-sans-serif" data-label="Related"&gt;&lt;a href="https://www.nature.com/articles/d41586-025-00862-1" class="u-link-inherit" data-track="click" data-track-label="recommended article"&gt;&lt;img class="recommended__image" alt="" src="//media.nature.com/w400/magazine-assets/d41586-025-02905-z/d41586-025-02905-z_50860700.jpg"&gt;&lt;p class="recommended__title u-serif"&gt;154 million lives and counting: 5 charts reveal the power of vaccines&lt;/p&gt;&lt;/a&gt;&lt;/article&gt;&lt;/p&gt;&lt;p&gt;The latest study is the first to investigate the change in NCD mortality across countries. It finds that, from 2010 to 2019, the probability of dying from an NCD before the age of 80 fell in 152 countries for women and in 147 countries for men.&lt;/p&gt;&lt;p&gt;Despite these gains, more than half of the countries saw slower declines in the 2010s compared with the previous decade. “Around the beginning of the millennium, we saw significantly lowered mortality rates, but despite political attention suddenly over the last decade, things are not doing as well as before,” says Majid Ezzati, a co-author and global-health researcher at Imperial College London.&lt;/p&gt;&lt;p&gt;In 2019, women in Japan and men in Singapore had the lowest risk of dying from a NCD among the countries studied, while women in Afghanistan and men in Eswatini had the highest (see ‘Risk of dying from chronic disease’).&lt;/p&gt;&lt;figure class="figure"&gt;&lt;picture class="embed intensity--high"&gt;&lt;source type="image/webp" srcset="//media.nature.com/lw767/magazine-assets/d41586-025-02905-z/d41586-025-02905-z_51437432.jpg?as=webp 767w, //media.nature.com/lw319/magazine-assets/d41586-025-02905-z/d41586-025-02905-z_51437432.jpg?as=webp 319w" sizes="(max-width: 319px) 319px, (min-width: 1023px) 100vw,  767px"&gt;&lt;/source&gt;&lt;img class="figure__image" alt="Most and least improved: Graphic displaying data showing that among 25 high-income countries, the chance of dying from a non-communicable disease between 2001 and 2019 declined the most in Denmark, whereas the United States recorded the smallest decline." loading="lazy" src="//media.nature.com/lw767/magazine-assets/d41586-025-02905-z/d41586-025-02905-z_51437432.jpg"&gt;&lt;figcaption&gt;&lt;p class="figure__caption u-sans-serif"&gt;&lt;span&gt;Source: Ref. 1&lt;/span&gt;&lt;/p&gt;&lt;/figcaption&gt;&lt;/picture&gt;&lt;/figure&gt;&lt;p&gt;All 25 high-income countries in the data set saw declines in NCD mortality between 2010 and 2019, with Denmark recording the largest drop for both sexes and the United States the smallest (see ‘Most and least improved’). China, Egypt, Nigeria, Russia and Brazil had a reduction in chronic-disease deaths, whereas India and Papua New Guinea experienced an increase in NCD deaths over the same period.&lt;/p&gt;&lt;figure class="figure"&gt;&lt;picture class="embed intensity--high"&gt;&lt;source type="image/webp" srcset="//media.nature.com/lw767/magazine-assets/d41586-025-02905-z/d41586-025-02905-z_51437822.jpg?as=webp 767w, //media.nature.com/lw319/magazine-assets/d41586-025-02905-z/d41586-025-02905-z_51437822.jpg?as=webp 319w" sizes="(max-width: 319px) 319px, (min-width: 1023px) 100vw,  767px"&gt;&lt;/source&gt;&lt;img class="figure__image" alt="Most and least improved: Graphic displaying data showing that among 25 high-income countries, the chance of dying from a non-communicable disease between 2001 and 2019 declined the most in Denmark, whereas the United States recorded the smallest decline." loading="lazy" src="//media.nature.com/lw767/magazine-assets/d41586-025-02905-z/d41586-025-02905-z_51437822.jpg"&gt;&lt;figcaption&gt;&lt;p class="figure__caption u-sans-serif"&gt;&lt;span&gt;Source: Ref. 1&lt;/span&gt;&lt;/p&gt;&lt;/figcaption&gt;&lt;/picture&gt;&lt;/figure&gt;&lt;p&gt;Veronica Le Nevez, a public-policy specialist at the George Institute for Global Health in Sydney, Australia, says that the report finds the biggest drivers of improvements in death rates were embedding better treatments and preventions in health-care systems, the widespread adoption of statins and hypertensives to lower the risk of heart attack and stroke and the development of vaccines for hepatitis and &lt;a href="https://www.nature.com/articles/d41586-025-00862-1" data-track="click" data-label="https://www.nature.com/articles/d41586-025-00862-1" data-track-category="body text link"&gt;cervical cancer&lt;/a&gt;.&lt;/p&gt;&lt;p&gt;Government restrictions on tobacco and alcohol have also helped to reduce mortality from diseases linked to their use, such as lung cancer and alcohol-use disorder.&lt;/p&gt;&lt;/div&gt;
                        &lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Nature</author><pubDate>Thu, 11 Sep 2025 00:11:15 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMiX0FVX3lxTFA5WjJ4WDc2aXUxbmJtMEcyY0dFMmJHOUs3UXE5OW9QUkx0UXZJY3VxWmV4YXl1Ynl5V2g4WkZUYXJ2UFExeGRGUk5KTVJidlN1cmhUTzIyQmNjMkRMRml3</guid></item><item><title>一种纤维可能具有类似于Ozempic的减肥益处- ScienceAlert</title><link>https://www.sciencealert.com/a-type-of-fiber-may-have-weight-loss-benefits-similar-to-ozempic</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="post-content"&gt;
			&lt;p&gt;Research on the microbes living in our digestive tract has triggered a '&lt;a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503711/"&gt;revolution&lt;/a&gt;' in nutritional science.&lt;/p&gt;&lt;p&gt;In the last few years, dietary fiber has become the "&lt;a href="https://www.sciencealert.com/inulin-is-being-added-to-many-foods-but-it-could-be-causing-stomach-problems"&gt;new protein&lt;/a&gt;", added to foods &lt;a href="https://www.sciencealert.com/scientists-create-invisible-fiber-that-can-make-cakes-and-pizzas-better-for-you"&gt;in abundance&lt;/a&gt; to feed our gut's microbiome and boost our health.&lt;/p&gt;&lt;p&gt;However, a study on mice published in 2024 suggests that not all fiber supplements are equally beneficial.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Related: &lt;a href="https://www.sciencealert.com/eating-fiber-could-protect-you-from-infections-heres-why"&gt;Eating Fiber Could Protect You From Infections. Here's Why.&lt;/a&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;A form that is readily found in oats and barley, called &lt;a href="https://en.wikipedia.org/wiki/Oat_beta-glucan"&gt;beta-glucan&lt;/a&gt;, can control blood sugar and assist in weight loss among mice fed a high-fat diet.&lt;/p&gt;&lt;p&gt;Researchers at the University of Arizona (UA) and the University of Vienna found it decreased a mouse's fat content and body weight within 18 weeks.&lt;/p&gt;&lt;p&gt;Other fibers they tested, including wheat dextrin, pectin, resistant starch, and cellulose, had no such effect, despite shifting the makeup of the mouse microbiome significantly compared to mice fed no fiber supplements.&lt;/p&gt;&lt;p&gt;"We know that fiber is important and beneficial; the problem is that there are so many different types," &lt;a href="https://news.arizona.edu/news/how-your-morning-oats-could-help-you-manage-your-weight"&gt;explained&lt;/a&gt; biomedical scientist Frank Duca from UA in July last year.&lt;/p&gt;&lt;p&gt;"We wanted to know what kind of fiber would be most beneficial for weight loss and improvements in glucose homeostasis so that we can inform the community, the consumer, and then also inform the agricultural industry."&lt;/p&gt;&lt;p&gt;Dietary fibers are the &lt;a href="https://www.cambridge.org/core/journals/proceedings-of-the-nutrition-society/article/interactions-between-dietary-fibre-and-the-gut-microbiota/0BEF28B809F38D02AC0B1D4E4990210C"&gt;main source of energy&lt;/a&gt; for bacteria living in our guts, and &lt;a href="https://www.nih.gov/news-events/nih-research-matters/health-benefits-dietary-fibers-vary"&gt;yet less than 5 percent&lt;/a&gt; of people in the US consume the &lt;a href="https://www.ucsfhealth.org/education/increasing-fiber-intake"&gt;recommended 25–30 grams (0.9–1 ounce)&lt;/a&gt; of fiber a day.&lt;/p&gt;&lt;figure id="attachment_133570" aria-describedby="caption-attachment-133570" class="wp-caption alignnone"&gt;&lt;img decoding="async" src="https://www.sciencealert.com/images/2024/07/OatsAndABowl.jpg" alt="A bowl of oats and some oat grains " class="size-full wp-image-133570" srcset="https://www.sciencealert.com/images/2024/07/OatsAndABowl.jpg 642w, https://www.sciencealert.com/images/2024/07/OatsAndABowl-600x374.jpg 600w" sizes="(max-width: 642px) 100vw, 642px" loading="lazy"&gt;&lt;figcaption id="caption-attachment-133570" class="wp-caption-text"&gt;Beta-glucan is found in oats and barley. (&lt;a href="https://www.canva.com/photos/MADat1fdGi4/"&gt;ArxOnt/Canva Pro&lt;/a&gt;)&lt;/figcaption&gt;&lt;/figure&gt;&lt;p&gt;To make up for this, fiber supplements and &lt;a href="https://www.sciencealert.com/scientists-create-invisible-fiber-that-can-make-cakes-and-pizzas-better-for-you"&gt;'invisible fiber'-infused foods&lt;/a&gt; are &lt;a href="https://www.sciencealert.com/inulin-is-being-added-to-many-foods-but-it-could-be-causing-stomach-problems"&gt;growing in popularity&lt;/a&gt;. But fibers are extremely diverse, so which do we choose?&lt;/p&gt;&lt;p&gt;Some fibers, like oat beta-glucans and wheat dextrin, are water-&lt;a href="https://www.webmd.com/diet/compare-dietary-fibers"&gt;soluble&lt;/a&gt;, meaning they are easily fermented by gut bacteria.&lt;/p&gt;&lt;p&gt;Others, like cellulose and resistant starch, are less soluble or insoluble, meaning they &lt;a href="https://health.clevelandclinic.org/whats-the-difference-between-soluble-and-insoluble-fiber"&gt;stick to other materials to form stool&lt;/a&gt;.&lt;/p&gt;&lt;p&gt;Until now, &lt;a href="https://doi.org/10.1016/j.tjnut.2024.05.003"&gt;writes&lt;/a&gt; biomedical scientist Elizabeth Howard from UA and her colleagues, "there is no study that has investigated the role of various fibers in one cohort."&lt;/p&gt;&lt;p&gt;To make up for this, the current study tested several forms of fiber in one cohort of mice. Only beta-glucan was found to increase the number of &lt;em&gt;&lt;a href="https://en.wikipedia.org/wiki/Ileibacterium"&gt;Ileibacterium&lt;/a&gt;&lt;/em&gt; in the mouse intestine. Other &lt;a href="https://doi.org/10.1093/jn/nxy011"&gt;studies on mice&lt;/a&gt; have linked this bacterium to weight loss.&lt;/p&gt;&lt;p&gt;Sure enough, long before the 10-week marker, mice fed beta-glucan showed reduced body weight and body fat content compared to mice fed other forms of fiber.&lt;/p&gt;&lt;p&gt;The findings align with another recent &lt;a href="https://doi.org/10.1186/s12986-023-00767-8"&gt;study&lt;/a&gt; by Duca, which fed barley flour, rich in beta-glucan, to rodents. Even though the rats continued eating just as much of their high-fat diet as before, their energy expenditure increased and they lost weight anyway.&lt;/p&gt;&lt;p&gt;A similar outcome was observed in mice fed beta-glucan in the new study. These animals also showed increased concentrations of butyrate in their guts, which is a metabolite made when microbes break down fiber.&lt;/p&gt;&lt;p&gt;Butyrate induces the release of glucagon-like peptide-1 (GLP-1), which is the natural protein that synthetic drugs like &lt;a href="https://www.sciencealert.com/what-is-ozempic-and-why-are-people-saying-its-a-sad-way-to-lose-weight"&gt;Ozempic&lt;/a&gt; mimic to stimulate insulin release.&lt;/p&gt;&lt;figure id="attachment_124692" aria-describedby="caption-attachment-124692" class="wp-caption alignnone"&gt;&lt;img decoding="async" src="https://www.sciencealert.com/images/2024/04/FingersHoldOzempicPen-642x260.jpg" alt="Fingers Hold Ozempic Pen" class="size-medium wp-image-124692" srcset="https://www.sciencealert.com/images/2024/04/FingersHoldOzempicPen-642x260.jpg 642w, https://www.sciencealert.com/images/2024/04/FingersHoldOzempicPen-768x311.jpg 768w, https://www.sciencealert.com/images/2024/04/FingersHoldOzempicPen-600x243.jpg 600w, https://www.sciencealert.com/images/2024/04/FingersHoldOzempicPen.jpg 1024w" sizes="(max-width: 642px) 100vw, 642px" loading="lazy"&gt;&lt;figcaption id="caption-attachment-124692" class="wp-caption-text"&gt;Ozempic and other semaglutide drugs mimic the effects of GLP-1. (imyskin/Getty Images)&lt;/figcaption&gt;&lt;/figure&gt;&lt;p&gt;"Part of the benefits of consuming dietary fiber is through the release of GLP-1 and other gut peptides that regulate appetite and body weight," &lt;a href="https://news.arizona.edu/news/how-your-morning-oats-could-help-you-manage-your-weight"&gt;said&lt;/a&gt; Duca.&lt;/p&gt;&lt;p&gt;"However, we don't think that's all of the effect. We think that there are other beneficial things that butyrate could be doing that are not gut peptide related, such as improving gut barrier health and targeting peripheral organs like the liver."&lt;/p&gt;&lt;p&gt;Far more research is needed before these results can be extended to humans, but the findings suggest that some fibers may be better suited to weight loss and insulin control than others.&lt;/p&gt;&lt;p&gt;The study was published in the &lt;i&gt;&lt;a href="https://doi.org/10.1016/j.tjnut.2024.05.003"&gt;Journal of Nutrition&lt;/a&gt;.&lt;/i&gt;&lt;/p&gt;&lt;p&gt;&lt;em&gt;An earlier version of this article was published in July 2024.&lt;/em&gt;&lt;/p&gt;
		&lt;/div&gt;
	&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>ScienceAlert</author><pubDate>Wed, 10 Sep 2025 23:41:09 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMimAFBVV95cUxQbkJ5UzRDRGdoRTdjWVJhSzc3Q0x2N2RrYWNuNmJrOXFDYy04cHlpM1gzdENOQnBDTy1lVVhLOWVZUG8teE5mYkx0Ymg1Qk5tT1BNaFQ0XzhfVFVYOUNLcjdCVlRyZkN1MXA4UjRVdTlQTE4ySUtOcDNlckdrMko2LUhhWW4xWDBIaFJXRml1MTA0MDFOV3FrNw</guid></item><item><title>长期失眠？新的研究表明，这可能会导致你的大脑老化。-《华盛顿邮报》</title><link>https://www.washingtonpost.com/health/2025/09/10/chronic-insomnia-sleep-brain-aging/</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="wpds-c-PJLV article-body type-text" data-qa="article-body"&gt;&lt;p data-apitype="text" data-contentid="CBOJZLSJLNHRNDH2PT2MAJ3GWM" data-el="text" class="wpds-c-heFNVF wpds-c-heFNVF-iPJLV-css overrideStyles font-copy" dir="null"&gt;Persistent sleeplessness may be far worse than a passing annoyance — gradually unraveling memory and mental sharpness, according to new research.&lt;/p&gt;&lt;/div&gt;&lt;div class="wpds-c-PJLV article-body type-text" data-qa="article-body"&gt;&lt;p data-apitype="text" data-contentid="YZS6PIGMSREMTHBN3ZPZKS2GZQ" data-el="text" class="wpds-c-heFNVF wpds-c-heFNVF-iPJLV-css overrideStyles font-copy" dir="null"&gt;A study published Wednesday in &lt;a href="https://n.neurology.org/lookup/doi/10.1212/WNL.0000000000214155%20[press.aan.com]" target="_blank"&gt;Neurology&lt;/a&gt;, the journal of the American Academy of Neurology, identifies a troubling link: Older people who have chronic insomnia appear more likely to experience accelerated aging of the brain. These changes are revealed in both cognitive tests and imaging scans showing the altered structure of the brain.&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>The Washington Post</author><pubDate>Wed, 10 Sep 2025 23:01:35 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMijAFBVV95cUxNeEpBOURoRWZBU2RjMWFJYmtEUC1USTJnVGFjYUd4YWtNS3hNeF9nYmZHQWVsejloQzg3ZVZ6WVJKcHdNUDZ3ZTlmN1FaRFMzYS1HdG4yR2ZxMHA3TkxlQURmdEdjamdQQ0twOS0xTGh0dmZJTlRpd3J0YmkxQzJBb1Y5aWtJYzAwSjdGbQ</guid></item><item><title>2024年，新冠肺炎疫情从美国十大死亡原因中脱颖而出-美国国家公共广播电台</title><link>https://www.npr.org/sections/shots-health-news/2025/09/10/nx-s1-5537078/u-s-death-rates-covid-2024</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div id="storytext" class="storytext storylocation linkLocation"&gt;
      &lt;div id="resg-s1-88078" class="bucketwrap image large"&gt;
            
&lt;div class="credit-caption"&gt;
    &lt;div class="caption-wrap"&gt;
        &lt;div class="caption" aria-label="Image caption"&gt;
            &lt;p&gt;
                Activists gather during a vigil in Lafayette Park for nurses who died during the COVID-19 pandemic on January 13, 2022, in Washington, DC. (Photo by Brendan Smialowski / AFP) (Photo by BRENDAN SMIALOWSKI/AFP via Getty Images)
                &lt;b class="credit" aria-label="Image credit"&gt;
                    
                    BRENDAN SMIALOWSKI/AFP/Getty Images
                    
                &lt;/b&gt;
                &lt;b class="hide-caption"&gt;&lt;b&gt;hide caption&lt;/b&gt;&lt;/b&gt;
            &lt;/p&gt;
        &lt;/div&gt;


            &lt;b class="toggle-caption"&gt;&lt;b&gt;toggle caption&lt;/b&gt;&lt;/b&gt;
    &lt;/div&gt;

    &lt;span class="credit" aria-label="Image credit"&gt;
        
        BRENDAN SMIALOWSKI/AFP/Getty Images
        
    &lt;/span&gt;
&lt;/div&gt;
   &lt;/div&gt;
   &lt;p&gt;COVID-19 is no longer one of the top 10 causes of death in the U.S.&lt;/p&gt;   &lt;p&gt;Early data on deaths in 2024, &lt;a href="https://www.cdc.gov/nchs/data/vsrr/vsrr039.pdf" target="_blank"&gt;published by&lt;/a&gt; the Centers for Disease Control and Prevention, show that COVID dropped from the list for the first time since the start of the pandemic. It became the &lt;a href="https://www.cdc.gov/nchs/products/databriefs/db456.htm" target="_blank"&gt;third leading cause of death&lt;/a&gt; in the U.S. in 2020, and remained among the leading causes until now.&lt;/p&gt;   &lt;p&gt;"COVID is still in the top 15 leading causes of death, so it hasn't disappeared," says Farida Ahmad, a health scientist at the CDC's National Center for Health Statistics and lead author on the publication.&lt;/p&gt;   
   &lt;p&gt;Since its &lt;a href="https://www.cdc.gov/nchs/products/databriefs/db456.htm" target="_blank"&gt;peak in 2021&lt;/a&gt;, when more than 463,000 people died from COVID, it has been moving steadily down the list. Last year, it was a factor in around &lt;a href="https://www.cdc.gov/nchs/nvss/vsrr/covid19/index.htm" target="_blank"&gt;47,000&lt;/a&gt; U.S. deaths.&lt;/p&gt;   
   

   &lt;p&gt;Overall, deaths last year were down 4% from the previous year, and it was the third consecutive year of that downward trend, Ahmad says. The declines extend across the board, to most age groups and to people of all races and ethnicities, and can be attributed to a number of factors, such as fewer deaths from COVID and from drug overdoses, she says.&lt;/p&gt;   &lt;p&gt;The leading causes of death included suicide, diabetes, kidney disease, and unintentional injury. Heart disease and cancer — both chronic diseases — remained the top two leading causes of death, as they have been for more than a decade, and were responsible for more than 40% of U.S. deaths in 2024.&lt;/p&gt;   &lt;p&gt;Death rates were higher for men than women, for older adults, and for Black Americans compared with other racial and ethnic groups.&lt;/p&gt;   &lt;p&gt;"The fact that we're seeing people living into older and older age and dying of chronic diseases is a sign that we've been successful at dealing with infectious diseases," says Kathleen Ethier, a former CDC official at the &lt;a href="https://www.cdc.gov/nccdphp/index.html" target="_blank"&gt;National Center for Chronic Disease Prevention and Health Promotion&lt;/a&gt;, who left the agency in January and was not involved in this paper.&lt;/p&gt;   
   &lt;p&gt;Tackling chronic diseases takes a different strategy, Ethier says: "These are things that develop over time, that are highly impacted by our behavior and environments and genetics."&lt;/p&gt;   &lt;p&gt;With heart disease, for instance, a person may have higher risks if they have a family history of the condition, if they live in &lt;a href="https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.123.323613" target="_blank"&gt;stressful or polluted environments&lt;/a&gt;, if they mainly eat &lt;a href="https://www.npr.org/sections/health-shots/2023/05/25/1178163270/ultra-processed-foods-health-risk-weight-gain" target="_blank"&gt;ultraprocessed foods&lt;/a&gt;, and if they have spotty access to health care. "What kinds of food can people afford? Do they have insurance and money to pay for services? Those are difficult, entrenched things for public health to impact," Ethier says.&lt;/p&gt;   &lt;p&gt;Earlier this week, Health Secretary Robert F. Kennedy Jr. released a report titled "Make Our Children Healthy Again," which &lt;a href="https://www.npr.org/sections/shots-health-news/2025/09/09/nx-s1-5534412/rfk-maha-report-childrens-health" target="_blank"&gt;drew mixed reviews&lt;/a&gt; from public health advocates, who note that its goals clash with other recent moves by the Trump Administration, including cuts to food assistance, scientific research, Medicaid programs and changes that limit access to vaccines.&lt;/p&gt;   &lt;p&gt;"What this administration is doing is going to make the top ten causes of death worse," says Ethier. She notes that President Trump's &lt;a href="https://www.whitehouse.gov/wp-content/uploads/2025/05/Fiscal-Year-2026-Discretionary-Budget-Request.pdf" target="_blank"&gt;FY 2026 budget&lt;/a&gt; targets the &lt;a href="https://www.cdc.gov/nccdphp/index.html" target="_blank"&gt;CDC division&lt;/a&gt; that's focused on preventing chronic diseases for elimination in. This includes the &lt;a href="https://www.tobaccofreekids.org/press-releases/2025_05_05_administrations-budget-would-devastate-cdc-efforts-to-fight-chronic-disease-and-tobacco-use" target="_blank"&gt;office that deals with smoking&lt;/a&gt;, a major risk factor for heart disease, stroke and some cancers.&lt;br&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>NPR</author><pubDate>Wed, 10 Sep 2025 22:43:31 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMinwFBVV95cUxOTzd2RnpZMDdlTDQwUThRYzF0bFROVWMyUzFSR24xTDl3T0RmLTVqNGZlVGhTcF9ObEJFdk5BVDY1NGI1ZnNBRmdQSGQwUkZZdHNzdl9RVVFiVVdBOThKc29kdUFFeHRQZE9Dci14WGY5NDBWWmh4S2J3ay05UEt3SlN2cGpsYmRRcnBlWk5teEw3VFBJbjFTSmREMWZvRVU</guid></item><item><title>新研究发现，在高收入国家中，美国在降低慢性疾病死亡风险方面进展最慢- CNN</title><link>https://www.cnn.com/2025/09/10/health/chronic-disease-deaths-global-study-wellness</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="article__content" data-editable="content" itemprop="articleBody" data-reorderable="content"&gt;
                  &lt;div data-uri="cms.cnn.com/_components/action-bar/instances/cmfebu2hf006l28qj9727bu7w@published" data-label-id-prefix="action-bar-start-of-article" class="action-bar" data-dynamic-breakpoint-placement='{"extraLarge":{"placement":".layout-article-elevate__left"}}' data-expand-conditions='{"follow":{"extraLarge":{"alwaysExpand":true}},"shareOptions":{"large":{"maxNumOfActions":1},"medium":{"maxNumOfActions":1},"extraLarge":{"withAction":"follow","maxNumOfActions":2}}}'&gt;
    &lt;p class="action-bar__overlay"&gt;&lt;/p&gt;
    &lt;div class="action-bar__action-sheet" tabindex="-1"&gt;
        
            
            &lt;div class="action-bar__action-sheet--action" data-title="share options"&gt;
                  &lt;div data-uri="cms.cnn.com/_components/social-share/instances/cmfebu2hf006o28qjh1wfgc0r@published" class="social-share_labelled-list"&gt;
    &lt;div class="social-share_labelled-list__share-links vossi-social-share_labelled-list" data-type="share-links"&gt;
        &lt;button class="social-share_labelled-list__share" data-url="https://www.facebook.com/dialog/share?app_id=80401312489&amp;amp;href=https%3A%2F%2Fwww.cnn.com%2F2025%2F09%2F10%2Fhealth%2Fchronic-disease-deaths-global-study-wellness&amp;amp;display=popup" data-type="facebook" aria-label="share with facebook" title="Share with Facebook"&gt;
                &lt;svg class="icon-facebook-circle" xmlns="http://www.w3.org/2000/svg" viewbox="0 0 16 16" fill="none"&gt;
&lt;path d="M8.04139 1.33301C11.7458 1.33301 14.7488 4.33601 14.7488 8.04042C14.7488 11.3884 12.296 14.1632 9.08943 14.6663V9.97928H10.6523L10.9497 8.04042H9.08943V6.78225C9.08943 6.25182 9.34934 5.73475 10.1825 5.73475H11.0283V4.08409C11.0283 4.08409 10.2607 3.95309 9.52685 3.95309C7.99476 3.95309 6.99336 4.88165 6.99336 6.56269V8.04042H5.29031V9.97928H6.99336V14.6663C3.78677 14.1632 1.33398 11.3882 1.33398 8.04042C1.33398 4.33601 4.33699 1.33301 8.04139 1.33301Z" fill="#0C0C0C"&gt;&lt;/path&gt;
&lt;/svg&gt;

                &lt;span class="social-share_labelled-list__share-links--label"&gt;Facebook&lt;/span&gt;
        &lt;/button&gt;
        &lt;button class="social-share_labelled-list__share" data-url="https://twitter.com/intent/tweet?text=Check%20out%20this%20article%3A&amp;amp;url=https%3A%2F%2Fwww.cnn.com%2F2025%2F09%2F10%2Fhealth%2Fchronic-disease-deaths-global-study-wellness" data-type="x" aria-label="share with x" title="Share with X"&gt;
                &lt;svg class="icon-x-share" xmlns="http://www.w3.org/2000/svg" viewbox="0 0 16 16" fill="none"&gt;
&lt;path fill-rule="evenodd" clip-rule="evenodd" d="M5.99386 8.11503L0 0.666992H4.74756L8.44753 5.27039L12.4004 0.687719H15.0151L9.71175 6.84331L16 14.667H11.2666L7.2603 9.6887L2.98317 14.6532H0.354296L5.99386 8.11503ZM11.9565 13.287L2.91105 2.04698H4.0571L13.0912 13.287H11.9565Z" fill="#0C0C0C"&gt;&lt;/path&gt;
&lt;/svg&gt;

                &lt;span class="social-share_labelled-list__share-links--label"&gt;Tweet&lt;/span&gt;
        &lt;/button&gt;
        &lt;a class="social-share_labelled-list__share" href="mailto:?subject=CNN%20content%20share&amp;amp;body=Check%20out%20this%20article%3A%0Ahttps%3A%2F%2Fwww.cnn.com%2F2025%2F09%2F10%2Fhealth%2Fchronic-disease-deaths-global-study-wellness" data-type="email" target="_blank" rel="noopener noreferrer" aria-label="share with email" title="Share with email"&gt;
                &lt;svg class="icon-email-share" xmlns="http://www.w3.org/2000/svg" viewbox="0 0 24 24" fill="none"&gt;
&lt;path fill-rule="evenodd" clip-rule="evenodd" d="M2 6C2 4.89543 2.89543 4 4 4H20C21.1046 4 22 4.89543 22 6V18C22 19.1046 21.1046 20 20 20H4C2.89543 20 2 19.1046 2 18V6ZM4 6H20V9.11604L12 11.9396L4 9.11604V6ZM4 11.237V18H20V11.237L12.3328 13.943C12.1174 14.019 11.8825 14.019 11.6672 13.943L4 11.237Z" fill="#0C0C0C"&gt;&lt;/path&gt;
&lt;/svg&gt;

                &lt;span class="social-share_labelled-list__share-links--label"&gt;Email&lt;/span&gt;
        &lt;/a&gt;
        &lt;button class="social-share_labelled-list__share" data-url="https://www.cnn.com/2025/09/10/health/chronic-disease-deaths-global-study-wellness" data-type="copy" aria-label="copy link to clipboard" title="Copy link to clipboard"&gt;
                &lt;svg class="icon-hyperlink" xmlns="http://www.w3.org/2000/svg" viewbox="0 0 16 16" fill="none"&gt;
&lt;path fill-rule="evenodd" clip-rule="evenodd" d="M5.64373 10.3574C5.38338 10.0971 5.38338 9.67496 5.64373 9.41461L9.88637 5.17197C10.1467 4.91162 10.5688 4.91162 10.8292 5.17197C11.0895 5.43232 11.0895 5.85443 10.8292 6.11478L6.58654 10.3574C6.32619 10.6178 5.90408 10.6178 5.64373 10.3574Z" fill="#0C0C0C"&gt;&lt;/path&gt;
&lt;path d="M4.22952 8.94321L5.64373 7.52899C5.90408 7.26865 5.90408 6.84654 5.64373 6.58619C5.38338 6.32584 4.96127 6.32584 4.70092 6.58619L3.28671 8.0004C1.98496 9.30215 1.98496 11.4127 3.28671 12.7144C4.58846 14.0162 6.69901 14.0162 8.00075 12.7144L9.41497 11.3002C9.67532 11.0399 9.67532 10.6178 9.41497 10.3574C9.15462 10.0971 8.73251 10.0971 8.47216 10.3574L7.05795 11.7716C6.2769 12.5527 5.01057 12.5527 4.22952 11.7716C3.44847 10.9906 3.44847 9.72426 4.22952 8.94321Z" fill="#0C0C0C"&gt;&lt;/path&gt;
&lt;path d="M8.94356 4.22916L7.52935 5.64338C7.269 5.90373 6.84689 5.90373 6.58654 5.64338C6.32619 5.38303 6.32619 4.96092 6.58654 4.70057L8.00075 3.28635C9.3025 1.98461 11.4131 1.98461 12.7148 3.28635C14.0165 4.5881 14.0165 6.69865 12.7148 8.0004L11.3006 9.41461C11.0402 9.67496 10.6181 9.67496 10.3578 9.41461C10.0974 9.15426 10.0974 8.73215 10.3578 8.4718L11.772 7.05759C12.553 6.27654 12.553 5.01021 11.772 4.22916C10.9909 3.44812 9.72461 3.44811 8.94356 4.22916Z" fill="#0C0C0C"&gt;&lt;/path&gt;
&lt;/svg&gt;

                &lt;span class="social-share_labelled-list__share-links--label"&gt;Link&lt;/span&gt;
        &lt;/button&gt;
        
    &lt;/div&gt;
    &lt;button class="social-share_labelled-list__open" data-type="open" aria-label="open social share" title="Open social share"&gt;
        &lt;svg class="icon-ui-share-os" viewbox="0 0 24 24" xmlns="http://www.w3.org/2000/svg"&gt;&lt;path d="M19 12c.394 0 .714.32.714.714v8.572c0 .394-.32.714-.714.714H4.714A.715.715 0 014 21.286v-8.572a.715.715 0 011.429 0v7.857h12.857v-7.857c0-.394.32-.714.714-.714zm-7.664-9.79a.73.73 0 011.024 0l.076.075 4.916 4.854c.183.18.27.449.188.69a.734.734 0 01-1.216.314L12.57 4.5v11.786c0 .357-.357.714-.714.714s-.714-.359-.714-.714V4.5L7.372 8.143a.73.73 0 01-1.102-.091c-.21-.289-.149-.694.106-.946l4.884-4.821z"&gt;&lt;/path&gt;&lt;/svg&gt;

    &lt;/button&gt;
    &lt;button class="social-share_labelled-list__close" data-type="close" aria-label="close social share" title="Close social share"&gt;
        &lt;svg class="icon-ui-close" viewbox="0 0 24 24" xmlns="http://www.w3.org/2000/svg"&gt;&lt;path d="M19.787 18.758l-6.792-6.781 6.746-6.735a.728.728 0 00-1.028-1.03l-6.747 6.737-6.711-6.7a.728.728 0 00-1.028 1.03l6.71 6.698-6.723 6.712a.727.727 0 101.027 1.03l6.725-6.714 6.793 6.782a.725.725 0 001.028 0 .727.727 0 000-1.03"&gt;&lt;/path&gt;&lt;/svg&gt;

    &lt;/button&gt;
&lt;/div&gt;

            &lt;/div&gt;
    &lt;/div&gt;
    
&lt;/div&gt;


    &lt;p class="paragraph-elevate inline-placeholder vossi-paragraph" data-uri="cms.cnn.com/_components/paragraph/instances/cmfebu2hf006n28qjhooq33cd@published" data-editable="text" data-component-name="paragraph" data-article-gutter="true"&gt;
            Among all high-income Western countries, the United States has shown the worst performance in reducing the probability of dying from chronic diseases, a new study finds.
    &lt;/p&gt;

    &lt;p class="paragraph-elevate inline-placeholder vossi-paragraph" data-uri="cms.cnn.com/_components/paragraph/instances/cmfebvyce00043b6ngt3q0w0d@published" data-editable="text" data-component-name="paragraph" data-article-gutter="true"&gt;
            From 2010 to 2019, deaths due to chronic diseases declined in most age groups in the US but increased among adults 20 to 45, “a rare phenomenon in high-income western countries,” according to the study, published Wednesday in the journal &lt;a href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)01388-1/fulltext" target="_blank"&gt;The Lancet&lt;/a&gt;.
    &lt;/p&gt;

  





    &lt;p class="paragraph-elevate inline-placeholder vossi-paragraph" data-uri="cms.cnn.com/_components/paragraph/instances/cmfebvyce00053b6njctdoh28@published" data-editable="text" data-component-name="paragraph" data-article-gutter="true"&gt;
            The study, led by researchers at Imperial College London, analyzed data on 185 countries and territories and found that, from 2010 to 2019, the probability of dying by age 80 from a noncommunicable disease — such as cancer, heart disease and stroke — declined in most of those countries, but the decline&lt;strong&gt; &lt;/strong&gt;had slowed compared with&lt;strong&gt; &lt;/strong&gt;the previous decade.&lt;strong&gt; &lt;/strong&gt;
    &lt;/p&gt;

    &lt;p class="paragraph-elevate inline-placeholder vossi-paragraph" data-uri="cms.cnn.com/_components/paragraph/instances/cmfebvyce00063b6nild6cgho@published" data-editable="text" data-component-name="paragraph" data-article-gutter="true"&gt;
            “The risk of dying – or what we call probability in the paper – from chronic diseases in most countries in the world is coming down,” said Majid Ezzati, the study’s senior author and a professor in the School of Public Health at Imperial College London and Imperial Global Ghana.
    &lt;/p&gt;

    &lt;p class="paragraph-elevate inline-placeholder vossi-paragraph" data-uri="cms.cnn.com/_components/paragraph/instances/cmfebvyce00073b6necpuru5j@published" data-editable="text" data-component-name="paragraph" data-article-gutter="true"&gt;
            “But we were doing better before,” he said.
    &lt;/p&gt;

    &lt;p class="paragraph-elevate inline-placeholder vossi-paragraph" data-uri="cms.cnn.com/_components/paragraph/instances/cmfebvyce00083b6nz5rda8n1@published" data-editable="text" data-component-name="paragraph" data-article-gutter="true"&gt;
            Among the 25 high-income Western countries in the study, Denmark had the largest decline in chronic disease deaths, while the United States had the smallest, and Germany did only slightly better than the United States.
    &lt;/p&gt;

    &lt;p class="paragraph-elevate inline-placeholder vossi-paragraph" data-uri="cms.cnn.com/_components/paragraph/instances/cmfebvyce00093b6nqn9mrc75@published" data-editable="text" data-component-name="paragraph" data-article-gutter="true"&gt;
            “The US is the slowest, but it’s by no means the exception,” Ezzati said. “Germany is doing nearly as badly.”
    &lt;/p&gt;

  





    &lt;p class="paragraph-elevate inline-placeholder vossi-paragraph" data-uri="cms.cnn.com/_components/paragraph/instances/cmfebvycf000a3b6nuznk8at0@published" data-editable="text" data-component-name="paragraph" data-article-gutter="true"&gt;
            Among the high-income Western countries, there were small to moderate declines in the probability of dying from a chronic disease by age 80 from 2010 to 2019&lt;strong&gt; &lt;/strong&gt;overall. But the researchers noted that a possible reason why the declines were not larger as a group is that in many countries, neuropsychiatric conditions such as dementia increased and contributed unfavorably to the trends.
    &lt;/p&gt;

    &lt;p class="paragraph-elevate inline-placeholder vossi-paragraph" data-uri="cms.cnn.com/_components/paragraph/instances/cmfebvycf000b3b6nt75iqwnh@published" data-editable="text" data-component-name="paragraph" data-article-gutter="true"&gt;
            The new study included data from the World Health Organization’s &lt;a href="https://www.who.int/data/global-health-estimates" target="_blank"&gt;Global Health Estimates&lt;/a&gt;, and the team of researchers analyzed deaths between time periods, countries and by age groups: young adults 20 to 45, working-age adults 45 to 65, and older adults 65 to 80.
    &lt;/p&gt;

    &lt;p class="paragraph-elevate inline-placeholder vossi-paragraph" data-uri="cms.cnn.com/_components/paragraph/instances/cmfebvycf000c3b6n7sccev1z@published" data-editable="text" data-component-name="paragraph" data-article-gutter="true"&gt;
            The data showed that from 2010 to 2019, chronic disease deaths declined in about 80% of the world’s countries, home to more than 70% of the global population.
    &lt;/p&gt;

  





    &lt;p class="paragraph-elevate inline-placeholder vossi-paragraph" data-uri="cms.cnn.com/_components/paragraph/instances/cmfebvycf000d3b6nazce3hrr@published" data-editable="text" data-component-name="paragraph" data-article-gutter="true"&gt;
            The reasons for widespread decline in chronic disease mortality could be tied to improvements in diagnosing and treating chronic diseases, according to the study. For instance, there have been changes in clinical guidelines as well as increases in the use of certain medications and the early detection of certain cancers.
    &lt;/p&gt;

    &lt;p class="paragraph-elevate inline-placeholder vossi-paragraph" data-uri="cms.cnn.com/_components/paragraph/instances/cmfebvycf000e3b6nchlfuy6c@published" data-editable="text" data-component-name="paragraph" data-article-gutter="true"&gt;
            But in about 60% of countries, either the decline in chronic disease deaths from 2010 to 2019 was smaller than it had been in the preceding decade or there was a reversal of an earlier decline, the data showed.
    &lt;/p&gt;

    &lt;p class="paragraph-elevate inline-placeholder vossi-paragraph" data-uri="cms.cnn.com/_components/paragraph/instances/cmfebvycf000f3b6nzrshd1ia@published" data-editable="text" data-component-name="paragraph" data-article-gutter="true"&gt;
            “The countries that did really well did well both in older and working ages. Countries that did really badly did badly in both older and working ages,” Ezzati said. “And then there was some tradeoff between these. Some places never slowed down in older ages, but they have in working ages, and vice versa.”
    &lt;/p&gt;

  





    &lt;p class="paragraph-elevate inline-placeholder vossi-paragraph" data-uri="cms.cnn.com/_components/paragraph/instances/cmfebvycf000g3b6ndumo1prx@published" data-editable="text" data-component-name="paragraph" data-article-gutter="true"&gt;
            From 2010 to 2019, Finland, Norway and Denmark all had a slower decline in chronic disease deaths among older ages than they had in the previous decade. But they still maintained significant progress in reducing the risk of chronic disease deaths overall because that slower decline among older adults was countered by faster declines among working-age adults.
    &lt;/p&gt;

    &lt;p class="paragraph-elevate inline-placeholder vossi-paragraph" data-uri="cms.cnn.com/_components/paragraph/instances/cmfebvycf000h3b6n2nyupit9@published" data-editable="text" data-component-name="paragraph" data-article-gutter="true"&gt;
            In the United States, small reductions in mortality among older adults were combined with a stagnation among working-age adults and increases in mortality among young adults, leading to the nation’s poor performance compared with other high-income Western countries.
    &lt;/p&gt;

    &lt;p class="paragraph-elevate inline-placeholder vossi-paragraph" data-uri="cms.cnn.com/_components/paragraph/instances/cmfebvycf000i3b6nndxkmozs@published" data-editable="text" data-component-name="paragraph" data-article-gutter="true"&gt;
            The study did not analyze why some countries had greater improvements than others in reducing the probability of chronic disease deaths, but Ezzati had some ideas.
    &lt;/p&gt;

    &lt;p class="paragraph-elevate inline-placeholder vossi-paragraph" data-uri="cms.cnn.com/_components/paragraph/instances/cmfebvycf000j3b6nxtz69a9w@published" data-editable="text" data-component-name="paragraph" data-article-gutter="true"&gt;
            In both high-income Western countries that performed poorly compared with their peers – the United States and Germany – there are segments of the population in which there has been less investment in public health, he noted, and these disparities in investment can lead to broad barriers to accessing care.
    &lt;/p&gt;

    &lt;p class="paragraph-elevate inline-placeholder vossi-paragraph" data-uri="cms.cnn.com/_components/paragraph/instances/cmfebvycf000k3b6nw55t9kn7@published" data-editable="text" data-component-name="paragraph" data-article-gutter="true"&gt;
            For instance, a barrier can be not having a primary care physician in your local area, which can lead to the delayed screening for and diagnosis of chronic conditions, Ezzati said.
    &lt;/p&gt;

  





    &lt;p class="paragraph-elevate inline-placeholder vossi-paragraph" data-uri="cms.cnn.com/_components/paragraph/instances/cmfebvycf000l3b6nnw91guzz@published" data-editable="text" data-component-name="paragraph" data-article-gutter="true"&gt;
            Many Americans live in areas where critical-care services are lacking. It’s estimated that &lt;a href="https://www.cnn.com/2017/08/03/health/hospital-deserts"&gt;nearly 30 million Americans don’t live within an hour of trauma care&lt;/a&gt;. And a CNN analysis has found that people living in 16% of the mainland United States are 30 miles or more from the nearest hospital.
    &lt;/p&gt;

    &lt;p class="paragraph-elevate inline-placeholder vossi-paragraph" data-uri="cms.cnn.com/_components/paragraph/instances/cmfebvycf000m3b6n5o94sfdp@published" data-editable="text" data-component-name="paragraph" data-article-gutter="true"&gt;
            The United States also has had a rise in the probability of dying from neuropsychiatric conditions, such as dementia and alcohol use disorders, which did not appear to offset continued declines in deaths from cancers and cardiovascular diseases – and these trends could have contributed to the nation’s poor performance in reducing chronic disease mortality, according to the researchers.
    &lt;/p&gt;

    &lt;p class="paragraph-elevate inline-placeholder vossi-paragraph" data-uri="cms.cnn.com/_components/paragraph/instances/cmfebvycf000p3b6nr7214aud@published" data-editable="text" data-component-name="paragraph" data-article-gutter="true"&gt;
            The new study was published a day after the Trump administration released the &lt;a href="https://www.cnn.com/2025/09/09/health/make-america-healthy-again-maha-report"&gt;Make America Healthy Again Commission&lt;/a&gt;’s action plan on reducing &lt;a href="https://www.hhs.gov/press-room/maha-commission-report-childhood-disease-strategy.html" target="_blank"&gt;childhood chronic diseases&lt;/a&gt; in the United States.
    &lt;/p&gt;

    &lt;p class="paragraph-elevate inline-placeholder vossi-paragraph" data-uri="cms.cnn.com/_components/paragraph/instances/cmfebvycf000q3b6n1dbgpobx@published" data-editable="text" data-component-name="paragraph" data-article-gutter="true"&gt;
            US Health and Human Services Secretary Robert F. Kennedy Jr. has made tackling chronic diseases a primary focus. In an &lt;a href="https://www.instagram.com/bretbaier/reel/DOZjGEPj3c3/" target="_blank"&gt;interview Tuesday on Fox News&lt;/a&gt;, Kennedy noted that the share of &lt;a href="https://www.cdc.gov/pcd/issues/2025/24_0539.htm" target="_blank"&gt;US adults with at least one chronic condition is 76.4%&lt;/a&gt;, according to data from the US Centers for Disease Control and Prevention.
    &lt;/p&gt;

  





    &lt;p class="paragraph-elevate inline-placeholder vossi-paragraph" data-uri="cms.cnn.com/_components/paragraph/instances/cmfebvycf000s3b6nxakxnxm9@published" data-editable="text" data-component-name="paragraph" data-article-gutter="true"&gt;
            Elena Ladas, a professor of global integrative medicine at Columbia University and an expert on noncommunicable diseases in young people, said she is optimistic the United States is heading toward embracing wellness as a prevention tool to reduce chronic disease deaths, but she wants to see a clear implementation plan.
    &lt;/p&gt;

    &lt;p class="paragraph-elevate inline-placeholder vossi-paragraph" data-uri="cms.cnn.com/_components/paragraph/instances/cmfebvycf000t3b6n69djci5b@published" data-editable="text" data-component-name="paragraph" data-article-gutter="true"&gt;
            “They’re talking about the right things: Ultraprocessed foods need to really be minimized, and exposures to pesticides and environmental contaminants,” Ladas said of the MAHA report. “They’re talking about what I think a lot of epidemiologists and clinicians have been saying for a very long time. But how they’re going to implement that remains to be seen.”
    &lt;/p&gt;

    &lt;p class="paragraph-elevate inline-placeholder vossi-paragraph" data-uri="cms.cnn.com/_components/paragraph/instances/cmfebvycf000u3b6nta4i7ft8@published" data-editable="text" data-component-name="paragraph" data-article-gutter="true"&gt;
            Ladas, who was not involved in the new study but has done public health work in nearly two dozen countries, said the United States should “think about wellness comprehensively” to reduce the burden of chronic disease.
    &lt;/p&gt;

    &lt;p class="paragraph-elevate inline-placeholder vossi-paragraph" data-uri="cms.cnn.com/_components/paragraph/instances/cmfebvycf000v3b6n9brmur57@published" data-editable="text" data-component-name="paragraph" data-article-gutter="true"&gt;
            “Wellness approaches include good nutrition. We need to make healthy food reasonably priced. A lot of times, farmer’s markets are more expensive than the grocery store. You don’t see that in Europe. In Europe, farmer’s markets are far less expensive than grocery stores,” Ladas said.
    &lt;/p&gt;

    &lt;p class="paragraph-elevate inline-placeholder vossi-paragraph" data-uri="cms.cnn.com/_components/paragraph/instances/cmfebvycf000w3b6nxyp4yfic@published" data-editable="text" data-component-name="paragraph" data-article-gutter="true"&gt;
            “And mental health can include meditation and deep-breathing,” she added. “There are more holistic wellness approaches to include for a lot of these chronic conditions versus being only medication-based resolutions. You need both.”
    &lt;/p&gt;

              &lt;/div&gt;
                &lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>CNN</author><pubDate>Wed, 10 Sep 2025 22:30:00 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMiigFBVV95cUxOQVM1UGQ1aFRpM0dGSFdoTGRESzJvcXdsQmxkbk9QYkRhQ0FVZV93cW9xQTE3OFNWc052VFN0U3Y1YmF6ZG5FaHRCWFh2Z09qczR1a0x0eWVCMnRtYWJXNXRPQ1lWdl9uNVQwbW5jODQtbzJZckRVYUpmV2piUG9xTVZld1J1LUVwZHc</guid></item><item><title>新泽西州是扩大获取最新新冠疫情疫苗的最新州--《纽约时报》</title><link>https://www.nytimes.com/2025/09/10/nyregion/new-jersey-covid-vaccine-pharmacies.html</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;body id="readabilityBody"&gt;&lt;p id="cmsg"&gt;Please enable JS and disable any ad blocker&lt;/p&gt;&lt;/body&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>The New York Times</author><pubDate>Wed, 10 Sep 2025 22:11:16 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMijAFBVV95cUxNRVFEQ3BCWFNUUUdhNGNmNE1TVkQ3ckNHSWNJQmZ5YXVaWHBKcEh2NFUzcmtLQzNZemRCMGpXV0ZldklpX3NGRWhJeTJxN3M5SHlyS3RhbjZQVmFhQ2xVUzJQSkxQR1hPbzY2dTlNc3diLXlxUzFma2hPY3U4cmFwY1ZONnpSRVZ6SjFvUA</guid></item><item><title>西尼罗河病毒病例高于正常水平，引发健康警告-美联社新闻</title><link>https://apnews.com/article/west-nile-cdc-d0fe355b8351f52b39ca4d39046da9de</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;p class="LeaderBoardAd-Mobile "&gt;
                                    
                                        
                                            
                                        
                                    
                                &lt;/p&gt;
                            
                            
                                
                                
                                    &lt;div class="RichTextStoryBody RichTextBody"&gt;
                                        &lt;p&gt;NEW YORK (AP) — West Nile virus infections are intense so far this year, with case counts running 40% higher than normal, health officials say.&lt;/p&gt;&lt;p&gt;More than 770 cases, including about 490 severe cases, were reported as of early September, according to Centers for Disease Control and Prevention &lt;span class="LinkEnhancement"&gt;&lt;a class="Link AnClick-LinkEnhancement" data-gtm-enhancement-style="LinkEnhancementA" href="https://www.cdc.gov/west-nile-virus/data-maps/current-year-data.html" target="_blank" rel="noopener"&gt;data posted this week&lt;/a&gt;&lt;/span&gt;. About 550 cases — 350 of them severe — are usually reported by this time of year.&lt;/p&gt;&lt;p&gt;Health officials are ramping up warnings to the public, because most cases of the mosquito-borne disease are reported in August and September.&lt;/p&gt;&lt;p&gt;“West Nile virus can be a very serious disease and its presence in mosquitoes remains high right now in Massachusetts,” said the state’s public health commissioner, Dr. Robbie Goldstein, in a statement last week.&lt;/p&gt;&lt;p&gt;People can protect themselves by wearing long-sleeved shirts and pants when possible, and using an EPA-registered &lt;span class="LinkEnhancement"&gt;&lt;a class="Link AnClick-LinkEnhancement" data-gtm-enhancement-style="LinkEnhancementA" href="https://apnews.com/article/mosquito-repellent-cdc-recommends-e47c0c35ffe49d6f36b39d03f1b95e06"&gt;insect repellent&lt;/a&gt;&lt;/span&gt; when spending time outdoors, health officials say.&lt;/p&gt;
    
&lt;p&gt;West Nile virus was first reported in the United States in 1999 in New York, and then gradually spread across the country. It &lt;span class="LinkEnhancement"&gt;&lt;a class="Link AnClick-LinkEnhancement" data-gtm-enhancement-style="LinkEnhancementA" href="https://www.cdc.gov/west-nile-virus/data-maps/historic-data.html" target="_blank" rel="noopener"&gt;peaked&lt;/a&gt;&lt;/span&gt; in 2003, when nearly 10,000 cases were reported. &lt;/p&gt;

&lt;p&gt;Scientists say many people — perhaps tens of thousands each year — are infected but don’t know it because they have no symptoms, or only mild ones such as headaches, body aches, joint pain, vomiting, diarrhea and rashes. &lt;/p&gt;&lt;p&gt;In severe cases, damage to the central nervous system causes inflammation of the brain or spinal cord, and even death.&lt;/p&gt;
    
    
    
&lt;p&gt;In the last decade, health officials have fielded reports of 2,000 cases annually on average, including 1,200 life-threatening neurological illnesses and approximately 120 deaths. Deaths are on pace to be higher this year, CDC officials said, but they declined to discuss specifics, saying mortality statistics are too preliminary.&lt;/p&gt;&lt;p&gt;The problem is not that there are more mosquitoes this year, but rather that a higher proportion of the bugs are carrying the virus, CDC officials said. Mosquito infection rates can be affected by such factors as temperature, rainfall, the amount of insect control going on, and how many nearby birds are infected.&lt;/p&gt;
    
&lt;p&gt;Colorado, which tends to see more West Nile virus, has reported about 150 of the nation’s cases — more than double what other states are reporting. &lt;/p&gt;&lt;p&gt;Fort Collins is a hot spot. Monitoring last month in an area in the southwest part of the city found that 35 out of every 1,000 female mosquitoes were infected — far higher than the 8 per 1,000 that would be expected for that time of year — said Roxanne Connelly, a CDC entomologist who lives there.&lt;/p&gt;&lt;p&gt;It’s not clear why, but she noted it’s been a wet and warm year.&lt;/p&gt;&lt;p&gt;___&lt;/p&gt;&lt;p id="optimizelyHubpeekId" class="optimizelyHubpeekClass"&gt;&lt;/p&gt;&lt;p&gt;The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.&lt;/p&gt;
                                    &lt;/div&gt;
                                
                            

                            
                    &lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>AP News</author><pubDate>Wed, 10 Sep 2025 22:06:00 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMifkFVX3lxTE1pTno4QzNlWmpwTFgzbDJaWFBsQWFHX2dSUy05THA1eGZKYldSQzV4UDBLN013cVlIRnpJUENVQUZYNG9iQlBUb0RDNjQ0VlJwTnhTdFRQb0VjV0plYjN1SEFUekdKN1l4QXdWN01XMmhnT2taenA4a09sVy1TQQ</guid></item><item><title>沃尔格林表示，由于加利福尼亚州新冠肺炎发病率飙升，疫苗无需“证明”。- SFGATE</title><link>https://www.sfgate.com/bayarea/article/walgreens-covid-vaccine-california-21041231.php</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="r1udwkp5 d1uy5mhj articleBody mb32" data-block-type="text" data-dropcap="false"&gt;&lt;p&gt;For weeks, COVID-19 activity has been circulating in California, with &lt;a href="https://skylab.cdph.ca.gov/calwws/" data-link="native" class=""&gt;wastewater &lt;/a&gt;showing high levels of the virus since June. &lt;/p&gt;&lt;/div&gt;&lt;div class="r1udwkp5 d1uy5mhj articleBody mb32" data-block-type="text" data-dropcap="false"&gt;&lt;p&gt;Now, hospitalizations are spiking in the state, rising 144% since early July through the end of August, although hospitalization levels are still significantly lower than the COVID-19 spikes California saw in the winter of 2020 and 2021. And while overall levels in the Bay Area are no longer spiking, they are still increasing in most San Francisco test sites.&lt;/p&gt;&lt;/div&gt;&lt;div class="r1udwkp5 d1uy5mhj articleBody mb32" data-block-type="text" data-dropcap="false"&gt;&lt;p&gt;Unlikely previous years, the Food and Drug Administration has put more limits on who qualifies for the COVID-19 vaccine. Adults under the age of 65 only &lt;a href="https://www.sfgate.com/bayarea/article/covid-19-flu-vaccine-explainer-21033342.php" data-link="native" class=""&gt;qualify for a COVID-19 vaccine&lt;/a&gt; if they have an &lt;a href="https://www.cdc.gov/covid/hcp/clinical-care/underlying-conditions.html" data-link="native" class=""&gt;underlying condition&lt;/a&gt;.&lt;/p&gt;&lt;/div&gt;&lt;div class="r1udwkp5 d1uy5mhj articleBody mb32" data-block-type="text" data-dropcap="false"&gt;&lt;p&gt;In a statement to SFGATE, a Walgreens official confirmed that many adults under 65 do not need a prescription if they want the shot. The spokesperson said the COVID-19 vaccine is available for people who qualify, and no extra “proof” is needed if people confirm they have an underlying condition such as diabetes, asthma or depression.&lt;/p&gt;&lt;/div&gt;&lt;div class="r1udwkp5 d1uy5mhj articleBody mb32" data-block-type="text" data-dropcap="false"&gt;&lt;p&gt;“Patients may self-attest to their qualifying condition—no proof or additional documentation is required,” Walgreens spokesperson Brigid Sweeny told SFGATE in an email. “We encourage anyone with questions about their eligibility or personal risk factors to speak directly with our pharmacists, who are available to provide guidance and support.”&lt;/p&gt;&lt;/div&gt;&lt;div class="r1udwkp5 d1uy5mhj articleBody mb32" data-block-type="text" data-dropcap="false"&gt;&lt;p&gt;The new restrictions from the FDA have been &lt;a href="https://publications.aap.org/aapnews/news/33053/AAP-FDA-COVID-vaccine-recommendations-are-deeply" data-link="native" class=""&gt;criticized &lt;/a&gt;by medical groups. These groups, including the&lt;a href="https://www.aafp.org/news/media-center/statements/aafp-announces-fall-immunization-recommendations-reaffirming-commitment-to-vaccine-safety-and-public-health.html" data-link="native" class=""&gt; American Academy of Family Physicians&lt;/a&gt;, recommend all adults get a COVID-19 shot regardless of whether they have an underlying condition. &lt;/p&gt;&lt;/div&gt;&lt;div class="r1udwkp5 d1uy5mhj articleBody mb32" data-block-type="text" data-dropcap="false"&gt;&lt;p&gt;Dr. Monica Gandhi, an infectious disease physician at UC San Francisco, said the different advice from the FDA compared with major medical groups is confusing.&lt;/p&gt;&lt;/div&gt;&lt;div class="r1udwkp5 d1uy5mhj articleBody mb32" data-block-type="text" data-dropcap="false"&gt;&lt;p&gt;“The issue is that vagaries in the guidance is going to make it more difficult for people to get the vaccine,” Gandhi told SFGATE.&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>SFGATE</author><pubDate>Wed, 10 Sep 2025 21:17:22 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMijwFBVV95cUxQTFdFQ2s3Rlk2dW1EUEpKTGVzcnRnTnV6d3BueHBENUhBN1hLUXFScnM4NzF2U2l4Z2RxMjFaV0JXR3gxMmFRYkhZZnBsNEp6UFlLOS13MDllbi1XRUYtMi1neUtEdEQtV3ZVMWc0NVFBMW5kSU5iMklVMVYwSVBvOG90OFJoOU83MklCOHQyWQ</guid></item><item><title>美国死亡率降至2020年以来的最低水平， COVID不再是主要原因- CBS新闻</title><link>https://www.cbsnews.com/news/us-death-rate-2024-covid-cdc/</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;section class="content__body"&gt;
    &lt;p&gt;The mortality rate in the United States declined by 3.8% in 2024, and COVID-19 was no longer among the 10 leading causes of death, according to &lt;a href="https://www.cdc.gov/nchs/data/vsrr/vsrr039.pdf" target="_blank" rel="nofollow noopener"&gt;a federal report&lt;/a&gt; released Wednesday.&lt;/p&gt;&lt;p&gt;Using provisional death certificate data, the Centers for Disease Control and Prevention's National Center for Health Statistics estimates there were 3,072,039 deaths last year, which equates to about 722 deaths per 100,000 people compared to 750.5 per 100,000 in 2023. This is the lowest death rate since 2020, the authors of the report note.&lt;/p&gt;&lt;p&gt;And for the first time since 2020, COVID-19 was not one of the 10 leading causes of death. &lt;/p&gt;&lt;p&gt;The top three causes of death were heart disease with 683,037 deaths, cancer with 619,812 and unintentional injury with 196,488. The other leading causes were stroke, chronic lower respiratory disease, Alzheimer's disease, diabetes, kidney disease, chronic liver disease and cirrhosis, and suicide.&lt;/p&gt;&lt;p&gt;Despite the overall death rate decline, deaths for both heart disease and cancer, the two leading causes, increased from 2023. &lt;/p&gt;

    
&lt;p id="mpu-plus-outstream-middle" data-ad="mpu-plus-outstream-middle" class="ad-mpu-plus-outstream-middle ad-wrapper " data-ad-unit='"mpu-plus-outstream-middle"'&gt;
    &lt;/p&gt;
&lt;p&gt;Broken down by demographics, death rates were highest for males, older adults and Black people, the data shows.&lt;/p&gt;&lt;p&gt;The findings are limited due to the use of provisional data, but the estimates still give "researchers and policymakers an early signal about shifts in mortality trends," the authors said.&lt;/p&gt;&lt;p&gt;While heart disease is the leading cause of death in the U.S., &lt;span class="link"&gt;&lt;a href="https://www.cbsnews.com/news/heart-disease-risk-factors/" target="_blank" data-invalid-url-rewritten-http=""&gt;a survey from the Cleveland Clinic&lt;/a&gt;&lt;/span&gt; earlier this year found many Americans are unaware of the &lt;a href="https://www.cbsnews.com/video/watch-out-for-these-top-heart-disease-risk-factors/" target="_blank" rel="nofollow" data-invalid-url-rewritten-http=""&gt;risk factors&lt;/a&gt;, including things like tobacco use and air pollution. And the risk doesn't appear to be slowing anytime soon — &lt;span class="link"&gt;&lt;a href="https://www.cbsnews.com/news/61-percent-us-adults-cardiovascular-disease-2050-american-heart-association/" target="_blank" data-invalid-url-rewritten-http=""&gt;a 2024 report&lt;/a&gt;&lt;/span&gt; from the American Heart Association projected more than six in 10 U.S. adults, about 61%, will have some type of cardiovascular disease by 2050.&lt;/p&gt;

      

                    
        
      
        
    

    &lt;aside class="component list recirculation component--type-recirculation component--type-recirculation-collection"&gt;
                    
                                            
        &lt;div class="component__heading-wrapper"&gt;
          &lt;h3 class="component__title"&gt;Coronavirus Pandemic
                          &lt;a href="https://www.cbsnews.com/feature/coronavirus/?intcid=CNI-00-10aaa3a" class="component__view-more component__view-more--lg" data-invalid-url-rewritten-http=""&gt;
                More
                &lt;svg viewbox="0 0 32 32" class="icon__caret-right" aria-hidden="true"&gt;
                  &lt;use xlink:href="#icon-caret-down"&gt;&lt;/use&gt;
                &lt;/svg&gt;
              &lt;/a&gt;
                      &lt;/h3&gt;
        &lt;/div&gt;

        
                    &lt;/aside&gt;



    
      
    
  

          
  
        
      &lt;div class="content-author"&gt;
      &lt;a href="https://www.cbsnews.com/team/sara-moniuszko/" class="content-author__name" data-invalid-url-rewritten-http=""&gt;Sara  Moniuszko&lt;/a&gt;

      &lt;div class="content-author__bio"&gt;
        &lt;div class="content-author__full-information"&gt;
          &lt;p class="content-author__text"&gt;Sara Moniuszko is a health and lifestyle reporter at CBSNews.com. Previously, she wrote for USA Today, where she was selected to help launch the newspaper's wellness vertical. She now covers breaking and trending news for CBS News' HealthWatch.&lt;/p&gt;
        &lt;/div&gt;
      &lt;/div&gt;
    &lt;/div&gt;
        &lt;/section&gt;

  
  

  &lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>CBS News</author><pubDate>Wed, 10 Sep 2025 19:21:00 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMiakFVX3lxTE9kMGRvNmlKVjhxeGpERzAxYlFYSzBldTQwaEZ4aFdZX1NXQnRCby1oNktSRWZOelJnUm95LS16R1R2cXh4ODg2NjQxbUN0MXFUR3ZWaFZaZkZkeFRKbkVvLVNpWVZEWnNUaGfSAW9BVV95cUxOQm42ZVNnT0hJeVJORjFZN2paSFluOXAyNXhITWZ4T29zYktEMUZvMDhOTTZUZFlTWWpNUmo2VHZJUTd5SU5lVVE3OW5XTFNhc21FX3lhWUV0SlZUOXUxM1ZaSEdnNFVlM2lrdmZQR28</guid></item><item><title>宾夕法尼亚大学的研究人员发现杀死休眠的“睡眠”乳腺癌细胞可以防止复发- WHYY</title><link>https://whyy.org/articles/sleeper-dormant-breast-cancer-cells/</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="flexible-content-container wysiwyg-styles"&gt;
                    &lt;h2&gt;Reducing anxiety and providing reassurance for patients&lt;/h2&gt;
&lt;p&gt;The team at Penn is currently enrolling patients in &lt;a href="https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2021-12420"&gt;two ongoing&lt;/a&gt;, &lt;a href="https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2021-06208"&gt;large-scale studies&lt;/a&gt; that could help support their findings. Trial sites are located across the country, including &lt;a href="https://www.med.upenn.edu/acc-cancer-research/breast-cancer-tce/"&gt;at the University of Pennsylvania&lt;/a&gt; in Philadelphia.&lt;/p&gt;
&lt;p&gt;The ultimate goal, Chodosh said, is to not only identify and treat those who are at a higher risk of recurrence, but to be able to offer reassurance to survivors who don’t have dormant cells.&lt;/p&gt;
&lt;p&gt;“The goal would be to get a test that’s so good that, if you’re negative with this test, you could confidently say your risk of recurring is extremely low over the course of your lifetime,” he said. “That would have such a big benefit.”&lt;/p&gt;
&lt;p&gt;Researchers are also following breast cancer survivors who don’t ever test positive for dormant cancer cells in order to compare their long-term survival outcomes to those who get treated for sleeper cells.&lt;/p&gt;
&lt;p&gt;Some clinicians and experts were worried about whether participation in these kinds of trials would cause more distress in survivors, DiMichele said. But her team studied that, too, and found it to be the opposite.&lt;/p&gt;
&lt;p&gt;“Regardless of the answer, whether the patient found out they were positive or negative, overall their anxiety went down,” she said. “And we think it’s because, and what patients tell us is, ‘Look, at least I’m doing something.’ It was the not doing something, not knowing, that was so anxiety-provoking.”&lt;/p&gt;
&lt;p&gt;Over the years, LaScala has become more involved in research efforts and now serves as a patient advocate on research boards at Penn, where she can help shape studies and participant guidelines.&lt;/p&gt;
&lt;p&gt;Among breast cancer survivors, she said there has always been passion and an eagerness for &lt;a href="https://whyy.org/articles/breast-density-cancer-mammogram-counseling/"&gt;advancing testing&lt;/a&gt; and &lt;a href="https://www.cancer.org/cancer/types/breast-cancer/treatment.html"&gt;treatment options&lt;/a&gt; for everyone — survivors, people actively battling disease and those who may one day get a diagnosis.&lt;/p&gt;
&lt;p&gt;“It’s so energizing,” LaScala said. “To be around the research and to be able to participate … it’s incredible.”&lt;/p&gt;
        &lt;/div&gt;
      &lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>WHYY</author><pubDate>Wed, 10 Sep 2025 19:03:20 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMib0FVX3lxTE05M0YxNG9fYk5qVVVacFhfUmZuNlBHZ1Z1aVd2QjBPdW9yZEhkajVITEpiLW5DVFkxRXQ5MWczYWVvM3YzRkI4enpKRWRjcVBYRmhmeG5BaUk3eC1DdlBCbWFjeURDVUFPd3lXVGNIaw</guid></item><item><title>莱姆病的未经批准的测试和替代疗法正在增殖- PBS</title><link>https://www.pbs.org/newshour/health/unapproved-tests-and-alternative-treatments-for-lyme-disease-are-proliferating</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="body-text"&gt;
                    &lt;p&gt;WASHINGTON (AP) — Lyme disease can cause serious harm, but so can bogus tests and treatments.&lt;/p&gt;
&lt;p&gt;The complexity of diagnosing the tick-borne disease has given rise to an entire industry of unapproved tests and unproven alternative treatments that experts say should be avoided, including lasers, herbal remedies and electromagnets&lt;/p&gt;
&lt;p&gt;“It really is a buyer-beware situation,” said Dr. Robert Smith, a Lyme specialist at MaineHealth Institute for Research.&lt;/p&gt;
&lt;p&gt;There is no one-size-fits-all approach to diagnosing Lyme. Doctors use a combination of visual clues, information reported by their patients and the standard medical test, which has a number of limitations.&lt;/p&gt;
&lt;p&gt;When patients show the classic symptoms — including a bull’s eye rash, fever and fatigue — a short course of antibiotics usually resolves them. But a subset of patients will go on to experience months or even years of arthritis, pain and fatigue — poorly understood symptoms that overlap with a number of other medical conditions.&lt;/p&gt;
&lt;p&gt;That has left an opening for so-called “nonstandard” Lyme tests and treatments. Interest in those products has been amplified by influencers and a growing list of celebrities attributing various health problems to the disease, most recently Justin Timberlake.&lt;/p&gt;
&lt;p&gt;That might lead patients to spend hundreds or thousands of dollars on bogus tests, which aren’t covered by insurance, followed by unapproved treatments that may do more harm than good. And it’s possible some of them may not have had Lyme at all.&lt;/p&gt;
&lt;p&gt;In a recent consensus report from the National Academies of Sciences, Engineering, and Medicine, Smith and other experts called for more funding and research into the chronic symptoms experienced by some Lyme patients.&lt;/p&gt;
&lt;p&gt;“The key thing is that these people are suffering and we need to come up with strategies to alleviate that suffering, whatever the trigger was,” Smith said.&lt;/p&gt;
&lt;p&gt;At the same time, Smith and his colleagues warn that “profiteering entities” are pushing Lyme products that are “costly, may not work and may cause harm.”&lt;/p&gt;
&lt;p&gt;Here’s a look at the established approach for testing and treating Lyme and how to spot unproven alternatives.&lt;/p&gt;
&lt;h3&gt;The standard Lyme test comes with limits&lt;/h3&gt;
&lt;p&gt;First identified 50 years ago, Lyme disease takes its name from the Connecticut town where the earliest cases were diagnosed.&lt;/p&gt;
&lt;p&gt;The challenge of diagnosing it begins with the standard laboratory test, which comes with a number of caveats that must be carefully weighed.&lt;/p&gt;
&lt;p&gt;The bacteria that causes Lyme, carried by certain ticks in the Northeast and Midwest, doesn’t circulate throughout the body. Often it stays in the skin near the tick bite, making it hard to detect.&lt;/p&gt;
&lt;p&gt;Instead, Lyme tests look for antibodies, proteins that help fight off foreign invaders, which usually only appear in the blood several weeks after an infection.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;WATCH: &lt;/strong&gt;&lt;a href="https://www.pbs.org/newshour/show/what-more-can-be-done-to-treat-lyme-disease-and-its-potential-long-term-effects"&gt;What more can be done to treat Lyme disease and its potential long-term effects&lt;/a&gt;&lt;/p&gt;
&lt;p&gt;That’s the best approach available, but experts acknowledge its shortcomings: If the test is given too early it will come back negative because antibodies haven’t yet appeared.&lt;/p&gt;
&lt;p&gt;“That’s one of the problems,” Smith says. “We can’t say for sure in the first couple of weeks that it’s Lyme disease or not based on these tests.”&lt;/p&gt;
&lt;p&gt;Also, these antibodies continue to circulate in the blood long after the infection. That means the test can return a positive result years or even decades later — making it difficult to distinguish between a new case and an old one.&lt;/p&gt;
&lt;p&gt;Medical guidelines deal with this ambiguity by recommending doctors diagnose and start antibiotics in all patients who have the signature bull’s eye rash associated with Lyme. But as many as 30% of those infected never get the rash, causing further uncertainty.&lt;/p&gt;
&lt;h3&gt;Unproven options for testing are plentiful&lt;/h3&gt;
&lt;p&gt;The limitations of the approved test has opened the door to alternative tests, ranging from over-the-counter kits to specialty laboratories.&lt;/p&gt;
&lt;p&gt;The more expensive tests are often ordered by self-described “Lyme literate” physicians and health providers, who may have backgrounds in fields unrelated to infectious disease, like homeopathy.&lt;/p&gt;
&lt;p&gt;Spotting unproven Lyme tests is relatively easy, since only antibody blood tests are approved by the Food and Drug Administration.&lt;/p&gt;
&lt;p&gt;Any Lyme test available for sale at a drugstore or website is unapproved, says Andrea Love, a microbiologist and director of the American Lyme Disease Foundation. Another red flag is the use of saliva, urine or other bodily fluids besides blood to detect Lyme.&lt;/p&gt;
&lt;p&gt;“When you see these other tests appear on the market, it’s very likely that they’re not accurate and haven’t done their due diligence, which should make people skeptical” Love says.&lt;/p&gt;
&lt;p&gt;Patients will bear most of the costs for unapproved tests, which may provide inaccurate information and derail a diagnosis for other conditions that are sometimes mistaken for Lyme, such as rheumatoid arthritis.&lt;/p&gt;
&lt;p&gt;While acceptance of post-treatment Lyme is growing, Love and some other experts recommend caution when approaching the topic. Studies estimate that 10% to 20% of people treated for Lyme will have ongoing symptoms that can’t be clearly explained. But she and others point to startlingly high numbers of people reporting such problems in regions that have no documented history of Lyme, such as Australia.&lt;/p&gt;
&lt;p&gt;“The sheer number of people who believe they have these post-treatment Lyme symptoms is orders of magnitude higher than what you would expect among people who legitimately have Lyme,” she said.&lt;/p&gt;
&lt;h3&gt;Serious risks with alternative Lyme treatments&lt;/h3&gt;
&lt;p&gt;While the downsides of ineffective Lyme tests are considerable, experts say they are often the gateway to even riskier therapies.&lt;/p&gt;
&lt;p&gt;A recent medical paper documented nearly 120 clinics across the U.S. offering unproven Lyme treatments, some with consultation fees as high as $3,000.&lt;/p&gt;
&lt;p&gt;Treatments include electrical stimulation, “ozone-based therapy” and hyperbaric oxygen therapy, procedures that aren’t covered by insurance and can carry price tags as high as $6,000.&lt;/p&gt;
&lt;p&gt;Love and other doctors say the most worrisome approach involves long-term intravenous use of antibiotics — sometimes multiple drugs for years.&lt;/p&gt;
&lt;p&gt;While antibiotics are effective for quickly killing Lyme bacteria, multiple large studies have shown no benefits to their long-term use for chronic Lyme symptoms.&lt;/p&gt;
&lt;p&gt;Smith and other experts have reported cases of patients who spent years getting regular antibiotic infusions, only to develop life-threatening gut infections after the drugs killed off healthy bacteria needed to support the digestive tract.&lt;/p&gt;
&lt;p&gt;“There is clearly harm being done to people who are suffering and who, out of desperation, take on these great expenses or can be harmed by treatments that are not proven effective,” Smith said.&lt;/p&gt;

                                            &lt;div class="inline-invite inline-invite-type__funding inline-invite-style__default"&gt;
        
                    &lt;div class="inline-invite-funding__box"&gt;
                &lt;figure class="invite__logo"&gt;
                    &lt;svg class="svg"&gt;&lt;use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#pbs-newshour-horiz-refresh"&gt;&lt;/use&gt;&lt;/svg&gt;
                &lt;/figure&gt;
                &lt;p class="invite_heading"&gt;
                    We're not going anywhere.
                &lt;/p&gt;
                &lt;p class="invite_body"&gt;
                    Stand up for truly independent, trusted news that you can count on!
                &lt;/p&gt;
                &lt;a href="https://give.newshour.org/page/85597/donate/1?ea.tracking.id=nh_july_2025_rescission_article&amp;amp;supporter.appealCode=N2507QW07000AA" class="donation-link ga-click-funding ga-click-ender-funding"&gt;
                    &lt;button class="donate-button"&gt;Donate now&lt;/button&gt;
                    &lt;svg viewbox="0 0 16 16" fill="#000000" class="bi bi-arrow-right-short" version="1.1" id="svg1" xmlns="http://www.w3.org/2000/svg" xmlns:svg="http://www.w3.org/2000/svg"&gt;
                    &lt;defs id="defs1"&gt;&lt;/defs&gt;
                    &lt;path fill-rule="evenodd" d="M4 8a.5.5 0 0 1 .5-.5h5.793L8.146 5.354a.5.5 0 1 1 .708-.708l3 3a.5.5 0 0 1 0 .708l-3 3a.5.5 0 0 1-.708-.708L10.293 8.5H4.5A.5.5 0 0 1 4 8z" id="path1"&gt;&lt;/path&gt;
                    &lt;/svg&gt;
                &lt;/a&gt;
            &lt;/div&gt;
            &lt;/div&gt;


                                    &lt;/div&gt;
            &lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>PBS</author><pubDate>Wed, 10 Sep 2025 18:48:17 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">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</guid></item><item><title>新泽西州成为扩大COVID-19疫苗接种的最新州- ABC新闻</title><link>https://abcnews.go.com/Health/new-jersey-latest-state-expand-access-covid-19/story?id=125444856</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="xvlfx ZRifP TKoO eaKKC EcdEg bOdfO qXhdi NFNeu UyHES " data-testid="prism-article-body"&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao MvWXB TjIXL aGjvy ebVHC "&gt;New Jersey has become the &lt;a class="zZygg UbGlr iFzkS qdXbA WCDhQ DbOXS tqUtK GpWVU iJYzE " data-testid="prism-linkbase" href="https://www.nj.gov/health/news/2025/approved/20250909a.shtml" target="_blank" dir="ltr"&gt;latest state to sign orders&lt;/a&gt; expanding access to COVID-19 vaccines, breaking with guidance from federal health agencies.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;The state Department of Health issued an executive directive on Tuesday allowing anyone aged six months or older to receive an updated COVID-19 vaccine, in time for the upcoming respiratory virus season.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;The agency issued a separate order directing pharmacists to administer COVID-19 vaccines without a prescription to those who are three years and older.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;"At a time when COVID-19 cases are increasing across the country and as part of my Administration's dedication to evidence-based public health action, I am committed to ensuring everyone in New Jersey who wants to receive a COVID-19 vaccination can receive a dose this fall from trusted health professionals," Gov. Phil Murphy said in a statement.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;In a statement to ABC News, Andrew Nixon, spokesperson for the Department of Health and Human Services (HHS), said, "Democrat-run states that pushed unscientific school lockdowns, toddler mask mandates, and draconian vaccine passports during the COVID era completely eroded the American people's trust in public health agencies."&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;He added that the Centers for Disease Control and Prevention's (CDC) vaccine advisory committee "remains the scientific body guiding immunization recommendations in this country, and HHS will ensure policy is based on rigorous evidence and Gold Standard Science, not the failed politics of the pandemic."&lt;/p&gt;&lt;div class="oLzSq QrHMO fnRUo pvsTF EhJPu vPlOC zNYgW OsTsW RMeqy daRVX ISNQ sKyCY eRftA acPPc MENS nFwaT MCnQE mEeeY SmBjI xegrY rPLsU iulOd NIuqO zzscu lzDCc aHUBM IEgzD OjMNy eQqcx SVqKB GQmdz jaoD VWDdR ONJdw vrZxD OnRTz gbbfF roDbV GPGwb oMlSS gfNzt oJhud eXZcf zhVlX "&gt;&lt;div&gt;&lt;div class="InlineImage GpQCA lZur asrEW " data-testid="prism-inline-image"&gt;&lt;figure class="kzIjN GNmeK pYrtp dSqFO " data-testid="prism-figure"&gt;&lt;figcaption&gt;&lt;div class="nMMea bNYiy Mjgpa dGwha DDmxa jgKNG RGHCC aBIU PriDW lZur " data-testid="prism-caption"&gt;&lt;p class="HXPPJ barbu yKsXL IzgMt VcHIt uhSzI YGNMU cRAsZ xqMcl QtRul "&gt;&lt;span class="hsDdd OOSI GpQCA lZur VlFaz " data-testid="prism-truncate"&gt;&lt;span&gt;&lt;span class="gtOSm FbbUW tUtYa vOCwz EQwFq yCufu eEak Qmvg nyTIa SRXVc vzLa jgBfc WXDas CiUCW kqbG zrdEG txGfn ygKVe BbezD UOtxr CVfpq xijV soGRS XgdC sEIlf daWqJ "&gt;In this Jan. 9, 2024, file photo, New Jersey Governor Phil Murphy delivers his State of the State address to a joint session of the Legislature at the Statehouse in Trenton, N.J.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p class="qinlA IpWvx oqZz tylGM lyWxS nWcVF UhTug PPcLh YxlyB "&gt;&lt;span class="gtOSm FbbUW tUtYa vOCwz EQwFq yCufu eEak Qmvg nyTIa SRXVc vzLa jgBfc WXDas CiUCW kqbG zrdEG txGfn ygKVe BbezD UOtxr CVfpq xijV soGRS XgdC sEIlf daWqJ YNujN JGtjI aZFDu rkKLh "&gt;Matt Rourke/AP, FILE&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/figcaption&gt;&lt;/figure&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;It comes two weeks after the Food and Drug Administration &lt;a class="zZygg UbGlr iFzkS qdXbA WCDhQ DbOXS tqUtK GpWVU iJYzE " data-testid="prism-linkbase" href="https://abcnews.go.com/Health/fda-approves-updated-covid-vaccines-restrictions-receive/story?id=125032817" target="_blank" dir="ltr"&gt;approved updated COVID-19 vaccines&lt;/a&gt; with restrictions. The vaccines were approved for use in all adults aged 65 and older and younger Americans with at least one underlying condition.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;New Jersey health officials said in a press release that the changes to COVID-19 vaccine access, announced by HHS Secretary Robert F. Kennedy Jr. on &lt;a class="zZygg UbGlr iFzkS qdXbA WCDhQ DbOXS tqUtK GpWVU iJYzE " data-testid="prism-linkbase" href="https://x.com/SecKennedy/status/1960742897201872969" target="_blank" dir="ltr"&gt;social media&lt;/a&gt;, "bypassed the normal scientific review process, creating confusion and uncertainty, especially because they conflicted with previous CDC recommendations."&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;Following the FDA's approval, CVS, the nation's largest pharmacy chain, said it would continue to offer COVID-19 vaccines for those who fall under the new FDA authorization.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;But in another 13 states, people will need a prescription to get a COVID shot, even if they are older or high-risk.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;Walgreens, another large pharmacy chain, said it would give shots where it was legally able to do so, but didn't specify which states would have which rules.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;In response, states, including New York and Minnesota, issued executive orders in an effort to protect vaccine access.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;Minnesota Gov. Tim Walz issued an &lt;a class="zZygg UbGlr iFzkS qdXbA WCDhQ DbOXS tqUtK GpWVU iJYzE " data-testid="prism-linkbase" href="https://content.govdelivery.com/attachments/MNGOV/2025/09/08/file_attachments/3381381/Executive%20Order%2025-09.pdf" target="_blank" dir="ltr"&gt;executive order&lt;/a&gt; directing the state epidemiologist to issue a standing order – a written protocol allowing health care professionals to perform specific tasks or provide certain treatments for the COVID-19 vaccine.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;Walz's office said in a &lt;a class="zZygg UbGlr iFzkS qdXbA WCDhQ DbOXS tqUtK GpWVU iJYzE " data-testid="prism-linkbase" href="https://mn.gov/governor/newsroom/press-releases/#/detail/appId/1/id/704332" target="_blank" dir="ltr"&gt;press release&lt;/a&gt; that this will "provide greater flexibility for health care providers and pharmacists to provide the vaccine."&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;New York's &lt;a class="zZygg UbGlr iFzkS qdXbA WCDhQ DbOXS tqUtK GpWVU iJYzE " data-testid="prism-linkbase" href="https://www.governor.ny.gov/executive-order/no-52-declaring-disaster-state-new-york-due-federal-actions-related-vaccine-access" target="_blank" dir="ltr"&gt;order&lt;/a&gt; allows physicians and nurse practitioners to issue patient-specific or non-patient-specific orders to pharmacists to administer COVID-19 vaccines among patients aged three and older.&lt;/p&gt;&lt;div class="oLzSq QrHMO fnRUo pvsTF EhJPu vPlOC zNYgW OsTsW RMeqy daRVX ISNQ sKyCY eRftA acPPc MENS nFwaT MCnQE mEeeY SmBjI xegrY rPLsU iulOd NIuqO zzscu lzDCc aHUBM IEgzD OjMNy eQqcx SVqKB GQmdz jaoD VWDdR ONJdw vrZxD OnRTz gbbfF roDbV GPGwb oMlSS gfNzt oJhud eXZcf zhVlX "&gt;&lt;div&gt;&lt;div class="InlineImage GpQCA lZur asrEW " data-testid="prism-inline-image"&gt;&lt;figure class="kzIjN GNmeK pYrtp dSqFO " data-testid="prism-figure"&gt;&lt;figcaption&gt;&lt;div class="nMMea bNYiy Mjgpa dGwha DDmxa jgKNG RGHCC aBIU PriDW lZur " data-testid="prism-caption"&gt;&lt;p class="HXPPJ barbu yKsXL IzgMt VcHIt uhSzI YGNMU cRAsZ xqMcl QtRul "&gt;&lt;span class="hsDdd OOSI GpQCA lZur VlFaz " data-testid="prism-truncate"&gt;&lt;span&gt;&lt;span class="gtOSm FbbUW tUtYa vOCwz EQwFq yCufu eEak Qmvg nyTIa SRXVc vzLa jgBfc WXDas CiUCW kqbG zrdEG txGfn ygKVe BbezD UOtxr CVfpq xijV soGRS XgdC sEIlf daWqJ "&gt;A pharmacy manager administers a patient with a COVID-19 vaccine at a CVS Pharmacy in Miami, Sept. 9, 2025.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p class="qinlA IpWvx oqZz tylGM lyWxS nWcVF UhTug PPcLh YxlyB "&gt;&lt;span class="gtOSm FbbUW tUtYa vOCwz EQwFq yCufu eEak Qmvg nyTIa SRXVc vzLa jgBfc WXDas CiUCW kqbG zrdEG txGfn ygKVe BbezD UOtxr CVfpq xijV soGRS XgdC sEIlf daWqJ YNujN JGtjI aZFDu rkKLh "&gt;Rebecca Blackwell/AP&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/figcaption&gt;&lt;/figure&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;The order also expands permits pharmacists to prescribe COVID-19 vaccines themselves for the first time.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;"I promised New Yorkers that their family would be my fight. In the absence of federal leadership, we must do everything we can to ensure that New Yorkers have access to the vaccines and preventative healthcare they have come to rely on," Gov. Kathy Hochul said in a &lt;a class="zZygg UbGlr iFzkS qdXbA WCDhQ DbOXS tqUtK GpWVU iJYzE " data-testid="prism-linkbase" href="https://www.governor.ny.gov/news/governor-hochul-signs-executive-order-expanding-access-vaccines-amid-uncertainty-washington" target="_blank" dir="ltr"&gt;statement.&lt;/a&gt; "By signing this executive order, we are sending a clear message that when Washington Republicans play politics with public health, New Yorkers can still get the care they need, close to home, from trusted providers in their own communities."&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;Meanwhile, states on the West Coast and several on the East Coast are forming geographic coalitions to offer their own consistent vaccine guidelines, which they say are backed by evidence and informed by major national medical groups.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC eTIW sUzSN "&gt;&lt;em class=" "&gt;ABC News' Cheyenne Haslett contributed to this report.&lt;/em&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>ABC News</author><pubDate>Wed, 10 Sep 2025 18:45:00 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMimwFBVV95cUxNTjV3T3RZanNNX1B5a1VMNGpmaWxUczZfN0Y4bF8xTkpjMjU4T0s0VmhMM0g2VmZaXzFfZW1qQXNkakxUcndVMlNQLVZXakVNdDJLdDlkTW14NkhXenFRcEpfODExSXE0UVB2MTlRY0ViQ2RyaWVLWU1RRjNWb2M1RElycGJsZGFOU01uTVg2WXNCeGxvMGZRLVhDVdIBoAFBVV95cUxQelZNQmVXTWI2eFkxM0VDVEh2aDBWMjJEN2dJdkRUSjI3LVRENFJEZWFZNGI0d0w1UnFMbWFteHI1aURCUXFyR3RfUTNvWXlFckkxOTQ2d21SZlllYUNsajUyZjFyTkRxV2ZrWDhfVDB3b1Y1ekhhNFhaLWVZa2toNU90MFMxNm8tblhGTkQ3VFRxQWV5dnlEZ2swOFVwVUFt</guid></item><item><title>研究人员说， “接吻虫”疾病现在在美国流行。您需要了解的信息。- KUSA.com</title><link>https://www.9news.com/article/news/nation-world/kissing-bug-disease-chagas-disease-now-endemic-in-us-researchers-say/507-6557279f-b15b-434c-b2be-2bc128d9e3fd</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;body id="readabilityBody"&gt;
&lt;h1&gt;Access Denied&lt;/h1&gt;
 
You don't have permission to access "http://www.9news.com/article/news/nation-world/kissing-bug-disease-chagas-disease-now-endemic-in-us-researchers-say/507-6557279f-b15b-434c-b2be-2bc128d9e3fd" on this server.&lt;p&gt;
Reference #18.1db74d68.1757546809.f23e31ec
&lt;/p&gt;&lt;p&gt;https://errors.edgesuite.net/18.1db74d68.1757546809.f23e31ec&lt;/p&gt;
&lt;/body&gt;
&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>KUSA.com</author><pubDate>Wed, 10 Sep 2025 18:37:00 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMi7gFBVV95cUxNVmNSRVVsalFIVVZFbGFFM0Y4WldTYzF3NHhuX2YtTGUyUk84X2UwaHRIMjA5RlRveWtzWU5fcm5aWDBGdTF4SmNuWlpUYXlUdGlTRlhpQl8zUS1NWXRzUnFTTUxPdHRmZno5NklHeEtVOXktN0IyaHZuTTVrY0tmeGVBZkJKNzRyaklEclFIdTRhVVFBVF83TlIwbEYzSjMwZDdZUDM4dlhZVFR3QkthVXhVMm5EOTFBS1RjaGdvd2JwLVZyUmZTdDkwa1QtYldSei1sSFpHN1dhTUFhb3c4RmNqa2NxQzhvbGQxekF3</guid></item><item><title>波动的DNA甲基化在临床规模上跟踪癌症演变-自然</title><link>https://www.nature.com/articles/s41586-025-09374-4</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="c-article-section__content" id="Sec10-content"&gt;&lt;h3 class="c-article__sub-heading" id="Sec11"&gt;Assembly and quality control of DNA methylation data&lt;/h3&gt;&lt;p&gt;We assembled and processed with a harmonized pipeline&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 14" title="Duran-Ferrer, M. et al. The proliferative history shapes the DNA methylome of B-cell tumors and predicts clinical outcome. Nat. Cancer 1, 1066–1081 (2020)." href="/articles/s41586-025-09374-4#ref-CR14" id="ref-link-section-d423344494e2464"&gt;14&lt;/a&gt;&lt;/sup&gt; (v4.1; see Code availability section) 2,430 bulk sample Illumina methylation array data of normal and neoplastic lymphoid cells from previous publications&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 14" title="Duran-Ferrer, M. et al. The proliferative history shapes the DNA methylome of B-cell tumors and predicts clinical outcome. Nat. Cancer 1, 1066–1081 (2020)." href="/articles/s41586-025-09374-4#ref-CR14" id="ref-link-section-d423344494e2468"&gt;14&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Kulis, M. et al. Whole-genome fingerprint of the DNA methylome during human B cell differentiation. Nat. Genet. 47, 746–756 (2015)." href="#ref-CR21" id="ref-link-section-d423344494e2471"&gt;21&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Nordlund, J. et al. Genome-wide signatures of differential DNA methylation in pediatric acute lymphoblastic leukemia. Genome Biol. 14, r105 (2013)." href="#ref-CR22" id="ref-link-section-d423344494e2471_1"&gt;22&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Reinius, L. E. et al. Differential DNA methylation in purified human blood cells: implications for cell lineage and studies on disease susceptibility. PLoS ONE 7, e41361 (2012)." href="#ref-CR23" id="ref-link-section-d423344494e2471_2"&gt;23&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Lee, S. T. et al. Epigenetic remodeling in B-cell acute lymphoblastic leukemia occurs in two tracks and employs embryonic stem cell-like signatures. Nucleic Acids Res. 43, 2590–2602 (2015)." href="#ref-CR24" id="ref-link-section-d423344494e2471_3"&gt;24&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Queirós, A. C. et al. Decoding the DNA methylome of mantle cell lymphoma in the light of the entire B cell lineage. Cancer Cell 30, 806–821 (2016)." href="#ref-CR25" id="ref-link-section-d423344494e2471_4"&gt;25&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Nadeu, F. et al. Genomic and epigenomic insights into the origin, pathogenesis, and clinical behavior of mantle cell lymphoma subtypes. Blood 136, 1419–1432 (2020)." href="#ref-CR26" id="ref-link-section-d423344494e2471_5"&gt;26&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Nadeu, F. et al. Detection of early seeding of Richter transformation in chronic lymphocytic leukemia. Nat. Med. 28, 1662–1671 (2022)." href="#ref-CR27" id="ref-link-section-d423344494e2471_6"&gt;27&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Oakes, C. C. et al. DNA methylation dynamics during B cell maturation underlie a continuum of disease phenotypes in chronic lymphocytic leukemia. Nat. Genet. 48, 253–264 (2016)." href="#ref-CR28" id="ref-link-section-d423344494e2471_7"&gt;28&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Dietrich, S. et al. Drug-perturbation-based stratification of blood cancer. J. Clin. Invest. 128, 427–445 (2018)." href="#ref-CR29" id="ref-link-section-d423344494e2471_8"&gt;29&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 30" title="Agirre, X. et al. Whole-epigenome analysis in multiple myeloma reveals DNA hypermethylation of B cell-specific enhancers. Genome Res. 25, 478–487 (2015)." href="/articles/s41586-025-09374-4#ref-CR30" id="ref-link-section-d423344494e2474"&gt;30&lt;/a&gt;&lt;/sup&gt;. As healthy control samples, this dataset contained sorted CD19&lt;sup&gt;+&lt;/sup&gt; B cells (&lt;i&gt;n&lt;/i&gt; = 40), CD3&lt;sup&gt;+&lt;/sup&gt; T cells (&lt;i&gt;n&lt;/i&gt; = 35), peripheral blood mononuclear cells (&lt;i&gt;n&lt;/i&gt; = 6) and whole-blood samples (&lt;i&gt;n&lt;/i&gt; = 6). As tumour samples, we included precursor 797 B-ALLs and 90 T-ALLs at diagnosis, 28 B-ALLs and 2 T-ALLs at relapse, as well as 74 B-ALLs and 12 T-ALLs at complete remission (that is, normal blood); 149 MCLs; 722 CLLs, 55 of its precursor condition MBL and 6 samples from patients with CLL undergoing a DLBCL transformation called Richter transformation; 62 primary DLBCL, not otherwise specified; and 104 multiple myeloma and 16 of its precursor condition monoclonal gammopathy of undetermined significance. In brief, raw idat files were loaded and processed with R (v4.3.1) using the minfi package&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 50" title="Aryee, M. J. et al. Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics 30, 1363–1369 (2014)." href="/articles/s41586-025-09374-4#ref-CR50" id="ref-link-section-d423344494e2495"&gt;50&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 51" title="Fortin, J.-P., Triche, T. J. Jr &amp;amp; Hansen, K. D. Preprocessing, normalization and integration of the Illumina HumanMethylationEPIC array with minfi. Bioinformatics 33, 558–560 (2017)." href="/articles/s41586-025-09374-4#ref-CR51" id="ref-link-section-d423344494e2498"&gt;51&lt;/a&gt;&lt;/sup&gt; (v1.46.0) in batches as specified in the column ‘SSNOB_NORMALIZATION_BATCH’ of Supplementary Table &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41586-025-09374-4#MOESM3"&gt;2&lt;/a&gt;. In brief, the data were processed for each batch as follows. First, idats files were loaded into a RGChannelSet object, and minfi quality metrics using the qcReport function were performed, removing samples with unexpected distributions of methylation values (that is, distributions markedly distinct from a bimodal centred around 0 and 1 β-values and/or from the remaining samples) and low signal intensities of internal control probes for each sample, including bisulfite conversions I and II, extension hybridization, hybridization, non-polymorphic, specificities I and II, and target removal probes.&lt;/p&gt;&lt;p&gt;Next, further quality metrics were derived using the function minfiQC on the unnormalized RGChannelSet obejct. Those samples with median signal intensities of unmethylated and methylated channels of at least 10.5 in log&lt;sub&gt;2&lt;/sub&gt; scale were considered as having good signal intensities. Subsequently, detection &lt;i&gt;P&lt;/i&gt; values were calculated across all CpGs and samples using the detectionP function for the unnormalized RGChannelSet object. Samples were considered as good if having a mean detection &lt;i&gt;P&lt;/i&gt; value across all CpGs of &lt;i&gt;P&lt;/i&gt; ≤ 0.01. On a CpG level, we retained CpGs with a detection &lt;i&gt;P&lt;/i&gt; ≤ 1 × 10&lt;sup&gt;−16&lt;/sup&gt; in 90% or more of the samples, which has been shown to improve the quality of downstream analyses&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 52" title="Lehne, B. et al. A coherent approach for analysis of the Illumina HumanMethylation450 BeadChip improves data quality and performance in epigenome-wide association studies. Genome Biol. 16, 37 (2015)." href="/articles/s41586-025-09374-4#ref-CR52" id="ref-link-section-d423344494e2525"&gt;52&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 53" title="Zhou, W., Triche, T. J., Laird, P. W. &amp;amp; Shen, H. SeSAMe: reducing artifactual detection of DNA methylation by Infinium BeadChips in genomic deletions. Nucleic Acids Res. 46, e123 (2018)." href="/articles/s41586-025-09374-4#ref-CR53" id="ref-link-section-d423344494e2528"&gt;53&lt;/a&gt;&lt;/sup&gt;. The RGChannelSet object was normalized with the single-sample batch-independent preprocessNoob function with dye bias correction. We next retained only CpGs (excluding CH probes) that did not contain any SNP neither in the interrogated CpGs nor in the probe extension using the dropMethylationLoci and dropLociWithSnps functions with default options (minor allele frequency (MAF) = 0). Further analyses using long-read nanopore data, Illumina array control probes, annotation packages and a data-driven approach were used to ensure the lack of any genetic confounding in the methylation values of the resulting fCpGs (see the next sections).&lt;/p&gt;&lt;p&gt;Furthermore, CpGs with any previous evidence of potential cross-hybridization were excluded&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 54" title="Chen, Y. A. et al. Discovery of cross-reactive probes and polymorphic CpGs in the Illumina Infinium HumanMethylation450 microarray. Epigenetics 8, 203–209 (2013)." href="/articles/s41586-025-09374-4#ref-CR54" id="ref-link-section-d423344494e2535"&gt;54&lt;/a&gt;&lt;/sup&gt; and only CpGs mapping to autosomal chromosomes were subsequently retained for downstream analyses. Finally, to further confirm the accuracy of the filtering criteria, we checked the distribution of normalized methylation values and performed principal component analyses separately for samples passing all quality checks as well as those considered as bad samples. The final DNA methylation matrix contained 2,204 samples and 389,180 CpGs passing all the aforementioned quality controls, and included 2,054 patients (22 technical replicates, 3 synchronic and 125 longitudinal samples from the same patients)&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 55" title="Duran-Ferrer, M., Gabbutt, C., Martin-Subero, J. I. &amp;amp; Graham, T. Harmonised methylation array matrix related to the article Fluctuating DNA methylation tracks cancer evolution at clinical scale. Zenodo 
                https://doi.org/10.5281/ZENODO.15479737
                
               (2025)." href="/articles/s41586-025-09374-4#ref-CR55" id="ref-link-section-d423344494e2539"&gt;55&lt;/a&gt;&lt;/sup&gt; (Supplementary Table &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41586-025-09374-4#MOESM3"&gt;2&lt;/a&gt;).&lt;/p&gt;&lt;p&gt;To determine the purity of samples, we used our previously deconvolution strategy to infer tumour cell content by DNA methylation&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 14" title="Duran-Ferrer, M. et al. The proliferative history shapes the DNA methylome of B-cell tumors and predicts clinical outcome. Nat. Cancer 1, 1066–1081 (2020)." href="/articles/s41586-025-09374-4#ref-CR14" id="ref-link-section-d423344494e2549"&gt;14&lt;/a&gt;&lt;/sup&gt;, which was used as a consensus purity in all the tumour samples except for DLBCL and multiple myeloma. In these two tumour entities, we have previously identified a DNA methylation signature loss causing inaccurate tumour purity predictions using DNA methylation data, and therefore we used available genetic or flow cytometry data for DLBCL and multiple myeloma, respectively.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec12"&gt;Pipeline to select fluctuating CpGs&lt;/h3&gt;&lt;p&gt;We constructed a pipeline to identify fCpGs in lymphoid tumours, based on the following criteria:&lt;/p&gt;&lt;ol class="u-list-style-none"&gt;
                &lt;li&gt;
                  &lt;span class="u-custom-list-number"&gt;(1)&lt;/span&gt;
                  
                    &lt;p&gt;Heterogeneous across different participants with the same disease (by accepting CpG loci with the top 5% of standard deviation of methylation value within a cancer type).&lt;/p&gt;
                  
                &lt;/li&gt;
                &lt;li&gt;
                  &lt;span class="u-custom-list-number"&gt;(2)&lt;/span&gt;
                  
                    &lt;p&gt;Equally likely to be methylated or unmethylated (by selecting CpGs with average methylation of approximately 0.5 within a cancer type).&lt;/p&gt;
                  
                &lt;/li&gt;
                &lt;li&gt;
                  &lt;span class="u-custom-list-number"&gt;(3)&lt;/span&gt;
                  
                    &lt;p&gt;Unlikely to be associated with specific cell or cancer types. We used an unsupervised Laplacian score feature selection metric&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 56" title="He, X., Cai, D. &amp;amp; Niyogi, P. Laplacian score for feature selection. In Advances in Neural Information Processing Systems 18 (eds. Weiss, Y., Schölkopf, B. &amp;amp; Platt, J.) (MIT Press, 2005)." href="/articles/s41586-025-09374-4#ref-CR56" id="ref-link-section-d423344494e2593"&gt;56&lt;/a&gt;&lt;/sup&gt; to rank CpG loci by their tendency to preserve the nearest-neighbour graph, and accepted the 5% least-informative CpGs.&lt;/p&gt;
                  
                &lt;/li&gt;
              &lt;/ol&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec13"&gt;Exclusion of genetic confounding on fCpGs&lt;/h3&gt;&lt;p&gt;We performed a series of analyses to exclude the potential genetic confounding (germline SNPs and somatic SNVs) on our fCpGs. We first excluded the possibility that common germline SNPs caused methylation heterogeneity at fCpG sites between individuals. We observed very distinct methylation dynamics of array control probes containing SNPs (which had been removed during the initial array processing) versus fCpGs. SNP probes showed the same distribution in all samples (Extended Data Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-09374-4#Fig7"&gt;2c&lt;/a&gt;), including longitudinally followed cases (Supplementary Fig. &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41586-025-09374-4#MOESM1"&gt;3&lt;/a&gt;), whereas fCpGs only showed a W distribution in cancer samples with ongoing fluctuations over time. Thus, although SNPs reflect the stable genetic identity of the individual, fCpGs reflect the identity of a single cell and its evolving lineage. In addition, we used the packages SNPlocs.Hsapiens.dbSNP155.GRCh38 (v0.99.24) and MafH5.gnomAD.v4.0.GRCh38 (v3.19) to check for any known significant germline or somatic genetic confounding on the resulting 978 fCpGs. We found approximately 60% of fCpGs reported in the gnomAD v4 database (with the array background having approximately 65%), but with a very low MAF (median of 1 × 10&lt;sup&gt;−5&lt;/sup&gt; and mean of 1 × 10&lt;sup&gt;−3&lt;/sup&gt;). To exclude the possibility of unknown or very rare genetic confounding, we used the data-driven gaphunting algorithm&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 57" title="Andrews, S. V., Ladd-Acosta, C., Feinberg, A. P., Hansen, K. D. &amp;amp; Fallin, M. D. “Gap hunting” to characterize clustered probe signals in Illumina methylation array data. Epigenetics Chromatin 9, 56 (2016)." href="/articles/s41586-025-09374-4#ref-CR57" id="ref-link-section-d423344494e2618"&gt;57&lt;/a&gt;&lt;/sup&gt; available in the minfi R package, which further discarded a possible cancer-specific single-nucleotide variation (SNV) that could confound the methylation values at the 978 identified fCpGs. Finally, Oxford Nanopore long read of a subset of normal and neoplastic samples further validated that fCpGs represent de/methylated cytosines (Extended Data Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-09374-4#Fig7"&gt;2d,e&lt;/a&gt;; see next section).&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec14"&gt;Generation and analyses of long-read nanopore data&lt;/h3&gt;&lt;p&gt;For long-read methylation sequencing in CLL and Richter transformation samples, concentration was assessed using the Qubit assay and DNA integrity was analysed either with the Femto Pulse System (Agilent) or the Fragment Analyzer (Agilent). When more than 6 µg of material with good integrity was available, DNA was additionally treated with the Short Fragment Eliminator Kit XS (PacBio) and eluted in EB buffer. Approximately 4 µg of DNA was used for library preparation according to the standard LSK114 kit and protocol from Oxford Nanopore. The time for DNA repair and end-prep was increased up to 30 min at 20 °C and 30 min at 65 °C. Adapter ligation was performed for 1 h at room temperature. All elutions were performed at 37 °C for 1.5 h, and 550–600 ng of DNA was loaded onto a FLO-PRO114M (CLL cells) flow cells. Flow cells were washed (EXP-WSH004) after 1–2 days, if pore count decreased to less than 30%. A total of 1–4 washes were performed for each flow cell. Flow cells were run for 100 (CLL cells) hours in total with the Fast model (MinKNOW 23.11.7, Dorado 7.2.13). The raw data were rebasecalled using dorado duplex (v0.5.3) and applying the SUP and modified call to detect 5mC and 5hmC, (model dna_r10.4.1_e8.2_400bps_sup@v4.3.0_5mCG_5hmCG@v1).&lt;/p&gt;&lt;p&gt;In normal B cell samples, 1–3 µg of DNA was used for WGS. Libraries were prepared with the DNA ligation kit LSK110 with no modifications. Libraries were loaded onto a flow cell version FLO-PRO002 (R9.4) and were run for 90–110 h. The basecalling was performed on live mode with the Guppy basecaller (v6.2.7), included in the MinKNOW (v22.08.6), using the SUP model for base modification detection of 5mC and 5hmC (dna_r9.4.1_450bps_modbases_5hmc_5mc_cg_sup.cfg).&lt;/p&gt;&lt;p&gt;In all samples, the generated unmapped BAM files after the basecalling were converted to FASTQ files using the SAMtools fastq -T Mm, Ml command. The FASTQ files were then mapped to BAM files using the command minimap2 -ax map-ont -y../GCA_000001405.15_GRCh38_no_alt_analysis_set.fna.mmi. The methylation values were extracted from the BAMs into bedMethyl files using the in-house tool bam2bedmethyl (v0.3.2) and compressed/indexed using bgzip/tabix. Reads from each strand were combined to generate DNA matrices for each CpG and were used for obtaining the methylation values of all fCpGs.&lt;/p&gt;&lt;p&gt;In addition, mini BAM files containing all reads from the 976 fCpGs were generated (in hg38 genome assembly). The reads showed excellent mappability, with a mean of perfect nucleotide matches (NM tag; Levenshtein distance) for all fCpGs across samples of 96.41% (range of 73.31–97.90), and mean mapping quality (MAPQ) of all the reads covering all fCpGs across samples of 59.510 (range of 2–60). Subsequently, long reads were phased using variants called using Clair 3 (v1.0.9, model r941_prom_hac_g360 + g422)&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 58" title="Zheng, Z. et al. Symphonizing pileup and full-alignment for deep learning-based long-read variant calling. Nat. Comput. Sci. 2, 797–803 (2022)." href="/articles/s41586-025-09374-4#ref-CR58" id="ref-link-section-d423344494e2643"&gt;58&lt;/a&gt;&lt;/sup&gt; with the Longphase package (v1.7)&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 59" title="Lin, J. H., Chen, L. C., Yu, S. C. &amp;amp; Huang, Y. T. LongPhase: an ultra-fast chromosome-scale phasing algorithm for small and large variants. Bioinformatics 38, 1816–1822 (2022)." href="/articles/s41586-025-09374-4#ref-CR59" id="ref-link-section-d423344494e2647"&gt;59&lt;/a&gt;&lt;/sup&gt;. The methylation status of each CpG was called using the modcall function within the Longphase package. At fCpGs, only 2.7% of the reads were non-canonical bases (Extended Data Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-09374-4#Fig7"&gt;2d&lt;/a&gt;). The variant allele frequency (VAF) of these mutations tended to be low and was negatively correlated with the coverage at that site (Supplementary Fig. &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41586-025-09374-4#MOESM1"&gt;4a&lt;/a&gt;). Hence, the majority of these non-canonical base pairs are probably due to errors in nucleotide assignment. There is also no association between the methylation status of different reads and the variants present within a 50-bp window of each fCpG locus (Supplementary Fig. &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41586-025-09374-4#MOESM1"&gt;4b&lt;/a&gt;). Hence, assessment of fCpG methylation via bead array was not majorly confounded by miscalled variants. The fCpG methylation patterns seen in the bead array data were replicated in the long-read data (Extended Data Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-09374-4#Fig7"&gt;2e&lt;/a&gt;) and the correlation between the fraction methylated measured via bead array and long-read sequencing at fCpGs was excellent (Extended Data Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-09374-4#Fig7"&gt;2e&lt;/a&gt;). The same correspondence was observed in WGBS data (Extended Data Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-09374-4#Fig7"&gt;2f&lt;/a&gt;).&lt;/p&gt;&lt;p&gt;To assess the intra-sample long-read diversity for each sample, the pairwise Hamming distances were calculated between every read on both haplotypes. The two lists of Hamming distances were concatenated, and the mean calculated as a summary statistic of the read diversity for each sample. One normal B cell sample contained only two reads from one haplotype, and zero from the other, and so was excluded from further analysis.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec15"&gt;Analysis of scRRBS data&lt;/h3&gt;&lt;p&gt;Previously published single-cell reduced representation bisulfite sequencing (scRRBS) data were obtained&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 6" title="Gaiti, F. et al. Epigenetic evolution and lineage histories of chronic lymphocytic leukaemia. Nature 569, 576–580 (2019)." href="/articles/s41586-025-09374-4#ref-CR6" id="ref-link-section-d423344494e2683"&gt;6&lt;/a&gt;&lt;/sup&gt; and the fCpG methylation values extracted methylation values for normal B cells from 6 donors and CLL cells from 12 patients. There was a high dropout rate, so to extract meaningful patterns we plotted a subset of 40 cells and 20 fCpGs with a high density and overlap of fCpGs across single cells as examples (Supplementary Fig. &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41586-025-09374-4#MOESM1"&gt;5a,b&lt;/a&gt;).&lt;/p&gt;&lt;p&gt;To compare the full set of data accounting for the high degree of missing data, we used a metric of heterogeneity at a given fCpG that weights by the number of non-missing fCpGs according to:&lt;/p&gt;&lt;div id="Equa" class="c-article-equation"&gt;&lt;p class="c-article-equation__content"&gt;&lt;span class="mathjax-tex"&gt;$${d}_{i}=\sqrt{\frac{{n}_{i}({n}_{i}-1)}{2}}\sigma ({\beta }_{i})$$&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p&gt;Where &lt;i&gt;n&lt;/i&gt;&lt;sub&gt;&lt;i&gt;i&lt;/i&gt;&lt;/sub&gt; is the number of non-NaN values for the &lt;i&gt;i&lt;/i&gt;th fCpG, &lt;span class="mathjax-tex"&gt;\(\frac{n(n-1)}{2}\)&lt;/span&gt; is the total possible pairwise comparisons between a set of &lt;i&gt;n&lt;/i&gt; objects and &lt;i&gt;σ&lt;/i&gt;(&lt;i&gt;β&lt;/i&gt;&lt;sub&gt;&lt;i&gt;i&lt;/i&gt;&lt;/sub&gt;) is the standard deviation across the methylation values of the &lt;i&gt;i&lt;/i&gt;th fCpG (Supplementary Fig. &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41586-025-09374-4#MOESM1"&gt;5c&lt;/a&gt;).&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec16"&gt;Characterization and annotation of fCpGs&lt;/h3&gt;&lt;p&gt;To characterize the genomic and regulatory context of fCpGs, we used a series of statistical analyses and database annotations. We annotated fCpGs using Illumina manifest and other genomic annotation packages available at Bioconductor including IlluminaHumanMethylation450kanno.ilmn12.hg19 (v0.6.1) and IlluminaHumanMethylationEPICanno.ilm10b2.hg19 (v0.6.0). We additionally used the packages SNPlocs.Hsapiens.dbSNP155.GRCh38 (v0.99.24) and MafH5.gnomAD.v4.0.GRCh38 (v3.19) to check any possible germline or somatic genetic confounding on the resulting 978 fCpGs. We found approximately 60% of fCpGs reported in the gnomAD v4 database (with the array background having approximately 65%), but with a very low MAF (median of 1 × 10&lt;sup&gt;−5&lt;/sup&gt; and mean of 1 × 10&lt;sup&gt;−3&lt;/sup&gt;). In addition, we used the Illumina 450k and EPIC array internal SNP probes and showed a dramatically distinct methylation dynamics compared with fCpGs in single-timepoint (Extended Data Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-09374-4#Fig7"&gt;2c&lt;/a&gt;) and longitudinal (Supplementary Fig. &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41586-025-09374-4#MOESM1"&gt;3&lt;/a&gt;) samples. Finally, the data-driven gaphunting algorithm available in the minfi R package was applied with all the previously published thresholds and cut-offs&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 57" title="Andrews, S. V., Ladd-Acosta, C., Feinberg, A. P., Hansen, K. D. &amp;amp; Fallin, M. D. “Gap hunting” to characterize clustered probe signals in Illumina methylation array data. Epigenetics Chromatin 9, 56 (2016)." href="/articles/s41586-025-09374-4#ref-CR57" id="ref-link-section-d423344494e2907"&gt;57&lt;/a&gt;&lt;/sup&gt;, which further discarded possible cancer-specific SNV that could confound the methylation values at the 978 identified fCpGs.&lt;/p&gt;&lt;p&gt;We used Chi-squared tests to assess the enrichment of fCpGs in distinct genomic regions or elements. We performed gene-set enrichment analysis on the fCpG-associated genes using gProfiler&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 60" title="Raudvere, U. et al. g:Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update). Nucleic Acids Res. 47, W191–W198 (2019)." href="/articles/s41586-025-09374-4#ref-CR60" id="ref-link-section-d423344494e2914"&gt;60&lt;/a&gt;&lt;/sup&gt;, specifically focusing on the Gene Ontology biological processes&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 61" title="Ashburner, M. et al. Gene Ontology: tool for the unification of biology. Nat. Genet. 25, 25–29 (2000)." href="/articles/s41586-025-09374-4#ref-CR61" id="ref-link-section-d423344494e2918"&gt;61&lt;/a&gt;&lt;/sup&gt; and the Human Protein Atlas&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 62" title="Uhlén, M. et al. Tissue-based map of the human proteome. Science 347, 1260419 (2015)." href="/articles/s41586-025-09374-4#ref-CR62" id="ref-link-section-d423344494e2922"&gt;62&lt;/a&gt;&lt;/sup&gt;. The statistical domain space was limited to genes targeted by at least one CpG in the 389,180 candidate CpG set and significance was determined using the g:SCS algorithm&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 63" title="Reimand, J., Kull, M., Peterson, H., Hansen, J. &amp;amp; Vilo, J. g:Profiler — a web-based toolset for functional profiling of gene lists from large-scale experiments. Nucleic Acids Res. 35, W193–W200 (2007)." href="/articles/s41586-025-09374-4#ref-CR63" id="ref-link-section-d423344494e2926"&gt;63&lt;/a&gt;&lt;/sup&gt;. Previous chromatin segmentation of normal and neoplastic B cells was used to assess the chromatin-state enrichment of fCpG&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 14" title="Duran-Ferrer, M. et al. The proliferative history shapes the DNA methylome of B-cell tumors and predicts clinical outcome. Nat. Cancer 1, 1066–1081 (2020)." href="/articles/s41586-025-09374-4#ref-CR14" id="ref-link-section-d423344494e2930"&gt;14&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 64" title="Beekman, R. et al. The reference epigenome and regulatory chromatin landscape of chronic lymphocytic leukemia. Nat. Med. 24, 868–880 (2018)." href="/articles/s41586-025-09374-4#ref-CR64" id="ref-link-section-d423344494e2933"&gt;64&lt;/a&gt;&lt;/sup&gt;.&lt;/p&gt;&lt;p&gt;fCpGs were checked for their overlap with previous ‘epigenetic clocks’, including mitotic&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 14" title="Duran-Ferrer, M. et al. The proliferative history shapes the DNA methylome of B-cell tumors and predicts clinical outcome. Nat. Cancer 1, 1066–1081 (2020)." href="/articles/s41586-025-09374-4#ref-CR14" id="ref-link-section-d423344494e2940"&gt;14&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Yang, Z. et al. Correlation of an epigenetic mitotic clock with cancer risk. Genome Biol. 17, 205 (2016)." href="#ref-CR65" id="ref-link-section-d423344494e2943"&gt;65&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Teschendorff, A. E. A comparison of epigenetic mitotic-like clocks for cancer risk prediction. Genome Med. 12, 56 (2020)." href="#ref-CR66" id="ref-link-section-d423344494e2943_1"&gt;66&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Youn, A. &amp;amp; Wang, S. The MiAge Calculator: a DNA methylation-based mitotic age calculator of human tissue types. Epigenetics 13, 192–206 (2018)." href="#ref-CR67" id="ref-link-section-d423344494e2943_2"&gt;67&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 68" title="Zhou, W. et al. DNA methylation loss in late-replicating domains is linked to mitotic cell division. Nat. Genet. 50, 591–602 (2018)." href="/articles/s41586-025-09374-4#ref-CR68" id="ref-link-section-d423344494e2946"&gt;68&lt;/a&gt;&lt;/sup&gt;, chronological age&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Bocklandt, S. et al. Epigenetic predictor of age. PLoS ONE 6, e14821 (2011)." href="#ref-CR69" id="ref-link-section-d423344494e2950"&gt;69&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Garagnani, P. et al. Methylation of ELOVL2 gene as a new epigenetic marker of age. Aging Cell 11, 1132–1134 (2012)." href="#ref-CR70" id="ref-link-section-d423344494e2950_1"&gt;70&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Hannum, G. et al. Genome-wide methylation profiles reveal quantitative views of human aging rates. Mol. Cell 49, 359–367 (2013)." href="#ref-CR71" id="ref-link-section-d423344494e2950_2"&gt;71&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Horvath, S. DNA methylation age of human tissues and cell types. Genome Biol. 14, R115 (2013)." href="#ref-CR72" id="ref-link-section-d423344494e2950_3"&gt;72&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Lin, Q. et al. DNA methylation levels at individual age-associated CpG sites can be indicative for life expectancy. Aging 8, 394–401 (2016)." href="#ref-CR73" id="ref-link-section-d423344494e2950_4"&gt;73&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Vidal-Bralo, L., Lopez-Golan, Y. &amp;amp; Gonzalez, A. Simplified assay for epigenetic age estimation in whole blood of adults. Front. Genet. 7, 209192 (2016)." href="#ref-CR74" id="ref-link-section-d423344494e2950_5"&gt;74&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Weidner, C. I. et al. Aging of blood can be tracked by DNA methylation changes at just three CpG sites. Genome Biol. 15, R24 (2014)." href="#ref-CR75" id="ref-link-section-d423344494e2950_6"&gt;75&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Zhang, Q. et al. Improved precision of epigenetic clock estimates across tissues and its implication for biological ageing. Genome Med. 11, 54 (2019)." href="#ref-CR76" id="ref-link-section-d423344494e2950_7"&gt;76&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Horvath, S. et al. Epigenetic clock for skin and blood cells applied to Hutchinson Gilford progeria syndrome and ex vivo studies. Aging 10, 1758–1775 (2018)." href="#ref-CR77" id="ref-link-section-d423344494e2950_8"&gt;77&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 78" title="Shireby, G. L. et al. Recalibrating the epigenetic clock: implications for assessing biological age in the human cortex. Brain 143, 3763–3775 (2020)." href="/articles/s41586-025-09374-4#ref-CR78" id="ref-link-section-d423344494e2953"&gt;78&lt;/a&gt;&lt;/sup&gt;, gestational age&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Bohlin, J. et al. Prediction of gestational age based on genome-wide differentially methylated regions. Genome Biol. 17, 207 (2016)." href="#ref-CR79" id="ref-link-section-d423344494e2957"&gt;79&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Knight, A. K. et al. An epigenetic clock for gestational age at birth based on blood methylation data. Genome Biol. 17, 206 (2016)." href="#ref-CR80" id="ref-link-section-d423344494e2957_1"&gt;80&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Lee, Y. et al. Placental epigenetic clocks: estimating gestational age using placental DNA methylation levels. Aging 11, 4238–4253 (2019)." href="#ref-CR81" id="ref-link-section-d423344494e2957_2"&gt;81&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Mayne, B. T. et al. Accelerated placental aging in early onset preeclampsia pregnancies identified by DNA methylation. Epigenomics 9, 279–289 (2017)." href="#ref-CR82" id="ref-link-section-d423344494e2957_3"&gt;82&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 83" title="McEwen, L. M. et al. The PedBE clock accurately estimates DNA methylation age in pediatric buccal cells. Proc. Natl Acad. Sci. USA 117, 23329–23335 (2020)." href="/articles/s41586-025-09374-4#ref-CR83" id="ref-link-section-d423344494e2960"&gt;83&lt;/a&gt;&lt;/sup&gt;, biological age and mortality&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Belsky, D. W. et al. DunedinPACE, a DNA methylation biomarker of the pace of aging. eLife 11, e73420 (2022)." href="#ref-CR84" id="ref-link-section-d423344494e2964"&gt;84&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Levine, M. E. et al. An epigenetic biomarker of aging for lifespan and healthspan. Aging 10, 573–591 (2018)." href="#ref-CR85" id="ref-link-section-d423344494e2964_1"&gt;85&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 86" title="Lu, A. T. et al. DNA methylation GrimAge strongly predicts lifespan and healthspan. Aging 11, 303–327 (2019)." href="/articles/s41586-025-09374-4#ref-CR86" id="ref-link-section-d423344494e2967"&gt;86&lt;/a&gt;&lt;/sup&gt; and trait predictors&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 87" title="McCartney, D. L. et al. Epigenetic prediction of complex traits and death. Genome Biol. 19, 136 (2018)." href="/articles/s41586-025-09374-4#ref-CR87" id="ref-link-section-d423344494e2971"&gt;87&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 88" title="Liang, X. et al. DNA methylation signature on phosphatidylethanol, not on self-reported alcohol consumption, predicts hazardous alcohol consumption in two distinct populations. Mol. Psychiatry 26, 2238–2253 (2020)." href="/articles/s41586-025-09374-4#ref-CR88" id="ref-link-section-d423344494e2974"&gt;88&lt;/a&gt;&lt;/sup&gt;. The package methylCIPHER (&lt;a href="https://github.com/MorganLevineLab/methylCIPHER"&gt;https://github.com/MorganLevineLab/methylCIPHER&lt;/a&gt;) was used to obtain the CpGs for most of the epigenetic clocks. The package methylclock (v1.10.0) was used to calculate all epigenetic clocks but epiCMIT, which was derived as previously described&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 14" title="Duran-Ferrer, M. et al. The proliferative history shapes the DNA methylome of B-cell tumors and predicts clinical outcome. Nat. Cancer 1, 1066–1081 (2020)." href="/articles/s41586-025-09374-4#ref-CR14" id="ref-link-section-d423344494e2986"&gt;14&lt;/a&gt;&lt;/sup&gt;.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec17"&gt;CLL RNA sequencing data&lt;/h3&gt;&lt;p&gt;Previously available RNA sequencing data for 294 patients with CLL were obtained&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 33" title="Puente, X. S. et al. Non-coding recurrent mutations in chronic lymphocytic leukaemia. Nature 526, 519–524 (2015)." href="/articles/s41586-025-09374-4#ref-CR33" id="ref-link-section-d423344494e2998"&gt;33&lt;/a&gt;&lt;/sup&gt; and processed as previously described&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 26" title="Nadeu, F. et al. Genomic and epigenomic insights into the origin, pathogenesis, and clinical behavior of mantle cell lymphoma subtypes. Blood 136, 1419–1432 (2020)." href="/articles/s41586-025-09374-4#ref-CR26" id="ref-link-section-d423344494e3002"&gt;26&lt;/a&gt;&lt;/sup&gt;. Matched RNA sequencing data and DNA methylation data for the same patients at the same timepoint were available for 224 patients with CLL. Transcript per million counts were used to represent differential gene expression values across genes and samples. We used the gene annotation provided in the R Bioconductor package IlluminaHumanMethylationEPICanno.ilm10b2.hg19 to classify genes associated with fCpGs. Genes targeted by any fCpG were considered as ‘fCpG genes’.&lt;/p&gt;&lt;p&gt;In each methylation sample, the 978 fCpGs were discretized as homozygous demethylated, heterozygous methylated or homozygous methylated (coded as [0,1,2], respectively). This was done by separately fitting a β-mixture model with three components to each sample using Stan&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 89" title="Carpenter, B. et al. Stan: a probabilistic programming language. J. Stat. Softw. 76, 1 (2017)." href="/articles/s41586-025-09374-4#ref-CR89" id="ref-link-section-d423344494e3009"&gt;89&lt;/a&gt;&lt;/sup&gt; and extracting the component mixture probability. The gene expression value for genes classified as having and fCpG with 0, 1 or 2 alleles methylated were plotted as previously described.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec18"&gt;DNA methylation data from normal blood samples&lt;/h3&gt;&lt;p&gt;External DNA methylation data were download from the Gene Expression Omnibus database using the GEOquery R package (v2.72.0). For sorted immune cells, these include &lt;a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE137594"&gt;GSE137594&lt;/a&gt; and &lt;a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE184269"&gt;GSE184269&lt;/a&gt;. For whole-blood samples, these include &lt;a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE72773"&gt;GSE72773&lt;/a&gt;, &lt;a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE55763"&gt;GSE55763&lt;/a&gt;, &lt;a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE40279"&gt;GSE40279&lt;/a&gt; and &lt;a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE36054"&gt;GSE36054&lt;/a&gt;. Data were analysed with the normalization procedure used in each study together with the metadata provided. Mean and standard deviation for fCpGs were calculated with fCpGs present in the provided normalized matrices.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec19"&gt;A stochastic model of fCpGs in a growing population&lt;/h3&gt;&lt;p&gt;We built a generative computational model of how the patterns of fCpGs vary over time (&lt;i&gt;t&lt;/i&gt;) according to the evolutionary history of a cancer. Initially, our model focused on neutral evolution, before expanding to non-neutral modes of tumour evolution below. For the full explanation of the model, see the &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41586-025-09374-4#MOESM1"&gt;Supplementary Information&lt;/a&gt;.&lt;/p&gt;&lt;p&gt;Our model was parameterized in terms of the age of the patient at which the MRCA emerged (&lt;i&gt;τ&lt;/i&gt;), the exponential growth rate of the cancer (&lt;i&gt;θ&lt;/i&gt;) and the epigenetic switching rates of the fCpGs (&lt;i&gt;μ&lt;/i&gt;, &lt;i&gt;ν&lt;/i&gt;, &lt;i&gt;γ&lt;/i&gt; and &lt;i&gt;ζ&lt;/i&gt;). The model was partitioned into two phases: before and after the emergence of the MRCA. At time &lt;i&gt;t&lt;/i&gt; = 0, the fCpGs were assumed to be equally likely to be homozygously methylated or demethylated. The fCpG status of the MRCA at time &lt;i&gt;t&lt;/i&gt; = &lt;i&gt;τ&lt;/i&gt; was calculated by applying matrix exponentiation.&lt;/p&gt;&lt;p&gt;The second phase of the model consisted of a discrete time Markov process. The effective population size of the growing cancer was modelled as growing according to a deterministic exponential growth equation, &lt;i&gt;N&lt;/i&gt;&lt;sub&gt;&lt;i&gt;e&lt;/i&gt;&lt;/sub&gt; = &lt;i&gt;e&lt;/i&gt;&lt;sup&gt;&lt;i&gt;θ&lt;/i&gt;(&lt;i&gt;T&lt;/i&gt; − &lt;i&gt;τ&lt;/i&gt;)&lt;/sup&gt;. Each fCpG was considered independently; at each time step, &lt;i&gt;t&lt;/i&gt; → &lt;i&gt;t&lt;/i&gt; + &lt;i&gt;δt&lt;/i&gt;, the number of homozygous-methylated (&lt;i&gt;m&lt;/i&gt;), heterozygous-methylated (&lt;i&gt;k&lt;/i&gt;) and homozygous-demethylated cells (&lt;i&gt;w&lt;/i&gt;) at a specific fCpG was updated according to the epigenetic switching rates.&lt;/p&gt;&lt;p&gt;At the time of sample, &lt;i&gt;T&lt;/i&gt;, the fraction methylation of each simulated fCpG was calculated by summing the number of methylated alleles and normalizing by the total number of alleles in the population:&lt;/p&gt;&lt;div id="Equb" class="c-article-equation"&gt;&lt;p class="c-article-equation__content"&gt;&lt;span class="mathjax-tex"&gt;$${\beta }_{c}=\frac{k+2m}{2{N}_{e}}$$&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p&gt;We further accounted for contaminating normal cells and the technical noise introduced by the methylation bead array. The methylation of the contaminated samples was assumed to be an average of the cancer methylation, &lt;i&gt;β&lt;/i&gt;&lt;sub&gt;&lt;i&gt;c&lt;/i&gt;&lt;/sub&gt;(&lt;i&gt;t&lt;/i&gt;), weighted by the tumour purity &lt;i&gt;ρ&lt;/i&gt;, and the average of the normal population, &lt;i&gt;β&lt;/i&gt;&lt;sub&gt;&lt;i&gt;n&lt;/i&gt;&lt;/sub&gt;, weighted by &lt;i&gt;1&lt;/i&gt; − &lt;i&gt;ρ&lt;/i&gt;. Following our previous work, the bead array was assumed to saturate at extreme methylation values, shifting the minimum and maximum methylation by &lt;i&gt;δ&lt;/i&gt; and &lt;i&gt;ε&lt;/i&gt;, respectively&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 4" title="Gabbutt, C. et al. Fluctuating methylation clocks for cell lineage tracing at high temporal resolution in human tissues. Nat. Biotechnol. 40, 720–730 (2022)." href="/articles/s41586-025-09374-4#ref-CR4" id="ref-link-section-d423344494e3255"&gt;4&lt;/a&gt;&lt;/sup&gt;. The noise of the bead array was assumed to be β-distributed, with precision parameter &lt;i&gt;κ&lt;/i&gt;.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec20"&gt;Non-neutral models of tumour evolution&lt;/h3&gt;&lt;p&gt;Alongside our model of neutral exponentially growing cancer populations, we devised two alternative models of cancer growth:&lt;/p&gt;&lt;ol class="u-list-style-none"&gt;
                &lt;li&gt;
                  &lt;span class="u-custom-list-number"&gt;(1)&lt;/span&gt;
                  
                    &lt;p&gt;A subclonal selection model in which a single cell within the cancer develops a selective advantage and begins to grow at an increased growth rate.&lt;/p&gt;
                  
                &lt;/li&gt;
                &lt;li&gt;
                  &lt;span class="u-custom-list-number"&gt;(2)&lt;/span&gt;
                  
                    &lt;p&gt;An independent clonal origins model, in which a patient has developed two distinct cancers concurrently.&lt;/p&gt;
                  
                &lt;/li&gt;
              &lt;/ol&gt;&lt;p&gt;For the subclonal selection model, we replaced the growth rate (&lt;i&gt;θ&lt;/i&gt;) and the time of the MRCA (&lt;i&gt;τ&lt;/i&gt;) with the growth rates and time of the MRCA of the initial, slower-growing population (&lt;i&gt;θ&lt;/i&gt;&lt;sub&gt;1&lt;/sub&gt; and &lt;i&gt;τ&lt;/i&gt;&lt;sub&gt;1&lt;/sub&gt;, respectively), and that of the more recently emerging, faster-growing population (&lt;i&gt;θ&lt;/i&gt;&lt;sub&gt;2&lt;/sub&gt; and &lt;i&gt;τ&lt;/i&gt;&lt;sub&gt;2&lt;/sub&gt;), constraining &lt;i&gt;τ&lt;/i&gt;&lt;sub&gt;1&lt;/sub&gt; &amp;lt; &lt;i&gt;τ&lt;/i&gt;&lt;sub&gt;2&lt;/sub&gt; and &lt;i&gt;θ&lt;/i&gt;&lt;sub&gt;1&lt;/sub&gt; &amp;lt; &lt;i&gt;θ&lt;/i&gt;&lt;sub&gt;2&lt;/sub&gt; (Extended Data Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-09374-4#Fig13"&gt;8a&lt;/a&gt;). We assumed that the initial cancer population began exponentially growing at &lt;i&gt;τ&lt;/i&gt;&lt;sub&gt;1&lt;/sub&gt; as above, but at time &lt;i&gt;t&lt;/i&gt; = &lt;i&gt;τ&lt;/i&gt;&lt;sub&gt;2&lt;/sub&gt;, we selected a single cell with a set of fCpG states drawn according to the cancer population and allowed this second population to grow concurrently with a growth rate &lt;i&gt;θ&lt;/i&gt;&lt;sub&gt;2&lt;/sub&gt;.&lt;/p&gt;&lt;p&gt;The independent-cancer model followed the same scheme as the nested subclonal selection model, except the methylation status of the emerging cancer was that of an independent cell that experienced random fluctuations between &lt;i&gt;t&lt;/i&gt; = 0 and &lt;i&gt;t&lt;/i&gt; = &lt;i&gt;τ&lt;/i&gt;&lt;sub&gt;2&lt;/sub&gt;.&lt;/p&gt;&lt;p&gt;If we let the number of cells in the less fit subclone in each methylation state be {&lt;i&gt;m&lt;/i&gt;&lt;sub&gt;1&lt;/sub&gt;, &lt;i&gt;k&lt;/i&gt;&lt;sub&gt;1&lt;/sub&gt;, &lt;i&gt;w&lt;/i&gt;&lt;sub&gt;1&lt;/sub&gt;} and in the fitter subclone be {&lt;i&gt;m&lt;/i&gt;&lt;sub&gt;2&lt;/sub&gt;, &lt;i&gt;k&lt;/i&gt;&lt;sub&gt;2&lt;/sub&gt;, &lt;i&gt;w&lt;/i&gt;&lt;sub&gt;2&lt;/sub&gt;}, following the convention above, then in both cases the measured methylation patterns at the time of sample are:&lt;/p&gt;&lt;div id="Equc" class="c-article-equation"&gt;&lt;p class="c-article-equation__content"&gt;&lt;span class="mathjax-tex"&gt;$${\beta }_{c}(T)=\frac{{k}_{1}(T)+2{m}_{1}(T)+{k}_{2}(T)+2{m}_{2}(T)}{2{N}_{e}(T)}$$&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p&gt;Where &lt;span class="mathjax-tex"&gt;\({N}_{e}(T)={e}^{{\theta }_{1}(T-{\tau }_{1})}+{e}^{{\theta }_{2}(T-{\tau }_{2})}\)&lt;/span&gt;.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec21"&gt;Adaption of simulations to a longitudinal setting&lt;/h3&gt;&lt;p&gt;We modified the simulations of how the fCpG methylation distribution changes over time to allow for multiple sequential sample collections. These simulations allow for neutral, independent clones, a single subclonal expansion or two subclonal expansions, which can either be nested or emerge from the clonal trunk in parallel. This required pre-specification of sampling times, along with the emergence times of any subclones or independent clones, which we collected to form a set of ‘landmark times’. The discrete time steps of the simulation were split into phases between the landmark times, which evolved according to the discrete time Markov process outlined above. At each sampling time, the fCpG methylation fraction was calculated as above and stored as a column in the output matrix.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec22"&gt;Prior functions&lt;/h3&gt;&lt;p&gt;For each methylation array blood sample, we had matched age (&lt;i&gt;T&lt;/i&gt;) and purity (&lt;i&gt;ρ&lt;/i&gt;) information. Hence, the parameters to be inferred are the growth rate (&lt;i&gt;θ&lt;/i&gt;), the age of the patient when the MRCA emerged (&lt;i&gt;τ&lt;/i&gt;), the epigenetic switching rates (&lt;i&gt;μ&lt;/i&gt;, &lt;i&gt;ν&lt;/i&gt;, &lt;i&gt;γ&lt;/i&gt;, &lt;i&gt;ζ&lt;/i&gt;), the average fraction methylated of contaminating normal cells (&lt;i&gt;β&lt;/i&gt;&lt;sub&gt;&lt;i&gt;n&lt;/i&gt;&lt;/sub&gt;), the β-offsets from 0 and 1 due to the background noise on the methylation array (&lt;i&gt;δ&lt;/i&gt; and &lt;i&gt;ε&lt;/i&gt;, respectively) and the precision of the β-distributed noise (&lt;i&gt;κ&lt;/i&gt;).&lt;/p&gt;&lt;p&gt;These parameters are constrained either to be positive (&lt;i&gt;θ&lt;/i&gt;, &lt;i&gt;μ, ν&lt;/i&gt;, &lt;i&gt;γ&lt;/i&gt;, &lt;i&gt;ζ&lt;/i&gt;, &lt;i&gt;κ&lt;/i&gt; &amp;gt; 0) or to lie within a specified range (0 &amp;lt; &lt;i&gt;τ/T&lt;/i&gt;, &lt;i&gt;δ&lt;/i&gt;, &lt;i&gt;ε&lt;/i&gt; &amp;lt; 1), which we achieved using appropriate prior distributions. To better allow for priors to be set on a biologically meaningful scale, the priors for the log-normal distribution were set in terms of the real scale mean and standard deviation, rather than the standard log-scale. To reduce correlations in the posterior and make sampling more efficient, the variables &lt;i&gt;ν&lt;/i&gt; and &lt;i&gt;ζ&lt;/i&gt; were normalized by &lt;i&gt;μ&lt;/i&gt; and &lt;i&gt;γ&lt;/i&gt;, respectively.&lt;/p&gt;&lt;p&gt;The priors are as follows:&lt;/p&gt;&lt;div id="Equd" class="c-article-equation"&gt;&lt;p class="c-article-equation__content"&gt;&lt;span class="mathjax-tex"&gt;$$\theta  \sim {\rm{lognormal}}(\mathrm{3,2})$$&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div id="Eque" class="c-article-equation"&gt;&lt;p class="c-article-equation__content"&gt;&lt;span class="mathjax-tex"&gt;$$\frac{\tau }{T} \sim {\rm{beta}}(2,2)$$&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div id="Equf" class="c-article-equation"&gt;&lt;p class="c-article-equation__content"&gt;&lt;span class="mathjax-tex"&gt;$$\mu  \sim {\rm{halfnormal}}(0,0.05)$$&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div id="Equg" class="c-article-equation"&gt;&lt;p class="c-article-equation__content"&gt;&lt;span class="mathjax-tex"&gt;$$\gamma  \sim {\rm{halfnormal}}(0,0.05)$$&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div id="Equh" class="c-article-equation"&gt;&lt;p class="c-article-equation__content"&gt;&lt;span class="mathjax-tex"&gt;$$\frac{\upsilon }{\mu } \sim {\rm{lognormal}}(1,0.7)$$&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div id="Equi" class="c-article-equation"&gt;&lt;p class="c-article-equation__content"&gt;&lt;span class="mathjax-tex"&gt;$$\frac{\zeta }{\gamma } \sim {\rm{lognormal}}(1,0.7)$$&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div id="Equj" class="c-article-equation"&gt;&lt;p class="c-article-equation__content"&gt;&lt;span class="mathjax-tex"&gt;$${\beta }_{n} \sim {\rm{beta}}(2,2)$$&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div id="Equk" class="c-article-equation"&gt;&lt;p class="c-article-equation__content"&gt;&lt;span class="mathjax-tex"&gt;$$\delta  \sim {\rm{beta}}(5,95)$$&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div id="Equl" class="c-article-equation"&gt;&lt;p class="c-article-equation__content"&gt;&lt;span class="mathjax-tex"&gt;$${\epsilon } \sim {\rm{beta}}(95,5)$$&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div id="Equm" class="c-article-equation"&gt;&lt;p class="c-article-equation__content"&gt;&lt;span class="mathjax-tex"&gt;$$\kappa  \sim {\rm{halfnormal}}(100,30)$$&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p&gt;When fitting non-neutral models of tumour growth, the inference was parameterized in terms of the relative growth of the fitter subclone, &lt;span class="mathjax-tex"&gt;\({\tilde{\theta }}_{2}=\frac{{\theta }_{2}}{{\theta }_{1}}\)&lt;/span&gt;, and the fraction of the population consisting of the fitter subclone, &lt;span class="mathjax-tex"&gt;\(f=\frac{{e}^{{\theta }_{2}(t-{\tau }_{2})}}{{e}^{{\theta }_{1}(t-{\tau }_{1})}+{e}^{{\theta }_{2}(t-{\tau }_{2})}}\)&lt;/span&gt;. The age at which the second clone emerges is then:&lt;/p&gt;&lt;div id="Equn" class="c-article-equation"&gt;&lt;p class="c-article-equation__content"&gt;&lt;span class="mathjax-tex"&gt;$${\tau }_{2}=T-\frac{(T-{\tau }_{1}){\theta }_{1}}{{\theta }_{2}}-\frac{{\rm{logit}}(f)}{{\theta }_{2}}$$&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p&gt;This parameterization induces less correlation in the resulting posterior, which greatly improves the sampling efficiency. The priors on these additional parameters are:&lt;/p&gt;&lt;div id="Equo" class="c-article-equation"&gt;&lt;p class="c-article-equation__content"&gt;&lt;span class="mathjax-tex"&gt;$$\frac{{\tau }_{1}}{T} \sim {\rm{beta}}(2,2)$$&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div id="Equp" class="c-article-equation"&gt;&lt;p class="c-article-equation__content"&gt;&lt;span class="mathjax-tex"&gt;$${\widetilde{\theta }}_{2} \sim {\rm{lognormal}}(1,0.7)$$&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div id="Equq" class="c-article-equation"&gt;&lt;p class="c-article-equation__content"&gt;&lt;span class="mathjax-tex"&gt;$$f \sim {\rm{beta}}(2,2)$$&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p&gt;All the other priors were the same as in the neutral case.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec23"&gt;Bayesian inference&lt;/h3&gt;&lt;p&gt;We developed a stochastic estimator of the log-likelihood function at a given set of parameters by simulating the fCpG methylation distribution a large number of times, correcting for the bias inherent with using a finite number of simulations and penalizing the log-likelihood for extreme values of the &lt;i&gt;N&lt;/i&gt;&lt;sub&gt;&lt;i&gt;e&lt;/i&gt;&lt;/sub&gt; (see &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41586-025-09374-4#MOESM1"&gt;Supplementary Information&lt;/a&gt; for details).&lt;/p&gt;&lt;p&gt;The standard Bayesian algorithms developed to infer the posterior for a given set of data (for example, Markov chain Monte Carlo (MCMC), nested sampling) are typically used when the log-likelihood is analytically tractable and can be calculated exactly. It has been shown that, as long as the stochastic approximation of the log-likelihood is unbiased, MCMC methods can obtain an exact Bayesian inference of the true posterior, as in pseudo-marginal Metropolis–Hastings&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 90" title="Andrieu, C. &amp;amp; Roberts, G. O. The pseudo-marginal approach for efficient Monte Carlo computations. Ann. Statist. 
                https://doi.org/10.1214/07-AOS574
                
               (2009)." href="/articles/s41586-025-09374-4#ref-CR90" id="ref-link-section-d423344494e4874"&gt;90&lt;/a&gt;&lt;/sup&gt;.&lt;/p&gt;&lt;p&gt;Here we used a nested sampling approach using the dynesty package&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Skilling, J. Nested sampling. In AIP Conference Proceedings 735 (eds Fischer, R. et al.) 395–405 (AIP Publishing, 2004)." href="#ref-CR91" id="ref-link-section-d423344494e4881"&gt;91&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Skilling, J. Nested sampling for general Bayesian computation. Bayesian Anal. 1, 833–860 (2006)." href="#ref-CR92" id="ref-link-section-d423344494e4881_1"&gt;92&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 93" title="Speagle, J. S. dynesty: A dynamic nested sampling package for estimating Bayesian posteriors and evidences. Mon. Not. R. Astron. Soc. 493, 3132–3158 (2019)." href="/articles/s41586-025-09374-4#ref-CR93" id="ref-link-section-d423344494e4884"&gt;93&lt;/a&gt;&lt;/sup&gt;. Unlike pseudo-marginal Metropolis–Hastings, nested sampling is able to efficiently explore multimodal posterior landscapes (which can occur under the subclonal and independent cancer models).&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec24"&gt;Model selection for the mode of tumour evolution&lt;/h3&gt;&lt;p&gt;We used an expected log pointwise predictive density&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 94" title="Vehtari, A., Gelman, A. &amp;amp; Gabry, J. Practical Bayesian model evaluation using leave-one-out cross-validation and WAIC. Stat. Comput. 27, 1413–1432 (2015)." href="/articles/s41586-025-09374-4#ref-CR94" id="ref-link-section-d423344494e4896"&gt;94&lt;/a&gt;&lt;/sup&gt; approach to compare our competing models of evolution for each sample using the arviz Python package&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 95" title="Kumar, R., Carroll, C., Hartikainen, A. &amp;amp; Martin, O. ArviZ a unified library for exploratory analysis of Bayesian models in Python. J. Open Source Softw. 4, 1143 (2019)." href="/articles/s41586-025-09374-4#ref-CR95" id="ref-link-section-d423344494e4900"&gt;95&lt;/a&gt;&lt;/sup&gt;, which uses PSIS-LOO-CV to compare the out-of-sample prediction accuracy between models while naturally penalizing more complex models. This required the log-likelihood per data point and the posterior predictive for every point in the posterior. The weights of the respective models were calculated using pseudo-Bayesian model averaging using Akaike-type weighting, stabilized using the Bayesian bootstrap&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 96" title="Yao, Y., Vehtari, A., Simpson, D. &amp;amp; Gelman, A. Using stacking to average Bayesian predictive distributions. Bayesian Anal. 13, 917–1007 (2017)." href="/articles/s41586-025-09374-4#ref-CR96" id="ref-link-section-d423344494e4904"&gt;96&lt;/a&gt;&lt;/sup&gt;.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec25"&gt;CLL and Richter transformation genomic analyses&lt;/h3&gt;&lt;p&gt;Previous mutated annotation files from WES&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 46" title="Knisbacher, B. A. et al. Molecular map of chronic lymphocytic leukemia and its impact on outcome. Nat. Genet. 54, 1664–1674 (2022)." href="/articles/s41586-025-09374-4#ref-CR46" id="ref-link-section-d423344494e4916"&gt;46&lt;/a&gt;&lt;/sup&gt; and WGS&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 27" title="Nadeu, F. et al. Detection of early seeding of Richter transformation in chronic lymphocytic leukemia. Nat. Med. 28, 1662–1671 (2022)." href="/articles/s41586-025-09374-4#ref-CR27" id="ref-link-section-d423344494e4920"&gt;27&lt;/a&gt;&lt;/sup&gt; data were used to further validate our distinct EVOFLUx evolutionary modes (that is, neutral, subclonal and independent) and Richter transformation phylogenies.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec26"&gt;Subclonal deconvolution of WES and WGS data&lt;/h3&gt;&lt;p&gt;To detect subclones in bulk WES and WGS data, we used MOBSTER&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 43" title="Caravagna, G. et al. Subclonal reconstruction of tumors by using machine learning and population genetics. Nat. Genet. 52, 898–907 (2020)." href="/articles/s41586-025-09374-4#ref-CR43" id="ref-link-section-d423344494e4932"&gt;43&lt;/a&gt;&lt;/sup&gt;, which fits the VAF spectrum with a mixture model containing a Pareto distribution to account for the neutral tail&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 97" title="Williams, M. J., Werner, B., Barnes, C. P., Graham, T. A. &amp;amp; Sottoriva, A. Identification of neutral tumor evolution across cancer types. Nat. Genet. 48, 238–244 (2016)." href="/articles/s41586-025-09374-4#ref-CR97" id="ref-link-section-d423344494e4936"&gt;97&lt;/a&gt;&lt;/sup&gt; and a variable number of β-distributions to account for the clonal and subclonal peaks.&lt;/p&gt;&lt;p&gt;We ran MOBSTER using the default parameters, except using a minimum 5% VAF threshold and lowering the minimum number of mutations to compose a cluster to five in WES samples due to the low number of mutations. We then manually quality controlled all 377 WES samples and 10 WGS, tuning the fitting parameters to better represent the data (for instance, when the clonal peak had been called at a low frequency despite the median tumour purity being 95%).&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec27"&gt;Phylogenetic inference of longitudinal methylation data&lt;/h3&gt;&lt;p&gt;A novel Bayesian phylogenetic method was used to reconstruct the evolutionary relationships and the time to MRCA of longitudinal samples from the same patients. This was carried out in the BEAST (v1.8.4) framework&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 98" title="Drummond, A. J. &amp;amp; Rambaut, A. BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol. Biol. 7, 214 (2007)." href="/articles/s41586-025-09374-4#ref-CR98" id="ref-link-section-d423344494e4952"&gt;98&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 99" title="Drummond, A. J., Suchard, M. A., Xie, D. &amp;amp; Rambaut, A. Bayesian phylogenetics with BEAUti and the BEAST 1.7. Mol. Biol. Evol. 29, 1969–1973 (2012)." href="/articles/s41586-025-09374-4#ref-CR99" id="ref-link-section-d423344494e4955"&gt;99&lt;/a&gt;&lt;/sup&gt; using custom models implemented in PISCA&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 100" title="Martinez, P. et al. Evolution of Barrett’s esophagus through space and time at single-crypt and whole-biopsy levels. Nat. Commun. 9, 794 (2018)." href="/articles/s41586-025-09374-4#ref-CR100" id="ref-link-section-d423344494e4959"&gt;100&lt;/a&gt;&lt;/sup&gt; (v1.1; available from &lt;a href="https://github.com/adamallo/PISCA"&gt;https://github.com/adamallo/PISCA&lt;/a&gt;).&lt;/p&gt;&lt;p&gt;EVOFLUx provided an estimate of the age of the patient when the MRCA of each bulk sample emerged. To estimate the methylation status of each fCpG at the MRCA of the sample in each of our longitudinal samples, we discretized the fCpGs as described above (see the section ‘CLL RNA sequencing data’).&lt;/p&gt;&lt;p&gt;We implemented a four-parameter biallelic binary substitution model analogous to the pre-growth EVOFLUx model in PISCA. This plugin contains all the required statistical machinery to use this model for somatic phylogenetic estimation. The biallelic binary substitution model has three relative rate parameters: (1) heterozygous methylation &lt;span class="mathjax-tex"&gt;\(\tilde{\upsilon }\)&lt;/span&gt;, (2) homozygous demethylation &lt;span class="mathjax-tex"&gt;\(\tilde{\gamma }\)&lt;/span&gt;, and (3) heterozygous demethylation &lt;span class="mathjax-tex"&gt;\(\tilde{\zeta }\)&lt;/span&gt;, where homozygous methylation &lt;span class="mathjax-tex"&gt;\(\tilde{\mu }\)&lt;/span&gt; was normalized to 1. For all relative transition rate parameters, a log-normal prior with mean of 1 and standard deviation of 0.6 was used, with a half-normal prior with mean of 0 and standard deviation of 0.13 for the molecular clock rate, using a strict clock model for the rate of evolution across the tree. Two demographic tree models, constant population size&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 101" title="Kingman, J. F. C. The coalescent. Stoch. Process Appl. 13, 235–248 (1982)." href="/articles/s41586-025-09374-4#ref-CR101" id="ref-link-section-d423344494e5068"&gt;101&lt;/a&gt;&lt;/sup&gt; and exponential growth&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 102" title="Griffiths, R. C. &amp;amp; Tavaré, S. Sampling theory for neutral alleles in a varying environment. Phil. Trans. R. Soc. Lond. B 344, 403–410 (1994)." href="/articles/s41586-025-09374-4#ref-CR102" id="ref-link-section-d423344494e5073"&gt;102&lt;/a&gt;&lt;/sup&gt;, were compared by marginal likelihood estimation using path-sampling&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 103" title="Baele, G. et al. Improving the accuracy of demographic and molecular clock model comparison while accommodating phylogenetic uncertainty. Mol. Biol. Evol. 29, 2157–2167 (2012)." href="/articles/s41586-025-09374-4#ref-CR103" id="ref-link-section-d423344494e5077"&gt;103&lt;/a&gt;&lt;/sup&gt; and a constant population model was deemed more appropriate.&lt;/p&gt;&lt;p&gt;MCMC chains were run for 100 million generations sampled every 100,000 generations and convergence was assessed using Tracer (v.1.7)&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 104" title="Rambaut, A., Drummond, A. J., Xie, D., Baele, G. &amp;amp; Suchard, M. A. Posterior summarization in Bayesian phylogenetics using Tracer 1.7. Syst. Biol. 67, 901–904 (2018)." href="/articles/s41586-025-09374-4#ref-CR104" id="ref-link-section-d423344494e5084"&gt;104&lt;/a&gt;&lt;/sup&gt;, ensuring effective sample sizes (ESS) greater than 500 for all parameters. Maximum clade credibility trees were then made using 10% burn-in and medium node heights. The resulting trees were plotted using ggtree&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 105" title="Yu, G., Smith, D. K., Zhu, H., Guan, Y. &amp;amp; Lam, T. T. Y. ggtree: An r package for visualization and annotation of phylogenetic trees with their covariates and other associated data. Methods Ecol. Evol. 8, 28–36 (2017)." href="/articles/s41586-025-09374-4#ref-CR105" id="ref-link-section-d423344494e5088"&gt;105&lt;/a&gt;&lt;/sup&gt;.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec28"&gt;Phylogenetic inference of SNVs from WGS data&lt;/h3&gt;&lt;p&gt;Each bulk sample is represented by a set of clonal mutations found during the deconvolution of WGS data (see above). Where a mutation was deemed absent in the clonal peak, the reference nucleotide was used. Mutational signature assignment&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 106" title="Díaz-Gay, M. et al. Assigning mutational signatures to individual samples and individual somatic mutations with SigProfilerAssignment. Bioinformatics 39, 12 (2023)." href="/articles/s41586-025-09374-4#ref-CR106" id="ref-link-section-d423344494e5100"&gt;106&lt;/a&gt;&lt;/sup&gt; was used to select mutations in the clock-like SBS1 channel&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 107" title="Tate, J. G. et al. COSMIC: the catalogue of somatic mutations in cancer. Nucleic Acids Res. 47, D941–D947 (2019)." href="/articles/s41586-025-09374-4#ref-CR107" id="ref-link-section-d423344494e5104"&gt;107&lt;/a&gt;&lt;/sup&gt;. BEAST (v1.10)&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 108" title="Suchard, M. A. et al. Bayesian phylogenetic and phylodynamic data integration using BEAST 1.10. Virus Evol. 4, vey016 (2018)." href="/articles/s41586-025-09374-4#ref-CR108" id="ref-link-section-d423344494e5108"&gt;108&lt;/a&gt;&lt;/sup&gt; was then used with the simple binary substitution model (as SBS1 effectively represents just C-to-T substitutions), a strict clock model, a constant population size prior&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 101" title="Kingman, J. F. C. The coalescent. Stoch. Process Appl. 13, 235–248 (1982)." href="/articles/s41586-025-09374-4#ref-CR101" id="ref-link-section-d423344494e5112"&gt;101&lt;/a&gt;&lt;/sup&gt; and a flat prior on the age of MRCA (from zero to earliest patient sample), with ancestral state estimation at the root. Chains were run and ESS values assessed as described above. The distances between the ancestral state of the root at each MCMC state and the clock rate were used to calculate the expected evolution distance between the root and the known germline. This was used to inform the length of the branch between germline (at birth) and the MRCA of the samples.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec29"&gt;Survival analysis&lt;/h3&gt;&lt;p&gt;Clinical analyses were performed in CLL for TTFT and overall survival from the time of sampling. Tumour growth rate (&lt;i&gt;θ&lt;/i&gt;), effective population size (&lt;i&gt;N&lt;/i&gt;&lt;sub&gt;&lt;i&gt;e&lt;/i&gt;&lt;/sub&gt;) and epigenetic switching rates were analysed as continuous variables in univariate Cox regression models for both TTFT and overall survival. The effect size of HRs for each evolutionary variable were analysed considering different scaling factors. In particular, the growth rate was analysed assuming exponential growth (that is, for &lt;i&gt;θ&lt;/i&gt; = 1, the population is &lt;i&gt;e&lt;/i&gt; = 2.71 times bigger per year), the &lt;i&gt;N&lt;/i&gt;&lt;sub&gt;&lt;i&gt;e&lt;/i&gt;&lt;/sub&gt; was considered per million cells, and the cancer age or time from the MRCA was analysed for each 10 years. Individual switching rate parameters (&lt;i&gt;μ&lt;/i&gt;, &lt;i&gt;ν&lt;/i&gt;, &lt;i&gt;γ&lt;/i&gt; and &lt;i&gt;ζ&lt;/i&gt;) were largely uninformative of prognosis and were summarized into a mean epigenetic switching rate, which was scaled by a factor of 100. In addition, growth rate and effective population were analysed as continuous variables in multivariate Cox regression models together with &lt;i&gt;TP53&lt;/i&gt; aberrations (considering mutations and deletions together), IGHV gene mutational status and the age of patients at sampling. Kaplan–Meier curves were generated for low and high growth rates and effective population size within IGHV subtypes using maximally selected log-rank statistic using the maxstats package (v0.7-25). &lt;i&gt;P&lt;/i&gt; values from Kaplan–Meier curves were derived using the log-rank statistic. Survival (v3.5-7), survminer (v0.4.9) and ggsurvfit (v0.3.1) packages were used under R (v4.3.1). Plots were generated using ggplot2 (v3.5.2).&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec30"&gt;Estimating the rate of change in lymphocyte counts&lt;/h3&gt;&lt;p&gt;Historical records of the absolute number of lymphocytes in blood obtained via haemocytometer were collected for patients with CLL over the whole disease course (that is, an approximate of the number of malignant CLL cells in blood). In 231 patients with CLL, we could obtain at least 10 sample timepoints (that is, at least 10 medical appointments, median &lt;i&gt;n&lt;/i&gt; = 27 and mean &lt;i&gt;n&lt;/i&gt; = 34) before the first treatment, allowing us to track the natural history of the disease before treatment intervention for the tumour (Supplementary Fig. &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41586-025-09374-4#MOESM1"&gt;10&lt;/a&gt;). We fitted a linear model to all 231 cases and obtained the slope of the observed log number of lymphocytes (that is, the coefficient of the univariate linear model) and compared it with growth rate estimates derived from EVOFLUx.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec31"&gt;Statistical analysis&lt;/h3&gt;&lt;p&gt;Statistical tests performed throughout the study were performed as two-sided. Appropriate multiple test correction, such as the Holm–Sidak correction, is noted when applied.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec32"&gt;Reporting summary&lt;/h3&gt;&lt;p&gt;Further information on research design is available in the &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41586-025-09374-4#MOESM2"&gt;Nature Portfolio Reporting Summary&lt;/a&gt; linked to this article.&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Nature</author><pubDate>Wed, 10 Sep 2025 18:14:23 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMiX0FVX3lxTE55RW1qY3U2QktTcWpwWFc1MnpZR0ZQQTA4QVllZzJNbU1VUVp6NU1WQnhIWVFyNVhhb3M4cVFqZUwxYm8tOW1XcnFHN0NVbGNFMnlaWWVmVkotMEN5TWRJ</guid></item><item><title>随着感染的蔓延，成千上万的人在重大体育赛事中接触麻疹-每日邮报</title><link>https://www.dailymail.co.uk/health/article-15084799/Thousands-people-exposed-measles-major-sporting-event-infections-spread.html</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div itemprop="articleBody"&gt;&lt;p class="mol-para-with-font"&gt;Several people have been infected with measles after a mass exposure at the &lt;a target="_self" href="/news/utah/index.html" id="mol-f7e15400-8e51-11f0-a9b3-618ddb70db89"&gt;Utah&lt;/a&gt; High School Cycling League event on August 16.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;More than 2,000 people attended the event. Four attendees were infected with the highly infectious disease, none of whom were vaccinated, but more are feared to be sick.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;The newest cases bring the state’s total measles count to 24. All but one of those patients had been vaccinated before getting sick. Nationwide, the US is facing the &lt;a target="_self" class="" href="/health/article-14772281/US-map-measles-MMR-vaccine-rate-study.html"&gt;largest measles caseload&lt;/a&gt;, over 1,400 infections, since the virus was declared ‘eliminated’ in 2000.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;Measles is an infectious, preventable disease caused by a virus that leads to flu-like symptoms, a rash that starts on the face and spreads downward across the body, and, in severe cases, &lt;a target="_self" href="/health/pneumonia/index.html" id="mol-f7dd5c60-8e51-11f0-a9b3-618ddb70db89"&gt;pneumonia&lt;/a&gt;, seizures, brain inflammation, permanent brain damage, and death.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;The virus is spread through direct contact with infectious droplets or through the air. Patients with a measles infection are contagious from four days before the rash through four days after the rash appears.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;People &lt;a target="_self" class="" href="/health/article-14583809/rfk-jr-u-turn-mmr-vaccine-measles-outbreak-milestone.html"&gt;who are not vaccinated&lt;/a&gt; have a 90 percent chance of getting sick if they are exposed, even from sharing the same air, briefly or hours later, with someone who has measles. Three in 1,000 people who contract measles will die.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;The two-dose measles, mumps and rubella vaccine (MMR) is about 97 percent effective at preventing the infection and is recommended as part of the childhood vaccine schedule. &lt;/p&gt;&lt;p class="mol-para-with-font"&gt;The US has recorded 1,454 cases of measles this year, with 266 of those cases having been confirmed within the past two months. Three people, including one in Colorado and two children in Texas, have died this year from the virus.&lt;/p&gt;&lt;div class="artSplitter mol-img-group"&gt;  &lt;p class="imageCaption"&gt;Several people have been infected with measles after a mass exposure at the Utah High School Cycling League event in Soldier Hollow on August 16&lt;/p&gt;&lt;/div&gt;
    
    
    &lt;p class="mol-para-with-font"&gt;The Soldier Hollow, Utah, event was a competition for teen cyclists, with teams that came from all over the state, which has a population of 3.5million people. &lt;/p&gt;&lt;p class="mol-para-with-font"&gt;Dr Leisha Nolen, an epidemiologist with the state of Utah, said: ‘Measles is highly contagious and spreads easily, even at outdoor events.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;‘Given the number of people who may have been exposed to measles at Soldier Hollow on August 16, 2025, we encourage attendees and participants of upcoming Utah High School Cycling League Region 6 events to check their MMR vaccination status.’&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;An estimated 90 percent of Utahns have received the MMR vaccine, below the CDC's target rate of 95 percent, the level needed to prevent community transmission of measles.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;Immunization rates for specific vaccines in Utah have decreased among kindergartners statewide since 2014.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;The rate fell from an average of more than 85 percent for the 2014-2015 school year statewide to slightly over 78 percent for the 2024-2025 school year, the second lowest rate since 77.4 percent were vaccinated in the 2020-2021 school year.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;Utah State Epidemiologist Leisha Nolan stated that vaccination is the most effective way to prevent the measles.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;Public health officials are working with the Utah High School Cycling League to inform families of the race participants who attended the Soldier Hollow event.&lt;/p&gt;&lt;div class="artSplitter mol-img-group"&gt;  &lt;p class="imageCaption"&gt;The virus virus leads to flu-like symptoms, a rash that starts on the face and spreads downward across the body, and, in severe cases, pneumonia , seizures, brain inflammation, permanent brain damage, and death (stock)&lt;/p&gt;&lt;/div&gt;&lt;div class="artSplitter mol-img-group"&gt;  &lt;p class="imageCaption"&gt;The US has reported more than 1,400 measles cases in 2025, the highest tally since the disease was declared 'eliminated' in 2000 &lt;/p&gt;&lt;/div&gt;&lt;p class="mol-para-with-font"&gt;Before the current two-dose childhood vaccine’s approval in 1968, there were up to 500 US deaths each year from measles, 48,000 hospitalizations, and 1,000 cases of brain swelling.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;Now, the virus is almost completely preventable, with a vaccine efficacy rate of 97 percent.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;Sporadic outbreaks have occurred since the virus was declared ‘eliminated’ by health agencies in 2000, but recent case counts are a tiny fraction of the 27,000 cases reported in 1990 or the 450,000 cases reported in 1964.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;The skyrocketing rate of measles cases in the US among a growing number of children and adults who have not been vaccinated has been attributed to renewed fervor in the anti-vax movement stoked by HHS Secretary Robert F Kennedy, Jr. &lt;/p&gt;&lt;p class="mol-para-with-font"&gt;A long-time vaccine skeptic, RFK Jr in the past has parroted the widely debunked link between the MMR shots and autism.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;RFK has also relayed mixed messages about the MMR vaccine, saying at once that it is the most effective way to prevent measles, while also telling Congress that he believes that the increased risk of autism in children is in part due to a wide array of childhood immunizations recommended now compared to when he was a child.&lt;/p&gt;&lt;div class="artSplitter mol-img-group"&gt;  &lt;p class="imageCaption"&gt;US MMR vaccination coverage among kindergartners dropped to 92 percent nationwide for the 2024–2025 school year, a decline from 95 percent during the 2019–2020 school year and is below the 95 percent threshold needed for herd immunity to protect communities&lt;/p&gt;&lt;/div&gt;&lt;div class="artSplitter mol-img-group"&gt;  &lt;p class="imageCaption"&gt;Texas is a hotspot for measles, though outbreaks have cropped up nationwide in 2025 &lt;/p&gt;&lt;/div&gt;&lt;p class="mol-para-with-font"&gt;He has also endorsed cod liver oil and vitamin A as treatments for measles. Doctors use doses of vitamin A as a supportive treatment in patients in the early stages of measles, but it is not a cure.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;In high doses, vitamin A supplementation can be toxic and potentially lead to chronic liver damage and failure, as well as death.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;It is generally used for people with measles in parts of the world where a deficiency in the vitamin is common, which increases the risk of severe or deadly outcomes. &lt;/p&gt;&lt;p class="mol-para-with-font"&gt;Vitamin A deficiency in the US affects less than one percent of the population, and last spring, Texas doctors saw a jump in the number of children with measles who had potentially irreversible vitamin A toxicity.&lt;/p&gt;&lt;/div&gt;
            

            
            
            
            
            &lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Daily Mail</author><pubDate>Wed, 10 Sep 2025 18:13:51 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMixwFBVV95cUxPczlEenp5V0RqN2VJUEFJX2FQMGZwNUtyTHRUWVNlYUlEM29aeTZVYWlMeUU4YzV0bkREZWN0S1h2Y3BubEtqTDVmOWVOZzNyaHdEZ1MtbWd0UEVPWTRoU3I2NWQtQW5zMmg4R1EtRzFEQjVtdUp1NDl3VUdrbzVfcExGMFV4Z2JCX1psN2VkM1pTMUpzMmszYWRrREpySFhjNGllWUFEN1hfV0ZCUGxFVy1YMzc5b2pRS2tfaDk0T1VxNDc0RUxz0gHMAUFVX3lxTE1RbVdLdV9wZHFOd2dBLVU4SDlWeXIzTG9JU2tZVDExSE83d1lnTjQ5ZjctajZhdGsyajBZR094QS16NGdoNHl6bnpOc0xCb0VfYnk4QkRlOGdBcnV4bzd1LVhGbnA1SEo1U0w4TFZfajJrUi1OU2V0cTlvSl9ya3dRNEYxTDkySlB0UE96RGlhUmdOUDR5eDVlR0RkTTJ4VFBKQmt5LVd1M0hoN2RNMDlaZGdmRWoyaGtPY1l2U1hpY1l5VXlSd0dITW5ucA</guid></item><item><title>慢性酒精使用停止肝细胞再生，新研究发现- Medical Xpress</title><link>https://medicalxpress.com/news/2025-09-chronic-alcohol-halts-liver-cell.html</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="mt-4 article-main"&gt;
									    
&lt;div class="article-gallery lightGallery"&gt;
    &lt;div data-thumb="https://scx1.b-cdn.net/csz/news/tmb/2022/liver-2.jpg" data-src="https://scx2.b-cdn.net/gfx/news/hires/2022/liver-2.jpg" data-sub-html="Credit: Pixabay/CC0 Public Domain"&gt;
        &lt;figure class="article-img"&gt;
            &lt;img src="https://scx1.b-cdn.net/csz/news/800a/2022/liver-2.jpg" alt="liver" title="Credit: Pixabay/CC0 Public Domain"&gt;
             &lt;figcaption class="text-darken text-low-up text-truncate-js text-truncate mt-3"&gt;
                Credit: Pixabay/CC0 Public Domain
            &lt;/figcaption&gt;        &lt;/figure&gt;
    &lt;/div&gt;
&lt;/div&gt;&lt;p&gt;Excessive alcohol consumption can disrupt the liver's unique regenerative abilities by trapping cells in limbo between their functional and regenerative states, even after a patient stops drinking, researchers at University of Illinois Urbana-Champaign and collaborators at Duke University and the Chan Zuckerberg Biohub Chicago describe in a new study.&lt;/p&gt;

                                        
                                                                                &lt;p class="w-100 my-4 d-print-none"&gt;
     
     
     &lt;ins class="adsbygoogle" data-ad-layout="in-article" data-ad-format="fluid" data-ad-client="ca-pub-0536483524803400" data-ad-slot="7587637799"&gt;&lt;/ins&gt;
     
&lt;/p&gt;  
                                         

                                                                                                                                    &lt;p&gt;This in-between state is a result of inflammation disrupting how RNA is spliced during the protein-making process, the researchers found, providing scientists with new treatment pathways to explore for the &lt;a href="https://medicalxpress.com/tags/deadly+disease/" rel="tag" class="textTag"&gt;deadly disease&lt;/a&gt;. The researchers &lt;a href="https://www.nature.com/articles/s41467-025-63251-2" target="_blank"&gt;published&lt;/a&gt; their findings in the journal &lt;i&gt;Nature Communications&lt;/i&gt;.&lt;/p&gt;
&lt;p&gt;The liver has a remarkable ability to regenerate itself after damage or partial removal. However, it loses that ability in patients with alcohol-associated liver disease—the leading cause of liver-related mortality worldwide, resulting in roughly 3 million deaths annually.&lt;/p&gt;
&lt;p&gt;"We knew that the liver stops functioning and stops regenerating in patients with alcohol-related hepatitis and cirrhosis, even when a patient has discontinued consuming alcohol, but we didn't know why," said U. of I. biochemistry professor Auinash Kalsotra, who co-led the study with Duke University School of Medicine professor Anna Mae Diehl. "The only real life-saving treatment option once a patient reaches the liver failure stage in those diseases is transplantation. But if we understood why these livers were failing, maybe we could intervene."&lt;/p&gt;
&lt;p&gt;Both the Kalsotra and Diehl labs have studied the molecular and cellular underpinnings of liver regeneration. Over the last five years, they found that in order to regenerate, &lt;a href="https://medicalxpress.com/tags/liver+cells/" rel="tag" class="textTag"&gt;liver cells&lt;/a&gt; reprogram their &lt;a href="https://medicalxpress.com/tags/gene+expression/" rel="tag" class="textTag"&gt;gene expression&lt;/a&gt; to revert to fetal-like progenitor cells, multiply and then reverse the process back to become mature functioning cells again. Armed with this knowledge, the group turned to the question of how those mechanisms were disrupted in alcohol-associated liver disease.&lt;/p&gt;

                                                                                                        
    &lt;p class="w-100 mb-4 ads"&gt;
          
        
        &lt;ins class="adsbygoogle" data-ad-layout="in-article" data-ad-format="fluid" data-ad-client="ca-pub-0536483524803400" data-ad-slot="7099578867"&gt;&lt;/ins&gt;
        
    &lt;/p&gt;
                                                                                                                                                                                                &lt;p&gt;The researchers compared samples of healthy livers and samples of livers with alcohol-associated hepatitis or cirrhosis obtained from Johns Hopkins University Hospital.&lt;/p&gt;
&lt;p&gt;The first thing the researchers noticed in diseased livers was that, although damaged cells had begun the process of reverting to the regenerative state, they did not complete the process and instead remained in transitional limbo.&lt;/p&gt;
&lt;p&gt;"They are neither functional adult cells nor proliferative progenitor cells. Since they are not functioning, more pressure builds on the remaining cells. So they try to regenerate, and they're all ending up in this unproductive quasi-progenitor state, and that's what is causing liver failure," said U. of I. graduate students Ullas Chembazhi and Sushant Bangru, the co-first authors of the study.&lt;/p&gt;
&lt;p&gt;To figure out why the cells were getting stuck in this state, the team investigated which proteins were being made by the liver cells and, in turn, the RNA molecules carrying the instructions for those proteins from the DNA to the cell's protein-building machinery.&lt;/p&gt;

&lt;div class="article-gallery lightGallery"&gt;
    &lt;div data-thumb="https://scx1.b-cdn.net/csz/news/tmb/2025/chronic-alcohol-use-ha-1.jpg" data-src="https://scx2.b-cdn.net/gfx/news/hires/2025/chronic-alcohol-use-ha-1.jpg" data-sub-html="Multiomic profiling of human alcohol-associated liver diseases. Credit: &amp;lt;i&amp;gt;Nature Communications&amp;lt;/i&amp;gt; (2025). DOI:10.1038/s41467-025-63251-2"&gt;
        &lt;figure class="article-img text-center"&gt;
            &lt;img src="https://scx1.b-cdn.net/csz/news/800a/2025/chronic-alcohol-use-ha-1.jpg" alt="Chronic alcohol use halts liver cell regeneration" title="Multiomic profiling of human alcohol-associated liver diseases. Credit: Nature Communications (2025). DOI:10.1038/s41467-025-63251-2"&gt;
             &lt;figcaption class="text-left text-darken text-truncate text-low-up mt-3"&gt;
                Multiomic profiling of human alcohol-associated liver diseases. Credit: &lt;i&gt;Nature Communications&lt;/i&gt; (2025). DOI:10.1038/s41467-025-63251-2
            &lt;/figcaption&gt;        &lt;/figure&gt;
    &lt;/div&gt;
&lt;/div&gt;
&lt;p&gt;While most studies focus only on the total amounts of RNA or protein in a cell, Kalsotra's team used deep RNA sequencing technology and computational analyses to zoom in on the splicing of RNA fragments, a key step in stitching together different parts of genetic instructions to make proteins.&lt;/p&gt;
&lt;p&gt;"In comparing the samples, we saw RNA was getting misspliced broadly in alcohol-related liver disease, across thousands of genes, and it was affecting major functions of proteins," said Kalsotra, who also is affiliated with the Carl R. Woese Institute for Genomic Biology at Illinois.&lt;/p&gt;

                                                                                                                                            &lt;p&gt;The researchers found a possible driver of the RNA missplicing: Alcohol-damaged liver cells had a deficiency of the protein ESRP2, which binds to RNA to splice it properly.&lt;/p&gt;
&lt;p&gt;"Proteins function at a very specific place in the cell, and that is directed by sequences within the protein that take the protein to that particular spot. We found that, in many cases, the sequence that dictates where the protein localizes within a cell was misspliced. That's why it was important that we did the multiple analyses we did," said Kalsotra, also a member of the Chan Zuckerberg Biohub Chicago.&lt;/p&gt;
&lt;p&gt;"There was the same amount of RNA and protein, but the protein was not at the right place to function. Due to missplicing, key proteins that are required for productive liver regeneration were getting stuck in the cytoplasm, when they needed to be in the nucleus."&lt;/p&gt;
&lt;p&gt;To verify that ESRP2 deficiency was a likely culprit, the researchers studied mice without the gene that produces ESRP2. They displayed similar liver damage and regeneration failure to that seen in patients with advanced alcohol-related hepatitis.&lt;/p&gt;
&lt;p&gt;But why was ESRP2 missing from liver cells from patients with alcohol-related hepatitis? Upon investigation, the researchers found that liver support cells and immune cells, drawn to the liver tissue damaged by alcohol processing, released high amounts of inflammatory and &lt;a href="https://medicalxpress.com/tags/growth+factors/" rel="tag" class="textTag"&gt;growth factors&lt;/a&gt;. Those factors suppress ESRP2 production and activity.&lt;/p&gt;
&lt;p&gt;To verify this finding, the researchers treated liver cell cultures with a molecule that inhibits the receptor for one of the inflammation-promoting factors. ESRP2 levels recovered and splicing activity was corrected, pointing to the pathway as a possible treatment target.&lt;/p&gt;
&lt;p&gt;"I'm hopeful these findings will become a launching pad for future clinical studies. We can use these misspliced RNAs as diagnostic markers or develop treatments that can curb the inflammation. And if we can correct the splicing defects, then maybe we can improve recovery and restore damaged livers," Kalsotra said.&lt;/p&gt;

                                                                                                                                    
                                                                                
                                        											&lt;div class="article-main__more p-4"&gt;
												                                                    &lt;p&gt;&lt;strong&gt;More information:&lt;/strong&gt;
                                                    Chembazhi, U.V. et al, Dysregulated RNA splicing impairs regeneration in alcohol-associated liver disease, &lt;i&gt;Nature Communications&lt;/i&gt; (2025). &lt;a data-doi="1" href="https://dx.doi.org/10.1038/s41467-025-63251-2" target="_blank"&gt;DOI: 10.1038/s41467-025-63251-2&lt;/a&gt;. &lt;a href="https://www.nature.com/articles/s41467-025-63251-2/" target="_blank"&gt;www.nature.com/articles/s41467-025-63251-2/&lt;/a&gt;
																								
																								&lt;/p&gt;
																							&lt;/div&gt;
                                        											
																					
                                                                                                                        
                                        
                                        &lt;div class="d-none d-print-block"&gt;
                                            &lt;p class="mb-4"&gt;
                                                 &lt;strong&gt;Citation&lt;/strong&gt;:
                                                 Chronic alcohol use halts liver cell regeneration, new study finds (2025, September 10)
                                                 retrieved 11 September 2025
                                                 from https://medicalxpress.com/news/2025-09-chronic-alcohol-halts-liver-cell.html
                                            &lt;/p&gt;
                                            &lt;p class="border text-muted p-3"&gt;
                                            This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
                                            part may be reproduced without the written permission. The content is provided for information purposes only.
                                            &lt;/p&gt;
                                        &lt;/div&gt;
                                        
									&lt;/div&gt;
								&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Medical Xpress</author><pubDate>Wed, 10 Sep 2025 18:10:04 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMiggFBVV95cUxPTjBZMDVONk1FdXJRR2V2UWVaQnN3ME45ZkppMS16R0JzMUUwdS0yM1Nza1Qyc0ZzeGpkU3dhOThNMnlCcllLbzZQMDJ0d0hXellHeXdmUlMtR0xCZjhFdTVsWDE0cVhmSGZEVlA0a0lnV3MyTkM4Q3FUbHBHejkyeUxB</guid></item><item><title>美国疾病控制与预防中心（ CDC ）对阿肯色州报道的致命虫病发出警告- 5newsonline.com</title><link>https://www.5newsonline.com/article/news/local/cdc-deadly-bug-disease-reported-arkansas/91-3a9838d8-4f6e-4de1-af34-f9f80774dcba</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;p class="article__summary"&gt;The CDC is warning people of a deadly bug that can be found in Arkansas and other states. Here's what we know about the insect.&lt;/p&gt;
        &lt;div class="article__body"&gt;
                    &lt;div class="article__section article__section_type_text utility__text"&gt;
&lt;p&gt;LITTLE ROCK, Ark. — The Center for Disease Control and Prevention is warning people of a deadly bug that can be found in Arkansas and other states.&lt;/p&gt;                    &lt;/div&gt;
                    &lt;div class="article__section article__section_type_text utility__text"&gt;
&lt;p&gt;The insect is known scientifically as Triatominae and commonly by its nickname the "kissing bug." &lt;/p&gt;                    &lt;/div&gt;
                    &lt;div class="article__section article__section_type_text utility__text"&gt;
&lt;p&gt;The insect has the ability to transmit Chagas disease. an illness that is primarily found in the rural areas of Mexico, Central America and South America. &lt;/p&gt;                    &lt;/div&gt;
                        
                    &lt;div class="article__section article__section_type_text utility__text"&gt;
&lt;p&gt;Recently Chagas disease has been reported in 32 states and out of those states, eight states have reported human cases. Those states are as follows: Arizona, Arkansas, California, Louisiana, Mississippi, Missouri, Tennessee and Texas. &lt;/p&gt;                    &lt;/div&gt;
                    &lt;div class="article__section article__section_type_text utility__text"&gt;
&lt;p&gt;The CDC has said that roughly 8 million globally have the disease, which includes roughly 280,000 in the United States. &lt;/p&gt;                    &lt;/div&gt;
                    &lt;div class="article__section article__section_type_text utility__text"&gt;
&lt;p&gt;Health officials with the CDC said that many times people are unaware that they even know they have the illness, but that if the illness is left untreated it can be deadly. &lt;/p&gt;                    &lt;/div&gt;
                    &lt;div class="article__section article__section_type_text utility__text"&gt;
&lt;p&gt;Here's what you need to know about the disease and the insect:&lt;/p&gt;                    &lt;/div&gt;
                    &lt;p class="article__section article__section_type_text utility__text"&gt;
&lt;h2&gt;What does the "kissing bug" look like? &lt;/h2&gt;                    &lt;/p&gt;
                    &lt;div class="article__section article__section_type_text utility__text"&gt;
&lt;p&gt;The kissing bug is primarily known for its distinctive orange-red to yellowish markings on its body and wings. According to the CDC, here's a look at the key characteristics for the insect: &lt;/p&gt;                    &lt;/div&gt;
                    &lt;div class="article__section article__section_type_text utility__text"&gt;
&lt;ul id="isPasted"&gt;&lt;li&gt;Orange-red to yellowish horizontal markings covering less than one-fourth of abdominal segment&lt;/li&gt;&lt;li&gt;Mouthparts relatively hairless&lt;/li&gt;&lt;li&gt;Pronotum black with orange-red to yellowish side and top margins&lt;/li&gt;&lt;li&gt;Tip of scutellum long, narrow&lt;/li&gt;&lt;li&gt;Distinctive orange-red to yellowish markings on wings&lt;/li&gt;&lt;/ul&gt;                    &lt;/div&gt;
                                
                    &lt;p class="article__section article__section_type_text utility__text"&gt;
&lt;h2&gt;How is Chagas disease spread?&lt;/h2&gt;                    &lt;/p&gt;
                    &lt;div class="article__section article__section_type_text utility__text"&gt;
&lt;p&gt;According to the CDC, Chagas disease is caused by a parasite named Trypanosoma cruzi — this parasite is usually spread through contact with the "kissing bugs." &lt;/p&gt;                    &lt;/div&gt;
                    &lt;div class="article__section article__section_type_text utility__text"&gt;
&lt;p&gt;Health professionals shared that the kissing bugs bite and suck blood animals and people who are infected, which causes the insects to then become infected with the parasite. &lt;/p&gt;                    &lt;/div&gt;
                    &lt;div class="article__section article__section_type_text utility__text"&gt;
&lt;p&gt;After biting, the bugs poop, and the poop has the parasite within it. From there, if the insect's poop gets in someone's body either through a cut, eyes, or mouth, it can lead to an infection. &lt;/p&gt;                    &lt;/div&gt;
                    &lt;div class="article__section article__section_type_text utility__text"&gt;
&lt;p&gt;CDC officials said that people could subconsciously rub the feces into a cut, eyes, or mouth without even knowing it. &lt;/p&gt;                    &lt;/div&gt;
                                
                    &lt;p class="article__section article__section_type_text utility__text"&gt;
&lt;h2 id="isPasted"&gt;Symptoms of Chagas disease in adults&lt;/h2&gt;                    &lt;/p&gt;
                    &lt;div class="article__section article__section_type_text utility__text"&gt;
&lt;p&gt;Health professionals said that shortly after infection, a type of eyelid swelling known as Romaña's sign may appear.&lt;/p&gt;                    &lt;/div&gt;
                    
                    &lt;div class="article__section article__section_type_text utility__text"&gt;
&lt;ul&gt;&lt;li&gt;Fever&lt;/li&gt;&lt;li&gt;Feeling tired&lt;/li&gt;&lt;li&gt;Body aches&lt;/li&gt;&lt;li&gt;Headache&lt;/li&gt;&lt;li&gt;Rash&lt;/li&gt;&lt;li&gt;Loss of appetite&lt;/li&gt;&lt;li&gt;Diarrhea&lt;/li&gt;&lt;li&gt;Vomiting&lt;/li&gt;&lt;/ul&gt;                    &lt;/div&gt;
                    &lt;div class="article__section article__section_type_text utility__text"&gt;
&lt;p&gt;Others impacted by the disease may experience symptoms for years or a lifetime — health officials said that is known as the "chronic phase of infection," and can include heart and digestive issues.&lt;/p&gt;                    &lt;/div&gt;
                    &lt;p class="article__section article__section_type_text utility__text"&gt;
&lt;h2 id="isPasted"&gt;Avoiding the "kissing bugs"&lt;/h2&gt;                    &lt;/p&gt;
                    &lt;div class="article__section article__section_type_text utility__text"&gt;
&lt;p&gt;Currently, there are no vaccines or drugs that can prevent Chagas disease, according to the CDC.&lt;/p&gt;                    &lt;/div&gt;
                    &lt;div class="article__section article__section_type_text utility__text"&gt;
&lt;p&gt;As a result, health officials emphasized that it's important to protect yourself through preventative measures. Here's a look at prevention measures you can take: &lt;/p&gt;                    &lt;/div&gt;
                    &lt;div class="article__section article__section_type_text utility__text"&gt;
&lt;ul&gt;&lt;li&gt;Staying in well-built places if traveling&lt;/li&gt;&lt;li&gt;Using insecticides and bug spray&lt;/li&gt;&lt;li&gt;Wearing clothes that cover your skin&lt;/li&gt;&lt;li&gt;Not eating raw fruits and vegetable (the infection can be acquired orally or via contaminated food).&lt;/li&gt;&lt;/ul&gt;                    &lt;/div&gt;
                    &lt;div class="article__section article__section_type_text utility__text"&gt;
&lt;p&gt;For more information on Chagas disease, you can &lt;a href="https://www.cdc.gov/chagas/about/index.html"&gt;click here.&lt;/a&gt;&lt;/p&gt;                    &lt;/div&gt;
    &lt;/div&gt;
        &lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>5newsonline.com</author><pubDate>Wed, 10 Sep 2025 18:08:00 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMixgFBVV95cUxPS0hiN1NSWFVYRzh6VGdLcXdMWUFvZnhnN1pSd280T0tlQzBiR1dUTmtzeHJKeDhHZTBRODZEZmo0QWozTnlFeXhOZXkyUnVrZ3daemJxbVB4eUdfUmJUaTdFQ3RHZkU2dk9KS05keUpMZVZMbjVDZzdreWdWVzc4S0JhZHlTRXpMU1JsQWVEYUpsWENxYnZaRS1qNUZTajlYTXRWY0FIdGd1TUd6djM3MnBPNHJhelZEX0xOREZKME1rWDQ3Q0E</guid></item><item><title>疾病预防控制中心警告阿肯色州报道的致命虫病- thv11.com</title><link>https://www.thv11.com/article/life/animals/cdc-deadly-bug-disease-reported-arkansas/91-3a9838d8-4f6e-4de1-af34-f9f80774dcba</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;p class="article__summary"&gt;The CDC is warning people of a deadly bug that can be found in Arkansas and other states. Here's what we know about the insect. &lt;/p&gt;
        &lt;div class="article__body"&gt;
                    &lt;div class="article__section article__section_type_text utility__text"&gt;
&lt;p&gt;LITTLE ROCK, Ark. — The Center for Disease Control and Prevention is warning people of a deadly bug that can be found in Arkansas and other states.&lt;/p&gt;                    &lt;/div&gt;
                    &lt;div class="article__section article__section_type_text utility__text"&gt;
&lt;p&gt;The insect is known scientifically as Triatominae and commonly by its nickname the "kissing bug." &lt;/p&gt;                    &lt;/div&gt;
                    &lt;div class="article__section article__section_type_text utility__text"&gt;
&lt;p&gt;The insect has the ability to transmit Chagas disease. an illness that is primarily found in the rural areas of Mexico, Central America and South America. &lt;/p&gt;                    &lt;/div&gt;
                        
                    &lt;div class="article__section article__section_type_text utility__text"&gt;
&lt;p&gt;Recently Chagas disease has been reported in 32 states and out of those states, eight states have reported human cases. Those states are as follows: Arizona, Arkansas, California, Louisiana, Mississippi, Missouri, Tennessee and Texas. &lt;/p&gt;                    &lt;/div&gt;
                    &lt;div class="article__section article__section_type_text utility__text"&gt;
&lt;p&gt;The CDC has said that roughly 8 million globally have the disease, which includes roughly 280,000 in the United States. &lt;/p&gt;                    &lt;/div&gt;
                    &lt;div class="article__section article__section_type_text utility__text"&gt;
&lt;p&gt;Health officials with the CDC said that many times people are unaware that they even know they have the illness, but that if the illness is left untreated it can be deadly. &lt;/p&gt;                    &lt;/div&gt;
                    &lt;div class="article__section article__section_type_text utility__text"&gt;
&lt;p&gt;Here's what you need to know about the disease and the insect:&lt;/p&gt;                    &lt;/div&gt;
                    &lt;p class="article__section article__section_type_text utility__text"&gt;
&lt;h2&gt;What does the "kissing bug" look like? &lt;/h2&gt;                    &lt;/p&gt;
                    &lt;div class="article__section article__section_type_text utility__text"&gt;
&lt;p&gt;The kissing bug is primarily known for its distinctive orange-red to yellowish markings on its body and wings. According to the CDC, here's a look at the key characteristics for the insect: &lt;/p&gt;                    &lt;/div&gt;
                    &lt;div class="article__section article__section_type_text utility__text"&gt;
&lt;ul id="isPasted"&gt;&lt;li&gt;Orange-red to yellowish horizontal markings covering less than one-fourth of abdominal segment&lt;/li&gt;&lt;li&gt;Mouthparts relatively hairless&lt;/li&gt;&lt;li&gt;Pronotum black with orange-red to yellowish side and top margins&lt;/li&gt;&lt;li&gt;Tip of scutellum long, narrow&lt;/li&gt;&lt;li&gt;Distinctive orange-red to yellowish markings on wings&lt;/li&gt;&lt;/ul&gt;                    &lt;/div&gt;
                                
                    &lt;p class="article__section article__section_type_text utility__text"&gt;
&lt;h2&gt;How is Chagas disease spread?&lt;/h2&gt;                    &lt;/p&gt;
                    &lt;div class="article__section article__section_type_text utility__text"&gt;
&lt;p&gt;According to the CDC, Chagas disease is caused by a parasite named Trypanosoma cruzi — this parasite is usually spread through contact with the "kissing bugs." &lt;/p&gt;                    &lt;/div&gt;
                    &lt;div class="article__section article__section_type_text utility__text"&gt;
&lt;p&gt;Health professionals shared that the kissing bugs bite and suck blood animals and people who are infected, which causes the insects to then become infected with the parasite. &lt;/p&gt;                    &lt;/div&gt;
                    &lt;div class="article__section article__section_type_text utility__text"&gt;
&lt;p&gt;After biting, the bugs poop, and the poop has the parasite within it. From there, if the insect's poop gets in someone's body either through a cut, eyes, or mouth, it can lead to an infection. &lt;/p&gt;                    &lt;/div&gt;
                    &lt;div class="article__section article__section_type_text utility__text"&gt;
&lt;p&gt;CDC officials said that people could subconsciously rub the feces into a cut, eyes, or mouth without even knowing it. &lt;/p&gt;                    &lt;/div&gt;
                                
                    &lt;p class="article__section article__section_type_text utility__text"&gt;
&lt;h2 id="isPasted"&gt;Symptoms of Chagas disease in adults&lt;/h2&gt;                    &lt;/p&gt;
                    &lt;div class="article__section article__section_type_text utility__text"&gt;
&lt;p&gt;Health professionals said that shortly after infection, a type of eyelid swelling known as Romaña's sign may appear.&lt;/p&gt;                    &lt;/div&gt;
                    
                    &lt;div class="article__section article__section_type_text utility__text"&gt;
&lt;ul&gt;&lt;li&gt;Fever&lt;/li&gt;&lt;li&gt;Feeling tired&lt;/li&gt;&lt;li&gt;Body aches&lt;/li&gt;&lt;li&gt;Headache&lt;/li&gt;&lt;li&gt;Rash&lt;/li&gt;&lt;li&gt;Loss of appetite&lt;/li&gt;&lt;li&gt;Diarrhea&lt;/li&gt;&lt;li&gt;Vomiting&lt;/li&gt;&lt;/ul&gt;                    &lt;/div&gt;
                    &lt;div class="article__section article__section_type_text utility__text"&gt;
&lt;p&gt;Others impacted by the disease may experience symptoms for years or a lifetime — health officials said that is known as the "chronic phase of infection," and can include heart and digestive issues.&lt;/p&gt;                    &lt;/div&gt;
                    &lt;p class="article__section article__section_type_text utility__text"&gt;
&lt;h2 id="isPasted"&gt;Avoiding the "kissing bugs"&lt;/h2&gt;                    &lt;/p&gt;
                    &lt;div class="article__section article__section_type_text utility__text"&gt;
&lt;p&gt;Currently, there are no vaccines or drugs that can prevent Chagas disease, according to the CDC.&lt;/p&gt;                    &lt;/div&gt;
                    &lt;div class="article__section article__section_type_text utility__text"&gt;
&lt;p&gt;As a result, health officials emphasized that it's important to protect yourself through preventative measures. Here's a look at prevention measures you can take: &lt;/p&gt;                    &lt;/div&gt;
                    &lt;div class="article__section article__section_type_text utility__text"&gt;
&lt;ul&gt;&lt;li&gt;Staying in well-built places when traveling&lt;/li&gt;&lt;li&gt;Using insecticides and bug spray&lt;/li&gt;&lt;li&gt;Wearing clothes that cover your skin&lt;/li&gt;&lt;li&gt;Not eating raw fruits and vegetables (the infection can be acquired orally or via contaminated food).&lt;/li&gt;&lt;/ul&gt;                    &lt;/div&gt;
                    &lt;div class="article__section article__section_type_text utility__text"&gt;
&lt;p&gt;For more information on Chagas disease, you can &lt;a href="https://www.cdc.gov/chagas/about/index.html"&gt;click here.&lt;/a&gt;&lt;/p&gt;                    &lt;/div&gt;
                                

    &lt;/div&gt;
        &lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>thv11.com</author><pubDate>Wed, 10 Sep 2025 18:08:00 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMiwAFBVV95cUxNUFlOV3V3WjlkWVFLMkVkT0haYV9FUnpkU0h0WHkwb205d3dMOVB3d2hVektXWUY1WUJpbHFmZHZVTE1PYXNuT0NOQlVXMXhzVnotVWtZVW5vNjFaS3hieTRwNmhmZ1l6akxtSk5sSEFIX01FNTBLRzBuN0tLMlY4QTFaeFVuaXNTakZFSl9uNVRZeVdXME9DUUxHUFlnUzBRR0hwUDZlZk95TUctT01OczU3Mzlfay16cjZHUkJvWEo</guid></item><item><title>更年期和癌症风险：为什么这个过渡阶段比你想象的更重要-印度时报</title><link>https://timesofindia.indiatimes.com/life-style/health-fitness/health-news/perimenopause-and-cancer-risk-why-this-transition-phase-matters-more-than-you-think/photostory/123813559.cms</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="COQxt" data-ua-type="1"&gt;&lt;p&gt;&lt;br&gt;Perimenopause is the normal transition period before menopause, typically beginning in a woman's early to mid-40s, when the ovaries slowly make less estrogen. This phase may last a few years and is characterized by irregular cycles, hot flashes, mood swings, sleep problems, and metabolic changes. It is often thought of as a simple hormonal change, but is a crucial time for early screenings and preventative medical treatment because it also occurs when women are more susceptible to osteoporosis, cardiovascular disease, and many types of cancer.&lt;br&gt;Here are six ways perimenopause quietly increases cancer risk and how awareness and prompt action can be lifesaving.&lt;br&gt;&lt;br&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>The Times of India</author><pubDate>Wed, 10 Sep 2025 18:01:00 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">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</guid></item><item><title>“接吻虫”病在美国呈上升趋势- TribLIVE.com</title><link>https://triblive.com/local/regional/kissing-bug-disease-on-the-rise-in-u-s/</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div id="storyContent"&gt;
&lt;p&gt;A deadly malady known as “kissing bug” disease is now an endemic illness in the United States, according to the &lt;a href="https://wwwnc.cdc.gov/eid/article/31/9/24-1700_article" target="_blank" rel="noopener"&gt;Centers for Disease Control and Prevention&lt;/a&gt;.

&lt;/p&gt;&lt;p&gt;The nation is seeing a rise in the illness, which is officially known as Chagas disease.

&lt;/p&gt;&lt;p&gt;It can be life-threatening and is transmitted through “kissing bugs” that bite human faces, &lt;a href="https://www.washingtonpost.com/health/2025/09/09/kissing-bug-disease-chagas-endemic/" target="_blank" rel="noopener"&gt;the Washington Post reported&lt;/a&gt;. Pets can carry the disease.

&lt;/p&gt;&lt;p&gt;A disease is considered endemic when it is constantly present within a specific area or population.

&lt;/p&gt;&lt;p&gt;More than 100 million people worldwide are considered at risk of being infected with Chagas disease, according to the &lt;a href="https://www.who.int/news-room/fact-sheets/detail/chagas-disease-(american-trypanosomiasis)#:~:text=development%20of%20information%2C%20education%20and,up%2C%20and%20notification%20of%20cases." target="_blank" rel="noopener"&gt;World Health &lt;/a&gt;&lt;a href="https://www.who.int/news-room/fact-sheets/detail/chagas-disease-(american-trypanosomiasis)#:~:text=development%20of%20information%2C%20education%20and,up%2C%20and%20notification%20of%20cases." target="_blank" rel="noopener"&gt;Organization&lt;/a&gt;.

&lt;/p&gt;&lt;p&gt;The “kissing bug” itself is caused by the parasite Trypanosoma cruzi, which is found in the feces of the triatomine bug — commonly known as the “kissing bug” because it often bites people’s faces, the Post said.

&lt;/p&gt;&lt;p&gt;Insects can become infected when they feed on the blood of hosts carrying the parasite.

&lt;/p&gt;&lt;p&gt;Humans and animals can become infected in a few ways, according to the Post:

&lt;/p&gt;&lt;ul&gt;
&lt;li&gt;When contaminated feces are accidentally rubbed into open wounds, the eyes or the mouth&lt;/li&gt;
&lt;li&gt;From pregnant mother to child&lt;/li&gt;
&lt;li&gt;Through contaminated blood transfusions (but this is rarer)&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;Dogs are one of the animals that can host the parasite, and there has been growing evidence of canine infections in states including Texas and California.

&lt;/p&gt;&lt;p&gt;There are at least eight states where cases of Chagas disease have been identified: California, Arizona, Texas, Tennessee, Louisiana, Missouri, Mississippi and Arkansas.

&lt;/p&gt;&lt;p&gt;The kissing bugs themselves “occur naturally in the southern half of the country and have been identified in 32 states,” according to the CDC, the Post said. They’re often found in rural parts of Mexico, Central America and South America.

&lt;/p&gt;&lt;p&gt;&lt;span class="neFMT neFMT_body-subhead"&gt;No vaccines&lt;/span&gt;

&lt;/p&gt;&lt;p&gt;There aren’t any vaccines or drugs right now to prevent Chagas disease, the CDC said.

&lt;/p&gt;&lt;p&gt;However, in the U.S., two anti-parasitic medicines have been approved for those who are suspected to have been infected, the Post said.

&lt;/p&gt;&lt;p&gt;Mitigation tactics include:

&lt;/p&gt;&lt;ul&gt;
&lt;li&gt;Spraying areas with long-lasting insecticides&lt;/li&gt;
&lt;li&gt;Wearing clothing that covers the skin&lt;/li&gt;
&lt;li&gt;Avoiding raw vegetables and unpeeled fruits in areas where Chagas disease has been detected&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;Pet owners can help prevent Chagas disease by using anti-flea and tick medications such as Nexgard and Bravecto.

&lt;/p&gt;&lt;p&gt;When traveling in areas where the insects are present, the CDC recommended reducing the risk of contact with infected kissing bugs, which are “sometimes found in the cracks and crevices of poorly constructed houses and can survive both indoors and outdoors,” according to the Post.

&lt;/p&gt;&lt;p&gt;There are two phases of Chagas disease — acute and chronic — with the former potentially being asymptomatic.

&lt;/p&gt;&lt;p&gt;The acute phase happens in the first few weeks or months after infection. It can cause mild symptoms like fever, fatigue, body aches or swelling of the eyelid.

&lt;/p&gt;&lt;p&gt;People should seek treatment at this stage, the CDC advised, according to the Post.

&lt;/p&gt;&lt;p&gt;Without treatment, the chronic disease can develop, lasting for several years or even a lifetime.

&lt;/p&gt;&lt;p&gt;As many as 30% can develop serious health complications — leading to conditions like heart failure or an enlarged esophagus or colon, according to the CDC. Others may remain asymptomatic.

&lt;/p&gt;&lt;p&gt;The disease is “often fatal by the time symptoms develop,” Paula Stigler Granados, an associate professor at the San Diego State University School of Public Health, told the Post.

&lt;/p&gt;

&lt;p class="s2nPlayer k-7fvO6bjp" data-type="float"&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;p class="credits"&gt;Megan Swift is a TribLive reporter covering trending news in Western Pennsylvania. A Murrysville native, she joined the Trib full time in 2023 after serving as editor-in-chief of The Daily Collegian at Penn State. She previously worked as a Jim Borden Scholarship intern at the Trib for three summers. She can be reached at mswift@triblive.com. &lt;/p&gt;


&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>TribLIVE.com</author><pubDate>Wed, 10 Sep 2025 18:00:00 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMigAFBVV95cUxQMjdkckUteWtpWlZ3NjBta2treVZaejk3ckVlMDJtV1FPQWN4VVluYjdPSmxpR212NE8wR2xyeFBmMUF0YXZVRWNhdW1SNTZwQUtzTUxMX2pUVl9XaXpZdVUydmhIM3QtbDRRTC1heUJsQTJHYk1wc293WkxQMnJmQw</guid></item><item><title>根据营养学家的说法，支持健康衰老的8种最佳饮料- marthastewart.com</title><link>https://www.marthastewart.com/best-drinks-for-healthy-aging-11801980</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div id="marthastewart-sc-page_1-0" class="comp marthastewart-sc-page mntl-sc-page mntl-block structured-content" data-sc-sticky-offset="90" data-sc-ad-label-height="24" data-sc-ad-track-spacing="100" data-sc-min-track-height="250" data-sc-max-track-height="600" data-sc-breakpoint="50em" data-sc-load-immediate="4" data-sc-content-positions="[1, 1250, 1550, 1950, 2350, 2750, 3150, 3550, 3950]" data-bind-scroll-on-start="true"&gt;&lt;p id="mntl-sc-block_1-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; While a &lt;a class="recommendation-inline-link-ai" href="https://www.marthastewart.com/healthy-aging-guide-7571546" link-destination-recommendation-ai="true" data-component="link" data-source="inlineLink" data-type="internalLink" data-ordinal="1"&gt;well-balanced diet and frequent exercise&lt;/a&gt; are often emphasized in discussions about healthy aging, the fluids you drink are just as important. Many beverages are marketed as "good for you," but they often contain added sugar and fall short on their promises.
&lt;/p&gt;
&lt;p id="mntl-sc-block_2-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;p id="mntl-sc-block_3-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; To find out which drinks actually support healthy aging, we spoke to &lt;a class="recommendation-inline-link-ai" href="https://www.marthastewart.com/8231942/common-foods-support-longevity-aging" link-destination-recommendation-ai="true" data-component="link" data-source="inlineLink" data-type="internalLink" data-ordinal="1"&gt;registered dietitians&lt;/a&gt;. Here, they share some of the best options to include in your diet. Some may surprise you, while others might already be a staple in your daily routine.
&lt;/p&gt;
&lt;p id="mntl-sc-block_4-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;

&lt;span class="heading-toc" id="toc-the-best-drinks-for-healthy-aging"&gt;&lt;/span&gt;&lt;h2 id="mntl-sc-block_6-0" class="comp mntl-sc-block marthastewart-sc-block-heading mntl-sc-block-heading"&gt; &lt;span class="mntl-sc-block-heading__text"&gt; The Best Drinks for Healthy Aging &lt;/span&gt; &lt;/h2&gt;
&lt;p id="mntl-sc-block_7-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; Below, our nutrition experts share their go-to beverages for aging well.
&lt;/p&gt;
&lt;p id="mntl-sc-block_8-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;h3 id="mntl-sc-block_9-0" class="comp mntl-sc-block marthastewart-sc-block-subheading mntl-sc-block-subheading"&gt; &lt;span class="mntl-sc-block-subheading__text"&gt; Kefir &lt;/span&gt; &lt;/h3&gt;
&lt;p id="mntl-sc-block_10-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; Probiotics are a vital part of a &lt;a class="recommendation-inline-link-ai" href="https://www.marthastewart.com/best-fermented-foods-for-gut-health-11792497" link-destination-recommendation-ai="true" data-component="link" data-source="inlineLink" data-type="internalLink" data-ordinal="1"&gt;balanced gut microbiome&lt;/a&gt;.&lt;span class="ql-inline-citation" data-cite="9"&gt;&lt;/span&gt; Kefir, a fermented milk product, is a &lt;a class="recommendation-inline-link-ai" href="https://www.marthastewart.com/best-probiotic-foods-11791312" link-destination-recommendation-ai="true" data-component="link" data-source="inlineLink" data-type="internalLink" data-ordinal="2"&gt;probiotic powerhouse&lt;/a&gt;. It can feature many dozens of 60 strains of bacteria and yeast that promote a &lt;a class="recommendation-inline-link-ai" href="https://www.marthastewart.com/8197882/best-recipes-gut-health" link-destination-recommendation-ai="true" data-component="link" data-source="inlineLink" data-type="internalLink" data-ordinal="3"&gt;healthier microbiome&lt;/a&gt; for our gut. "As we age, gut health can play a huge part in disease prevention, immunity, and even mental health," says Shelley Balls, registered dietitian and founder of Fueling Your Lifestyle.&lt;span class="ql-inline-citation" data-cite="1"&gt;&lt;/span&gt;
&lt;/p&gt;
&lt;p id="mntl-sc-block_11-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;p id="mntl-sc-block_12-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; If you're looking to add Kefir into your daily routine, Adiana Castro, a New York City-based metabolic dietitian and founder of Compass Nutrition, recommends going for the plain version at the grocery store, and to make sure it includes information about live and active cultures on the label for maximum health benefits. "I would recommend drinking 4 to 8 ounces of kefir every day. Start with 2 ounces per day and then work your way up to 4 to 8 ounces per day," says Castro.&lt;br&gt;
&lt;/p&gt;
&lt;p id="mntl-sc-block_13-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;h3 id="mntl-sc-block_14-0" class="comp mntl-sc-block marthastewart-sc-block-subheading mntl-sc-block-subheading"&gt; &lt;span class="mntl-sc-block-subheading__text"&gt; Bone Broth &lt;/span&gt; &lt;/h3&gt;
&lt;figure id="mntl-sc-block_15-0" class="comp mntl-sc-block marthastewart-sc-block-image mntl-sc-block-image mntl-sc-block-image--no-theme no-theme figure-landscape figure-high-res"&gt; 
&lt;figcaption id="mntl-figure-caption_1-0" class="comp mntl-figure-caption text-utility-100 figure-article-caption"&gt; &lt;span class="figure-article-caption-owner"&gt;Credit: &lt;p&gt;Getty Images&lt;/p&gt;&lt;/span&gt;
&lt;/figcaption&gt;&lt;/figure&gt;
&lt;p id="mntl-sc-block_16-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; If you enjoy the &lt;a class="recommendation-inline-link-ai" href="https://www.marthastewart.com/1511230/restorative-chicken-soup-ginger" link-destination-recommendation-ai="true" data-component="link" data-source="inlineLink" data-type="internalLink" data-ordinal="1"&gt;savory flavors of chicken broth&lt;/a&gt;, try incorporating 3 to 4 cups of &lt;a class="recommendation-inline-link-ai" href="https://www.marthastewart.com/how-to-eat-bone-broth-7479697" link-destination-recommendation-ai="true" data-component="link" data-source="inlineLink" data-type="internalLink" data-ordinal="2"&gt;bone broth&lt;/a&gt; into your wellness routine each week. It's a warm drink that is packed with nutrients to help support the function of the intestinal barrier, says Castro.&lt;span class="ql-inline-citation" data-cite="2"&gt;&lt;/span&gt; It's rich in amino acids such as glutamine, glycine, proline, histidine, arginine, as well as minerals including calcium, phosphorus, potassium, magnesium, and zinc. Getting enough minerals is essential to maintaining bone strength.
&lt;/p&gt;
&lt;p id="mntl-sc-block_17-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;p id="mntl-sc-block_18-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; "Glutamine is especially helpful in &lt;a class="recommendation-inline-link-ai" href="https://www.marthastewart.com/best-anti-inflammatory-foods-11716890" link-destination-recommendation-ai="true" data-component="link" data-source="inlineLink" data-type="internalLink" data-ordinal="1"&gt;reducing inflammation&lt;/a&gt;," says Castro. The gelatin in bone broth helps repair the gut lining, improving absorption, which is crucial as digestion capacity decreases with age.&lt;span class="ql-inline-citation" data-cite="2"&gt;&lt;/span&gt;
&lt;/p&gt;
&lt;p id="mntl-sc-block_19-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;p id="mntl-sc-block_20-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; In addition to promoting bone and gut health, bone broth can also benefit the skin.&lt;span class="ql-inline-citation" data-cite="3"&gt;&lt;/span&gt; It contains a significant amount of collagen, which helps with skin elasticity. When buying bone broth, check the label to see if it has been simmered for at least eight hours, "the levels of nutrients released from the bones are higher with longer cooking times," says Castro.&lt;br&gt;
&lt;/p&gt;
&lt;p id="mntl-sc-block_21-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;

&lt;p id="mntl-sc-block_23-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;h3 id="mntl-sc-block_24-0" class="comp mntl-sc-block marthastewart-sc-block-subheading mntl-sc-block-subheading"&gt; &lt;span class="mntl-sc-block-subheading__text"&gt; Herbal Tea &lt;/span&gt; &lt;/h3&gt;
&lt;p id="mntl-sc-block_25-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; Getting enough sleep each night supports healthy aging, and &lt;a class="recommendation-inline-link-ai" href="https://www.marthastewart.com/8097801/health-benefits-drinking-tea" link-destination-recommendation-ai="true" data-component="link" data-source="inlineLink" data-type="internalLink" data-ordinal="1"&gt;herbal tea&lt;/a&gt; can help.&lt;span class="ql-inline-citation" data-cite="4"&gt;&lt;/span&gt; These teas are rich in plant compounds such as polyphenols and flavonoids, which protect the cells from oxidative stress that accelerates the aging process. "Chamomile or lemon balm can help with restful sleep and stress reduction, which are both crucial for aging well.&lt;span class="ql-inline-citation" data-cite="5"&gt;&lt;/span&gt; I recommend 1 cup of any flavor of herbal tea daily," says Castro.
&lt;/p&gt;
&lt;p id="mntl-sc-block_26-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;h3 id="mntl-sc-block_27-0" class="comp mntl-sc-block marthastewart-sc-block-subheading mntl-sc-block-subheading"&gt; &lt;span class="mntl-sc-block-subheading__text"&gt; Coffee &lt;/span&gt; &lt;/h3&gt;
&lt;figure id="mntl-sc-block_28-0" class="comp mntl-sc-block marthastewart-sc-block-image mntl-sc-block-image mntl-sc-block-image--no-theme no-theme figure-landscape figure-high-res"&gt; 
&lt;figcaption id="mntl-figure-caption_2-0" class="comp mntl-figure-caption text-utility-100 figure-article-caption"&gt; &lt;span class="figure-article-caption-owner"&gt;Credit: &lt;p&gt;jmsilva / Getty Images&lt;/p&gt;&lt;/span&gt;
&lt;/figcaption&gt;&lt;/figure&gt;
&lt;p id="mntl-sc-block_29-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; &lt;a class="recommendation-inline-link-ai" href="https://www.marthastewart.com/benefits-of-coffee-11705221" link-destination-recommendation-ai="true" data-component="link" data-source="inlineLink" data-type="internalLink" data-ordinal="1"&gt;Coffee is rich in antioxidants&lt;/a&gt;, which have protective effects on our health concerning Alzheimer's and Parkinson's disease. "There is increasing evidence in favor of protective effects of coffee consumption in development and progression of liver disease. Caffeine may stimulate liver enzymes and improve liver function," says Castro.&lt;span class="ql-inline-citation" data-cite="10"&gt;&lt;/span&gt;
&lt;/p&gt;
&lt;p id="mntl-sc-block_30-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;p id="mntl-sc-block_31-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; She also notes that the recommended daily coffee intake varies based on the individual, but the average tolerance is up to 2 to 4 cups per day before 2:00 p.m. To ensure that your body properly absorbs the benefits, it's best to &lt;a class="recommendation-inline-link-ai" href="https://www.marthastewart.com/drinking-coffee-support-healthy-aging-study-says-11749717" link-destination-recommendation-ai="true" data-component="link" data-source="inlineLink" data-type="internalLink" data-ordinal="1"&gt;consume coffee at least one hour before mealtime&lt;/a&gt;, according to Balls. "If possible, it’s best to eat breakfast first, then drink it after breakfast, so you’re not consuming coffee on an empty stomach, which can irritate your stomach lining," says Balls.
&lt;/p&gt;
&lt;p id="mntl-sc-block_32-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;p id="mntl-sc-block_33-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; While drinking coffee has health benefits, it's essential to note that adding excess sugar, cream, or flavored syrups can cancel out these benefits.
&lt;/p&gt;
&lt;p id="mntl-sc-block_34-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;h3 id="mntl-sc-block_35-0" class="comp mntl-sc-block marthastewart-sc-block-subheading mntl-sc-block-subheading"&gt; &lt;span class="mntl-sc-block-subheading__text"&gt; Green Tea &lt;/span&gt; &lt;/h3&gt;
&lt;p id="mntl-sc-block_36-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; &lt;a class="recommendation-inline-link" href="https://www.marthastewart.com/benefits-of-green-tea-11721831" link-destination-recommendation="true" data-component="link" data-source="inlineLink" data-type="internalLink" data-ordinal="1"&gt;Green tea&lt;/a&gt; comes from the &lt;em&gt;Camellia sinensis&lt;/em&gt; plant and is brewed at a lower temperature, resulting in a lighter, fresher flavor. "It is rich in the polyphenol EGCG, which acts like a powerful antioxidant that helps reduce oxidative stress and inflammation, both of which greatly impact aging," says Castro.&lt;span class="ql-inline-citation" data-cite="11"&gt;&lt;/span&gt; Green tea helps balance blood sugar, which is also &lt;a class="recommendation-inline-link-ai" href="https://www.marthastewart.com/8193876/healthy-recipes-graceful-aging" link-destination-recommendation-ai="true" data-component="link" data-source="inlineLink" data-type="internalLink" data-ordinal="2"&gt;important for longevity&lt;/a&gt;.
&lt;/p&gt;
&lt;p id="mntl-sc-block_37-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;p id="mntl-sc-block_38-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; If you choose to drink green tea daily, Castro recommends 2 to 3 cups steeped for about 2 to 3 minutes and consumed before 2:00 p.m. to maximize health benefits and ensure good sleep.
&lt;/p&gt;
&lt;p id="mntl-sc-block_39-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;h3 id="mntl-sc-block_40-0" class="comp mntl-sc-block marthastewart-sc-block-subheading mntl-sc-block-subheading"&gt; &lt;span class="mntl-sc-block-subheading__text"&gt; Black Tea &lt;/span&gt; &lt;/h3&gt;
&lt;figure id="mntl-sc-block_41-0" class="comp mntl-sc-block marthastewart-sc-block-image mntl-sc-block-image mntl-sc-block-image--no-theme no-theme figure-portrait figure-high-res"&gt; 
&lt;/figure&gt;
&lt;p id="mntl-sc-block_42-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; Like green tea, black tea is from the &lt;em&gt;Camellia sinensis&lt;/em&gt; plant, but is brewed at a higher temperature and boasts a more bitter taste. Black tea contains polyphenols, such as theaflavins and thearubigins, that act like prebiotics, benefiting the bacteria in your microbiome.
&lt;/p&gt;
&lt;p id="mntl-sc-block_43-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;p id="mntl-sc-block_44-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; "These polyphenols feed keystone strains like &lt;em&gt;Bifidobacteria&lt;/em&gt; and &lt;em&gt;Lactobacillus&lt;/em&gt; that &lt;a class="recommendation-inline-link-ai" href="https://www.marthastewart.com/1542077/foods-healthy-immune-system" link-destination-recommendation-ai="true" data-component="link" data-source="inlineLink" data-type="internalLink" data-ordinal="1"&gt;support the immune system as you age&lt;/a&gt;. I recommend up to 1-2 cups of black tea daily, steeped for about 4-5 minutes before 2:00 PM to avoid sleep disruption," says Castro.&lt;span class="ql-inline-citation" data-cite="12"&gt;&lt;/span&gt;
&lt;/p&gt;
&lt;p id="mntl-sc-block_45-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;h3 id="mntl-sc-block_46-0" class="comp mntl-sc-block marthastewart-sc-block-subheading mntl-sc-block-subheading"&gt; &lt;span class="mntl-sc-block-subheading__text"&gt; Water &lt;/span&gt; &lt;/h3&gt;
&lt;p id="mntl-sc-block_47-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; Incorporating even one of these drinks into your weekly wellness routine can support healthy aging. But drinking enough water each day is essential. "Sure, it doesn't have a lot of bells or whistles, but water is such an important part of your body, and can help manage blood sugar levels if you're adequately hydrated," says Balls. "Staying hydrated with water helps lower your risk of heart disease, kidney stones, and diabetes, which are common concerns as we age."&lt;span class="ql-inline-citation" data-cite="6"&gt;&lt;/span&gt;&lt;span class="ql-inline-citation" data-cite="7"&gt;&lt;/span&gt;&lt;span class="ql-inline-citation" data-cite="8"&gt;&lt;/span&gt;
&lt;/p&gt;
&lt;p id="mntl-sc-block_48-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;div id="mntl-sc-block_49-0" class="comp mntl-sc-block marthastewart-sc-block-callout--tips mntl-sc-block-universal-callout--tips mntl-sc-block-universal-callout theme-tips callout--bordered" data-text="Tip" data-tracking-id="mntl-sc-block-callout" data-tracking-container="true"&gt;
&lt;div class="mntl-sc-block-universal-callout__body"&gt;&lt;p&gt;If plain water is hard to drink in large amounts, Castro recommends adding flavor without artificial sweeteners:&lt;/p&gt;&lt;ul&gt;&lt;li&gt;&lt;strong&gt;Infuse with fruit:&lt;/strong&gt; Slice citrus, berries, or cucumbers to give your water a natural flavor boost.&lt;/li&gt;&lt;li&gt;&lt;strong&gt;Freeze flavored ice cubes:&lt;/strong&gt; Make ice cubes from herbal tea or pureed fruit and drop them into your water for a burst of flavor as they melt.&lt;/li&gt;&lt;li&gt;&lt;strong&gt;Balance caffeine with water:&lt;/strong&gt; Drink a glass of water for every cup of coffee, tea, or energy drink.&lt;/li&gt;&lt;li&gt;&lt;strong&gt;Set reminders: &lt;/strong&gt;If you often forget to hydrate, set gentle phone reminders for water breaks and pay attention to your body's thirst and dehydration signals.&lt;/li&gt;&lt;/ul&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;p id="mntl-sc-block_50-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; Instead of relying on caffeinated drinks throughout the day, check in with yourself to be sure you're drinking enough water. Staying hydrated supports energy levels, which can motivate you to be active and maintain healthy habits, says Balls. "Your hydration status is also linked to your metabolic health, crucial for fat metabolism, nutrient transport, and waste removal."
&lt;/p&gt;
&lt;p id="mntl-sc-block_51-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;h3 id="mntl-sc-block_52-0" class="comp mntl-sc-block marthastewart-sc-block-subheading mntl-sc-block-subheading"&gt; &lt;span class="mntl-sc-block-subheading__text"&gt; Martha's Green Juice &lt;/span&gt; &lt;/h3&gt;
&lt;figure id="mntl-sc-block_53-0" class="comp mntl-sc-block marthastewart-sc-block-image mntl-sc-block-image mntl-sc-block-image--no-theme no-theme figure-landscape figure-high-res"&gt; 
&lt;figcaption id="mntl-figure-caption_3-0" class="comp mntl-figure-caption text-utility-100 figure-article-caption"&gt; &lt;span class="figure-article-caption-owner"&gt;Credit: &lt;p&gt;Emily Laurae&lt;/p&gt;&lt;/span&gt;
&lt;/figcaption&gt;&lt;/figure&gt;
&lt;p id="mntl-sc-block_54-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; And of course, we can't forget Martha's green juice. For years, she has credited her prized green juice for contributing to her good health. "This is what I recharge my batteries with every single morning," she says. "I don't leave my house without it." &lt;a href="https://www.marthastewart.com/1050707/green-juice" data-component="link" data-source="inlineLink" data-type="internalLink" data-ordinal="1"&gt;Her recipe&lt;/a&gt; includes pears, celery, cucumbers, parsley, ginger, and orange. While juice lacks the fiber of whole fruits and vegetables, green juice is a health-boosting blend that makes it easy to drink your greens. If certain ingredients are low or out of season, simply swap them out with other nutritious vegetables and fruits that you like. Note that we are referring to juice fresh-pressed at home, which doesn't include the sweeteners or other additives you might find in bottled versions.
&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>marthastewart.com</author><pubDate>Wed, 10 Sep 2025 18:00:00 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMid0FVX3lxTE12aWxUeFc5YnpnejA5alVKb09RbFQ3WUxpNWo3cEM3VFhjUjQtdVBQY01HTXZxZGM3V0VsUC1BVGVXYTVFOXQ4VERXZmFsVXQtYXc3NjdPVG15THFQM2NNQ01aMVNxZi1zNElCTmppd0xPMFY0WGdj</guid></item><item><title>根据一项新的研究- Earth.com ，吃辛辣食物可以保护心脏和大脑健康</title><link>https://www.earth.com/news/eating-spicy-food-chili-peppers-protects-the-heart-and-brain/</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="page_content__AwOj6"&gt;&lt;p&gt;Healthy eating often feels like a moving target. Advice flips, trends flare up, and people are left unsure about what actually supports the heart.&lt;/p&gt;&lt;p&gt;A careful look at spicy food offers a clear signal worth your attention. A new population analysis from Sichuan Province, China, tracked adults and linked frequent chili intake to lower rates of major heart and brain events.&lt;/p&gt;&lt;h2 class="wp-block-heading" id="h-spicy-food-and-heart-health"&gt;Spicy food and heart health&lt;/h2&gt;&lt;p&gt;&lt;a href="https://loop.frontiersin.org/people/706473/bio" target="_blank" rel="noreferrer noopener"&gt;Marialaura Bonaccio&lt;/a&gt; of &lt;a href="https://www.reteneuroscienze.it/en/Istituto/irccs-istituto-neurologico-mediterraneo-neuromed/" target="_blank" rel="noreferrer noopener"&gt;IRCCS&lt;/a&gt; Neuromed has spent years studying chili peppers and heart outcomes in Europe, and her work helps frame this topic globally. &lt;/p&gt;&lt;p&gt;Her perspective complements findings from China while reminding us to keep lifestyle and culture in the mix.&lt;/p&gt;&lt;p&gt;The Chinese team analyzed 54,859 adults and found that compared with people who rarely ate spicy food, those who ate it 6 to 7 days per week were less likely to develop ischemic heart disease and cerebrovascular diseases. &lt;/p&gt;&lt;p&gt;They also saw a reduced risk of ischemic stroke, a blockage in brain blood flow, with the likelihood of these problems dropping further as spicy food consumption became more frequent.&lt;/p&gt;&lt;p&gt;&lt;a href="https://www.earth.com/news/spicy-foods-can-slow-down-eating-and-cut-calorie-intake/"&gt;Moderate spice&lt;/a&gt; intensity tracked with a lower overall risk of cardio and cerebrovascular disease in the cohort. &lt;/p&gt;&lt;p&gt;Starting regular spicy intake earlier in life also lined up with lower risk, although the effect did not extend to hemorrhagic stroke.&lt;/p&gt;&lt;h2 class="wp-block-heading" id="h-how-food-gets-spicy"&gt;How food gets spicy&lt;/h2&gt;&lt;p&gt;The main bioactive in chilies is &lt;a href="https://npic.orst.edu/factsheets/capgen.html" target="_blank" rel="noreferrer noopener"&gt;capsaicin&lt;/a&gt;, which is responsible for the burning sensation people feel when eating spicy foods. &lt;/p&gt;&lt;p&gt;Beyond taste, capsaicin works on a special sensor in the body, found in nerves and in the lining of blood vessels. &lt;/p&gt;&lt;p&gt;When this sensor is stimulated regularly, research in animals shows that it can increase the natural production of nitric oxide, a chemical that relaxes blood vessels and helps blood flow more smoothly. &lt;/p&gt;&lt;p&gt;This process has also been linked to &lt;a href="https://www.earth.com/news/trying-to-lower-your-blood-pressure-this-common-nutrient-can-help/"&gt;lower blood pressure&lt;/a&gt;, especially in animals with hypertension, which is long term high blood pressure.&lt;/p&gt;&lt;h2 class="wp-block-heading" id="h-capsaicin-and-arteries"&gt;Capsaicin and arteries&lt;/h2&gt;&lt;p&gt;These changes are important because they improve the overall health of the inner walls of arteries. &lt;/p&gt;&lt;p&gt;Strong, flexible arteries are better able to expand and contract, which reduces the workload on the heart and lowers the chance of damage over time. &lt;/p&gt;&lt;p&gt;Better vessel relaxation means the circulatory system can adjust more easily when the body needs more blood flow, such as during exercise or stress.&lt;/p&gt;&lt;p&gt;Capsaicin’s impact is not just about the immediate burning feeling on the tongue. Inside the body, it sets off chemical signals that affect how cells behave. &lt;/p&gt;&lt;p&gt;Over time, researchers have measured changes in proteins connected to nitric oxide pathways, and these shifts line up with long term improvements in how &lt;a href="https://www.earth.com/news/tiny-blood-vessels-may-fuel-the-spread-of-cancer-cells/"&gt;blood vessels function&lt;/a&gt;. &lt;/p&gt;&lt;p&gt;This suggests that eating spicy foods regularly may provide benefits for cardiovascular health that go well beyond flavor or temporary sensation.&lt;/p&gt;&lt;h2 class="wp-block-heading" id="h-how-this-fits-with-past-evidence"&gt;How this fits with past evidence&lt;/h2&gt;&lt;p&gt;Large-scale work in China from 2004 to 2013 linked frequent spicy eating to lower all cause mortality. &lt;/p&gt;&lt;p&gt;In that &lt;a href="https://pubmed.ncbi.nlm.nih.gov/26242395/" target="_blank" rel="noreferrer noopener"&gt;study,&lt;/a&gt; participants who ate spicy food 6 or 7 days per week had a 14 percent lower risk of death than those who ate it less than once a week, with inverse associations also seen for ischemic heart disease and respiratory diseases.&lt;/p&gt;&lt;p&gt;A separate Italian &lt;a href="https://pubmed.ncbi.nlm.nih.gov/31856971/" target="_blank" rel="noreferrer noopener"&gt;cohort&lt;/a&gt; found that people who ate chili peppers more than four times per week had lower total and cardiovascular mortality. The association persisted even when researchers accounted for adherence to the Mediterranean diet.&lt;/p&gt;&lt;p&gt;Findings from the Italian study showed that chili pepper consumption appeared to offer protection for the heart even when overall eating habits differed. &lt;/p&gt;&lt;p&gt;The benefit was seen both in people who followed a &lt;a href="https://www.earth.com/news/mediterranean-diet-boosts-brain-power-by-altering-the-gut/"&gt;Mediterranean diet&lt;/a&gt; and in those whose diets were less healthy, suggesting that the positive effect of chili peppers was consistent across different dietary patterns. &lt;/p&gt;&lt;p&gt;Marialaura Bonaccio, who also led this study, underscored this point when presenting the results.&lt;/p&gt;&lt;h2 class="wp-block-heading" id="h-what-spicy-food-means-in-real-life"&gt;What spicy food means in real life&lt;/h2&gt;&lt;p&gt;None of these studies say &lt;a href="https://www.earth.com/news/mild-chili-peppers-may-be-the-anti-spice-weve-been-looking-for/"&gt;chili peppers&lt;/a&gt; cure heart disease. They do say that in large groups of people, more frequent spicy intake is linked to fewer heart and brain problems across time.&lt;/p&gt;&lt;p&gt;This is observational research, so cause and effect remain open questions. Still, the consistency across settings argues that spicy eating patterns often travel with other helpful choices or may deliver direct biological benefits.&lt;/p&gt;&lt;p&gt;Spice strength matters too. The Chinese work reported signals at weak to moderate levels, which gels with the simple idea that daily habits beat extremes.&lt;/p&gt;&lt;p&gt;Whole chilies, simple sauces, and meals that use chili to season real food are sensible places to start. People with reflux, ulcers, or other conditions should adjust to tolerance and talk to a clinician if symptoms flare.&lt;/p&gt;&lt;h2 class="wp-block-heading" id="h-limits-and-what-comes-next"&gt;Limits and what comes next&lt;/h2&gt;&lt;p&gt;A much larger China Kadoorie Biobank incidence&lt;strong&gt; &lt;/strong&gt;&lt;a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12273639/"&gt;paper&lt;/a&gt;&lt;strong&gt; &lt;/strong&gt;followed 486,335 adults for a median of 12.1 years. &lt;/p&gt;&lt;p&gt;They found lower risks of vascular disease in people who ate spicy foods one to seven days per week, with trends that held for ischemic heart disease and major coronary events. &lt;/p&gt;&lt;p&gt;The association was particularly clear in younger adults and those living in rural regions.&lt;/p&gt;&lt;p&gt;It is also possible that people who enjoy spicy foods eat differently in other ways, or live in places where chili use reflects cultural patterns that bring other benefits or risks. &lt;/p&gt;&lt;p&gt;Careful sensitivity checks, such as excluding early events, help probe these points but do not close the book on causality.&lt;/p&gt;&lt;p&gt;Future studies could test how foods high in capsaicin or standardized chili products influence blood pressure, cholesterol, and blood vessel health over time. &lt;/p&gt;&lt;p&gt;Researchers could also examine how chili affects nitric oxide activity in people by using amounts similar to those found in everyday cooking.&lt;/p&gt;&lt;h2 class="wp-block-heading" id="h-cutting-through-the-noise"&gt;Cutting through the noise&lt;/h2&gt;&lt;p&gt;Nutrition debates can feel noisy, yet some messages are steady. Frequent &lt;a href="https://www.earth.com/news/eating-chili-during-pregnancy-may-actually-be-a-good-idea/"&gt;chili&lt;/a&gt; use, inside a balanced pattern of eating, shows a consistent association with better heart and brain outcomes across very different populations.&lt;/p&gt;&lt;p&gt;People do not need to chase extreme heat or complicated protocols. A modest, regular habit built around meals you enjoy is easier to keep, and the data suggest that rhythm matters more than bragging rights.&lt;/p&gt;&lt;p&gt;Taste and tolerance vary, so personal comfort should lead the way. If spicy foods agree with you, using chilies to season home cooked meals looks like a choice with upside and little downside for most healthy adults.&lt;/p&gt;&lt;p&gt;The study is published in &lt;a href="https://pubmed.ncbi.nlm.nih.gov/40677177/" target="_blank" rel="noreferrer noopener"&gt;&lt;em&gt;Zhonghua Liu Xing Bing Xue Za Zh&lt;/em&gt;i&lt;/a&gt;.&lt;/p&gt;&lt;p&gt;—–&lt;/p&gt;&lt;p&gt;Like what you read?&lt;a href="https://www.earth.com/subscribe/"&gt; Subscribe to our newsletter&lt;/a&gt; for engaging articles, exclusive content, and the latest updates. &lt;/p&gt;&lt;p&gt;Check us out on&lt;a href="https://www.earth.com/earthsnap/"&gt; EarthSnap&lt;/a&gt;, a free app brought to you by&lt;a href="https://www.earth.com/author/eralls/"&gt; Eric Ralls&lt;/a&gt; and Earth.com.&lt;/p&gt;&lt;p&gt;—–&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Earth.com</author><pubDate>Wed, 10 Sep 2025 17:56:19 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMikgFBVV95cUxOWkc1VUNKXzhlQVRrd2M2VEMzYzhydF9UNXBJVHY4bWtIaF9fRE80WDNEd3MtZmlGVVdOODJYVENUOVY5dml4ajRQcXJ3TlhtbGtQbTJZa2o0eURGQlpLSi1GekIwVWxrQ2JSd3djTjlpVEQySFFfWjVpbEIzaHVxUGdKX0JlZkc0SmhnanFHLTZYZw</guid></item><item><title>一些阿灵顿药店开始提供没有处方的Covid-19疫苗- ARLnow</title><link>https://www.arlnow.com/2025/09/10/some-arlington-pharmacies-begin-offering-covid-19-shots-without-prescriptions/</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="entry-content pt-6 px-4 content-post"&gt;
		&lt;p&gt;Amid &lt;a href="https://www.arlnow.com/2025/09/08/arlington-pharmacies-requiring-prescriptions-for-new-covid-19-vaccine/"&gt;shifting federal guidelines&lt;/a&gt; on Covid-19 vaccines, some pharmacies around Arlington are now offering the shots without requiring a prescription.&lt;/p&gt;
&lt;p&gt;Only days ago, all CVS locations in Virginia required a prescription for most patients to receive the latest version of the vaccine. That’s no longer the case, CVS spokesperson Amy Thibault told ARLnow today (Wednesday).&lt;/p&gt;
&lt;p&gt;Virginia is now among the states where CVS can offer the vaccine “without a patient-specific prescription.” Thibault said the company’s approach is “based on FDA approval and recent regulatory action by certain states.”&lt;/p&gt;
&lt;p&gt;“Virginia law permits a prescriber to enter a protocol arrangement that authorizes pharmacist-administered vaccinations for adults,” she said.&lt;/p&gt;
&lt;p&gt;A sign at a Safeway in Falls Church also currently advertises Covid-19 shots for patients ages 18 and up, no prescription required.&lt;/p&gt;
&lt;p&gt;True to the business’s word, an ARLnow reporter successfully received a vaccine there this morning without a doctor’s prescription.&lt;/p&gt;
&lt;figure id="attachment_382767" aria-describedby="caption-attachment-382767" class="wp-caption aligncenter"&gt;&lt;img decoding="async" class="wp-image-382767 size-full" src="https://www.arlnow.com/wp-content/uploads/2025/09/img_6539.jpg" alt="" srcset="https://www.arlnow.com/wp-content/uploads/2025/09/img_6539.jpg 1600w, https://www.arlnow.com/wp-content/uploads/2025/09/img_6539-300x225.jpg 300w, https://www.arlnow.com/wp-content/uploads/2025/09/img_6539-600x450.jpg 600w, https://www.arlnow.com/wp-content/uploads/2025/09/img_6539-768x576.jpg 768w, https://www.arlnow.com/wp-content/uploads/2025/09/img_6539-1536x1152.jpg 1536w, https://www.arlnow.com/wp-content/uploads/2025/09/img_6539-730x548.jpg 730w" sizes="(max-width: 1600px) 100vw, 1600px"&gt;&lt;figcaption id="caption-attachment-382767" class="wp-caption-text"&gt;A sign advertising free Covid-19 shots at a Safeway in Falls Church (staff photo by Vernon Miles)&lt;/figcaption&gt;&lt;/figure&gt;
&lt;p&gt;A tipster told ARLnow that all 33 Safeway locations with pharmacies in Virginia have the same policy. As of this afternoon, patients over the age of 18 with Virginia zip codes can schedule Covid-19 vaccinations on the company’s &lt;a href="https://www.safeway.com/health/appointments/home"&gt;website&lt;/a&gt;.&lt;/p&gt;
&lt;p&gt;“The 2025-2026 COVID-19 vaccines are indicated for people ages 65 and older, and those under 65 years of age at increased risk for severe COVID-19,” the website says.&lt;/p&gt;
&lt;p&gt;Safeway’s parent company, Albertsons, did not immediately respond to a request for comment.&lt;/p&gt;
&lt;p&gt;More clarity on this topic could come once the Advisory Committee on Immunization Practices (ACIP) meets from Sept. 18-19. The Virginia Department of Health said last week that it “anticipates that ACIP will vote on the updated COVID-19 vaccines at this meeting.”&lt;/p&gt;
&lt;p&gt;“If approved by the CDC, pharmacists will be able to administer the COVID-19 vaccine,” the department said.&lt;/p&gt;
&lt;p&gt;The health agency encouraged Virginians to contact their health-care providers to ask about receiving the vaccine or request a prescription.&lt;/p&gt;
	&lt;/div&gt;
				&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>ARLnow</author><pubDate>Wed, 10 Sep 2025 17:45:28 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMisgFBVV95cUxOVVpTZEZSanJ3bE5jd0dQVHA4am1DUzFfZ2pUbkt3Sl9ZX25oNGFPM3dVWFhpUEZ6bzVXQXhNUmRUX0Y3LXBPcUFPQWNBWDN1dDZQX05oZWdMaWxQRldmbWM3czBDeVdTYWhqenZqMk5qN2NHS2JxY3hhNjVjMW1kSVFqM2pkNDNMUG5LOVliSDhqUmNHbUFhTFNycG5NdlBEeWpBRG1aYjI2S0RvMWRWVXhn</guid></item><item><title>为什么越来越多的老年人在跌倒后死亡？ - Yahoo News Canada</title><link>https://ca.news.yahoo.com/why-more-older-people-dying-173446408.html</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="" data-article-body="true"&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;For a while, walking the dog felt hazardous.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;Earl Vickers was accustomed to taking Molly, his shepherd-boxer-something-else mix, for strolls on the beach or around his neighborhood in Seaside, Calif. A few years ago, though, he started to experience problems staying upright.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;“If another dog came toward us, every single time I’d end up on the ground,” recalled Mr. Vickers, 69, a retired electrical engineer. “It seemed like I was falling every other month. It was kind of crazy.”&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;Most of those tumbles did no serious damage, though one time he fell backward and hit his head on a wall behind him. “I don’t think I had a concussion, but it’s not something I want to do every day,” Mr. Vickers said, ruefully. Another time, trying to break a fall, he broke two bones in his left hand.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;So in 2022, he told the oncologist who had been treating him for prostate cancer that he wanted to stop the cancer drug he had been taking, off and on, for four years: enzalutamide (sold as Xtandi).&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;Among the drug’s &lt;a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203415lbl.pdf" rel="nofollow noopener" target="_blank" data-ylk="slk:listed side effects;elm:context_link;itc:0;sec:content-canvas" class="link "&gt;listed side effects&lt;/a&gt; are higher rates of falls and fractures among patients who took it, compared with those given a placebo. His doctor agreed that he could discontinue the drug, and “I haven’t had a single fall since,” Mr. Vickers said.&lt;/p&gt;&lt;hr class="my-4"&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;Public health experts have warned of the perils of falls for older people for decades. In 2023, the most recent year of data from the Centers for Disease Control and Prevention, more than 41,000 Americans over 65 died from falls, &lt;a href="https://jamanetwork.com/journals/jama-health-forum/fullarticle/2837039" rel="nofollow noopener" target="_blank" data-ylk="slk:an opinion article in JAMA Health Forum;elm:context_link;itc:0;sec:content-canvas" class="link "&gt;an opinion article in JAMA Health Forum&lt;/a&gt; pointed out last month.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;More startling than that figure, though, was another statistic: Fall-related mortality among older adults has been climbing sharply.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;The author, Dr. Thomas Farley, an epidemiologist, reported that death rates from fall injuries among Americans over 65 had more than tripled over the past 30 years. Among those over 85, the cohort at highest risk, death rates from falls jumped to 339 per 100,000 in 2023, from 92 per 100,000 in 1990.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;The culprit, in his view, is Americans’ reliance on prescription drugs.&lt;/p&gt;&lt;blockquote class="mb-4 border-l-2 pl-5 italic text-tertiary"&gt;&lt;div class=""&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;“Older adults are heavily medicated, increasingly so, and with drugs that are inappropriate for older people,” Dr. Farley said in an interview. “This didn’t occur &lt;a href="https://pubmed.ncbi.nlm.nih.gov/31831549/" rel="nofollow noopener" target="_blank" data-ylk="slk:in Japan;elm:context_link;itc:0;sec:content-canvas" class="link "&gt;in Japan&lt;/a&gt; or in Europe.”&lt;/p&gt;&lt;/div&gt;&lt;/blockquote&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;Yet that same 30-year period saw a flurry of research and activity to try to reduce geriatric falls and their potentially devastating consequences, from hip fractures and brain bleeds to restricted mobility, persistent pain and institutionalization.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;The American Geriatrics Society adopted updated &lt;a href="https://geriatrictoolkit.missouri.edu/balance/AGS-BGS-CPG-Fall-Prevention-JAGS-2011.pdf" rel="nofollow noopener" target="_blank" data-ylk="slk:fall prevention guidelines;elm:context_link;itc:0;sec:content-canvas" class="link "&gt;fall prevention guidelines&lt;/a&gt; in 2011. The C.D.C. unveiled a program called &lt;a href="https://www.cdc.gov/steadi/index.html" rel="nofollow noopener" target="_blank" data-ylk="slk:STEADI;elm:context_link;itc:0;sec:content-canvas" class="link "&gt;STEADI&lt;/a&gt; in 2019. The United States Preventive Services Task Force recommended exercise or physical therapy for older adults at risk of falling in 2012, 2018 and again &lt;a href="https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/falls-prevention-community-dwelling-older-adults-interventions" rel="nofollow noopener" target="_blank" data-ylk="slk:last year;elm:context_link;itc:0;sec:content-canvas" class="link "&gt;last year&lt;/a&gt;.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;“There’ve been studies and interventions and investments, and they haven’t been particularly successful,” said Dr. Donovan Maust, a geriatric psychiatrist and researcher at the University of Michigan. “It’s a bad problem that seems to be getting worse.”&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;But are prescription drugs driving that increase? Geriatricians and others who research falls and prescribing practices question that conclusion.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;Dr. Farley, a former New York City health commissioner who teaches at Tulane University, acknowledged that many factors contribute to falls, including the physical impairments and deteriorating eyesight associated with advancing age; alcohol abuse; and tripping hazards in people’s homes.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;But “there’s no reason to think any of them have gotten three times worse in the past 30 years,” he said, pointing to studies showing &lt;a href="https://www.thelancet.com/journals/lanhl/article/PIIS2666-7568(24)00198-3/fulltext" rel="nofollow noopener" target="_blank" data-ylk="slk:declines in other high-income countries;elm:context_link;itc:0;sec:content-canvas" class="link "&gt;declines in other high-income countries&lt;/a&gt;.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;The difference, he believes, is Americans’ increasing use of medications — like benzodiazepines, opioids, antidepressants, and gabapentin — that act on the central nervous system.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;“The drugs that increase falls’ mortality are those that make you drowsy or dizzy,” he said.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;Problematic drugs are numerous enough to have acquired an acronym: FRIDs, or “fall risk increasing drugs,” a category that also includes various cardiac medications and early antihistamines like Benadryl.&lt;/p&gt;&lt;figure class="relative mb-4"&gt;&lt;figcaption class="relative text-sm mt-1 pr-2.5"&gt;&lt;p&gt;Getty Images&lt;/p&gt;&lt;/figcaption&gt;&lt;/figure&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;Such medications play a major role, agreed Dr. Thomas Gill, a geriatrician and epidemiologist at Yale University and a longtime falls researcher. But, he said, “there are alternative explanations” for the increase in death rates.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;He cited changes in reporting the causes of death, for instance. “Years ago, falls were considered a natural consequence of aging and no big deal,” he said.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;Death certificates often attributed fatalities among older people to ailments like heart failure instead of falls, making fall mortality appear lower in the 1980s and 1990s.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;Today’s over-85 cohort may also be frailer and sicker than the oldest-old were 30 years ago, Dr. Gill added, because contemporary medicine can keep people alive for longer.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;Their accumulating impairments, more than the drugs they take, could make them more likely to die after a fall.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;Another skeptic, Dr. Neil Alexander, a geriatrician and falls expert at the University of Michigan and V.A. Ann Arbor Healthcare System, argued that most doctors have come to understand the dangers of FRIDs and prescribe them less often.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;“Message delivered,” he said. Given the alarms sounded about opioids, about benzodiazepines and related drugs, and especially about opioids and benzos together, “a lot of primary care doctors have heard the gospel,” he said. “They know not to give older people Valium.”&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;Moreover, prescriptions for some fall-related drugs have already declined or hit plateaus, even as death rates because of falls have risen. Medicare data shows &lt;a href="https://link.springer.com/article/10.1007/s40266-025-01237-x" rel="nofollow noopener" target="_blank" data-ylk="slk:lower prescription opioid use;elm:context_link;itc:0;sec:content-canvas" class="link "&gt;lower prescription opioid use&lt;/a&gt; beginning a decade ago, for example. Benzodiazepine prescriptions for older patients have slowed, Dr. Maust said.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;On the other hand, the &lt;a href="https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2820722" rel="nofollow noopener" target="_blank" data-ylk="slk:use of antidepressants;elm:context_link;itc:0;sec:content-canvas" class="link "&gt;use of antidepressants&lt;/a&gt; and of &lt;a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11233090/" rel="nofollow noopener" target="_blank" data-ylk="slk:gabapentin;elm:context_link;itc:0;sec:content-canvas" class="link "&gt;gabapentin&lt;/a&gt; has increased.&lt;/p&gt;&lt;hr class="my-4"&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;Whether or not medication use outweighs all other factors, “nobody disputes that these agents are overused and inappropriately used” and contribute to the troubling increase in fall death rates among seniors, Dr. Gill said.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;Thus, the ongoing campaign for “de-prescribing” — stopping the medications whose potential harms outweigh their benefits, or reducing their dosage.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;“We know a lot of these drugs can increase falls by 50 to 75 percent” in older patients, said Dr. Michael Steinman, a geriatrician at the University of California, San Francisco, and co-director of the &lt;a href="https://deprescribingresearch.org/" rel="nofollow noopener" target="_blank" data-ylk="slk:US Deprescribing Research Network;elm:context_link;itc:0;sec:content-canvas" class="link "&gt;US Deprescribing Research Network&lt;/a&gt;, established in 2019.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;“It’s easy to start meds, but it often takes a lot of time and effort to have patients stop taking them,” he said. Harried doctors may pay less attention to drug regimens than to health issues that seem more pressing, and patients can be reluctant to give up pills that seem to help with pain, insomnia, reflux and other common age-related complaints.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;The Beers Criteria, a directory of drugs often deemed inadvisable for older adults, recently published &lt;a href="https://agsjournals.onlinelibrary.wiley.com/doi/epdf/10.1111/jgs.19500" rel="nofollow noopener" target="_blank" data-ylk="slk:recommendations for alternative medications and nonpharmacological treatments;elm:context_link;itc:0;sec:content-canvas" class="link "&gt;recommendations for alternative medications and nonpharmacological treatments&lt;/a&gt; for frequent problems. Cognitive behavioral therapy for sleeplessness. Exercise, physical therapy and psychological interventions for pain.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;“It’s a real tragedy when people have this life-altering event,” Dr. Steinman, co-chair of the Beers panel on alternatives, said of falls. He urged older patients to raise the issue of FRIDs themselves, if their doctors haven’t.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;“Ask, ‘Do any of my medications increase the risk of falls? Is there an alternative treatment?’” he suggested. “Being an informed patient or caregiver can put this on the agenda. Otherwise, it might not come up.”&lt;/p&gt;&lt;hr class="my-4"&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;&lt;em&gt;The New Old Age is produced through a partnership with &lt;a href="https://www.nytimes.com/column/the-new-old-age" rel="nofollow noopener" target="_blank" data-ylk="slk:The New York Times;elm:context_link;itc:0;sec:content-canvas" class="link "&gt;The New York Times&lt;/a&gt;.&lt;/em&gt;&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;&lt;em&gt;&lt;a href="https://kffhealthnews.org/about-us" rel="nofollow noopener" target="_blank" data-ylk="slk:KFF Health News;elm:context_link;itc:0;sec:content-canvas" class="link "&gt;KFF Health News&lt;/a&gt; is a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFF — an independent source of health policy research, polling, and journalism. Learn more about &lt;a href="https://www.kff.org/about-us" rel="nofollow noopener" target="_blank" data-ylk="slk:KFF;elm:context_link;itc:0;sec:content-canvas" class="link "&gt;KFF&lt;/a&gt;.&lt;/em&gt;&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;The post &lt;a href="https://katiecouric.com/news/older-person-falling-causes/" rel="nofollow noopener" target="_blank" data-ylk="slk:Why Are More Older People Dying After Falls?;elm:context_link;itc:0;sec:content-canvas" class="link "&gt;Why Are More Older People Dying After Falls?&lt;/a&gt; appeared first on &lt;a href="https://katiecouric.com" rel="nofollow noopener" target="_blank" data-ylk="slk:Katie Couric Media;elm:context_link;itc:0;sec:content-canvas" class="link "&gt;Katie Couric Media&lt;/a&gt;.&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Yahoo News Canada</author><pubDate>Wed, 10 Sep 2025 17:34:46 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMid0FVX3lxTE1IZ284VU10Y2diYXRaR09Nekl1M2ZKTXVUcWtQQ3d1V0xIdDFuZkQ3V1k3eVZOekpFRVRlWVpfbzJFZ3dGNmJsUlpFVUdBcnl6MmZkR3BEOHdDbkdhYmgxQnZWT0hYT05VRW84aThmTWd2MlVMdlZv</guid></item><item><title>为什么越来越多的老年人在跌倒后死亡？ - yahoo.com</title><link>https://www.yahoo.com/news/articles/why-more-older-people-dying-173446408.html</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="" data-article-body="true"&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;For a while, walking the dog felt hazardous.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;Earl Vickers was accustomed to taking Molly, his shepherd-boxer-something-else mix, for strolls on the beach or around his neighborhood in Seaside, Calif. A few years ago, though, he started to experience problems staying upright.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;“If another dog came toward us, every single time I’d end up on the ground,” recalled Mr. Vickers, 69, a retired electrical engineer. “It seemed like I was falling every other month. It was kind of crazy.”&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;Most of those tumbles did no serious damage, though one time he fell backward and hit his head on a wall behind him. “I don’t think I had a concussion, but it’s not something I want to do every day,” Mr. Vickers said, ruefully. Another time, trying to break a fall, he broke two bones in his left hand.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;So in 2022, he told the oncologist who had been treating him for prostate cancer that he wanted to stop the cancer drug he had been taking, off and on, for four years: enzalutamide (sold as Xtandi).&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;Among the drug’s &lt;a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203415lbl.pdf" rel="nofollow noopener" target="_blank" data-ylk="slk:listed side effects;elm:context_link;itc:0;sec:content-canvas" class="link "&gt;listed side effects&lt;/a&gt; are higher rates of falls and fractures among patients who took it, compared with those given a placebo. His doctor agreed that he could discontinue the drug, and “I haven’t had a single fall since,” Mr. Vickers said.&lt;/p&gt;&lt;hr class="my-4"&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;Public health experts have warned of the perils of falls for older people for decades. In 2023, the most recent year of data from the Centers for Disease Control and Prevention, more than 41,000 Americans over 65 died from falls, &lt;a href="https://jamanetwork.com/journals/jama-health-forum/fullarticle/2837039" rel="nofollow noopener" target="_blank" data-ylk="slk:an opinion article in JAMA Health Forum;elm:context_link;itc:0;sec:content-canvas" class="link "&gt;an opinion article in JAMA Health Forum&lt;/a&gt; pointed out last month.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;More startling than that figure, though, was another statistic: Fall-related mortality among older adults has been climbing sharply.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;The author, Dr. Thomas Farley, an epidemiologist, reported that death rates from fall injuries among Americans over 65 had more than tripled over the past 30 years. Among those over 85, the cohort at highest risk, death rates from falls jumped to 339 per 100,000 in 2023, from 92 per 100,000 in 1990.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;The culprit, in his view, is Americans’ reliance on prescription drugs.&lt;/p&gt;&lt;blockquote class="mb-4 border-l-2 pl-5 italic text-tertiary"&gt;&lt;div class=""&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;“Older adults are heavily medicated, increasingly so, and with drugs that are inappropriate for older people,” Dr. Farley said in an interview. “This didn’t occur &lt;a href="https://pubmed.ncbi.nlm.nih.gov/31831549/" rel="nofollow noopener" target="_blank" data-ylk="slk:in Japan;elm:context_link;itc:0;sec:content-canvas" class="link "&gt;in Japan&lt;/a&gt; or in Europe.”&lt;/p&gt;&lt;/div&gt;&lt;/blockquote&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;Yet that same 30-year period saw a flurry of research and activity to try to reduce geriatric falls and their potentially devastating consequences, from hip fractures and brain bleeds to restricted mobility, persistent pain and institutionalization.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;The American Geriatrics Society adopted updated &lt;a href="https://geriatrictoolkit.missouri.edu/balance/AGS-BGS-CPG-Fall-Prevention-JAGS-2011.pdf" rel="nofollow noopener" target="_blank" data-ylk="slk:fall prevention guidelines;elm:context_link;itc:0;sec:content-canvas" class="link "&gt;fall prevention guidelines&lt;/a&gt; in 2011. The C.D.C. unveiled a program called &lt;a href="https://www.cdc.gov/steadi/index.html" rel="nofollow noopener" target="_blank" data-ylk="slk:STEADI;elm:context_link;itc:0;sec:content-canvas" class="link "&gt;STEADI&lt;/a&gt; in 2019. The United States Preventive Services Task Force recommended exercise or physical therapy for older adults at risk of falling in 2012, 2018 and again &lt;a href="https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/falls-prevention-community-dwelling-older-adults-interventions" rel="nofollow noopener" target="_blank" data-ylk="slk:last year;elm:context_link;itc:0;sec:content-canvas" class="link "&gt;last year&lt;/a&gt;.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;“There’ve been studies and interventions and investments, and they haven’t been particularly successful,” said Dr. Donovan Maust, a geriatric psychiatrist and researcher at the University of Michigan. “It’s a bad problem that seems to be getting worse.”&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;But are prescription drugs driving that increase? Geriatricians and others who research falls and prescribing practices question that conclusion.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;Dr. Farley, a former New York City health commissioner who teaches at Tulane University, acknowledged that many factors contribute to falls, including the physical impairments and deteriorating eyesight associated with advancing age; alcohol abuse; and tripping hazards in people’s homes.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;But “there’s no reason to think any of them have gotten three times worse in the past 30 years,” he said, pointing to studies showing &lt;a href="https://www.thelancet.com/journals/lanhl/article/PIIS2666-7568(24)00198-3/fulltext" rel="nofollow noopener" target="_blank" data-ylk="slk:declines in other high-income countries;elm:context_link;itc:0;sec:content-canvas" class="link "&gt;declines in other high-income countries&lt;/a&gt;.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;The difference, he believes, is Americans’ increasing use of medications — like benzodiazepines, opioids, antidepressants, and gabapentin — that act on the central nervous system.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;“The drugs that increase falls’ mortality are those that make you drowsy or dizzy,” he said.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;Problematic drugs are numerous enough to have acquired an acronym: FRIDs, or “fall risk increasing drugs,” a category that also includes various cardiac medications and early antihistamines like Benadryl.&lt;/p&gt;&lt;figure class="relative mb-4"&gt;&lt;figcaption class="relative text-sm mt-1 pr-2.5"&gt;&lt;p&gt;Getty Images&lt;/p&gt;&lt;/figcaption&gt;&lt;/figure&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;Such medications play a major role, agreed Dr. Thomas Gill, a geriatrician and epidemiologist at Yale University and a longtime falls researcher. But, he said, “there are alternative explanations” for the increase in death rates.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;He cited changes in reporting the causes of death, for instance. “Years ago, falls were considered a natural consequence of aging and no big deal,” he said.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;Death certificates often attributed fatalities among older people to ailments like heart failure instead of falls, making fall mortality appear lower in the 1980s and 1990s.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;Today’s over-85 cohort may also be frailer and sicker than the oldest-old were 30 years ago, Dr. Gill added, because contemporary medicine can keep people alive for longer.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;Their accumulating impairments, more than the drugs they take, could make them more likely to die after a fall.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;Another skeptic, Dr. Neil Alexander, a geriatrician and falls expert at the University of Michigan and V.A. Ann Arbor Healthcare System, argued that most doctors have come to understand the dangers of FRIDs and prescribe them less often.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;“Message delivered,” he said. Given the alarms sounded about opioids, about benzodiazepines and related drugs, and especially about opioids and benzos together, “a lot of primary care doctors have heard the gospel,” he said. “They know not to give older people Valium.”&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;Moreover, prescriptions for some fall-related drugs have already declined or hit plateaus, even as death rates because of falls have risen. Medicare data shows &lt;a href="https://link.springer.com/article/10.1007/s40266-025-01237-x" rel="nofollow noopener" target="_blank" data-ylk="slk:lower prescription opioid use;elm:context_link;itc:0;sec:content-canvas" class="link "&gt;lower prescription opioid use&lt;/a&gt; beginning a decade ago, for example. Benzodiazepine prescriptions for older patients have slowed, Dr. Maust said.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;On the other hand, the &lt;a href="https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2820722" rel="nofollow noopener" target="_blank" data-ylk="slk:use of antidepressants;elm:context_link;itc:0;sec:content-canvas" class="link "&gt;use of antidepressants&lt;/a&gt; and of &lt;a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11233090/" rel="nofollow noopener" target="_blank" data-ylk="slk:gabapentin;elm:context_link;itc:0;sec:content-canvas" class="link "&gt;gabapentin&lt;/a&gt; has increased.&lt;/p&gt;&lt;hr class="my-4"&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;Whether or not medication use outweighs all other factors, “nobody disputes that these agents are overused and inappropriately used” and contribute to the troubling increase in fall death rates among seniors, Dr. Gill said.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;Thus, the ongoing campaign for “de-prescribing” — stopping the medications whose potential harms outweigh their benefits, or reducing their dosage.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;“We know a lot of these drugs can increase falls by 50 to 75 percent” in older patients, said Dr. Michael Steinman, a geriatrician at the University of California, San Francisco, and co-director of the &lt;a href="https://deprescribingresearch.org/" rel="nofollow noopener" target="_blank" data-ylk="slk:US Deprescribing Research Network;elm:context_link;itc:0;sec:content-canvas" class="link "&gt;US Deprescribing Research Network&lt;/a&gt;, established in 2019.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;“It’s easy to start meds, but it often takes a lot of time and effort to have patients stop taking them,” he said. Harried doctors may pay less attention to drug regimens than to health issues that seem more pressing, and patients can be reluctant to give up pills that seem to help with pain, insomnia, reflux and other common age-related complaints.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;The Beers Criteria, a directory of drugs often deemed inadvisable for older adults, recently published &lt;a href="https://agsjournals.onlinelibrary.wiley.com/doi/epdf/10.1111/jgs.19500" rel="nofollow noopener" target="_blank" data-ylk="slk:recommendations for alternative medications and nonpharmacological treatments;elm:context_link;itc:0;sec:content-canvas" class="link "&gt;recommendations for alternative medications and nonpharmacological treatments&lt;/a&gt; for frequent problems. Cognitive behavioral therapy for sleeplessness. Exercise, physical therapy and psychological interventions for pain.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;“It’s a real tragedy when people have this life-altering event,” Dr. Steinman, co-chair of the Beers panel on alternatives, said of falls. He urged older patients to raise the issue of FRIDs themselves, if their doctors haven’t.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;“Ask, ‘Do any of my medications increase the risk of falls? Is there an alternative treatment?’” he suggested. “Being an informed patient or caregiver can put this on the agenda. Otherwise, it might not come up.”&lt;/p&gt;&lt;hr class="my-4"&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;&lt;em&gt;The New Old Age is produced through a partnership with &lt;a href="https://www.nytimes.com/column/the-new-old-age" rel="nofollow noopener" target="_blank" data-ylk="slk:The New York Times;elm:context_link;itc:0;sec:content-canvas" class="link "&gt;The New York Times&lt;/a&gt;.&lt;/em&gt;&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;&lt;em&gt;&lt;a href="https://kffhealthnews.org/about-us" rel="nofollow noopener" target="_blank" data-ylk="slk:KFF Health News;elm:context_link;itc:0;sec:content-canvas" class="link "&gt;KFF Health News&lt;/a&gt; is a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFF — an independent source of health policy research, polling, and journalism. Learn more about &lt;a href="https://www.kff.org/about-us" rel="nofollow noopener" target="_blank" data-ylk="slk:KFF;elm:context_link;itc:0;sec:content-canvas" class="link "&gt;KFF&lt;/a&gt;.&lt;/em&gt;&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;The post &lt;a href="https://katiecouric.com/news/older-person-falling-causes/" rel="nofollow noopener" target="_blank" data-ylk="slk:Why Are More Older People Dying After Falls?;elm:context_link;itc:0;sec:content-canvas" class="link "&gt;Why Are More Older People Dying After Falls?&lt;/a&gt; appeared first on &lt;a href="https://katiecouric.com" rel="nofollow noopener" target="_blank" data-ylk="slk:Katie Couric Media;elm:context_link;itc:0;sec:content-canvas" class="link "&gt;Katie Couric Media&lt;/a&gt;.&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>yahoo.com</author><pubDate>Wed, 10 Sep 2025 17:34:46 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMihAFBVV95cUxPT29VZlZQcWx5X0ZDQ3JEYlkwamc0Tnd2WkZDc3o1dnlSSFZYeFpYTktPTnhWTXFjcDdEem4tT3ZkYjdhaUVudGhpcHNlekF1RE9tQXloMkVpRzBkM3ZwRTlnaHpIaWdEeU80SEJ4UE5HRjZTM2JtNllUNkJVYWpfTEllTzg</guid></item><item><title>NBC康涅狄格州州长就获得新冠疫苗的问题采取行政行动</title><link>https://www.nbcconnecticut.com/news/coronavirus/covid-vaccine/governor-issues-executive-actions-over-access-to-covid-vaccines/3636378/</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="article-content rich-text"&gt;
									
					
&lt;p&gt;The governor has issued executive actions that his office said would allow Connecticut residents who want COVID vaccines to be able to get them and “that coverage under state-regulated health insurance policies remains uninterrupted.”&lt;/p&gt;

&lt;p&gt;This comes at a time when new federal guidance has raised questions about who will be eligible for the vaccines.&lt;/p&gt;


&lt;p&gt;Gov. Ned Lamont issued executive actions on Wednesday.&lt;/p&gt;

&lt;p&gt;His office said the state Department of Public Health is recommending that children 6 months and older receive the vaccine, as well as adults of all ages.&lt;/p&gt;

&lt;p&gt;&lt;a href="https://www.nbcconnecticut.com/news/health/covid-19-vaccine-complicated-process/3631179/" target="_blank" rel="noreferrer noopener"&gt;The U.S. Food and Drug Administration has OK’d new shots for adults 65 and older and younger adults who a health condition that makes them vulnerable to severe COVID-19.&lt;/a&gt;&lt;/p&gt;

&lt;p&gt;“As uncertainty in Washington continues, our administration is doing everything we can to ensure the residents of Connecticut have access to the health care they need to stay safe,” Lamont said in a statement. “Making vaccines accessible is grounded in health and safety, which is too important to leave to the whims of a political agenda. Vaccines have been proven for many decades to prevent serious illness, hospitalization, and death, and patients and their doctors should be able to decide what is the best course of treatment for themselves. We will not allow gridlock in Washington to put the people of our state at risk.”&lt;/p&gt;

&lt;p&gt;The state Department of Public Health has released interim guidance for the 2025-2026 season, which the governor said is similar to those issued in previous years, recommending that children 6 months and older receive the vaccine, as well as adults of all ages.&lt;/p&gt;

&lt;figure class="wp-block-embed is-type-rich is-provider-documentcloud wp-block-embed-documentcloud"&gt;&lt;p class="wp-block-embed__wrapper"&gt;

&lt;/p&gt;&lt;/figure&gt;

&lt;p&gt;“We cannot predict which respiratory viral infection will be most prevalent this season, but we can protect our families against them and potential severe complications by getting vaccinated this fall,” Department of Public Health Commissioner Juthani said in a statement. “I am currently assembling an advisory committee to work with me on matters relating to recommendations by the Centers for Disease Control and Prevention and the federal Food and Drug Administration using evidence-based data from peer-reviewed literature and studies. We are in the process of scheduling our first meeting for this month. I am looking forward to discussing with this group the ongoing changes at the federal level regarding vaccines and other public health recommendations to ensure that we continue to provide the best care and guidance to the people of Connecticut.”&lt;/p&gt;

&lt;p&gt;And the Connecticut Department of Consumer Protection is &lt;a href="https://portal.ct.gov/dcp/home/knowledge-base/articles/drug-control/pharmacy/covid-vaccine-guidance-update?language=en_US" target="_blank" rel="noreferrer noopener"&gt;providing pharmacists with guidance&lt;/a&gt; on distribution of vaccines and says pharmacists may continue to order, prescribe, and administer FDA-approved or authorized COVID-19 vaccines using the most recent CDC administration instructions until the later of:&lt;/p&gt;

&lt;p&gt;30 days from issuance of DCP’s notice, or the vaccine’s inclusion on the CDC Adult Immunization Schedule.&lt;/p&gt;

&lt;p&gt;“While federal actions restrict eligibility for adults ages 18 to 65 with no underlying medical conditions, prescribers and pharmacists may order, prescribe, and administer the COVID-19 vaccine to individuals who fall outside the eligibility criteria authorized by the FDA, consistent with “off-label” use,” according to the statement from the governor’s office.  &lt;/p&gt;

&lt;p&gt;“Here in Connecticut, pharmacists played a critical role in combatting the COVID-19 pandemic, and that will continue this fall as patients seek protection against the most current strains of the virus,” DCP Commissioner Bryan T. Cafferelli said in a statement. “Pharmacists are trusted frontline healthcare workers who are often the first point of contact for patients seeking vaccination. While federal vaccine schedules are in flux, we have issued interim guidance to provide clarity and consistency for our pharmacists administering COVID-19 vaccines.”&lt;/p&gt;

&lt;p&gt;And the Connecticut Insurance Department has issued a bulletin issued to all health insurers and health care centers in Connecticut that affirms that the state Department of Public Health interim guidance for the 2025-2026 season aligns with existing state law requiring immunization coverage in Connecticut-issued health insurance policies.&lt;/p&gt;

&lt;figure class="wp-block-embed is-provider-wordpress wp-block-embed-wordpress"&gt;&lt;p class="wp-block-embed__wrapper"&gt;

&lt;/p&gt;&lt;/figure&gt;

&lt;p&gt;The governor’s office said, based the current guidance from the Department of Public Health and the medical academies, there will be no change to existing COVID-19 immunization coverage in Connecticut-issued insurance policies, regardless of the CDC’s position.&lt;/p&gt;

&lt;p&gt;“This bulletin confirms that based on current DPH guidance, there will be no change to existing COVID-19 immunization coverage in Connecticut-issued insurance policies,” CID Commissioner Andrew Mais said.&lt;/p&gt;

&lt;p&gt;The governor’s office said pharmacists in Connecticut may continue to order, prescribe, and administer FDA-approved/authorized COVID-19 vaccines to adults using the most recent CDC administration instructions until the later of 30 days from DCP’s notice or the vaccine’s inclusion on the CDC Adult Immunization Schedule.&lt;/p&gt;

&lt;p&gt;Pharmacists can also continue to vaccinate pursuant to a prescriber’s verbal or written prescription, and prescribers may order the vaccine consistent with FDA labeling and prevailing clinical recommendations. Vaccine supply and guidance for children will continue through the Connecticut Vaccine Program and medical homes.&lt;/p&gt;

&lt;p&gt;The governor’s office said the administration is in frequent communication with public health officials from regional states in the Northeast to coordinate on a collaborative approach to these issues and the Lamont administration is researching potential legislative changes that might be needed within state statutes to “ensure continued stability in the future, regardless of any potential shifts in positions from the federal government.”&lt;/p&gt;

&lt;p&gt;You can learn more at &lt;a href="http://www.easyvax.com" target="_blank" rel="noreferrer noopener"&gt;www.easyvax.com&lt;/a&gt; or speak with their local pharmacy or medical provider.&lt;/p&gt;

									&lt;/div&gt;
												&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>NBC Connecticut</author><pubDate>Wed, 10 Sep 2025 17:26:16 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">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</guid></item><item><title>《The Little Round Pill That's Winning Awards Season》-好莱坞记者</title><link>https://www.hollywoodreporter.com/news/general-news/little-pill-awards-season-1236366170/</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="pmc-paywall"&gt;&lt;h2 class="heading larva //   lrv-a-font-accent-l   "&gt;
		The Little Round Pill That’s Winning Awards Season	&lt;/h2&gt;





&lt;p class="paragraph larva //  a-font-body-m     "&gt;
	When EGOT winners step up to the mic, they usually thank Steven Spielberg, Bryan Lourd or whichever other deity delivered their career. Lately, though, a new name keeps sneaking into the acceptance-speech shout-outs: beta-blockers.&lt;/p&gt;



&lt;p class="paragraph larva //  a-font-body-m     "&gt;
	Over the past year, a slew of stars — from Rachel Sennott to Robert Downey Jr. — have been openly admitting that their preshow ritual involves more than Spanx and stylists. It now also includes a little pill to help to steady the hands and keep one’s pits dry.

	&lt;/p&gt;






&lt;p class="paragraph larva //  a-font-body-m     "&gt;
	At the 2024 Tonys, &lt;em&gt;Stereophonic&lt;/em&gt; playwright David Adjmi quipped, “Oh, no. My agent gave me a beta-blocker, but it’s not working,” before collecting his best play award. Downey cracked a similar gag at the last Golden Globes: “I took a beta-blocker, so this will be a breeze.” Kristen Bell at the 2025 SAG &lt;a href="https://www.hollywoodreporter.com/t/awards/" id="auto-tag_awards_1" data-tag="awards"&gt;Awards&lt;/a&gt;, Natasha Rothwell at the 2025 Spirit Awards and Sennott at the 2025 Oscars also jokingly — perhaps not entirely — confessed to popping blockers before staring down ballrooms filled with black ties and gowns.&lt;/p&gt;



&lt;p class="paragraph larva //  a-font-body-m     "&gt;
	Doctors say the pills don’t exactly cure stage fright — they just keep the body from betraying it. “Using beta-blockers for performance anxiety is off-label, but it’s not uncommon,” notes Dr. Andrew Leuchter, director of UCLA’s neuromodulation division. “This is a drug that prevents adrenaline from activating the fight-or-flight response.”&lt;/p&gt;



&lt;p class="paragraph larva //  a-font-body-m     "&gt;
	Still, like most Hollywood quick fixes, there’s a dark side. Harvard psychiatrist Helen Riess warns that overuse or a too-high dose can lead to “a risk of fainting.” And fainting, as any publicist will tell you, makes for a much worse viral moment than a sweaty brow. — ANDREW ZUCKER

	&lt;/p&gt;




	&lt;h2 class="heading larva //   lrv-a-font-accent-l   "&gt;
		Who Launched Armani in Hollywood?  It Wasn’t Richard Gere	&lt;/h2&gt;



&lt;p class="paragraph larva //  a-font-body-m     "&gt;
	Paul Schrader’s &lt;em&gt;American Gigolo&lt;/em&gt; gets all the credit, but it was a very different film — Brian De Palma’s &lt;em&gt;The Untouchables&lt;/em&gt; — that really put the late, great Giorgio Armani on the map. Or at least so claims one legendary Hollywood heavyweight.&lt;/p&gt;



&lt;p class="paragraph larva //  a-font-body-m     "&gt;
	“Everything Giorgio designed after that got better and better,” says former über agent Mike Ovitz, 78, who, in a completely unrelated and not-at-all self-serving coincidence, happened to package De Palma’s 1987 star-studded drama about Eliot Ness and his gang of G-men. Yes, &lt;em&gt;Untouchables&lt;/em&gt; came out seven years after &lt;a href="https://www.hollywoodreporter.com/t/richard-gere/" id="auto-tag_richard-gere_1" data-tag="richard-gere"&gt;Richard Gere&lt;/a&gt; made a huge splash swanning around &lt;em&gt;Gigolo&lt;/em&gt; in Armani’s breezy, unstructured tailoring, but never mind. “All our clients were in it — Sean Connery, Kevin Costner, Bobby De Niro, Andy Garcia,” Ovitz goes on.&lt;/p&gt;



&lt;p class="paragraph larva //  a-font-body-m     "&gt;
	“I introduced Bobby and Sean to Giorgio, and he ended up getting the nod from Brian to do everybody’s wardrobe.”&lt;/p&gt;



&lt;p class="paragraph larva //  a-font-body-m     "&gt;
	History will judge which film was more responsible for making soft-shouldered, mini-malistic menswear a fashion hit, but Ovitz can rightfully grab credit for turning Armani — who died Sept. 4 at the age of 91 — into the go-to power-suit designer for Hollywood agents. “We told both the men and women in our office that they had to dress a step up — a suit and tie for the men, and the women had to dress accordingly,” Ovitz tells Rambling, recalling how, after co-founding CAA during the mid-1970s, he’d send his executives to the Armani outpost in Beverly Hills to get fitted with what quickly became the agency’s de facto uniform.

	&lt;/p&gt;




&lt;p class="paragraph larva //  a-font-body-m     "&gt;
	“We gave that store a lot of business, and in return, they gave us a bit of a discount,” he says. “Not that they were losing anything by doing so — they did very well with us, and they were smart to do so.”&lt;/p&gt;



&lt;p class="paragraph larva //  a-font-body-m     "&gt;
	What made Armani’s designs so appealing to Ovitz and his minions wasn’t just their confident power-suit cut. It was the comfort. Compared to the boxy old Brooks Brothers armor that had once dominated the agency biz, Armani felt downright breathable. “They had this loose fit, and that was novel for the time,” Ovitz says. “When you had to wear a suit from 8 in the morning until you’re getting home from a dinner at 10 p.m., comfort was important.” — LAURIE BROOKINS&lt;/p&gt;



	&lt;h2 class="heading larva //   lrv-a-font-accent-l   "&gt;
		How Emily Brontë Got Her New Bra Font	&lt;/h2&gt;



&lt;p class="paragraph larva //  a-font-body-m     "&gt;
	Monet took inspiration from the Seine. Van Gogh found his spark in a star-filled sky. Teddy Blanks? He discovered his muse in his wife’s underwear drawer.&lt;/p&gt;



&lt;p class="paragraph larva //  a-font-body-m     "&gt;
	“Warner Bros. contacted me about doing a custom logo for their &lt;em&gt;&lt;a href="https://www.hollywoodreporter.com/t/wuthering-heights/" id="auto-tag_wuthering-heights_1" data-tag="wuthering-heights"&gt;Wuthering Heights&lt;/a&gt;&lt;/em&gt; marketing campaign,” explains the title designer behind the eye-catching fonts in the key art for Emerald Fennell’s upcoming adaptation of Emily Brontë’s bodice-ripping 19th century gothic novel. “I was working on a bunch of different designs, and my wife suggested something sultry and sexy that had lace inside of it. That’s when I came up with the idea to use one of her bras to get the texture right.”&lt;/p&gt;



&lt;p class="paragraph larva //  a-font-body-m     "&gt;
	Blanks’ wife, by the way, has highbrow literary credentials of her own — she’s former &lt;em&gt;New York Times&lt;/em&gt; book critic Molly Young — but still seems delighted to have her unmentionables plastered on posters nationwide. “From a young age I always knew my Intimate Apparel would be 1 inch from Jacob Elordi’s head, I just didn’t know how,” she recently joked on Instagram.

	&lt;/p&gt;




&lt;p class="paragraph larva //  a-font-body-m     "&gt;
	Blanks started designing titles in the mid-2000s when he did the cards for Lena Dunham’s first short films, then her debut feature, 2010’s &lt;em&gt;Tiny Furniture&lt;/em&gt;. Since then, he’s gone on to create title treatments for &lt;em&gt;Barbie&lt;/em&gt; (designing a whole alphabet based on the 1980s doll packaging) as well as for Apple TV+’s trippy dystopian workplace dramedy &lt;em&gt;Severance&lt;/em&gt; (for which he just picked up his second Creative Arts Emmy).&lt;/p&gt;



&lt;p class="paragraph larva //  a-font-body-m     "&gt;
	But the lacy logo for &lt;em&gt;Wuthering Heights&lt;/em&gt; could mark a breakthrough for Blanks and his Brooklyn-based CHIPS Studio. “I’m hoping this will become my thing — anyone who’s looking for lingerie to be placed in their title cards will come to me,” he quips. “Underwear of any kind — boxer briefs, jock straps, I’m willing to go there.”&lt;/p&gt;



&lt;p class="paragraph larva //  a-font-body-m     "&gt;
	&lt;em&gt;This story appeared in the Sept. 10 issue of The Hollywood Reporter magazine. &lt;a href="https://subscriptions.hollywoodreporter.com/site/thr-subscribe" target="_blank" rel="noreferrer noopener"&gt;Click here to subscribe&lt;/a&gt;&lt;/em&gt;.&lt;/p&gt;














&lt;/div&gt;					
&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>The Hollywood Reporter</author><pubDate>Wed, 10 Sep 2025 17:01:00 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMikwFBVV95cUxPT04yY3U1WlNLSUo3TzE5RTQ5U2RBTkw3eXFZMklnS3FoQ0lhSlNyUGptLUZyMm5MdVNXQUgxb3UzN015cXRxT1R0T1hjeVlJYThNTDVrVmNqUERhT0d2dUNrTzNrT0RXLW1LMm9wRDJnMzJrTVlFNERnTFc5Y294Y05EV1g3NHBJQmoxN1RKM2hiREU</guid></item><item><title>拉蒙特州长宣布保护COVID-19疫苗获取的行政行动- CT.GOV-Connecticut官方网站(.gov)</title><link>https://portal.ct.gov/governor/news/press-releases/2025/09-2025/governor-lamont-announces-executive-actions-to-protect-covid-19-vaccine-access</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="cg-c-article__content"&gt;
        &lt;p&gt;&lt;span&gt;(HARTFORD, CT) – In the face of recent actions within the federal government that have created uncertainty in the ability of Americans to access COVID-19 vaccines during the upcoming respiratory virus season, Governor Ned Lamont today announced a series of executive actions his administration is implementing to ensure that Connecticut residents who wish to be vaccinated continue to have access to these vaccines and that coverage under state-regulated health insurance policies remains uninterrupted.&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;span&gt;“As uncertainty in Washington continues, our administration is doing everything we can to ensure the residents of Connecticut have access to the health care they need to stay safe,” &lt;strong&gt;Governor Lamont said&lt;/strong&gt;. “Making vaccines accessible is grounded in health and safety, which is too important to leave to the whims of a political agenda. Vaccines have been proven for many decades to prevent serious illness, hospitalization, and death, and patients and their doctors should be able to decide what is the best course of treatment for themselves. We will not allow gridlock in Washington to put the people of our state at risk.”&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;span&gt;The Lamont administration’s actions include a multi-pronged approach among several state agencies, notably the Connecticut Department of Public Health (DPH), the Connecticut Department of Consumer Protection (DCP), and the Connecticut Insurance Department (CID).&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;span&gt;&lt;/span&gt;&lt;strong&gt;DPH releases interim guidance on who should receive COVID vaccines&lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;&lt;span&gt;Under the leadership of Commissioner Manisha Juthani, MD, DPH today released interim guidance for the 2025-2026 season emphasizing that vaccination remains the most effective defense against severe COVID-19. The guidance is similar to those issued in previous years, recommending that children six months and older receive the vaccine, as well as adults of all ages.&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;span&gt;The guidance was developed based on evidence-based recommendations from professional and expert medical organizations such as the recently released guidance from &lt;/span&gt;&lt;a href="https://publications.aap.org/redbook/resources/15585/AAP-Immunization-Schedule?autologincheck=redirected&amp;amp;utm_source=substack&amp;amp;utm_medium=email"&gt;&lt;span&gt;American Academy of Pediatrics&lt;/span&gt;&lt;/a&gt;&lt;span&gt; (AAP), &lt;/span&gt;&lt;a href="https://www.acog.org/news/news-releases/2025/08/acog-releases-updated-maternal-immunization-guidance-covid-influenza-rsv?utm_source=substack&amp;amp;utm_medium=email"&gt;&lt;span&gt;American College of Obstetricians and Gynecologists&lt;/span&gt;&lt;/a&gt;&lt;span&gt; (ACOG), and &lt;/span&gt;&lt;a href="https://www.aafp.org/news/media-center/statements/aafp-announces-fall-immunization-recommendations-reaffirming-commitment-to-vaccine-safety-and-public-health.html"&gt;&lt;span&gt;American Academy of Family Physicians&lt;/span&gt;&lt;/a&gt;&lt;span&gt; (AAFP).&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;span&gt;“We cannot predict which respiratory viral infection will be most prevalent this season, but we can protect our families against them and potential severe complications by getting vaccinated this fall,” &lt;strong&gt;Commissioner Juthani said&lt;/strong&gt;. “I am currently assembling an advisory committee to work with me on matters relating to recommendations by the Centers for Disease Control and Prevention and the federal Food and Drug Administration using evidence-based data from peer-reviewed literature and studies. We are in the process of scheduling our first meeting for this month. I am looking forward to discussing with this group the ongoing changes at the federal level regarding vaccines and other public health recommendations to ensure that we continue to provide the best care and guidance to the people of Connecticut.”&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;&lt;span&gt;DCP provides guidance on distribution of vaccines to pharmacists&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;&lt;span&gt;To maintain seamless access while federal schedules are in flux, DCP today issued a guidance document to pharmacists, advising that – consistent with state law (&lt;/span&gt;&lt;a href="https://www.cga.ct.gov/current/pub/chap_400j.htm#sec_20-633"&gt;&lt;span&gt;C.G.S. § 20-633&lt;/span&gt;&lt;/a&gt;&lt;span&gt;) – pharmacists may continue to order, prescribe, and administer FDA-approved or authorized COVID-19 vaccines using the most recent CDC administration instructions until the later of:&lt;/span&gt;&lt;/p&gt;
&lt;ol&gt;
    &lt;li&gt;&lt;span&gt;30 days from issuance of DCP’s notice, or&lt;/span&gt;&lt;/li&gt;
    &lt;li&gt;&lt;span&gt; &lt;/span&gt;The vaccine’s inclusion on the CDC Adult Immunization Schedule.&lt;/li&gt;
&lt;/ol&gt;
&lt;p&gt;&lt;span&gt;While federal actions restrict eligibility for adults ages 18 to 65 with no underlying medical conditions, prescribers and pharmacists may order, prescribe, and administer the COVID-19 vaccine to individuals who fall outside the eligibility criteria authorized by the FDA, consistent with “off-label” use.&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;span&gt;“Here in Connecticut, pharmacists played a critical role in combatting the COVID-19 pandemic, and that will continue this fall as patients seek protection against the most current strains of the virus,” &lt;strong&gt;DCP Commissioner Bryan T. Cafferelli said&lt;/strong&gt;. “Pharmacists are trusted frontline healthcare workers who are often the first point of contact for patients seeking vaccination. While federal vaccine schedules are in flux, we have issued interim guidance to provide clarity and consistency for our pharmacists administering COVID-19 vaccines.”&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;&lt;span&gt;CID issues bulletin on insurance coverage&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;&lt;span&gt;A bulletin issued today by CID to all health insurers and health care centers in Connecticut affirms that the DPH interim guidance for the 2025-2026 season aligns with existing state law requiring immunization coverage in Connecticut-issued health insurance policies. It also affirms that the DPH guidance is consistent with the COVID-19 immunization recommendations by the American Academy of Pediatrics, the American Academy of Family Physicians or the American College of Obstetricians and Gynecologists, for which coverage is mandated by state law.&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;span&gt;Based the current guidance from DPH and the medical academies, there will be no change to existing COVID-19 immunization coverage in Connecticut-issued insurance policies, regardless of the CDC’s position.&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;span&gt;“This bulletin confirms that based on current DPH guidance, there will be no change to existing COVID-19 immunization coverage in Connecticut-issued insurance policies,” &lt;strong&gt;CID Commissioner Andrew Mais said&lt;/strong&gt;.&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;&lt;span&gt;What this means for Connecticut residents&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;&lt;span&gt;Combined, these actions will help address some restrictions created by the CDC to access to the COVID-19 vaccines in Connecticut. Adults of all ages can receive COVID-19 vaccinations at pharmacies and medical practices, and children between 6 months and 18 years can receive vaccinations through pediatric providers participating in the Connecticut Vaccine Program (CVP).&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;span&gt;Additionally, these actions ensure that insurance coverage for COVID-19 vaccines based on current guidance from DPH, continues unchanged for state-regulated plans. For employers that offer self-funded (ERISA) plans, individuals should confirm their immunization benefits with their plan administrator.&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;&lt;span&gt;What this means for Connecticut pharmacists and providers&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;&lt;span&gt;Following these actions, pharmacists in Connecticut may continue to order, prescribe, and administer FDA-approved/authorized COVID-19 vaccines to adults using the most recent CDC administration instructions until the later of 30 days from DCP’s notice or the vaccine’s inclusion on the CDC Adult Immunization Schedule.&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;span&gt;Additionally, pharmacists may continue to vaccinate pursuant to a prescriber’s verbal or written prescription, and prescribers may order the vaccine consistent with FDA labeling and prevailing clinical recommendations. Vaccine supply and guidance for children will continue through the Connecticut Vaccine Program and medical homes.&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;&lt;span&gt;Next steps to bring stability amid uncertainty in the federal government&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;&lt;span&gt;Looking forward, Governor Lamont and officials within his administration continue to be in frequent communication with public health officials from regional states in the Northeast to coordinate on a collaborative approach to these issues. Additionally, the Lamont administration is researching potential legislative changes that may be needed within state statutes to ensure continued stability in the future, regardless of any potential shifts in positions from the federal government.&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;span&gt;For information on how to be vaccinated in Connecticut, residents are encouraged to visit &lt;/span&gt;&lt;a href="http://www.easyvax.com/"&gt;&lt;span&gt;www.easyvax.com&lt;/span&gt;&lt;/a&gt;&lt;span&gt; or speak with their local pharmacy or medical provider.&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;span&gt; &lt;/span&gt;&lt;/p&gt;
    &lt;/div&gt;



&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>CT.GOV-Connecticut's Official State Website (.gov)</author><pubDate>Wed, 10 Sep 2025 16:49:38 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMi2gFBVV95cUxNN1VrUi00STRKenE1ZFNzMkpPMHo2NHVxaXRYYlRaaU9PcHp0dUpMeUxILUtYOVRoUVZSelFVdDU4aEFwbTF2dS0wdUJyb1pwVnMxV1dhaGVpVUFRSTlTc1hENjlCd3VRTjlKd1pvc2tweGpXVExONXZtV1BObU9GaHRZbkJZbTlfZ054ZXA2c3pGcVBfOWFvaFlmOE1yMW1YbHpzOU42blRPb3BJOVhUdFNhdUFULUsyX0FxaEZHcWFZbzdnS3l5UWJQa1RqdlNhQWxGZndLUE1fUQ</guid></item><item><title>大幅降低癌症风险的10种生活习惯--《印度时报》</title><link>https://timesofindia.indiatimes.com/life-style/health-fitness/home-remedies/10-lifestyle-habits-that-lower-cancer-risk-dramatically/photostory/123810144.cms</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="COQxt" data-ua-type="1"&gt;&lt;p&gt;&lt;br&gt;A diet rich in vibrant fruits and vegetables, especially those with deep hues like berries, spinach, carrots, and tomatoes, brings a high concentration of antioxidants. &lt;a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6562590/" target="_blank"&gt;&lt;em&gt;Studies&lt;/em&gt;&lt;/a&gt; link diets rich in carotenoids and flavonoids with reduced risks of breast, lung, and colorectal cancers. Colour on the plate isn’t just pleasing, it’s protective.&lt;br&gt;&lt;br&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>The Times of India</author><pubDate>Wed, 10 Sep 2025 16:30:00 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMi7AFBVV95cUxNcTJmQUFwbjNuLVBBZmd0TWlxWFlHRnBhSDRoaTE2dDR3S2djY2tOQ3B1TkNQRERiWEo1VV8tc2k1MjJqRWFNSUdvUDRwcmd6UTl1TkRtNDdKNEE0ZzhTaTVMRllRb0Q4RU9yZnJ2WlJFN1oySlh5ZWh4RFdza1o2bmpPaVoxR29mM2RMbEdhRndTSGc4MTdXQUZWd3h1blAtM2pzd1FqRjJYNS1NMVRDcUR4VGNwTUh6U2N6YWtqSjFNYkhEMGFYazBqa0pRX2R5S196UVE4NTVMUUgxamx3TU5nS3lIMHpBS2ZRNdIB9AFBVV95cUxQXzNEM0JFRC1XMzZNQ0ZxVTlNX3V0V29NZW56RGlTRU1HQnQ0anNRN2VZNFV0OVFjUlhFM3VyUmE5UzBhR3VhUmhEdjB3cmdVbEduV2FIVno0R2RlSThLZ2NhTF9YRGVVQVJKdEd6aXRQRFpxY2ppcDI4UWFPR2xHOVNXWjNKY2pIQXJ1S1R4TG8wNTRnQWpxczlPT1NDY1M5a0o1VTBOb3M4OVR6VU9JYXQ4NkV2RFBnLTZSVHRwOEtQaGVHRDd6OE41UFVYUVFxRnlmeENRN3J4eHZMS1RDUXExbElfZkpTMGk1cW9SampvTXo4</guid></item><item><title>小细胞肺癌发病机制的神经元活性依赖性机制-自然</title><link>https://www.nature.com/articles/s41586-025-09492-z</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="c-article-section__content" id="Sec13-content"&gt;&lt;h3 class="c-article__sub-heading" id="Sec14"&gt;Mice and housing conditions&lt;/h3&gt;&lt;p&gt;All in vivo experiments were conducted in accordance with protocols approved by the Brigham and Women’s Hospital Institutional Animal Care and Use Committee (IACUC) and Stanford University IACUC. Mice were housed according to the standard guidelines with free access to food and water in a 12 h light:12 h dark cycle.&lt;/p&gt;&lt;p&gt;For brain tumour allograft experiments, NSG mice (NOD-SCID-IL2R gamma chain-deficient, the Jackson Laboratory) were used. Male and female mice were used equally. According to the IACUC guidelines, signs of morbidity rather than maximal tumour volume was used as indication for termination of brain allograft mouse experiments. Mice were euthanized if they exhibited signs of neurological disease or if they lost 15% or more of their body weight. For in vivo optogenetic stimulation of the premotor circuit (M2), &lt;i&gt;Thy1&lt;/i&gt;-ChR2; NSG or WT; NSG mice were used.&lt;/p&gt;&lt;p&gt;For lung tumour experiments, mice were euthanized when they exhibited signs of sickness behaviour (such as dyspnea, abnormal gait or posturing, or ill-groomed fur) or lost &amp;gt;15% of body weight in accordance with IACUC guidelines. No limits were exceeded in any mouse experiments. In these experiments, &lt;i&gt;Rb1&lt;/i&gt;&lt;sup&gt;&lt;i&gt;fl/fl&lt;/i&gt;&lt;/sup&gt;;&lt;i&gt;Trp53&lt;/i&gt;&lt;sup&gt;&lt;i&gt;fl/fl&lt;/i&gt;&lt;/sup&gt;;&lt;i&gt;p130&lt;/i&gt;&lt;sup&gt;&lt;i&gt;fl/fl&lt;/i&gt;&lt;/sup&gt;, luciferase-expressing (RPR2-luc) genetic mouse models were used as described previously&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 39" title="Schaffer, B. E. et al. Loss of p130 accelerates tumor development in a mouse model for human small-cell lung carcinoma. Cancer Res. 70, 3877–3883 (2010)." href="/articles/s41586-025-09492-z#ref-CR39" id="ref-link-section-d9808965e2637"&gt;39&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 44" title="Denny, S. K. et al. Nfib promotes metastasis through a widespread increase in chromatin accessibility. Cell 166, 328–342 (2016)." href="/articles/s41586-025-09492-z#ref-CR44" id="ref-link-section-d9808965e2640"&gt;44&lt;/a&gt;&lt;/sup&gt;. In these mice, lung tumours and later distant metastases form spontaneously after intratracheal administration of Adeno-CMV-Cre (University of Iowa Vector Core) at 2 months of age as described&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 44" title="Denny, S. K. et al. Nfib promotes metastasis through a widespread increase in chromatin accessibility. Cell 166, 328–342 (2016)." href="/articles/s41586-025-09492-z#ref-CR44" id="ref-link-section-d9808965e2645"&gt;44&lt;/a&gt;&lt;/sup&gt; and following a published protocol&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 60" title="DuPage, M., Dooley, A. L. &amp;amp; Jacks, T. Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase. Nat. Protoc. 4, 1064–1072 (2009)." href="/articles/s41586-025-09492-z#ref-CR60" id="ref-link-section-d9808965e2649"&gt;60&lt;/a&gt;&lt;/sup&gt;. To study MYC-driven lung tumour models, we used RPM mice&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 42" title="Mollaoglu, G. et al. MYC drives progression of small cell lung cancer to a variant neuroendocrine subtype with vulnerability to aurora kinase inhibition. Cancer Cell 31, 270–285 (2017)." href="/articles/s41586-025-09492-z#ref-CR42" id="ref-link-section-d9808965e2653"&gt;42&lt;/a&gt;&lt;/sup&gt;. These mice were infected intratracheally as above with Adeno-CMV-Cre or Adeno-CGRP-Cre at 3 to 4 months of age.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec15"&gt;Intracranial allografts&lt;/h3&gt;&lt;p&gt;All SCLC brain allografts were performed as described&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 2" title="Venkatesh, H. S. et al. Electrical and synaptic integration of glioma into neural circuits. Nature 573, 539–545 (2019)." href="/articles/s41586-025-09492-z#ref-CR2" id="ref-link-section-d9808965e2665"&gt;2&lt;/a&gt;&lt;/sup&gt;. In brief, a single-cell suspension from cells cultured from either 16T-mGFP or NCI-H446-GFP SCLC neurospheres was prepared in sterile HBSS immediately before surgery. Mice at postnatal day (P)21–35 were anaesthetized with 1–4% isoflurane and placed in a stereotactic apparatus. The cranium was exposed via midline incision under aseptic conditions. 70,000 cells in 3 µl sterile HBSS were stereotactically injected into the M2 region of the cortex through a 31-gauge burr hole using a digital pump at an infusion rate of 0.4 µl min&lt;sup&gt;−1&lt;/sup&gt; and a 31-gauge Hamilton syringe. Stereotactic coordinates for &lt;i&gt;Thy1&lt;/i&gt;-ChR2 mouse allografts used were as follows: 0.5 mm lateral to midline, 1.0 mm anterior to bregma, −1.5 mm deep to cortical surface. At the completion of infusion, the syringe needle was allowed to remain in place for a minimum of 2 min, then withdrawn at a rate of 0.875 mm min&lt;sup&gt;−1&lt;/sup&gt; to minimize backflow of the injected cell suspension. To generate mice with interneuron-specific expression of light-sensitive ion channels, 1 µl of AAV8-Dlx-ChRmine-p2A-mCherry&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 61" title="Chen, R. et al. Deep brain optogenetics without intracranial surgery. Nat. Biotechnol. 39, 161–164 (2021)." href="/articles/s41586-025-09492-z#ref-CR61" id="ref-link-section-d9808965e2676"&gt;61&lt;/a&gt;&lt;/sup&gt; (virus titre = 6.9 × 10&lt;sup&gt;12&lt;/sup&gt;) (a gift from K. Deisseroth) was unilaterally injected using a Hamilton Neurosyringe and 450 Stoelting stereotaxic injector over 5 min. These mice then received allografts of 16T-mGFP or xenografts of NCI-H446-GFP SCLC cells as described above at 0.8 mm lateral to midline, 1.0 mm anterior to bregma, −1.2 mm deep relative to the cortical surface. Allografts of 16T-mGFP-ChR2 SCLC cells were performed following the procedure as above with exception for the following alterations: 15,000 cells were injected in 1 µl sterile HBSS 0.8 mm lateral to midline, 1.0 mm anterior to bregma, −1.2 mm deep relative to cortical surface. For electrophysiology experiments and electron microscopy tissue analysis, 16T-mGFP cells were allografted into the CA1 region of the hippocampus at the following coordinates: 1.5 mm lateral to midline, 1.8 mm posterior to bregma, −1.35 mm deep to the cortical surface.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec16"&gt;In vivo optogenetic manipulation&lt;/h3&gt;&lt;p&gt;For in vivo optogenetic stimulation of M2 region of &lt;i&gt;Thy1&lt;/i&gt;-ChR2; NSG or WT; NSG mice, a single stimulation paradigm was employed as previously described&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 1" title="Venkatesh, H. S. et al. Neuronal activity promotes glioma growth through neuroligin-3 secretion. Cell 161, 803–816 (2015)." href="/articles/s41586-025-09492-z#ref-CR1" id="ref-link-section-d9808965e2694"&gt;1&lt;/a&gt;&lt;/sup&gt;. In brief, a fibre optic ferule was placed 1 week following or simultaneously with and ipsilateral to the SCLC allografts. After 1–2 weeks to allow for recovery from the procedure, the mice were connected to a 100-mW 473-nm diode-pumped solid-state laser system with a mono fibre patch cord, which freely permits wakeful behaviour of the mice. Pulses of light with approximately 4 mW measured output at tip of the patch cord were administered at a frequency of 20 Hz for periods of 30 s, followed by 90 s recovery periods, for a total session duration of 30 min. The mice were euthanized after 24 h post stimulation, and brains were collected for histological analysis. For stimulation of cortical interneurons in Dlx-ChRmine mice, 595-nm light was used at 40 Hz frequency and 10 ms width. Pulses of light with approximately 10 mW measured output at tip of the patch cord were administered.&lt;/p&gt;&lt;p&gt;For in vivo optogenetic depolarization of SCLC cells, ChR2–YFP (pLV-ef1-ChR2(H134R)-eYFP WPRE) construct (generated by the laboratory of K. Deisseroth and placed in the piggyback transposon system by M. Su in the laboratory of M.M.) was lentivirally transduced into 16T SCLC cells, which were then allografted into premotor cortex (M2) following the procedure described above. A fibre optic ferule was implanted during the same surgery ipsilateral to the cell injection site at following coordinates: 0.8 mm lateral to midline, 1.0 mm anterior to bregma, −0.9 mm deep relative to cortical surface. At 1 week post-allograft and for three consecutive days, all mice were connected to the laser system to receive blue light or mock stimulations at a frequency of 10 Hz for periods of 30 s, followed by 90 s recovery periods for a total session duration of 30 min. Mice were euthanized 24 h after the final (3rd) stimulation session.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec17"&gt;Immunohistochemistry of patient tissue&lt;/h3&gt;&lt;p&gt;Patient tissue samples were obtained with informed consent and analysed in accordance with institutional review board-approved protocols. Immunohistochemistry of patient SCLC brain metastases tissue samples was performed on formalin-fixed paraffin-embedded tissue sections per standard protocols including deparaffinization, antigen retrieval, incubation with primary antibody and detection per the manufacturers’ instructions. The following antibodies were used: mouse anti-Ki67 (Dako/Agilent), mouse anti-neurofilament (Ventana Roche; prediluted). Staining for Ki67 was performed on a Leica Bond III automated stainer. Staining for neurofilament was performed on a Ventana Ultra automated stainer. Proliferation index was determined by quantifying the fraction of Ki67&lt;sup&gt;+&lt;/sup&gt; cells out of the total number of cells in the region.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec18"&gt;Single-cell sequencing from SCLC-neuron co-culture&lt;/h3&gt;&lt;p&gt;16T SCLC cells were cultured alone or in neuron co-cultures with or without 1 µM TTX for 24 h per protocol below and collected in PBS 0.5% BSA, 1 mM EDTA (Invitrogen), 1x DNAse (Worthington Biochemical). GFP-negative cells were collected in parallel to serve as negative control during FACS. Calcein violet (Thermo Fisher) was used to label live cells. GFP&lt;sup&gt;+&lt;/sup&gt;calcein&lt;sup&gt;+&lt;/sup&gt; cells were sorted and collected then lysed and combined into droplets with barcoded beads which captured the mRNA then used for reverse transcription with the The Chromium Single Cell Gene Expression platform (10X Genomics) per the manufacturer’s instructions. We then followed the rest of the 10X standard or high-throughput protocols and used the Dual Index Kit TT Set A for library production. The experiment was repeated for a total of three biological replicates.&lt;/p&gt;&lt;p&gt;Processing of fastq files from monoculture and co-culture samples was performed individually using the 10X Genomics Cell Ranger 7.1.0 based on the mm10 mouse genome reference, with the incorporation of the eGFP sequence. Seurat&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 62" title="Hao, Y. et al. Dictionary learning for integrative, multimodal and scalable single-cell analysis. Nat. Biotechnol. 42, 293–304 (2024)." href="/articles/s41586-025-09492-z#ref-CR62" id="ref-link-section-d9808965e2727"&gt;62&lt;/a&gt;&lt;/sup&gt; (v.5.0.1) was employed for data loading at the individual sample level. Subsequently, the scCB2&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 63" title="Ni, Z., Chen, S., Brown, J. &amp;amp; Kendziorski, C. CB2 improves power of cell detection in droplet-based single-cell RNA sequencing data. Genome Biol. 21, 137 (2020)." href="/articles/s41586-025-09492-z#ref-CR63" id="ref-link-section-d9808965e2731"&gt;63&lt;/a&gt;&lt;/sup&gt; (v.1.12.0) package was utilized to filter out empty droplets, employing an FDR threshold of 0.01 to identify real cells, while potential doublets were removed using the scDblFinder&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 64" title="Germain, P.-L., Lun, A., Garcia Meixide, C., Macnair, W. &amp;amp; Robinson, M. D. Doublet identification in single-cell sequencing data using scDblFinder. F1000Research 10, 979 (2021)." href="/articles/s41586-025-09492-z#ref-CR64" id="ref-link-section-d9808965e2735"&gt;64&lt;/a&gt;&lt;/sup&gt; (v.1.16.0) package. Cells with no GFP expression, exhibiting a high fraction of mitochondrial molecules (&amp;gt;5%) and those expressing a low number of unique genes (indicating low library complexity) were excluded.&lt;/p&gt;&lt;p&gt;Samples from the same replicate were merged, and highly variable genes were selected using the Seurat package. The relative expression values of these highly variable genes were used for principal component analysis (PCA). The number of PCA components for each replicate was determined based on achieving a cumulative proportion greater than 80% in the PCA plot. Subsequently, UMAP embeddings were generated and cells were clustered using Seurat’s Louvain algorithm-based FindClusters function.&lt;/p&gt;&lt;p&gt;Differentially expressed genes were identified using the SeuratWrapper’s (v.0.3.19) RunPrestoAll function. Genes detected in a minimum of 30% of the cells within each cluster, with at least a 0.25-fold mean log difference, were subjected to statistical testing using the Wilcoxon rank sum test with Bonferroni correction for multiple testing. Genes with adjusted &lt;i&gt;P&lt;/i&gt; value  &amp;lt;  0.05 were retained.&lt;/p&gt;&lt;p&gt;GSEA was conducted using the fgsea&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 65" title="Korotkevich, G. et al. Fast gene set enrichment analysis. Preprint at bioRxiv 
                https://doi.org/10.1101/060012
                
               (2021)." href="/articles/s41586-025-09492-z#ref-CR65" id="ref-link-section-d9808965e2752"&gt;65&lt;/a&gt;&lt;/sup&gt; (v.1.28.0) and genekitr&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 66" title="Liu, Y. &amp;amp; Li, G. Empowering biologists to decode omics data: the Genekitr R package and web server. BMC Bioinformatics 24, 214 (2023)." href="/articles/s41586-025-09492-z#ref-CR66" id="ref-link-section-d9808965e2756"&gt;66&lt;/a&gt;&lt;/sup&gt; (v.1.2.5) packages, exploring GO, KEGG, REACTOME, Hallmarks, Biocarta and WikiPathways databases. Finally, the GSVA&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 67" title="Hänzelmann, S., Castelo, R. &amp;amp; Guinney, J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics 14, 7 (2013)." href="/articles/s41586-025-09492-z#ref-CR67" id="ref-link-section-d9808965e2760"&gt;67&lt;/a&gt;&lt;/sup&gt; (v.1.50.0) package was used to calculate the ssGSEA scores for synaptome, astrocytes, and cell proliferation signatures.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec19"&gt;Single-cell sequencing from human primary or metastatic SCLC lesions&lt;/h3&gt;&lt;h4 class="c-article__sub-heading c-article__sub-heading--small" id="Sec20"&gt;Human SCLC brain tissue transcriptomic library preparation&lt;/h4&gt;&lt;p&gt;Frozen tissues were processed as described&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 68" title="Luthria, K. et al. Single-cell profiling of sarcomas from archival tissue reveals programs associated with resistance to immune checkpoint blockade. Clin. Cancer Res. 30, 4530–4541 (2024)." href="/articles/s41586-025-09492-z#ref-CR68" id="ref-link-section-d9808965e2776"&gt;68&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 69" title="Wang, Y. et al. Multimodal single-cell and whole-genome sequencing of small, frozen clinical specimens. Nat. Genet. 55, 19–25 (2023)." href="/articles/s41586-025-09492-z#ref-CR69" id="ref-link-section-d9808965e2779"&gt;69&lt;/a&gt;&lt;/sup&gt;. Tissue blocks were embedded in optimal cutting temperature (Tissue-Tek, Sankura 4583), and then sectioned on a Leica CM1950 cryostat (Leica) into 20-µm-thick curls (generating up to 20 curls for each sample). These were then placed in 5-ml tubes (Eppendorf), washed with ice-cold PBS (Thermo Fisher Scientific, 10010023), centrifuged at 400&lt;i&gt;g&lt;/i&gt; for 2 min, and the supernatant was discarded. The tissue was resuspended in 1 ml Salt Tris (ST) buffer (146 mM NaCl, 10 mM Tris-HCL pH 7.5, 1 mM CaCl&lt;sub&gt;2&lt;/sub&gt; and 21 mM MgCl2 in ultrapure water) with 0.03% Tween-20 (Sigma Aldrich, P7949; TST buffer), supplemented with 0.1% BSA (New England Biolabs, B9000S) and optionally 40 U ml&lt;sup&gt;−1&lt;/sup&gt; RNAse inhibitor (RNAse OUT, Thermo Fisher Scientific). The suspension was mechanically dissociated by pipetting 15 times with a 1-ml pipette and incubated on ice for 5 min. Afterward, the pipetting step was repeated, and the reaction was quenched with 4 ml ST buffer, with or without RNAse inhibitor. The mixture was filtered through pre-wetted 70-µm nylon mesh filters (Thermo Fisher Scientific) into 50-ml conical tubes, washed with 5 ml ST buffer, and centrifuged at 500&lt;i&gt;g&lt;/i&gt; for 5 min to isolate the nuclei. The nuclei pellet was resuspended in 100–400 µl ST buffer, filtered through a 40-µm mesh (Thermo Fisher Scientific), and counted using a Neubauer counting chamber (Bulldog Bio) after staining nuclear DNA with 50 µg ml&lt;sup&gt;−1&lt;/sup&gt; Hoechst 33342 (Thermo Fisher Scientific, H3570). Approximately 0.9 to 1.5 × 10³ nuclei were loaded into a Chromium Controller using ST buffer without RNAse inhibitor and processed with Chromium reagents and 5′V2 capture kits (1000006 and 1000263) from 10X Genomics. Following reverse transcription and cleanup, cDNA libraries were prepared per manufacturer protocols, including one additional cycle of amplification to account for the lower RNA content in nuclei compared with whole cells. Final sequencing libraries were created using the library construction kit (1000190) and Dual Index Kit TT Set A (1000215) and sequenced on an Illumina NovaSeq S4 platform with 2× 150 bp paired-end reads, achieving a minimum of 25,000 reads per cell.&lt;/p&gt;&lt;h4 class="c-article__sub-heading c-article__sub-heading--small" id="Sec21"&gt;Filtering background noise in gene expression matrices&lt;/h4&gt;&lt;p&gt;Demultiplex FASTQ files from raw RNA-sequencing reads were aligned using CellRanger v.6.1.1 (10X Genomics) to the GRCh38 genome&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 70" title="Zheng, G. X. Y. et al. Massively parallel digital transcriptional profiling of single cells. Nat. Commun. 8, 14049 (2017)." href="/articles/s41586-025-09492-z#ref-CR70" id="ref-link-section-d9808965e2804"&gt;70&lt;/a&gt;&lt;/sup&gt;. Gene counts were quantified with CellRanger’s ‘count’ function, including intronic reads. The feature_bc_matrix.h5 files generated by CellRanger were used as inputs for the ‘remove-background’ function in CellBender v.0.2.0, which removed ambient RNA gene counts and empty droplets&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 71" title="Fleming, S. J. et al. Unsupervised removal of systematic background noise from droplet-based single-cell experiments using CellBender. Nat. Methods 20, 1323–1335 (2023)." href="/articles/s41586-025-09492-z#ref-CR71" id="ref-link-section-d9808965e2808"&gt;71&lt;/a&gt;&lt;/sup&gt;. The CellRanger metric ‘expected-cells’ defined the ‘Expected Number of Cells’ parameter, and the total-droplets-included parameter was set to a value between 10,000 and 40,000, chosen from the plateau region of the barcode-rank plot generated by CellRanger.&lt;/p&gt;&lt;h4 class="c-article__sub-heading c-article__sub-heading--small" id="Sec22"&gt;Quality control and normalization&lt;/h4&gt;&lt;p&gt;Each generated matrix for was processed with R v.4.1.1 and Seurat v.4.1.0 on a per-sample basis&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 72" title="Butler, A., Hoffman, P., Smibert, P., Papalexi, E. &amp;amp; Satija, R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat. Biotechnol. 36, 411–420 (2018)." href="/articles/s41586-025-09492-z#ref-CR72" id="ref-link-section-d9808965e2820"&gt;72&lt;/a&gt;&lt;/sup&gt;. Filters were applied based on the Seurat pipeline to retain only cells with 500–10,000 detected genes, 1,000–60,000 unique molecular identifiers and less than 10% mitochondrial gene content. Scrublet v.0.2.1 was used to identify and remove doublets, with the expected doublet rate set between 2.5% and 7.5%, depending on the initial loading rate&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 73" title="Wolock, S. L., Lopez, R. &amp;amp; Klein, A. M. Scrublet: computational identification of cell doublets in single-cell transcriptomic data. Cell Syst. 8, 281–291.e9 (2019)." href="/articles/s41586-025-09492-z#ref-CR73" id="ref-link-section-d9808965e2824"&gt;73&lt;/a&gt;&lt;/sup&gt;. Following Seurat’s pipeline, the data were log-normalized using the NormalizeData function. The top 2,000 variable genes from each sample were identified with the FindVariableFeatures function, and the resulting matrix was centred and scaled with the ScaleData function. All signatures were computed through entered the gene list and a merged Seurat object of all samples on a per-cohort basis using the AddModuleScore function provided by Seurat.&lt;/p&gt;&lt;h4 class="c-article__sub-heading c-article__sub-heading--small" id="Sec23"&gt;Integration of cohort samples&lt;/h4&gt;&lt;p&gt;Individual Seurat samples were integrated using Seurat canonical correlation analysis (CCA) pipeline to remove batch effects from individual samples. Samples from the labelled Chan cohort from and CUIMC cohort were integrated separately&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 72" title="Butler, A., Hoffman, P., Smibert, P., Papalexi, E. &amp;amp; Satija, R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat. Biotechnol. 36, 411–420 (2018)." href="/articles/s41586-025-09492-z#ref-CR72" id="ref-link-section-d9808965e2836"&gt;72&lt;/a&gt;&lt;/sup&gt;. Per the CCA pipeline, SelectIntegrationFeatures and FindIntegrationAnchors was then run to select 2,000 anchors between each sample with the top 50 dimensions from CCA to define search space for integration, using the raw RNA counts assay for each sample. IntegrateData was then run using the previously defined anchors to generate the integrated dataset. The integrated data were then scaled, and clustered using ‘FindNeighbors’ with 10 dimensions and FindClusters using a resolution of 0.5. UMAPs were calculated with the top 30 PCA dimensions, using Seurat’s RunUMAP.&lt;/p&gt;&lt;h4 class="c-article__sub-heading c-article__sub-heading--small" id="Sec24"&gt;Cell-type identification&lt;/h4&gt;&lt;p&gt;Cell types were initially labelled using SingleR v.1.8.0 using the built in BlueprintEncodeData reference&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 74" title="Aran, D. et al. Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. Nat. Immunol. 20, 163–172 (2019)." href="/articles/s41586-025-09492-z#ref-CR74" id="ref-link-section-d9808965e2849"&gt;74&lt;/a&gt;&lt;/sup&gt;. Immune cells identified through this process were used as a diploid reference for inferCNV v.1.10.1 to infer chromosomal copy number alteration (CNA) profiles for each cell. A minimum average read count threshold of 0.1 per gene was applied for reference nuclei. The ‘subcluster’ setting was used for clustering, and results were denoised with the default ‘sd_amplifier’ value of 1.5. InferCNV used a hidden Markov model to predict CNA levels, and the proportion of scaled CNAs was averaged across all chromosomes for each cell&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 74" title="Aran, D. et al. Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. Nat. Immunol. 20, 163–172 (2019)." href="/articles/s41586-025-09492-z#ref-CR74" id="ref-link-section-d9808965e2853"&gt;74&lt;/a&gt;&lt;/sup&gt;. Malignant cells were identified using sample-specific thresholds based on these average values, which distinguished immune and non-immune CNA levels.&lt;/p&gt;&lt;p&gt;Non-malignant cell types were further analysed following CCA-based integration. Clustering of non-malignant cells was performed with the FindClusters function at varying resolutions, followed by differential gene expression analysis with FindAllMarkers&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 72" title="Butler, A., Hoffman, P., Smibert, P., Papalexi, E. &amp;amp; Satija, R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat. Biotechnol. 36, 411–420 (2018)." href="/articles/s41586-025-09492-z#ref-CR72" id="ref-link-section-d9808965e2860"&gt;72&lt;/a&gt;&lt;/sup&gt;. Broad cell-type annotations were assigned manually based on established marker genes identified as differentially expressed in each cluster.&lt;/p&gt;&lt;h4 class="c-article__sub-heading c-article__sub-heading--small" id="Sec25"&gt;Non-negative matrix factorization&lt;/h4&gt;&lt;p&gt;Non-negative matrix factorization (NMF) was employed for feature extraction and dimensionality reduction on non-negative gene expression data&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 75" title="Lee, D. D. &amp;amp; Seung, H. S. Learning the parts of objects by non-negative matrix factorization. Nature 401, 788–791 (1999)." href="/articles/s41586-025-09492-z#ref-CR75" id="ref-link-section-d9808965e2872"&gt;75&lt;/a&gt;&lt;/sup&gt;. The NMF function implemented in RcppML v.0.3.7, was selected for its computational efficiency by minimizing reconstruction error and optimizations matrix factorization&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 76" title="DeBruine, Z. J., Pospisilik, J. A. &amp;amp; Triche, T. J. Fast and interpretable non-negative matrix factorization for atlas-scale single cell data. Preprint at bioRxiv 
                https://doi.org/10.1101/2021.09.01.458620
                
               (2021)." href="/articles/s41586-025-09492-z#ref-CR76" id="ref-link-section-d9808965e2876"&gt;76&lt;/a&gt;&lt;/sup&gt;. RcppML operates directly on raw count matrices and incorporates L1 regularization with reproducible factor scaling, enabling robust handling of ambiguous zeroes in single-cell data. NMF iteratively decomposing the data matrix into two lower-dimensional non-negative matrices, a basis matrix representing gene programmes and a coefficient matrix capturing the effect of each gene programmes on each cell. To incorporate prior biological knowledge, the supervised framework from Tagore et. al was adapted&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 77" title="Tagore, S. et al. KINOMO: a non-negative matrix factorization framework for recovering intra- and inter-tumoral heterogeneity from single-cell RNA-seq data. Preprint at bioRxiv 
                https://doi.org/10.1101/2022.05.02.490362
                
               (2022)." href="/articles/s41586-025-09492-z#ref-CR77" id="ref-link-section-d9808965e2880"&gt;77&lt;/a&gt;&lt;/sup&gt;. NMF was run on each sample to identify latent gene programmes, followed by rank-factor. Genes were pre-filtered to retain the top 7,000 genes based on total counts from the filtered RNA assay, serving as input.&lt;/p&gt;&lt;p&gt;Metaprogrammes (also referred to as consensus factors) were identified through co-correlation analysis using Spearman’s correlation applied to sample-specific factors generated by NMF. The optimal number of consensus factors was determined using silhouette and distortion scores. Ward’s clustering was then performed on individual factors, with the optimal number of consensus factors setting the clustering thresholds to define metaprogrammes&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 77" title="Tagore, S. et al. KINOMO: a non-negative matrix factorization framework for recovering intra- and inter-tumoral heterogeneity from single-cell RNA-seq data. Preprint at bioRxiv 
                https://doi.org/10.1101/2022.05.02.490362
                
               (2022)." href="/articles/s41586-025-09492-z#ref-CR77" id="ref-link-section-d9808965e2887"&gt;77&lt;/a&gt;&lt;/sup&gt;. This analysis was conducted on a per-cohort basis.&lt;/p&gt;&lt;h4 class="c-article__sub-heading c-article__sub-heading--small" id="Sec26"&gt;Metaprogramme correlation with annotated hallmarks of tumour heterogeneity&lt;/h4&gt;&lt;p&gt;To annotate the biological functions underlying each metaprogramme, gene signatures were defined based on the top genes with the highest normalized contributions to each metaprogramme. Functional characterization of these gene signatures was performed through GSEA using recently described transcriptional hallmarks of tumour heterogeneity&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 46" title="Gavish, A. et al. Hallmarks of transcriptional intratumour heterogeneity across a thousand tumours. Nature 618, 598–606 (2023)." href="/articles/s41586-025-09492-z#ref-CR46" id="ref-link-section-d9808965e2899"&gt;46&lt;/a&gt;&lt;/sup&gt;. To assess the similarity between gene signatures, the Jaccard similarity index and a derived correlation metric were calculated. The Jaccard similarity index quantifies overlap between two sets as the size of their intersection divided by the size of their union. To facilitate interpretation in a heatmap, pairwise Jaccard similarity scores were scaled linearly to a correlation-like metric ranging from 0 to 1. The resulting heatmap highlights pairwise relationships between gene signatures, with metaprogrammes exhibiting the highest correlation with a given metaprogramme annotated as representing biologically related functions.&lt;/p&gt;&lt;h4 class="c-article__sub-heading c-article__sub-heading--small" id="Sec27"&gt;Normalized gene contribution towards metaprogrammes&lt;/h4&gt;&lt;p&gt;For each metaprogramme, genes were ranked based on a weighted Stouffer-integrated expression value. The top 50 genes per metaprogramme, determined by this ranking, were selected for downstream analyses. Within each sample, cell barcodes from the H matrix generated by NMF were assigned to a specific metaprogramme based on their highest association with a corresponding factor. These assignments linked individual barcodes to metaprogrammes according to their factor membership. To evaluate the gene contributions to each metaprogramme, an expectation-maximization Gaussian mixture model (EM-GMM) was applied to the normalized gene expression matrices&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 77" title="Tagore, S. et al. KINOMO: a non-negative matrix factorization framework for recovering intra- and inter-tumoral heterogeneity from single-cell RNA-seq data. Preprint at bioRxiv 
                https://doi.org/10.1101/2022.05.02.490362
                
               (2022)." href="/articles/s41586-025-09492-z#ref-CR77" id="ref-link-section-d9808965e2911"&gt;77&lt;/a&gt;&lt;/sup&gt;. This model assessed the modality of gene expression distributions, enabling the identification of peaks that correspond to the ‘normalized gene contribution’ for each metaprogramme. These contributions were subsequently scaled between 0 and 1 across all metaprogrammes to ensure comparability.&lt;/p&gt;&lt;h4 class="c-article__sub-heading c-article__sub-heading--small" id="Sec28"&gt;GSEA across metaprogrammes&lt;/h4&gt;&lt;p&gt;The top 50 ranked genes for each metaprogramme, based on the weighted Stouffer-integrated expression values, were used for functional enrichment analysis. GSEA was performed using EnrichR v.3.1, leveraging the Hallmarks of MSigDB v.7.4.1 and GO Biological Process 2021 databases&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 78" title="Chen, E. Y. et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics 14, 128 (2013)." href="/articles/s41586-025-09492-z#ref-CR78" id="ref-link-section-d9808965e2923"&gt;78&lt;/a&gt;&lt;/sup&gt;. Enrichment results were aggregated across cohorts, with the top-ranked gene sets identified for each metaprogramme. The &lt;i&gt;P&lt;/i&gt; values and &lt;i&gt;q&lt;/i&gt; scores returned by EnrichR were scaled and visualized to highlight significant functional associations for each metaprogramme.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec29"&gt;Sample preparation and image acquisition for electron microscopy&lt;/h3&gt;&lt;p&gt;NSG mice were engrafted with either 16T-mGFP or NCI-H446-GFP cells into mouse hippocampi. Three weeks after engraftment, mice were sacrificed by transcardial perfusion with Karnovsky’s fixative: 2% glutaraldehyde (EMS 16000) and 4% paraformaldehyde (PFA) (EMS 15700) in 0.1 M sodium cacodylate (EMS 12300), pH 7.4. The samples were then post-fixed in 1% osmium tetroxide (EMS 19100) for 1 h at room temperature, washed 3 times with ultrafiltered water, then en bloc stained for 2 h at room temperature. Samples were dehydrated in graded ethanol (50%, 75% and 95%) for 15 min each at 4 °C; the samples were then allowed to equilibrate to room temperature and were rinsed in 100% ethanol 2 times, followed by acetonitrile for 15 min. Samples were infiltrated with EMbed-812 resin (EMS 14120) mixed 1:1 with acetonitrile for 2 h followed by 2:1 EMbed-812:acetonitrile for 2 h. The samples were then placed into EMbed-812 for 2 h, then placed into TAAB capsules filled with fresh resin, which were then placed into a 65 °C oven overnight. Sections were taken between 40 and 60 nm on a Leica Ultracut S (Leica) and mounted on 100-mesh Ni grids (EMS FCF100-Ni). For immunohistochemistry, microetching was done with 10% periodic acid and eluting of osmium with 10% sodium metaperiodate for 15 min at room temperature on parafilm. Grids were rinsed with water three times in between and followed by 0.5 M Glycine quench. Grids were incubated in blocking solution (0.5% BSA, 0.5% Ovalbumin in PBST) at room temperature for 20 min. Primary rabbit anti-GFP (1:300; MBL International) was diluted in the same blocking solution and incubated overnight at 4 °C. The following day, grids were rinsed in PBS three times, and incubated in secondary antibody (1:10 10 nm Gold conjugated IgG TED Pella 15732) for 1 h at room temperature and rinsed with PBST followed by water. For each staining set, samples that did not contain any GFP-expressing cells were stained simultaneously to control for any non-specific binding. Grids were contrast stained for 30 s in 3.5% uranyl acetate in 50% acetone followed by staining in 0.2% lead citrate for 90 s. Samples were imaged in the tumour mass within the CA1 region of the hippocampus or within the contralateral normal hippocampus using a JEOL JEM-1400 transmission electron microscope at 120 kV and images were collected using a Gatan Orius digital camera.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec30"&gt;Electron microscopy data analysis&lt;/h3&gt;&lt;p&gt;Sections from the allografted hippocampi of mice were imaged as above using transmission electron microscopy. Here, 36 sections of 16T-mGFP across 6 mice were analysed. Electron microscopy images were taken at 6,000× with a field of view of 15.75 μm&lt;sup&gt;2&lt;/sup&gt;. Synapses were inspected by two individual investigators. SCLC cells were counted and analysed after unequivocal identification of immunogold particle labelling with four or more particles. For identification of synaptic structures, all three of the following criteria had to be clearly met: (1) visually apparent synaptic cleft; (2) presence of synaptic vesicle clusters in a cell on one side of the cleft; and (3) identification of clear post-synaptic density on the cell on opposite side of cleft. For identification of neuron-to-tumour synapses, the post-synaptic cell had to exhibit clear immunogold particle labelling. Tumour cells in perisynaptic positions were identified when an immunogold-particle-positive SCLC cell was seen apposed to or surrounding the synaptic structures between two other immunogold-particle-negative cells. Density of both types of synaptic relationships (neuron-to-tumour synapses, neuron-to-tumour perisynaptic connections) were quantified as the number of connections per number of SCLC cells identified within the region.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec31"&gt;Histology&lt;/h3&gt;&lt;p&gt;Mice with intracranial tumour allografts were anaesthetized with intraperitoneal avertin (tribromoethanol), then transcardially perfused with 20 ml of ice-cold PBS. Brains were fixed in 4% PFA overnight at 4 °C, then cryoprotected in 30% sucrose, embedded in Tissue-Tek O.C.T. (Sakura) and sectioned in the coronal plane at 40 μm using a sliding microtome. Lung tumour mice were perfused as above but also with 10 ml ice-cold 4% PFA. The lungs were inflated with 1–3 ml 2% UltraPure Low Melting Point Agarose (Invitrogen). Lungs and livers were fixed overnight at 4 °C on a shaker, then transferred to 70% ethanol and sectioned at 15 μm for H&amp;amp;E and immunohistochemistry, or cryoprotected in 30% sucrose and sectioned at 150 μm on a cryotome for visualizing tumour innervation.&lt;/p&gt;&lt;p&gt;For immunofluorescence staining, the coronal sections were incubated in blocking solution (3% normal donkey serum, 0.3% Triton X-100 in TBS) at room temperature for 45 min, followed by an overnight incubation with primary antibodies in antibody diluent solution (1% normal donkey serum in 0.3% Triton X-100 in TBS) at 4 °C. On the next day, after a 5-min rinse in TBS, sections were incubated with DAPI (1 μg ml&lt;sup&gt;−1&lt;/sup&gt; in TBS, Thermo Fisher) for 5 min, and rinsed again with TBS for 5 min. Afterwards, slices were incubated in secondary antibody solution at 4 °C overnight, then washed thrice in TBS and mounted with ProLong Gold Mounting medium (Life Technologies). All images were acquired with Zen 3.4 and analysed using Fiji ImageJ 2.1.0. For quantifying SCLC proliferation, average number of Ki67&lt;sup&gt;+&lt;/sup&gt; SCLC cells divided by total number of SCLC cells labelled by GFP was calculated within regions of interest either in axon-rich/axon-poor areas of the tumour or in response to various optogenetic manipulations. For quantification of SCLC spread, average distance from the core was measured as longest distance from the initial site of injection to outer core of the tumour. For quantification of tumour invasion, average number of SCLC cells that migrated out of the circumscribed tumour edge over ~500 μm was calculated.&lt;/p&gt;&lt;p&gt;For visualizing lung and liver tumour innervation with immunofluorescence, 150-μm-thick sections were processed as above, except primary antibody incubation time was extended to 72 h. Streptavidin Alexa Fluor 594 conjugate (Invitrogen) was used to visualized airway epithelium&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 79" title="Scott, G. D., Blum, E. D., Fryer, A. D. &amp;amp; Jacoby, D. B. Tissue optical clearing, three-dimensional imaging, and computer morphometry in whole mouse lungs and human airways. Am. J. Respir. Cell Mol. Biol. 51, 43–55 (2014)." href="/articles/s41586-025-09492-z#ref-CR79" id="ref-link-section-d9808965e2970"&gt;79&lt;/a&gt;&lt;/sup&gt;. To quantify lung and liver tumour burden, five equidistant H&amp;amp;E sections from each organ were evaluated by a pathologist blinded to the experimental conditions to estimate percent of section area occupied by the tumour. Any section with &amp;lt;5% of tissue estimated to be occupied by tumour was given a score of 0, 5–25% was given a score of 1, 25–50% was given a score of 2, 50–75% was given a score of 3, and &amp;gt;75% was given a score of 4. The score for each mouse was then generated as an average across the five sections.&lt;/p&gt;&lt;p&gt;The following primary antibodies were used: chicken anti-GFP (Aves Labs, 1:500), rabbit anti-MAP2 (EMD Millipore, 1:500), mouse anti-NeuN (EMD Millipore, 1:500), rabbit anti-Ki67 (Abcam, 1:500), guinea pig anti-synapsin (Synaptic Systems, 1:500), rabbit anti-HOMER1 (Synaptic Systems, 1:500), mouse anti-neurofilament (Abcam, 1:500), mouse anti-nestin (Abcam, 1:1,000), guinea pig anti-VChAT (Synaptic Systems, 1:200), mouse anti-TH (Abcam, 1:200), and rat anti-MBP (Abcam, 1:200). The following secondary antibodies were used (all Jackson Immuno Research, 1:500): DyLight 405 Donkey Anti-Mouse IgG, Alexa Fluor 488 Donkey Anti-Chicken IgG, Alexa Fluor 488 Donkey Anti-Guinea Pig IgG, Alexa Fluor 488 Donkey Anti-Rabbit IgG, Alexa Fluor 594 Donkey Anti-Rabbit IgG, Alexa Fluor 647 Donkey Anti-Mouse IgG, Alexa Fluor 647 Donkey Anti-Rabbit IgG, Alexa Fluor 647 Donkey Anti-Rat IgG.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec32"&gt;Cell culture&lt;/h3&gt;&lt;p&gt;The mouse 16T SCLC line was derived from a primary tumour from the lungs of an Rb/p53 mutant mouse&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 44" title="Denny, S. K. et al. Nfib promotes metastasis through a widespread increase in chromatin accessibility. Cell 166, 328–342 (2016)." href="/articles/s41586-025-09492-z#ref-CR44" id="ref-link-section-d9808965e2985"&gt;44&lt;/a&gt;&lt;/sup&gt;. 16T-GFP cells were generated by transducing 16T cells with pLV-CMV-GFP followed by FACS selection&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 28" title="Yang, D. et al. Axon-like protrusions promote small cell lung cancer migration and metastasis. eLife 8, e50616 (2019)." href="/articles/s41586-025-09492-z#ref-CR28" id="ref-link-section-d9808965e2989"&gt;28&lt;/a&gt;&lt;/sup&gt;. These cells are grown as neurospheres (unless otherwise stated) in 10% FBS medium consisting of DMEM (Invitrogen) and 1× liquid antibiotic-antimycotic (Invitrogen). The spheres were dissociated using TrypLE (Gibco) for seeding of in vitro experiments. For human cell lines, SCLC22H, H69, CORL47, and H526 were generously provided by M. Oser. SCLC22H was cultured in DMEM plus 10% FBS (Cytiva) and 1× Glutamax. H69, CORL47, H446 and H526 were cultured in RPMI with 10% FBS and 1× Glutamax. H1048 was cultured in RPMI plus 10% FBS, 1× Glutamax, and 1× Insulin transferrin selenium (Fisher Scientific). Primary small airway epithelial cells (HSAECs) were purchased from ATCC and grown in airway epithelial cell basal media supplemented with bronchial epithelial cell growth components (ATCC). All cultures were monitored by short tandem repeat fingerprinting for authenticity throughout the culture period and mycoplasma testing was routinely performed.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec33"&gt;Co-culture of SCLC cells with primary mouse neurons&lt;/h3&gt;&lt;p&gt;Neurons were isolated from the brains of CD1 mice using the Neural Tissue Dissociation Kit - Postnatal Neurons (Miltenyi), followed by the Neuron Isolation Kit, Mouse (Miltenyi) per the manufacturer’s instructions. After isolation, 300,000 neurons were plated onto circular glass coverslips (Electron Microscopy Services) pre-treated for 20 min at 37 °C with poly-&lt;span class="u-small-caps"&gt;l&lt;/span&gt;-lysine (Sigma) and then 3 h at 37 °C with 5 μg ml&lt;sup&gt;−1&lt;/sup&gt; mouse laminin (Thermo Fisher). Neurons were cultured in BrainPhys neuronal medium (Stemcell Technologies) supplemented with 1× Glutamax (Invitrogen), pen/strep (Invitrogen), B27 supplement (Invitrogen), BDNF (10 ng ml&lt;sup&gt;−1&lt;/sup&gt;; Shenandoah), and GDNF (5 ng ml&lt;sup&gt;−1&lt;/sup&gt;; Shenandoah), TRO19622 (5 μM; Tocris), β-mercaptoethanol (1×, Gibco) and 2% fetal bovine serum. Half of the medium was replenished on day in vitro (DIV) 1 and 5-fluoro-2'-deoxyuridine (UFDU) was added at 1 μM. This was repeated at DIV 3. On DIV 5, half of the medium was replaced with serum-free medium in the morning. In the afternoon, the medium was again replaced with half serum-free medium containing 75,000 SCLC cells dissociated from neurospheres or attached cultures with TrypLE. Tumour cells were cultured with neurons for 24 h and then fixed with 4% PFA for 20 min at room temperature and stained for immunofluorescence analysis as described below.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec34"&gt;Co-culture of SCLC cells with human iPS cell-derived glutamatergic neurons&lt;/h3&gt;&lt;p&gt;iPS cell lines were obtained from the Brigham and Women’s Hospital NeuroHub Core Facility and all permissions were received for use (from BWH NeuroHub Core and Rush Alzheimer’s Disease Center’s Biospecimen Distribution Committee). Induced neurons were generated from BR33 iPS cells as described&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 80" title="Lagomarsino, V. N. et al. Stem cell-derived neurons reflect features of protein networks, neuropathology, and cognitive outcome of their aged human donors. Neuron 109, 3402–3420.e9 (2021)." href="/articles/s41586-025-09492-z#ref-CR80" id="ref-link-section-d9808965e3019"&gt;80&lt;/a&gt;&lt;/sup&gt;. In brief, iPS cells were plated in mTeSR1 medium at a density of 95,000 cells per cm&lt;sup&gt;2&lt;/sup&gt; on Matrigel-coated plates for viral transduction. Viral plasmids were obtained from Addgene (plasmids #19780, #52047 and #30130). FUdeltaGW-rtTA was a gift from K. Hochedlinger (Addgene plasmid #19780; &lt;a href="http://n2t.net/addgene:19780"&gt;http://n2t.net/addgene:19780&lt;/a&gt;; RRID: &lt;a href="https://scicrunch.org/resolver/Addgene_19780/"&gt;Addgene_19780&lt;/a&gt;). TetO-FUW-EGFP was a gift from M. Wernig (Addgene plasmid #30130; &lt;a href="http://n2t.net/addgene:30130"&gt;http://n2t.net/addgene:30130&lt;/a&gt;; RRID: &lt;a href="https://scicrunch.org/resolver/Addgene_30130/"&gt;Addgene_30130&lt;/a&gt;). pTet-O-Ngn2-puro was a gift from M. Wernig (Addgene plasmid #52047; &lt;a href="http://n2t.net/addgene:52047"&gt;http://n2t.net/addgene:52047&lt;/a&gt;; RRID: &lt;a href="https://scicrunch.org/resolver/Addgene_52047/"&gt;Addgene_52047&lt;/a&gt;). Lentiviruses were obtained from Alstem with ultrahigh titres (~1 × 10&lt;sup&gt;9&lt;/sup&gt;) and used at the following concentrations: pTet-ONGN2-puro: 0.13 µl, 50,000 cells; TetO-FUW-eGFP: 0.13 µl, 50,000 cells; FUdelta GW-rtTA: 0.13 µl, 50,000 cells. Transduced cells were dissociated with 3:1 DPBS: Accutase (Stemcell Technologies) + ROCKi (10 µM, Stemcell Technologies) and plated onto Matrigel-coated plates at 200,000 cells per cm&lt;sup&gt;2&lt;/sup&gt; in StemFlex medium + ROCKi (10 µM, Stemcell Technologies) (day 0). On day 1, medium was changed to KSR medium with doxycycline (2 µg ml&lt;sup&gt;−1&lt;/sup&gt;, Sigma). Doxycycline was maintained in the medium for the remainder of the differentiation. On day 2, medium was changed to 1:1 KSR: N2B medium with puromycin (5 µg ml&lt;sup&gt;−1&lt;/sup&gt;, GIBCO). Puromycin was maintained in the medium throughout the differentiation. On day 3, medium was changed to N2B medium + 1:100 B27 supplement (Life Technologies). From day 4 on, cells were cultured in NBM medium + 1:50 B27 + puromycin (5 µg ml&lt;sup&gt;−1&lt;/sup&gt;) + BDNF, GDNF, CNTF (10 ng ml&lt;sup&gt;−1&lt;/sup&gt;, Peprotech). Half medium changes were performed every 2–3 days. Around D10, puromycin was removed from medium. Around D12-D-15, SCLC cells were added at a ratio of 1:3 (cancer cells:neurons). Cultures were monitored over the next ten days in the case of MEA recordings. For histological analyses, SCLC cells were added in the presence of 1 μM TTX (Tocris), 50 μM MK801 (Selleck Chemicals), 50 μM CNQX (Tocris), or vehicle. Co-cultures were then fixed and analysed 24 h later in the case of proliferation assays, and 5 days after co-culture in the case of synapse quantification.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec35"&gt;Co-culture of SCLC cells with human iPS cell-derived GABAergic neurons&lt;/h3&gt;&lt;p&gt;Induced pluripotent stem cell lines were obtained from the Brigham and Women’s Hospital NeuroHub Core Facility and all permissions were received for use (from BWH NeuroHub Core and Rush Alzheimer’s Disease Center’s Biospecimen Distribution Committee). In brief, iPS cells were plated in mTeSR1 medium at a density of 95,000 cells per cm&lt;sup&gt;2&lt;/sup&gt; on Matrigel-coated plates for viral transduction. Viral plasmids were obtained from Addgene (plasmids #19780, #97329 and #97330). FUdeltaGW-rtTA was a gift from K. Hochedlinger (Addgene plasmid #19780). TetO-Ascl1-puro was a gift from M. Wernig (Addgene plasmid #97329; &lt;a href="http://n2t.net/addgene:97329"&gt;http://n2t.net/addgene:97329&lt;/a&gt;; RRID: &lt;a href="https://scicrunch.org/resolver/Addgene_97329/"&gt;Addgene_97329&lt;/a&gt;). DLX2-hygro was a gift from M. Wernig (Addgene plasmid #97330; &lt;a href="http://n2t.net/addgene:97330"&gt;http://n2t.net/addgene:97330&lt;/a&gt;; RRID: &lt;a href="https://scicrunch.org/resolver/Addgene_97330/"&gt;Addgene_97330&lt;/a&gt;). Lentiviruses were obtained from Alstem with ultrahigh titres (~1 × 10&lt;sup&gt;9&lt;/sup&gt;) and used at the following concentrations: TetO-Ascl1-T2A-Puro: 0.13 µl, 50,000 cells; DLX2-hygro: 0.13 µl, 50,000 cells: FUdelta GW-rtTA: 0.13 µl, 50,000 cells. Transduced cells were dissociated with 3:1 DPBS: Accutase + ROCKi (10 µM) and plated onto Matrigel-coated plates at 200,000 cells per cm&lt;sup&gt;2&lt;/sup&gt; in StemFlex medium + ROCKi (10 µM) (day 0). On day 1, medium was changed to N2B medium with doxycycline (2 µg ml&lt;sup&gt;−1&lt;/sup&gt;) and forskolin (10 µM, Sigma). Doxycycline and forskolin were maintained in the medium for the remainder of the differentiation. On day 2, medium was replaced with fresh N2B medium. On day 3, medium was changed to N2B medium + puromycin (10 µg ml&lt;sup&gt;−1&lt;/sup&gt;, GIBCO). On day 4 onwards, cells were cultured in N2B medium + puromycin (8 µg ml&lt;sup&gt;−1&lt;/sup&gt;). From day 5 onwards, cells were cultured with NBM medium + 1:50 B27 + puromycin (5 µg ml&lt;sup&gt;−1&lt;/sup&gt;) + BDNF, GDNF, CNTF (10 ng ml&lt;sup&gt;−1&lt;/sup&gt;) + doxycycline (2 µg ml&lt;sup&gt;−1&lt;/sup&gt;) + forskolin (10 µM) + AraC (2 µM, Sigma). Half medium changes were performed every 2–3 days. Around day 14, puromycin, doxycycline, AraC, and forskolin were removed from medium. Around day 20 to day 25, SCLC cells were added at a ratio of 1:3 (cancer cells:neurons). For histological analyses, SCLC cells were added in the presence of 1 μM TTX (Tocris), 20 μM gabazine (Tocris) or vehicle. Co-cultures were then fixed and analysed 24 h later in the case of proliferation assays, and 5 days after co-culture in the case of synapse quantification.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec36"&gt;Induced neuron protocol medium&lt;/h3&gt;&lt;p&gt;KSR medium: Knockout DMEM, 15% KOSR, 1× MEM-NEAA, 55 µM β-mercaptoethanol, 1× Glutamax (Life Technologies). N2B medium: DMEM/F12, 1× GlutaMAX (Life Technologies), 1× N2 supplement B (StemCell Technologies), 0.3% dextrose (&lt;span class="u-small-caps"&gt;d&lt;/span&gt;-(+)-glucose, Sigma). NBM medium: neurobasal medium, 0.5× MEM-NEAA, 1× GlutaMAX (Life Technologies), 0.3% dextrose (&lt;span class="u-small-caps"&gt;d&lt;/span&gt;-(+)-glucose, Sigma).&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec37"&gt;Conditioned media assays&lt;/h3&gt;&lt;p&gt;For conditioned media assays, either glutamatergic or GABAergic iPS cell-derived neurons were cultured as above. On day 17–18, neurons were replenished with a full medium change with or without the presence of 1 μM TTX. Conditioned medium was collected 24 h later for immediate use. Mouse 16T cells were then plated (30,000 cells in a 48 well plate) with 500 μL neuronal conditioned medium (again in the absence or presence of TTX) with the addition of 10 μM EdU to each well. After 24 h, cells were fixed cells with 4% PFA and stained using Click-iT 594 EdU kit and protocol (Invitrogen). All conditioned media assays were performed alongside direct co-culture assays described above.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec38"&gt;EdU incorporation assay&lt;/h3&gt;&lt;p&gt;EdU staining was performed on glass coverslips in 24-well plates which were precoated with poly-&lt;span class="u-small-caps"&gt;l&lt;/span&gt;-lysine (Sigma) and 5 μg ml&lt;sup&gt;−1&lt;/sup&gt; mouse laminin (Thermo Fisher). Neurosphere cultures were dissociated with TrypLE and plated onto coated slides with 10 μM of EdU. After 24 h the cells were fixed with 4% PFA in PBS for 20 min and then stained using the Click-iT 594 EdU kit and protocol (Invitrogen) with or without additional antibody staining and mounted using Prolong Gold mounting medium (Life Technologies). Proliferation index was determined by quantifying the fraction of EdU-labelled cells/GFP-labelled cells using confocal microscopy at 40× magnification.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec39"&gt;Synaptic puncta staining and visualization&lt;/h3&gt;&lt;p&gt;For immunohistochemistry, fixed coverslips were incubated in blocking solution (3% normal donkey serum, 0.3% Triton X-100 in TBS) at room temperature for 1 h. Primary antibodies guinea pig anti-synapsin1/2 (1:500; Synaptic Systems), rabbit anti-HOMER1 (1:500; Synaptic Systems), rabbit anti-gephyrin (1:300, Cell Signaling Technologies), or mouse anti-neurofilament (1:500; Abcam) in 0.3% Triton X-100 in TBS and incubated overnight at 4 °C. Samples were then rinsed 3 times in TBS and incubated in secondary antibody solution (Alexa 488 donkey anti-guinea pig IgG; Alexa 594 donkey anti-rabbit IgG, and Alexa 647 donkey anti-mouse IgG, all at 1:500 (Jackson Immuno Research)) in antibody diluent solution at 4 °C overnight. Coverslips were rinsed three times in TBS and mounted with ProLong Gold Mounting medium (Life Technologies). Images were collected using a 63× oil-immersion objective on a Zeiss LSM800 confocal microscope and processed with Airyscan. Colocalization of puncta was quantified as described&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 2" title="Venkatesh, H. S. et al. Electrical and synaptic integration of glioma into neural circuits. Nature 573, 539–545 (2019)." href="/articles/s41586-025-09492-z#ref-CR2" id="ref-link-section-d9808965e3181"&gt;2&lt;/a&gt;&lt;/sup&gt;.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec40"&gt;MEA recordings&lt;/h3&gt;&lt;p&gt;All MEA recordings were taken and analysed using the Axion Biosystems platform. Prior to culturing, 6-well Axion plates were coated with poly-&lt;span class="u-small-caps"&gt;l&lt;/span&gt;-lysine and laminin. Day 4 iNs (created as described&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 80" title="Lagomarsino, V. N. et al. Stem cell-derived neurons reflect features of protein networks, neuropathology, and cognitive outcome of their aged human donors. Neuron 109, 3402–3420.e9 (2021)." href="/articles/s41586-025-09492-z#ref-CR80" id="ref-link-section-d9808965e3196"&gt;80&lt;/a&gt;&lt;/sup&gt;) were then thawed and plated in neurobasal medium, at 100,000 cells per well. For the initial week prior to co-culture, iNs were subjected to a half medium change every 3–4 days. Doxycycline and puromycin treatment were stopped after day 10 to allow for the addition of tumour cells. On day 14–15, SCLC cells were added at 30,000 cells per well MEA plates. MEA plates were recorded every day for 10 min for up to 2 weeks after co-culture. All spike numbers and amplitude were assessed using proprietary Axion Software.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec41"&gt;Electrophysiology&lt;/h3&gt;&lt;p&gt;For all electrophysiology experiments, 35,000 16T-GFP cells were allografted into the CA1 hippocampus of 4–6 week old NSG mice. Three weeks after allograft, brain slices were obtained using standard techniques. Mice were anaesthetized by isoflurane inhalation and perfused transcardially with ice-cold ACSF containing (in mM) 125 NaCl, 2.5 KCl, 25 NaHCO&lt;sub&gt;3&lt;/sub&gt;, 2 CaCl&lt;sub&gt;2&lt;/sub&gt;, 1 MgCl&lt;sub&gt;2&lt;/sub&gt;, 1.25 NaH&lt;sub&gt;2&lt;/sub&gt;PO&lt;sub&gt;4&lt;/sub&gt; and 25 glucose (295 mOsm kg&lt;sup&gt;−1&lt;/sup&gt;). Brains were blocked and transferred into a slicing chamber containing ice-cold ACSF. Coronal slices of hippocampus were cut at 300-μm thickness with a Leica VT1000s vibratome in ice-cold ACSF, transferred for 10 min to a holding chamber containing choline-based solution consisting of (in mM) 110 choline chloride, 25 NaHCO&lt;sub&gt;3&lt;/sub&gt;, 2.5 KCl, 7 MgCl&lt;sub&gt;2&lt;/sub&gt;, 0.5 CaCl&lt;sub&gt;2&lt;/sub&gt;, 1.25 NaH&lt;sub&gt;2&lt;/sub&gt;PO&lt;sub&gt;4&lt;/sub&gt;, 25 glucose, 11.6 ascorbic acid, and 3.1 pyruvic acid at 34 °C then transferred to a secondary holding chamber containing ACSF at 34 °C for 30 min and subsequently maintained at room temperature (20–22 °C) until use. All recordings were obtained within 5 h of slicing. Both choline solution and ACSF were constantly bubbled with 95% O&lt;sub&gt;2&lt;/sub&gt;/5% CO&lt;sub&gt;2&lt;/sub&gt;.&lt;/p&gt;&lt;p&gt;Individual brain slices were transferred into a recording chamber, mounted on an upright microscope (Olympus BX51WI or Scientifica SliceScope Pro 1000) and continuously superfused (2–3 ml min&lt;sup&gt;−1&lt;/sup&gt;) with ACSF and bubbled with 95% O&lt;sub&gt;2&lt;/sub&gt;/5% CO&lt;sub&gt;2&lt;/sub&gt; warmed to 32–34 °C by passing it through a feedback-controlled in-line heater (SH-27B; Warner Instruments). Cells were visualized through 40× or 60× water immersion objectives with either infrared differential interference contrast optics or epifluorescence to identify GFP&lt;sup&gt;+&lt;/sup&gt; cells. For whole-cell voltage clamp recording, patch pipettes (2–4 MΩ) pulled from borosilicate glass (Sutter Instruments) were filled with internal solution containing (in mM) 135 CsMeSO&lt;sub&gt;3&lt;/sub&gt;, 10 HEPES, 1 EGTA, 3.3 QX-314 (Cl&lt;sup&gt;−&lt;/sup&gt; salt), 4 Mg-ATP, 0.3 Na-GTP, 8 sodium phosphocreatine (pH 7.3 adjusted with CsOH; 295 mOsm·kg−1). sEPSCs and spontaneous inhibitory post-synaptic currents (sIPSCs) of GFP&lt;sup&gt;+&lt;/sup&gt; cells were recorded for 5 min at –70 or 0 mV holding potential. For membrane current variance, 10 consecutive sweeps, each 10 s long, recorded in voltage clamp at −70 mV holding potential were analysed by calculating the s.d. of the current after applying a 3-point median filter. To record evoked excitatory post-synaptic currents (eEPSCs) and evoked inhibitory post-synaptic currents (eIPSCs), the membrane voltages were clamped at –70 mV or 0 mV. For perforated-patch recording eIPSCs (gramicidin D, 40–60 μg ml&lt;sup&gt;−1&lt;/sup&gt;) with access resistance 40–60 MΩ, variable holding membrane voltages were applied to generate an &lt;i&gt;I&lt;/i&gt;–&lt;i&gt;V&lt;/i&gt; curve and identify chloride’s equilibrium potential. Extracellular stimulation was performed with a stimulus isolation unit (MicroProbes, ISO-Flex), bipolar electrodes (75 μm apart, PlasticOne or MicroProbes) which were placed away 100–400 μm along the CA1–CA2 axis from the recorded cells. Stimuli were delivered at 10 s intervals with 0.1 ms duration and 100–200 μA amplitude. In some recordings, to confirm whether sEPSCs or eIPSCs were glutamatergic or GABAergic, 10 μM NBQX and CPP (Sigma) or 10 μM gabazine (Tocris) were added to bath ACSF. For perforated patched recordings, 10 μM NBQX and CPP were in bath continuously. Pyramidal cells in allografted and contralateral sites of hippocampus were recorded in whole-cell current clamp to study intrinsic properties. Patch pipettes were filled with internal solution containing (in mM) 135 potassium methanesulfonate, 10 HEPES, 1 EGTA, 4 Mg-ATP, 0.4 Na-GTP, 8 sodium phosphocreatine (pH 7.3 adjusted with KOH; 295 mOsm kg&lt;sup&gt;−1&lt;/sup&gt;). From a resting potential of −70 mV, currents were injected for 1,000 ms at 50 pA steps from −100 to 1,000 pA. Intrinsic properties of hippocampus pyramidal cells were analysed with software in Matlab.&lt;/p&gt;&lt;p&gt;Extracellular local field potentials (fEPSPs) were recorded from hippocampal allograft and contralateral sites under current clamp (&lt;i&gt;I&lt;/i&gt; = 0 mode). A bipolar electrode (75 μm spacing, MicroProbes) was placed in stratum radiatum near the allograft or in the correspondent contralateral site. Recording glass electrodes (2–3 MΩ) filled ACSF were place 100–200 μm perpendicularly away from the stimulating bipolar electrode at a depth of 50 100 μm. The stimulation currents were delivered at 20 s intervals with 0.1 ms duration and variable intensities from 20 μA to 140 μA using 20 μA steps and repeated 10 times. The average slopes of fEPSPs for each current intensity were measured.&lt;/p&gt;&lt;p&gt;The resting membrane potential of SCLC was assessed through cell-attached configuration (Rseal &amp;gt; 1 GΩ) using the procedure previously described in Antel et al.&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 81" title="Antal, M., Acuna-Goycolea, C., Pressler, R. T., Blitz, D. M. &amp;amp; Regehr, W. G. Cholinergic activation of M2 receptors leads to context-dependent modulation of feedforward inhibition in the visual thalamus. PLoS Biol. 8, e1000348 (2010)." href="/articles/s41586-025-09492-z#ref-CR81" id="ref-link-section-d9808965e3273"&gt;81&lt;/a&gt;&lt;/sup&gt;. Glass pipettes were filled with a solution containing (in mM) 145 KCL, 2 MgCl2, 5 HEPES (pH was adjusted to 7.3 with KOH). A voltage protocol consisting of hold at 0 mV, stepping to 100 mV and ramping back to −120 mV over 137.5 ms was applied to GFP&lt;sup&gt;+&lt;/sup&gt; cells. Five to ten consecutive traces were recorded and averaged. All data were acquired with a MultiClamp 700B amplifier (Molecular Devices) and digitized at 3 kHz with a National Instruments data acquisition device (NI USB- 6343).&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec42"&gt;Calcium imaging&lt;/h3&gt;&lt;p&gt;For calcium imaging, the genetically encoded calcium indicator GCaMP6s was lentivirally transduced into mouse SCLC 16T (pLV-ef1-GCaMP6s-P2A-nls-tdTomato). In this case, SCLC cells containing the GCaMP6s reporter can be identified using the tdTomato nuclear tag. These cells were isolated and grafted into the CA1 region of the hippocampus as described above. Two-photon calcium imaging experiments were performed using Prairie Ultima XY upright two-photon microscope for tissue slices equipped with an Olympus LUM Plan FI W/IR-2 40× water immersion objective. The temperature of the perfusion medium, ACSF as described above, was kept at 30 °C, and perfused through the system at rate of 2 ml min&lt;sup&gt;−1&lt;/sup&gt;. Excitation light was provided at a wavelength of 920 nm through a tunable Ti:Sapphire laser (Spectra Physics Mai Tai DeepSee) to allow for excitation of both tdTomato and GCaMP6s. The actual laser power reaching the scanhead for each scope is dynamically controlled by Pockels cells via software interface. Pockels cell were set at 10 for all experiments, and photomultiplier tubes (PMTs) were set at 800 for each channel. For these settings, power at back aperture of the objective was approximately 30 mW at 920 nm. The wavelength ranges for the emission filters were PMT1: 607 nm centre wavelength with 45 nm bandpass (full-width at half-maximum) and PMT2: 525-nm centre wavelength with 70-nm bandpass (full-width at half-maximum). Recordings were made at 0.65 frames per second (~1.5 Hz) for about 30 min in the case of spontaneous activity and 10 min in the case of response to periodic electrical stimulation. Cells were identified via the expression for the nuclear tdTomato tag and were only imaged in the area of interest, specifically in the CA1 region of the hippocampus. Similar to the electrophysiology paradigm, for neuronal stimulation experiments, the electrode was placed in the hippocampus to stimulate the neuronal inputs originating in CA3. For electrical stimulation, approximately 20 µA over 200 µs was delivered to local axons using a stimulating bipolar microelectrode. For inhibitor experiments, TTX was directly diluted into the ACSF perfusion medium at 500 nM, oxygenated, and delivered to the slices through the perfusion system.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec43"&gt;Calcium imaging analysis&lt;/h3&gt;&lt;p&gt;Quantitative fluorescence intensity analysis was done on calcium transients that were reliably evoked by axonal stimulation. To determine the effect of TTX on the calcium transients in response to electrical stimulation of the CA3 Schaffer collaterals, the field of cells were stimulated three times in 1-min intervals to ensure synaptic connectivity. TTX (500 nM) was then perfused into the slices and the stim was repeated on the same field of cells to gauge direct effect of TTX on stimulation response. For analysis, regions of interest of each responding nucleus were set and Δ&lt;i&gt;F&lt;/i&gt;&lt;sub&gt;max&lt;/sub&gt;/&lt;i&gt;F&lt;/i&gt;&lt;sub&gt;0&lt;/sub&gt; (maximum difference in fluorescence intensity normalized to background fluorescence) measurements were determined before and after TTX treatment.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec44"&gt;Visualization of human SCLC lung tumour gene expression&lt;/h3&gt;&lt;p&gt;Expression data from 81 patients with SCLC primary tumours&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 38" title="George, J. et al. Comprehensive genomic profiles of small cell lung cancer. Nature 524, 47–53 (2015)." href="/articles/s41586-025-09492-z#ref-CR38" id="ref-link-section-d9808965e3313"&gt;38&lt;/a&gt;&lt;/sup&gt; as FPKM values was accessed and plotted for genes of interest.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec45"&gt;Unilateral cervical vagotomy&lt;/h3&gt;&lt;p&gt;Adult RPR2-luc mice (4–7 months old, 2–5 months from virus administration) weighing more than 17 g were anaesthetized with 1–4% isoflurane through a nose cone in a supine position. Skin of the ventral surface of the neck was shaved and aseptically prepared according to IACUC guidelines. Under a dissection microscope, a 1 cm midline skin incision was made, and salivary glands revealed were separated with blunt dissection to expose the airways. The right vagal nerve was then carefully dissected from the carotid sheath and cut at the cervical level posterior to the pharyngeal branch. Sham mice underwent the same surgical procedure for blunt dissection of the vagus nerve but the latter was left intact. The mice were monitored until recovery from anaesthesia for changes in heart rate and respiration and after that monitored bi-weekly for changes in weight, eating, drinking, and general activity. RPM mice were handled the same way, except vagotomy was performed within 1 week of virus administration.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec46"&gt;Bioluminescence imaging&lt;/h3&gt;&lt;p&gt;For in vivo monitoring of tumour growth, bioluminescence imaging was performed using an IVIS imaging system (Xenogen). Mice were placed under 1–4% isofluorane anaesthesia and injected with luciferin substrate, then imaged in pronated position for intracranial allograft experiments or supine position for lung tumour mice. Baseline bioluminescence was used to randomize mice by a blinded investigator so that experimental groups contained an equivalent range of tumour sizes. For vagotomy experiments, each cohort of mice was imaged weekly for a total of 6 months.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec47"&gt;Survival studies&lt;/h3&gt;&lt;p&gt;For survival studies, morbidity criteria used were either reduction of weight by 15% of initial weight, sickness behaviour (such as dyspnea, abnormal gait or posturing, or ill-groomed fur), or severe neurological motor deficits consistent with brainstem dysfunction (that is, hemiplegia or an incessant stereotyped circling behaviour seen with ventral midbrain dysfunction). Kaplan–Meier survival analysis using log-rank testing was performed to determine statistical significance.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec48"&gt;Mouse drug treatment studies&lt;/h3&gt;&lt;p&gt;For all drug studies, NSG mice were xenografted as above with either 16T-GFP or NCI-H446-GFP cells and randomized to treatment group by a blinded investigator. One week post-engraftment, tumour-bearing mice were treated with systemic administration of levetiracetam (20 mg kg&lt;sup&gt;−1&lt;/sup&gt;; Selleck Chemicals; formulated in a sterile saline solution) via intraperitoneal injection daily for 2 weeks. Controls were treated with an identical volume of vehicle.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec49"&gt;Statistical analyses&lt;/h3&gt;&lt;p&gt;Statistical tests were conducted using Prism v.9.3.1 (GraphPad) software unless otherwise indicated. Gaussian distribution was confirmed by the Shapiro–Wilk normality test. For parametric data, unpaired two-tailed Student’s &lt;i&gt;t&lt;/i&gt;-test or one-way ANOVA with Tukey’s post hoc tests to examine pairwise differences were used as indicated. Paired two-tailed Student’s &lt;i&gt;t&lt;/i&gt;-tests were used in the case of same-cell or same-animal experiments (as in electrophysiological recordings and vagotomy experiments). For non-parametric data, a two-sided unpaired Mann–Whitney test was used as indicated, or a one-tailed Wilcoxon matched pairs signed rank test was used for same-cell experiments. Two-tailed log-rank analyses were used to analyse statistical significance of Kaplan–Meier survival curves. In all box-and-whiskers plots, whiskers indicate minimum and maximum values, the box extends to the 25th and 75th percentile, and the centre line is plotted at the median. In all violin plots, lines are drawn at the median and quartiles.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec50"&gt;Reporting summary&lt;/h3&gt;&lt;p&gt;Further information on research design is available in the &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41586-025-09492-z#MOESM1"&gt;Nature Portfolio Reporting Summary&lt;/a&gt; linked to this article.&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Nature</author><pubDate>Wed, 10 Sep 2025 16:29:05 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMiX0FVX3lxTFAyWUprOTFIbU5KejZJUTM1R3AyckE0WUdheldtb3RveU1NcS1tLTB1M1JlQlY3Uzd1b3lGUldldzdXMjRJdDFGWHBpa0FEblJmWXBOeGRQVEIzS1dGRDRv</guid></item><item><title>小RFK表示，美国儿童最多可接种92剂疫苗。孩子们实际上有多少次射击？ - ABC新闻</title><link>https://abcnews.go.com/Health/rfk-jr-us-children-receive-92-vaccine-doses/story?id=125401242</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="xvlfx ZRifP TKoO eaKKC EcdEg bOdfO qXhdi NFNeu UyHES " data-testid="prism-article-body"&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao MvWXB TjIXL aGjvy ebVHC "&gt;Health and Human Services Secretary Robert F. Kennedy Jr. said at a Senate hearing on Thursday that children receive up to 92 vaccine doses in early childhood "in order to be fully compliant between maternity and 18 years."&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;But doctors tell ABC News that that number isn't accurate. Excluding annual flu and COVID-19 shots, children generally receive roughly 30 vaccine doses – many in combined injections – before the age of 18&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;Combination vaccines are single shots that include two or more vaccines that might otherwise be given separately: the MMR (measles, mumps and rubella) vaccine is a common example. This reduces the number of shots children get while protecting them from the same number of infectious diseases.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;Additionally, vaccines given today contain far fewer antigens – that is, substances that trigger an immune response in the body – &lt;a class="zZygg UbGlr iFzkS qdXbA WCDhQ DbOXS tqUtK GpWVU iJYzE " data-testid="prism-linkbase" href="https://www.chop.edu/vaccine-education-center/vaccine-schedule/science-behind-vaccine-schedule" target="_blank"&gt;than vaccines did decades ago&lt;/a&gt;. &lt;a class="zZygg UbGlr iFzkS qdXbA WCDhQ DbOXS tqUtK GpWVU iJYzE " data-testid="prism-linkbase" href="https://www.healthychildren.org/English/safety-prevention/immunizations/Pages/vaccine-studies-examine-the-evidence.aspx" target="_blank"&gt;Research&lt;/a&gt; has shown these vaccines are safe and effective and do not overwhelm the immune system, as Kennedy has previously suggested.&lt;/p&gt;&lt;h2 class="RxNCg ykkUm PvZ nIjPJ PMXYp LmsHF SfAHY mNgye lNbol LBPRq rBLIK "&gt;How many vaccines are recommended?&lt;/h2&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;In the Senate hearing, Kennedy said, "When I was a kid, I got three vaccines. I was fully compliant. Today's children have to get between 69 and 92 vaccines in order to be fully compliant."&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;&lt;a class="zZygg UbGlr iFzkS qdXbA WCDhQ DbOXS tqUtK GpWVU iJYzE " data-testid="prism-linkbase" href="https://www.chop.edu/vaccine-education-center/science-history/vaccine-history/developments-by-year" target="_blank"&gt;The number of available, recommended immunizations has grown&lt;/a&gt; since the first vaccines were recommended in the late 1940s based on evolving science and manufacturing capacity. For example, children can now receive a chickenpox vaccine, which became available in the 1990s.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;When Kennedy was a young child in the 1950s, there were three vaccines recommended to protect against smallpox, poliovirus, and a combined shot that included diphtheria, pertussis and tetanus vaccines.&lt;/p&gt;&lt;div class="oLzSq QrHMO fnRUo pvsTF EhJPu vPlOC zNYgW OsTsW RMeqy daRVX ISNQ sKyCY eRftA acPPc MENS nFwaT MCnQE mEeeY SmBjI xegrY rPLsU iulOd NIuqO zzscu lzDCc aHUBM IEgzD OjMNy eQqcx SVqKB GQmdz jaoD VWDdR ONJdw vrZxD OnRTz gbbfF roDbV GPGwb oMlSS gfNzt oJhud eXZcf zhVlX "&gt;&lt;div&gt;&lt;div class="InlineImage GpQCA lZur asrEW " data-testid="prism-inline-image"&gt;&lt;figure class="kzIjN GNmeK pYrtp dSqFO " data-testid="prism-figure"&gt;&lt;figcaption&gt;&lt;div class="nMMea bNYiy Mjgpa dGwha DDmxa jgKNG RGHCC aBIU PriDW lZur " data-testid="prism-caption"&gt;&lt;p class="HXPPJ barbu yKsXL IzgMt VcHIt uhSzI YGNMU cRAsZ xqMcl QtRul "&gt;&lt;span class="hsDdd OOSI GpQCA lZur VlFaz " data-testid="prism-truncate"&gt;&lt;span&gt;&lt;span class="gtOSm FbbUW tUtYa vOCwz EQwFq yCufu eEak Qmvg nyTIa SRXVc vzLa jgBfc WXDas CiUCW kqbG zrdEG txGfn ygKVe BbezD UOtxr CVfpq xijV soGRS XgdC sEIlf daWqJ "&gt;A member of medical staff administers a dose of the measles vaccine to a child at a health center in Lubbock, Texas, Feb. 27, 2025.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p class="qinlA IpWvx oqZz tylGM lyWxS nWcVF UhTug PPcLh YxlyB "&gt;&lt;span class="gtOSm FbbUW tUtYa vOCwz EQwFq yCufu eEak Qmvg nyTIa SRXVc vzLa jgBfc WXDas CiUCW kqbG zrdEG txGfn ygKVe BbezD UOtxr CVfpq xijV soGRS XgdC sEIlf daWqJ YNujN JGtjI aZFDu rkKLh "&gt;Ronaldo Schemidt/AFP via Getty Images&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/figcaption&gt;&lt;/figure&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;Currently, younger children, who are more vulnerable to infectious diseases, receive dozens of shots in the early years of life, but doctors told ABC News that the numbers shared by Kennedy are an overcount and a misleading criticism of the childhood vaccine schedule.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;Even now, there are no vaccines for most of the hundreds of known infectious diseases. The shots that are available protect against diseases that have a large public health impact, cause severe disease or that can be deadly or disabling.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;Kids and teens who follow the Centers for Disease Control and Prevention's (CDC) &lt;a class="zZygg UbGlr iFzkS qdXbA WCDhQ DbOXS tqUtK GpWVU iJYzE " data-testid="prism-linkbase" href="https://www.cdc.gov/vaccines/hcp/imz-schedules/index.html" target="_blank"&gt;recommended immunization schedule&lt;/a&gt; get about 30 injections, excluding annual COVID-19 and flu shots, before they turn 18. Because several routine vaccines are combined and given in the same injection, that number of shots can vary.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;"I count 33 doses from birth to 18 years on the immunization schedule. Many of those can be given as combination vaccines, particularly at the early ages," Dr. Pia Pannaraj, a professor of pediatrics and member of the American Academy of Pediatrics (AAP) Committee on Infectious Diseases, told ABC News.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;If that still sounds like a lot, consider the number of germs children are exposed to every day, pediatricians say.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;"Kids are exposed to 2,000 to 6,000 antigens every day just by playing at the playground or going to school. That is significantly more than what they receive in vaccines," Pannaraj said.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;"If you count RSV, there are 18 or 19 infections for which children are recommended to be vaccinated against," Dr. Robert W. Frenck, Jr., pediatrician and chair of the AAP Section on Infectious Disease, told ABC News.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;Frenck noted that many vaccines are combination vaccines. These include the diphtheria, tetanus and pertussis (DTaP) vaccine, the hepatitis B vaccine, Haemophilus influenzae type b (Hib) vaccine, polio vaccine, and measles, mumps and rubella (MMR) vaccine.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;"Most vaccines need two to three doses, some four to five to complete the series. But it is not 60 to 90 vaccines," Frenck said.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;Studies have also shown that vaccines do not overwhelm or weaken the immune system and don't make children more susceptible to other infections. These include a &lt;a class="zZygg UbGlr iFzkS qdXbA WCDhQ DbOXS tqUtK GpWVU iJYzE " data-testid="prism-linkbase" href="https://jamanetwork.com/journals/jama/fullarticle/201371" target="_blank"&gt;Danish study published in 2005&lt;/a&gt; and a &lt;a class="zZygg UbGlr iFzkS qdXbA WCDhQ DbOXS tqUtK GpWVU iJYzE " data-testid="prism-linkbase" href="https://jamanetwork.com/journals/jama/fullarticle/2673970" target="_blank"&gt;2018 study&lt;/a&gt; that included about 1,000 American kids.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;Researchers in the latter study concluded: "Despite using a different population, study period, study design, and method of defining the exposure, this current nested case-control study arrived at the same conclusion" as the earlier Danish study.&lt;/p&gt;&lt;h2 class="RxNCg ykkUm PvZ nIjPJ PMXYp LmsHF SfAHY mNgye lNbol LBPRq rBLIK "&gt;How many vaccines are mandated?&lt;/h2&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;While the CDC makes recommendations for routine immunizations, many are not mandated in order for Americans kids to attend school. School vaccine mandates are determined by each state but the most common shots kids need are the MMR, varicella, DTaP, polio and meningitis vaccines, &lt;a class="zZygg UbGlr iFzkS qdXbA WCDhQ DbOXS tqUtK GpWVU iJYzE " data-testid="prism-linkbase" href="https://www.cdc.gov/phlp/docs/school-vaccinations.pdf" target="_blank"&gt;the CDC says&lt;/a&gt;.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;Additionally, all states allow &lt;a class="zZygg UbGlr iFzkS qdXbA WCDhQ DbOXS tqUtK GpWVU iJYzE " data-testid="prism-linkbase" href="https://www.ncsl.org/health/state-non-medical-exemptions-from-school-immunization-requirements" target="_blank"&gt;medical vaccine exemptions&lt;/a&gt;, and most states have exemption policies in place for people with strong religious objections in an effort to balance the need for public health with freedom of choice. Some states allow exemptions based on personal belief alone.&lt;/p&gt;&lt;h2 class="RxNCg ykkUm PvZ nIjPJ PMXYp LmsHF SfAHY mNgye lNbol LBPRq rBLIK "&gt;How effective are vaccines?&lt;/h2&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;Doctors say the safety, efficacy and lifesaving success of vaccines has been proven by decades of rigorous research.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;Over the last 50 years, vaccines have saved an estimated 154 million lives, according to a 2024 study led by the &lt;a class="zZygg UbGlr iFzkS qdXbA WCDhQ DbOXS tqUtK GpWVU iJYzE " data-testid="prism-linkbase" href="https://www.who.int/news/item/24-04-2024-global-immunization-efforts-have-saved-at-least-154-million-lives-over-the-past-50-years" target="_blank"&gt;World Health Organization&lt;/a&gt;. Of those lives, about 101 million were infants.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;Still, many vaccine-preventable diseases remain a problem around the globe and some have become a growing problem in the U.S., such as measles, evidenced by &lt;a class="zZygg UbGlr iFzkS qdXbA WCDhQ DbOXS tqUtK GpWVU iJYzE " data-testid="prism-linkbase" href="https://abcnews.go.com/Health/measles-outbreak-sickened-700-declared-texas/story?id=124749372" target="_blank"&gt;a recent outbreak in Texas&lt;/a&gt; that was the largest in the U.S. in decades.&lt;/p&gt;&lt;div class="oLzSq QrHMO fnRUo pvsTF EhJPu vPlOC zNYgW OsTsW RMeqy daRVX ISNQ sKyCY eRftA acPPc MENS nFwaT MCnQE mEeeY SmBjI xegrY rPLsU iulOd NIuqO zzscu lzDCc aHUBM IEgzD OjMNy eQqcx SVqKB GQmdz jaoD VWDdR ONJdw vrZxD OnRTz gbbfF roDbV GPGwb oMlSS gfNzt oJhud eXZcf zhVlX "&gt;&lt;div&gt;&lt;div class="InlineImage GpQCA lZur asrEW " data-testid="prism-inline-image"&gt;&lt;figure class="kzIjN GNmeK pYrtp dSqFO " data-testid="prism-figure"&gt;&lt;figcaption&gt;&lt;div class="nMMea bNYiy Mjgpa dGwha DDmxa jgKNG RGHCC aBIU PriDW lZur " data-testid="prism-caption"&gt;&lt;p class="HXPPJ barbu yKsXL IzgMt VcHIt uhSzI YGNMU cRAsZ xqMcl QtRul "&gt;&lt;span class="hsDdd OOSI GpQCA lZur VlFaz " data-testid="prism-truncate"&gt;&lt;span&gt;&lt;span class="gtOSm FbbUW tUtYa vOCwz EQwFq yCufu eEak Qmvg nyTIa SRXVc vzLa jgBfc WXDas CiUCW kqbG zrdEG txGfn ygKVe BbezD UOtxr CVfpq xijV soGRS XgdC sEIlf daWqJ "&gt;Secretary of Health and Human Services Robert F. Kennedy Jr., appears before the Senate Finance Committee, on Capitol Hill in Washington, Sept. 4, 2025.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p class="qinlA IpWvx oqZz tylGM lyWxS nWcVF UhTug PPcLh YxlyB "&gt;&lt;span class="gtOSm FbbUW tUtYa vOCwz EQwFq yCufu eEak Qmvg nyTIa SRXVc vzLa jgBfc WXDas CiUCW kqbG zrdEG txGfn ygKVe BbezD UOtxr CVfpq xijV soGRS XgdC sEIlf daWqJ YNujN JGtjI aZFDu rkKLh "&gt;Andrew Harnik/Getty Images&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/figcaption&gt;&lt;/figure&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;So far this year, measles has been detected in nearly every state with more than 1,400 total confirmed cases, the &lt;a class="zZygg UbGlr iFzkS qdXbA WCDhQ DbOXS tqUtK GpWVU iJYzE " data-testid="prism-linkbase" href="https://abcnews.go.com/Health/us-measles-cases-hit-highest-number-33-years/story?id=123564379" target="_blank"&gt;highest number of nationwide cases seen in 33 years&lt;/a&gt;, according to the CDC. 2025 has seen 35 measles outbreaks in the U.S., with most cases outbreak-associated as opposed to isolated cases from international travel. By comparison, last year there were 16 outbreaks in the U.S. with about 70% outbreak-associated compared to nearly 90% this year, &lt;a class="zZygg UbGlr iFzkS qdXbA WCDhQ DbOXS tqUtK GpWVU iJYzE " data-testid="prism-linkbase" href="https://www.cdc.gov/measles/data-research/index.html" target="_blank"&gt;CDC data shows&lt;/a&gt;.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;In 2000, measles was declared eliminated in the U.S., but many public health experts and scientists worry that current declines in routine immunization rates could allow the virus to again become endemic, meaning constantly present.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;&lt;a class="zZygg UbGlr iFzkS qdXbA WCDhQ DbOXS tqUtK GpWVU iJYzE " data-testid="prism-linkbase" href="https://abcnews.go.com/Health/small-uptick-vaccination-prevent-millions-us-measles-cases/story?id=121270669" target="_blank"&gt;One recent study&lt;/a&gt; used a model that predicted measles could once again become endemic in the U.S. with a projected 851,300 cases over the next 25 years. If vaccination rates were to decline by just 10%, the model estimates the U.S. could see 11.1 million cases of measles over 25 years.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;"I know there's a lot of misinformation and mistrust but one thing that should not be under fire is vaccination and the public health story success that vaccination has been in this country," Dr. Tara Narula, ABC News chief medical correspondent, said on "Good Morning America" on Friday.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;"We know that has saved millions of lives. We know that it prevents disability from disease," Narula continued. "Polio can cause paralysis. Measles can lead to brain inflammation, so if you get sick, it can end up resulting in complications. We have vaccines for cancer, HPV and hepatitis. We need vaccinations to protect the vulnerable, the ill, the immunocompromised, children, right? So it is so important that we not forget the powerful impact."&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;According to a &lt;a class="zZygg UbGlr iFzkS qdXbA WCDhQ DbOXS tqUtK GpWVU iJYzE " data-testid="prism-linkbase" href="https://www.cdc.gov/mmwr/volumes/73/wr/mm7331a2.htm" target="_blank"&gt;2024 CDC report&lt;/a&gt;, it's estimated routine vaccines will have prevented more than 500 million lifetime cases of illness, 32 million hospitalizations and over a million deaths among kids born from 1994 to 2023, resulting in $540 billion in direct savings and $2.7 trillion in societal savings.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;Reflecting on her own clinical experience during the COVID-19 pandemic, Narula said, "Let us not forget the toll that can happen, the immeasurable loss and suffering when we let our guard down."&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC eTIW sUzSN "&gt;&lt;em class=" "&gt;Jade A. Cobern, M.D., MPH, is a practicing physician, board-certified in pediatrics and general preventive medicine, and is a medical fellow of the ABC News Medical Unit.&lt;/em&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>ABC News</author><pubDate>Wed, 10 Sep 2025 16:18:45 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMilwFBVV95cUxQQjMyMmItTEJSaE1ibFVGb3k1ZmdyZDBoZTEzM2FTRnVCSW9zTzVzMjFvNHByZXBGZHlXQ1pTSlQzcXAyWVhWdGtrVUN6cmdUNFExZllKaEFzRFlfREYxQnROV3V5aERQbmVWMzlrNjdNc2dWUzNITVFSa2M0d0c3Mk85cllmc1AtY2ZKN3E4cTRLVDFBclMw0gGcAUFVX3lxTE0zM1g3aWdlVzQ1ZU1OX1ZQcUE3UF82X1prbzA3WUlLdVN5Vl8wcWd0MHRtbTNqUjNGOU53R3VXUjMzZ3JqSHl0cDgyc0VVWWVtSFVFRmQtcU5CVUE4aWJLY2VyeVVBdnZTRnotZjRzYzhSYlZJdnY3YUZCU05pdDBuVV90Z2d2MFVMdzFJc1FJU1FWU0k0aTJaWTFPVQ</guid></item><item><title>髓系祖细胞失调助长肿瘤中的免疫抑制巨噬细胞-自然</title><link>https://www.nature.com/articles/s41586-025-09493-y</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;ol class="c-article-references" data-track-component="outbound reference" data-track-context="references section"&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="1."&gt;&lt;p class="c-article-references__text" id="ref-CR1"&gt;DeNardo, D. G. &amp;amp; Ruffell, B. Macrophages as regulators of tumour immunity and immunotherapy. &lt;i&gt;Nat. Rev. Immunol.&lt;/i&gt; &lt;b&gt;19&lt;/b&gt;, 369–382 (2019).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41577-019-0127-6" data-track-item_id="10.1038/s41577-019-0127-6" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41577-019-0127-6" aria-label="Article reference 1" data-doi="10.1038/s41577-019-0127-6"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=30718830" aria-label="PubMed reference 1"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7339861" aria-label="PubMed Central reference 1"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC1MXmtFKhtrw%3D" aria-label="CAS reference 1"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 1" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Macrophages%20as%20regulators%20of%20tumour%20immunity%20and%20immunotherapy&amp;amp;journal=Nat.%20Rev.%20Immunol.&amp;amp;doi=10.1038%2Fs41577-019-0127-6&amp;amp;volume=19&amp;amp;pages=369-382&amp;amp;publication_year=2019&amp;amp;author=DeNardo%2CDG&amp;amp;author=Ruffell%2CB"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="2."&gt;&lt;p class="c-article-references__text" id="ref-CR2"&gt;Swann, J. W., Olson, O. C. &amp;amp; Passegue, E. Made to order: emergency myelopoiesis and demand-adapted innate immune cell production. &lt;i&gt;Nat. Rev. Immunol.&lt;/i&gt; &lt;b&gt;24&lt;/b&gt;, 596–613 (2024).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41577-024-00998-7" data-track-item_id="10.1038/s41577-024-00998-7" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41577-024-00998-7" aria-label="Article reference 2" data-doi="10.1038/s41577-024-00998-7"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=38467802" aria-label="PubMed reference 2"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB2cXlsFKmsrg%3D" aria-label="CAS reference 2"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 2" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Made%20to%20order%3A%20emergency%20myelopoiesis%20and%20demand-adapted%20innate%20immune%20cell%20production&amp;amp;journal=Nat.%20Rev.%20Immunol.&amp;amp;doi=10.1038%2Fs41577-024-00998-7&amp;amp;volume=24&amp;amp;pages=596-613&amp;amp;publication_year=2024&amp;amp;author=Swann%2CJW&amp;amp;author=Olson%2COC&amp;amp;author=Passegue%2CE"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="3."&gt;&lt;p class="c-article-references__text" id="ref-CR3"&gt;Goswami, S., Anandhan, S., Raychaudhuri, D. &amp;amp; Sharma, P. Myeloid cell-targeted therapies for solid tumours. &lt;i&gt;Nat. Rev. Immunol.&lt;/i&gt; &lt;b&gt;23&lt;/b&gt;, 106–120 (2023).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41577-022-00737-w" data-track-item_id="10.1038/s41577-022-00737-w" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41577-022-00737-w" aria-label="Article reference 3" data-doi="10.1038/s41577-022-00737-w"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=35697799" aria-label="PubMed reference 3"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB38XhsFaksbbE" aria-label="CAS reference 3"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 3" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Myeloid%20cell-targeted%20therapies%20for%20solid%20tumours&amp;amp;journal=Nat.%20Rev.%20Immunol.&amp;amp;doi=10.1038%2Fs41577-022-00737-w&amp;amp;volume=23&amp;amp;pages=106-120&amp;amp;publication_year=2023&amp;amp;author=Goswami%2CS&amp;amp;author=Anandhan%2CS&amp;amp;author=Raychaudhuri%2CD&amp;amp;author=Sharma%2CP"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="4."&gt;&lt;p class="c-article-references__text" id="ref-CR4"&gt;Sica, A., Guarneri, V. &amp;amp; Gennari, A. Myelopoiesis, metabolism and therapy: a crucial crossroads in cancer progression. &lt;i&gt;Cell Stress&lt;/i&gt; &lt;b&gt;3&lt;/b&gt;, 284–294 (2019).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.15698/cst2019.09.197" data-track-item_id="10.15698/cst2019.09.197" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.15698%2Fcst2019.09.197" aria-label="Article reference 4" data-doi="10.15698/cst2019.09.197"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=31535085" aria-label="PubMed reference 4"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6732213" aria-label="PubMed Central reference 4"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXitVCjsrbN" aria-label="CAS reference 4"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 4" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Myelopoiesis%2C%20metabolism%20and%20therapy%3A%20a%20crucial%20crossroads%20in%20cancer%20progression&amp;amp;journal=Cell%20Stress&amp;amp;doi=10.15698%2Fcst2019.09.197&amp;amp;volume=3&amp;amp;pages=284-294&amp;amp;publication_year=2019&amp;amp;author=Sica%2CA&amp;amp;author=Guarneri%2CV&amp;amp;author=Gennari%2CA"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="5."&gt;&lt;p class="c-article-references__text" id="ref-CR5"&gt;Giles, A. J. et al. Activation of hematopoietic stem/progenitor cells promotes immunosuppression within the pre-metastatic niche. &lt;i&gt;Cancer Res.&lt;/i&gt; &lt;b&gt;76&lt;/b&gt;, 1335–1347 (2016).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1158/0008-5472.CAN-15-0204" data-track-item_id="10.1158/0008-5472.CAN-15-0204" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1158%2F0008-5472.CAN-15-0204" aria-label="Article reference 5" data-doi="10.1158/0008-5472.CAN-15-0204"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=26719537" aria-label="PubMed reference 5"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC28XktlWqtL8%3D" aria-label="CAS reference 5"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 5" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Activation%20of%20hematopoietic%20stem%2Fprogenitor%20cells%20promotes%20immunosuppression%20within%20the%20pre-metastatic%20niche&amp;amp;journal=Cancer%20Res.&amp;amp;doi=10.1158%2F0008-5472.CAN-15-0204&amp;amp;volume=76&amp;amp;pages=1335-1347&amp;amp;publication_year=2016&amp;amp;author=Giles%2CAJ"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="6."&gt;&lt;p class="c-article-references__text" id="ref-CR6"&gt;Casbon, A. J. et al. Invasive breast cancer reprograms early myeloid differentiation in the bone marrow to generate immunosuppressive neutrophils. &lt;i&gt;Proc. Natl Acad. Sci. USA&lt;/i&gt; &lt;b&gt;112&lt;/b&gt;, E566–E575 (2015).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1073/pnas.1424927112" data-track-item_id="10.1073/pnas.1424927112" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1073%2Fpnas.1424927112" aria-label="Article reference 6" data-doi="10.1073/pnas.1424927112"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=25624500" aria-label="PubMed reference 6"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4330753" aria-label="PubMed Central reference 6"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2MXhsVeiu70%3D" aria-label="CAS reference 6"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 6" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Invasive%20breast%20cancer%20reprograms%20early%20myeloid%20differentiation%20in%20the%20bone%20marrow%20to%20generate%20immunosuppressive%20neutrophils&amp;amp;journal=Proc.%20Natl%20Acad.%20Sci.%20USA&amp;amp;doi=10.1073%2Fpnas.1424927112&amp;amp;volume=112&amp;amp;pages=E566-E575&amp;amp;publication_year=2015&amp;amp;author=Casbon%2CAJ"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="7."&gt;&lt;p class="c-article-references__text" id="ref-CR7"&gt;Wu, W. C. et al. Circulating hematopoietic stem and progenitor cells are myeloid-biased in cancer patients. &lt;i&gt;Proc. Natl Acad. Sci. USA&lt;/i&gt; &lt;b&gt;111&lt;/b&gt;, 4221–4226 (2014).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1073/pnas.1320753111" data-track-item_id="10.1073/pnas.1320753111" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1073%2Fpnas.1320753111" aria-label="Article reference 7" data-doi="10.1073/pnas.1320753111"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="ads reference" data-track-action="ads reference" href="http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&amp;amp;bibcode=2014PNAS..111.4221W" aria-label="ADS reference 7"&gt;ADS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=24591638" aria-label="PubMed reference 7"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3964061" aria-label="PubMed Central reference 7"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2cXjtl2gsLk%3D" aria-label="CAS reference 7"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 7" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Circulating%20hematopoietic%20stem%20and%20progenitor%20cells%20are%20myeloid-biased%20in%20cancer%20patients&amp;amp;journal=Proc.%20Natl%20Acad.%20Sci.%20USA&amp;amp;doi=10.1073%2Fpnas.1320753111&amp;amp;volume=111&amp;amp;pages=4221-4226&amp;amp;publication_year=2014&amp;amp;author=Wu%2CWC"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="8."&gt;&lt;p class="c-article-references__text" id="ref-CR8"&gt;Porembka, M. R. et al. Pancreatic adenocarcinoma induces bone marrow mobilization of myeloid-derived suppressor cells which promote primary tumor growth. &lt;i&gt;Cancer Immunol. Immunother.&lt;/i&gt; &lt;b&gt;61&lt;/b&gt;, 1373–1385 (2012).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="noopener" data-track-label="10.1007/s00262-011-1178-0" data-track-item_id="10.1007/s00262-011-1178-0" data-track-value="article reference" data-track-action="article reference" href="https://link.springer.com/doi/10.1007/s00262-011-1178-0" aria-label="Article reference 8" data-doi="10.1007/s00262-011-1178-0"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=22215137" aria-label="PubMed reference 8"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3697836" aria-label="PubMed Central reference 8"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC38Xht1Ogt7jJ" aria-label="CAS reference 8"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 8" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Pancreatic%20adenocarcinoma%20induces%20bone%20marrow%20mobilization%20of%20myeloid-derived%20suppressor%20cells%20which%20promote%20primary%20tumor%20growth&amp;amp;journal=Cancer%20Immunol.%20Immunother.&amp;amp;doi=10.1007%2Fs00262-011-1178-0&amp;amp;volume=61&amp;amp;pages=1373-1385&amp;amp;publication_year=2012&amp;amp;author=Porembka%2CMR"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="9."&gt;&lt;p class="c-article-references__text" id="ref-CR9"&gt;Trzebanski, S. et al. Classical monocyte ontogeny dictates their functions and fates as tissue macrophages. &lt;i&gt;Immunity&lt;/i&gt; &lt;b&gt;57&lt;/b&gt;, 1225–1243 (2024).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.immuni.2024.04.019" data-track-item_id="10.1016/j.immuni.2024.04.019" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.immuni.2024.04.019" aria-label="Article reference 9" data-doi="10.1016/j.immuni.2024.04.019"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=38749446" aria-label="PubMed reference 9"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB2cXhtFSmur7L" aria-label="CAS reference 9"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 9" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Classical%20monocyte%20ontogeny%20dictates%20their%20functions%20and%20fates%20as%20tissue%20macrophages&amp;amp;journal=Immunity&amp;amp;doi=10.1016%2Fj.immuni.2024.04.019&amp;amp;volume=57&amp;amp;pages=1225-1243&amp;amp;publication_year=2024&amp;amp;author=Trzebanski%2CS"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="10."&gt;&lt;p class="c-article-references__text" id="ref-CR10"&gt;Ikeda, N. et al. The early neutrophil-committed progenitors aberrantly differentiate into immunoregulatory monocytes during emergency myelopoiesis. &lt;i&gt;Cell Rep.&lt;/i&gt; &lt;b&gt;42&lt;/b&gt;, 112165 (2023).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.celrep.2023.112165" data-track-item_id="10.1016/j.celrep.2023.112165" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.celrep.2023.112165" aria-label="Article reference 10" data-doi="10.1016/j.celrep.2023.112165"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=36862552" aria-label="PubMed reference 10"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3sXjvFCjsL8%3D" aria-label="CAS reference 10"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 10" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=The%20early%20neutrophil-committed%20progenitors%20aberrantly%20differentiate%20into%20immunoregulatory%20monocytes%20during%20emergency%20myelopoiesis&amp;amp;journal=Cell%20Rep.&amp;amp;doi=10.1016%2Fj.celrep.2023.112165&amp;amp;volume=42&amp;amp;publication_year=2023&amp;amp;author=Ikeda%2CN"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="11."&gt;&lt;p class="c-article-references__text" id="ref-CR11"&gt;LaMarche, N. M. et al. An IL-4 signalling axis in bone marrow drives pro-tumorigenic myelopoiesis. &lt;i&gt;Nature&lt;/i&gt; &lt;b&gt;625&lt;/b&gt;, 166–174 (2024).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41586-023-06797-9" data-track-item_id="10.1038/s41586-023-06797-9" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41586-023-06797-9" aria-label="Article reference 11" data-doi="10.1038/s41586-023-06797-9"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="ads reference" data-track-action="ads reference" href="http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&amp;amp;bibcode=2024Natur.625..166L" aria-label="ADS reference 11"&gt;ADS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=38057662" aria-label="PubMed reference 11"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3sXisFGhu7jL" aria-label="CAS reference 11"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 11" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=An%20IL-4%20signalling%20axis%20in%20bone%20marrow%20drives%20pro-tumorigenic%20myelopoiesis&amp;amp;journal=Nature&amp;amp;doi=10.1038%2Fs41586-023-06797-9&amp;amp;volume=625&amp;amp;pages=166-174&amp;amp;publication_year=2024&amp;amp;author=LaMarche%2CNM"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="12."&gt;&lt;p class="c-article-references__text" id="ref-CR12"&gt;Hao, X. et al. Osteoprogenitor–GMP crosstalk underpins solid tumor-induced systemic immunosuppression and persists after tumor removal. &lt;i&gt;Cell Stem Cell&lt;/i&gt; &lt;b&gt;30&lt;/b&gt;, 648–664 (2023).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.stem.2023.04.005" data-track-item_id="10.1016/j.stem.2023.04.005" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.stem.2023.04.005" aria-label="Article reference 12" data-doi="10.1016/j.stem.2023.04.005"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=37146584" aria-label="PubMed reference 12"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10165729" aria-label="PubMed Central reference 12"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3sXpt1emtbw%3D" aria-label="CAS reference 12"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 12" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Osteoprogenitor%E2%80%93GMP%20crosstalk%20underpins%20solid%20tumor-induced%20systemic%20immunosuppression%20and%20persists%20after%20tumor%20removal&amp;amp;journal=Cell%20Stem%20Cell&amp;amp;doi=10.1016%2Fj.stem.2023.04.005&amp;amp;volume=30&amp;amp;pages=648-664&amp;amp;publication_year=2023&amp;amp;author=Hao%2CX"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="13."&gt;&lt;p class="c-article-references__text" id="ref-CR13"&gt;Gerber-Ferder, Y. et al. Breast cancer remotely imposes a myeloid bias on haematopoietic stem cells by reprogramming the bone marrow niche. &lt;i&gt;Nat. Cell Biol.&lt;/i&gt; &lt;b&gt;25&lt;/b&gt;, 1736–1745 (2023).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41556-023-01291-w" data-track-item_id="10.1038/s41556-023-01291-w" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41556-023-01291-w" aria-label="Article reference 13" data-doi="10.1038/s41556-023-01291-w"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=38036749" aria-label="PubMed reference 13"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3sXisFSmu7fK" aria-label="CAS reference 13"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 13" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Breast%20cancer%20remotely%20imposes%20a%20myeloid%20bias%20on%20haematopoietic%20stem%20cells%20by%20reprogramming%20the%20bone%20marrow%20niche&amp;amp;journal=Nat.%20Cell%20Biol.&amp;amp;doi=10.1038%2Fs41556-023-01291-w&amp;amp;volume=25&amp;amp;pages=1736-1745&amp;amp;publication_year=2023&amp;amp;author=Gerber-Ferder%2CY"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="14."&gt;&lt;p class="c-article-references__text" id="ref-CR14"&gt;Dey, S., Curtis, D. J., Jane, S. M. &amp;amp; Brandt, S. J. The TAL1/SCL transcription factor regulates cell cycle progression and proliferation in differentiating murine bone marrow monocyte precursors. &lt;i&gt;Mol. Cell. Biol.&lt;/i&gt; &lt;b&gt;30&lt;/b&gt;, 2181–2192 (2010).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1128/MCB.01441-09" data-track-item_id="10.1128/MCB.01441-09" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1128%2FMCB.01441-09" aria-label="Article reference 14" data-doi="10.1128/MCB.01441-09"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=20194619" aria-label="PubMed reference 14"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2863590" aria-label="PubMed Central reference 14"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC3cXlt1Khur8%3D" aria-label="CAS reference 14"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 14" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=The%20TAL1%2FSCL%20transcription%20factor%20regulates%20cell%20cycle%20progression%20and%20proliferation%20in%20differentiating%20murine%20bone%20marrow%20monocyte%20precursors&amp;amp;journal=Mol.%20Cell.%20Biol.&amp;amp;doi=10.1128%2FMCB.01441-09&amp;amp;volume=30&amp;amp;pages=2181-2192&amp;amp;publication_year=2010&amp;amp;author=Dey%2CS&amp;amp;author=Curtis%2CDJ&amp;amp;author=Jane%2CSM&amp;amp;author=Brandt%2CSJ"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="15."&gt;&lt;p class="c-article-references__text" id="ref-CR15"&gt;Pham, T. H. et al. Dynamic epigenetic enhancer signatures reveal key transcription factors associated with monocytic differentiation states. &lt;i&gt;Blood&lt;/i&gt; &lt;b&gt;119&lt;/b&gt;, e161–e171 (2012).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1182/blood-2012-01-402453" data-track-item_id="10.1182/blood-2012-01-402453" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1182%2Fblood-2012-01-402453" aria-label="Article reference 15" data-doi="10.1182/blood-2012-01-402453"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=22550342" aria-label="PubMed reference 15"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC38XhtVGns73E" aria-label="CAS reference 15"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 15" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Dynamic%20epigenetic%20enhancer%20signatures%20reveal%20key%20transcription%20factors%20associated%20with%20monocytic%20differentiation%20states&amp;amp;journal=Blood&amp;amp;doi=10.1182%2Fblood-2012-01-402453&amp;amp;volume=119&amp;amp;pages=e161-e171&amp;amp;publication_year=2012&amp;amp;author=Pham%2CTH"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="16."&gt;&lt;p class="c-article-references__text" id="ref-CR16"&gt;Mandula, J. K. &amp;amp; Rodriguez, P. C. Tumor-related stress regulates functional plasticity of MDSCs. &lt;i&gt;Cell Immunol.&lt;/i&gt; &lt;b&gt;363&lt;/b&gt;, 104312 (2021).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.cellimm.2021.104312" data-track-item_id="10.1016/j.cellimm.2021.104312" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.cellimm.2021.104312" aria-label="Article reference 16" data-doi="10.1016/j.cellimm.2021.104312"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=33652258" aria-label="PubMed reference 16"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8026602" aria-label="PubMed Central reference 16"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3MXls1Sksbw%3D" aria-label="CAS reference 16"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 16" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Tumor-related%20stress%20regulates%20functional%20plasticity%20of%20MDSCs&amp;amp;journal=Cell%20Immunol.&amp;amp;doi=10.1016%2Fj.cellimm.2021.104312&amp;amp;volume=363&amp;amp;publication_year=2021&amp;amp;author=Mandula%2CJK&amp;amp;author=Rodriguez%2CPC"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="17."&gt;&lt;p class="c-article-references__text" id="ref-CR17"&gt;Paul, F. et al. Transcriptional heterogeneity and lineage commitment in myeloid progenitors. &lt;i&gt;Cell&lt;/i&gt; &lt;b&gt;163&lt;/b&gt;, 1663–1677 (2015).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.cell.2015.11.013" data-track-item_id="10.1016/j.cell.2015.11.013" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.cell.2015.11.013" aria-label="Article reference 17" data-doi="10.1016/j.cell.2015.11.013"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=26627738" aria-label="PubMed reference 17"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2MXhvFagur7P" aria-label="CAS reference 17"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 17" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Transcriptional%20heterogeneity%20and%20lineage%20commitment%20in%20myeloid%20progenitors&amp;amp;journal=Cell&amp;amp;doi=10.1016%2Fj.cell.2015.11.013&amp;amp;volume=163&amp;amp;pages=1663-1677&amp;amp;publication_year=2015&amp;amp;author=Paul%2CF"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="18."&gt;&lt;p class="c-article-references__text" id="ref-CR18"&gt;Kwart, D. et al. Cancer cell-derived type I interferons instruct tumor monocyte polarization. &lt;i&gt;Cell Rep.&lt;/i&gt; &lt;b&gt;41&lt;/b&gt;, 111769 (2022).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.celrep.2022.111769" data-track-item_id="10.1016/j.celrep.2022.111769" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.celrep.2022.111769" aria-label="Article reference 18" data-doi="10.1016/j.celrep.2022.111769"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=36476866" aria-label="PubMed reference 18"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB38XjtVKksb%2FM" aria-label="CAS reference 18"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 18" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Cancer%20cell-derived%20type%20I%20interferons%20instruct%20tumor%20monocyte%20polarization&amp;amp;journal=Cell%20Rep.&amp;amp;doi=10.1016%2Fj.celrep.2022.111769&amp;amp;volume=41&amp;amp;publication_year=2022&amp;amp;author=Kwart%2CD"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="19."&gt;&lt;p class="c-article-references__text" id="ref-CR19"&gt;Alicea-Torres, K. et al. Immune suppressive activity of myeloid-derived suppressor cells in cancer requires inactivation of the type I interferon pathway. &lt;i&gt;Nat. Commun.&lt;/i&gt; &lt;b&gt;12&lt;/b&gt;, 1717 (2021).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41467-021-22033-2" data-track-item_id="10.1038/s41467-021-22033-2" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41467-021-22033-2" aria-label="Article reference 19" data-doi="10.1038/s41467-021-22033-2"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="ads reference" data-track-action="ads reference" href="http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&amp;amp;bibcode=2021NatCo..12.1717A" aria-label="ADS reference 19"&gt;ADS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=33741967" aria-label="PubMed reference 19"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7979850" aria-label="PubMed Central reference 19"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3MXntl2qsL0%3D" aria-label="CAS reference 19"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 19" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Immune%20suppressive%20activity%20of%20myeloid-derived%20suppressor%20cells%20in%20cancer%20requires%20inactivation%20of%20the%20type%20I%20interferon%20pathway&amp;amp;journal=Nat.%20Commun.&amp;amp;doi=10.1038%2Fs41467-021-22033-2&amp;amp;volume=12&amp;amp;publication_year=2021&amp;amp;author=Alicea-Torres%2CK"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="20."&gt;&lt;p class="c-article-references__text" id="ref-CR20"&gt;Kwak, H. J. et al. Myeloid cell-derived reactive oxygen species externally regulate the proliferation of myeloid progenitors in emergency granulopoiesis. &lt;i&gt;Immunity&lt;/i&gt; &lt;b&gt;42&lt;/b&gt;, 159–171 (2015).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.immuni.2014.12.017" data-track-item_id="10.1016/j.immuni.2014.12.017" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.immuni.2014.12.017" aria-label="Article reference 20" data-doi="10.1016/j.immuni.2014.12.017"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=25579427" aria-label="PubMed reference 20"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4303526" aria-label="PubMed Central reference 20"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2MXmtFCqug%3D%3D" aria-label="CAS reference 20"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 20" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Myeloid%20cell-derived%20reactive%20oxygen%20species%20externally%20regulate%20the%20proliferation%20of%20myeloid%20progenitors%20in%20emergency%20granulopoiesis&amp;amp;journal=Immunity&amp;amp;doi=10.1016%2Fj.immuni.2014.12.017&amp;amp;volume=42&amp;amp;pages=159-171&amp;amp;publication_year=2015&amp;amp;author=Kwak%2CHJ"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="21."&gt;&lt;p class="c-article-references__text" id="ref-CR21"&gt;Pizzato, H. A. et al. Mitochondrial pyruvate metabolism and glutaminolysis toggle steady-state and emergency myelopoiesis. &lt;i&gt;J. Exp. Med.&lt;/i&gt; &lt;b&gt;220&lt;/b&gt;, e20221373 (2023).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1084/jem.20221373" data-track-item_id="10.1084/jem.20221373" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1084%2Fjem.20221373" aria-label="Article reference 21" data-doi="10.1084/jem.20221373"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=37249600" aria-label="PubMed reference 21"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227646" aria-label="PubMed Central reference 21"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3sXht1yhs7nN" aria-label="CAS reference 21"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 21" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Mitochondrial%20pyruvate%20metabolism%20and%20glutaminolysis%20toggle%20steady-state%20and%20emergency%20myelopoiesis.&amp;amp;journal=J.%20Exp.%20Med.&amp;amp;doi=10.1084%2Fjem.20221373&amp;amp;volume=220&amp;amp;publication_year=2023&amp;amp;author=Pizzato%2CHA"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="22."&gt;&lt;p class="c-article-references__text" id="ref-CR22"&gt;Pietras, E. M. et al. Re-entry into quiescence protects hematopoietic stem cells from the killing effect of chronic exposure to type I interferons. &lt;i&gt;J. Exp. Med.&lt;/i&gt; &lt;b&gt;211&lt;/b&gt;, 245–262 (2014).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1084/jem.20131043" data-track-item_id="10.1084/jem.20131043" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1084%2Fjem.20131043" aria-label="Article reference 22" data-doi="10.1084/jem.20131043"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=24493802" aria-label="PubMed reference 22"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3920566" aria-label="PubMed Central reference 22"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2cXisFarurc%3D" aria-label="CAS reference 22"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 22" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Re-entry%20into%20quiescence%20protects%20hematopoietic%20stem%20cells%20from%20the%20killing%20effect%20of%20chronic%20exposure%20to%20type%20I%20interferons&amp;amp;journal=J.%20Exp.%20Med.&amp;amp;doi=10.1084%2Fjem.20131043&amp;amp;volume=211&amp;amp;pages=245-262&amp;amp;publication_year=2014&amp;amp;author=Pietras%2CEM"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="23."&gt;&lt;p class="c-article-references__text" id="ref-CR23"&gt;Molgora, M. et al. TREM2 modulation remodels the tumor myeloid landscape enhancing anti-PD-1 immunotherapy. &lt;i&gt;Cell&lt;/i&gt; &lt;b&gt;182&lt;/b&gt;, 886–900 (2020).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.cell.2020.07.013" data-track-item_id="10.1016/j.cell.2020.07.013" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.cell.2020.07.013" aria-label="Article reference 23" data-doi="10.1016/j.cell.2020.07.013"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=32783918" aria-label="PubMed reference 23"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7485282" aria-label="PubMed Central reference 23"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXhsF2qt73J" aria-label="CAS reference 23"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 23" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=TREM2%20modulation%20remodels%20the%20tumor%20myeloid%20landscape%20enhancing%20anti-PD-1%20immunotherapy&amp;amp;journal=Cell&amp;amp;doi=10.1016%2Fj.cell.2020.07.013&amp;amp;volume=182&amp;amp;pages=886-900&amp;amp;publication_year=2020&amp;amp;author=Molgora%2CM"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="24."&gt;&lt;p class="c-article-references__text" id="ref-CR24"&gt;Katzenelenbogen, Y. et al. Coupled scRNA-seq and intracellular protein activity reveal an immunosuppressive role of TREM2 in cancer. &lt;i&gt;Cell&lt;/i&gt; &lt;b&gt;182&lt;/b&gt;, 872–885 (2020).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.cell.2020.06.032" data-track-item_id="10.1016/j.cell.2020.06.032" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.cell.2020.06.032" aria-label="Article reference 24" data-doi="10.1016/j.cell.2020.06.032"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=32783915" aria-label="PubMed reference 24"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXhsF2qt73L" aria-label="CAS reference 24"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 24" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Coupled%20scRNA-seq%20and%20intracellular%20protein%20activity%20reveal%20an%20immunosuppressive%20role%20of%20TREM2%20in%20cancer&amp;amp;journal=Cell&amp;amp;doi=10.1016%2Fj.cell.2020.06.032&amp;amp;volume=182&amp;amp;pages=872-885&amp;amp;publication_year=2020&amp;amp;author=Katzenelenbogen%2CY"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="25."&gt;&lt;p class="c-article-references__text" id="ref-CR25"&gt;Matusiak, M. et al. Spatially segregated macrophage populations predict distinct outcomes in colon cancer. &lt;i&gt;Cancer Discov.&lt;/i&gt; &lt;b&gt;14&lt;/b&gt;, 1418–1439 (2024).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1158/2159-8290.CD-23-1300" data-track-item_id="10.1158/2159-8290.CD-23-1300" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1158%2F2159-8290.CD-23-1300" aria-label="Article reference 25" data-doi="10.1158/2159-8290.CD-23-1300"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=38552005" aria-label="PubMed reference 25"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11294822" aria-label="PubMed Central reference 25"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB2MXjslyktLs%3D" aria-label="CAS reference 25"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 25" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Spatially%20segregated%20macrophage%20populations%20predict%20distinct%20outcomes%20in%20colon%20cancer&amp;amp;journal=Cancer%20Discov.&amp;amp;doi=10.1158%2F2159-8290.CD-23-1300&amp;amp;volume=14&amp;amp;pages=1418-1439&amp;amp;publication_year=2024&amp;amp;author=Matusiak%2CM"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="26."&gt;&lt;p class="c-article-references__text" id="ref-CR26"&gt;Mulder, K. et al. Cross-tissue single-cell landscape of human monocytes and macrophages in health and disease. &lt;i&gt;Immunity&lt;/i&gt; &lt;b&gt;54&lt;/b&gt;, 1883–1900 (2021).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.immuni.2021.07.007" data-track-item_id="10.1016/j.immuni.2021.07.007" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.immuni.2021.07.007" aria-label="Article reference 26" data-doi="10.1016/j.immuni.2021.07.007"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=34331874" aria-label="PubMed reference 26"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3MXhs1yiu7zK" aria-label="CAS reference 26"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 26" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Cross-tissue%20single-cell%20landscape%20of%20human%20monocytes%20and%20macrophages%20in%20health%20and%20disease&amp;amp;journal=Immunity&amp;amp;doi=10.1016%2Fj.immuni.2021.07.007&amp;amp;volume=54&amp;amp;pages=1883-1900&amp;amp;publication_year=2021&amp;amp;author=Mulder%2CK"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="27."&gt;&lt;p class="c-article-references__text" id="ref-CR27"&gt;McGinnis, C. S. et al. The temporal progression of lung immune remodeling during breast cancer metastasis. &lt;i&gt;Cancer Cell&lt;/i&gt; &lt;b&gt;42&lt;/b&gt;, 1018–1031 (2024).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.ccell.2024.05.004" data-track-item_id="10.1016/j.ccell.2024.05.004" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.ccell.2024.05.004" aria-label="Article reference 27" data-doi="10.1016/j.ccell.2024.05.004"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=38821060" aria-label="PubMed reference 27"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11255555" aria-label="PubMed Central reference 27"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB2cXhtF2mur%2FE" aria-label="CAS reference 27"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 27" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=The%20temporal%20progression%20of%20lung%20immune%20remodeling%20during%20breast%20cancer%20metastasis&amp;amp;journal=Cancer%20Cell&amp;amp;doi=10.1016%2Fj.ccell.2024.05.004&amp;amp;volume=42&amp;amp;pages=1018-1031&amp;amp;publication_year=2024&amp;amp;author=McGinnis%2CCS"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="28."&gt;&lt;p class="c-article-references__text" id="ref-CR28"&gt;Beury, D. W. et al. Myeloid-derived suppressor cell survival and function are regulated by the transcription factor Nrf2. &lt;i&gt;J. Immunol.&lt;/i&gt; &lt;b&gt;196&lt;/b&gt;, 3470–3478 (2016).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.4049/jimmunol.1501785" data-track-item_id="10.4049/jimmunol.1501785" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.4049%2Fjimmunol.1501785" aria-label="Article reference 28" data-doi="10.4049/jimmunol.1501785"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=26936880" aria-label="PubMed reference 28"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC28XltlSksL0%3D" aria-label="CAS reference 28"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 28" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Myeloid-derived%20suppressor%20cell%20survival%20and%20function%20are%20regulated%20by%20the%20transcription%20factor%20Nrf2&amp;amp;journal=J.%20Immunol.&amp;amp;doi=10.4049%2Fjimmunol.1501785&amp;amp;volume=196&amp;amp;pages=3470-3478&amp;amp;publication_year=2016&amp;amp;author=Beury%2CDW"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="29."&gt;&lt;p class="c-article-references__text" id="ref-CR29"&gt;Namgaladze, D., Fuhrmann, D. C. &amp;amp; Brune, B. Interplay of Nrf2 and BACH1 in inducing ferroportin expression and enhancing resistance of human macrophages towards ferroptosis. &lt;i&gt;Cell Death Discov.&lt;/i&gt; &lt;b&gt;8&lt;/b&gt;, 327 (2022).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41420-022-01117-y" data-track-item_id="10.1038/s41420-022-01117-y" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41420-022-01117-y" aria-label="Article reference 29" data-doi="10.1038/s41420-022-01117-y"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=35853860" aria-label="PubMed reference 29"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296510" aria-label="PubMed Central reference 29"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB38Xit1Slsb7P" aria-label="CAS reference 29"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 29" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Interplay%20of%20Nrf2%20and%20BACH1%20in%20inducing%20ferroportin%20expression%20and%20enhancing%20resistance%20of%20human%20macrophages%20towards%20ferroptosis&amp;amp;journal=Cell%20Death%20Discov.&amp;amp;doi=10.1038%2Fs41420-022-01117-y&amp;amp;volume=8&amp;amp;publication_year=2022&amp;amp;author=Namgaladze%2CD&amp;amp;author=Fuhrmann%2CDC&amp;amp;author=Brune%2CB"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="30."&gt;&lt;p class="c-article-references__text" id="ref-CR30"&gt;Kobayashi, E. H. et al. Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription. &lt;i&gt;Nat. Commun.&lt;/i&gt; &lt;b&gt;7&lt;/b&gt;, 11624 (2016).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/ncomms11624" data-track-item_id="10.1038/ncomms11624" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fncomms11624" aria-label="Article reference 30" data-doi="10.1038/ncomms11624"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="ads reference" data-track-action="ads reference" href="http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&amp;amp;bibcode=2016NatCo...711624K" aria-label="ADS reference 30"&gt;ADS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=27211851" aria-label="PubMed reference 30"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4879264" aria-label="PubMed Central reference 30"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC28Xos12ms7w%3D" aria-label="CAS reference 30"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 30" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Nrf2%20suppresses%20macrophage%20inflammatory%20response%20by%20blocking%20proinflammatory%20cytokine%20transcription&amp;amp;journal=Nat.%20Commun.&amp;amp;doi=10.1038%2Fncomms11624&amp;amp;volume=7&amp;amp;publication_year=2016&amp;amp;author=Kobayashi%2CEH"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="31."&gt;&lt;p class="c-article-references__text" id="ref-CR31"&gt;Ryan, D. G. et al. Nrf2 activation reprograms macrophage intermediary metabolism and suppresses the type I interferon response. &lt;i&gt;iScience&lt;/i&gt; &lt;b&gt;25&lt;/b&gt;, 103827 (2022).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.isci.2022.103827" data-track-item_id="10.1016/j.isci.2022.103827" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.isci.2022.103827" aria-label="Article reference 31" data-doi="10.1016/j.isci.2022.103827"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="ads reference" data-track-action="ads reference" href="http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&amp;amp;bibcode=2022iSci...25j3827R" aria-label="ADS reference 31"&gt;ADS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=35198887" aria-label="PubMed reference 31"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844662" aria-label="PubMed Central reference 31"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB38XjsFCnurk%3D" aria-label="CAS reference 31"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 31" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Nrf2%20activation%20reprograms%20macrophage%20intermediary%20metabolism%20and%20suppresses%20the%20type%20I%20interferon%20response&amp;amp;journal=iScience&amp;amp;doi=10.1016%2Fj.isci.2022.103827&amp;amp;volume=25&amp;amp;publication_year=2022&amp;amp;author=Ryan%2CDG"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="32."&gt;&lt;p class="c-article-references__text" id="ref-CR32"&gt;Olagnier, D. et al. Nrf2 negatively regulates STING indicating a link between antiviral sensing and metabolic reprogramming. &lt;i&gt;Nat. Commun.&lt;/i&gt; &lt;b&gt;9&lt;/b&gt;, 3506 (2018).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41467-018-05861-7" data-track-item_id="10.1038/s41467-018-05861-7" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41467-018-05861-7" aria-label="Article reference 32" data-doi="10.1038/s41467-018-05861-7"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="ads reference" data-track-action="ads reference" href="http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&amp;amp;bibcode=2018NatCo...9.3506O" aria-label="ADS reference 32"&gt;ADS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=30158636" aria-label="PubMed reference 32"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6115435" aria-label="PubMed Central reference 32"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 32" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Nrf2%20negatively%20regulates%20STING%20indicating%20a%20link%20between%20antiviral%20sensing%20and%20metabolic%20reprogramming&amp;amp;journal=Nat.%20Commun.&amp;amp;doi=10.1038%2Fs41467-018-05861-7&amp;amp;volume=9&amp;amp;publication_year=2018&amp;amp;author=Olagnier%2CD"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="33."&gt;&lt;p class="c-article-references__text" id="ref-CR33"&gt;Ting, K. K. Y. et al. Oxidized low-density lipoprotein accumulation suppresses glycolysis and attenuates the macrophage inflammatory response by diverting transcription from the HIF-1alpha to the Nrf2 pathway. &lt;i&gt;J. Immunol.&lt;/i&gt; &lt;b&gt;211&lt;/b&gt;, 1561–1577 (2023).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.4049/jimmunol.2300293" data-track-item_id="10.4049/jimmunol.2300293" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.4049%2Fjimmunol.2300293" aria-label="Article reference 33" data-doi="10.4049/jimmunol.2300293"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=37756544" aria-label="PubMed reference 33"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3sXisFantLfE" aria-label="CAS reference 33"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 33" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Oxidized%20low-density%20lipoprotein%20accumulation%20suppresses%20glycolysis%20and%20attenuates%20the%20macrophage%20inflammatory%20response%20by%20diverting%20transcription%20from%20the%20HIF-1alpha%20to%20the%20Nrf2%20pathway&amp;amp;journal=J.%20Immunol.&amp;amp;doi=10.4049%2Fjimmunol.2300293&amp;amp;volume=211&amp;amp;pages=1561-1577&amp;amp;publication_year=2023&amp;amp;author=Ting%2CKKY"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="34."&gt;&lt;p class="c-article-references__text" id="ref-CR34"&gt;Park, M. D. et al. TREM2 macrophages drive NK cell paucity and dysfunction in lung cancer. &lt;i&gt;Nat. Immunol.&lt;/i&gt; &lt;b&gt;24&lt;/b&gt;, 792–801 (2023).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41590-023-01475-4" data-track-item_id="10.1038/s41590-023-01475-4" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41590-023-01475-4" aria-label="Article reference 34" data-doi="10.1038/s41590-023-01475-4"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=37081148" aria-label="PubMed reference 34"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11088947" aria-label="PubMed Central reference 34"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3sXot1artrg%3D" aria-label="CAS reference 34"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 34" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=TREM2%20macrophages%20drive%20NK%20cell%20paucity%20and%20dysfunction%20in%20lung%20cancer&amp;amp;journal=Nat.%20Immunol.&amp;amp;doi=10.1038%2Fs41590-023-01475-4&amp;amp;volume=24&amp;amp;pages=792-801&amp;amp;publication_year=2023&amp;amp;author=Park%2CMD"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="35."&gt;&lt;p class="c-article-references__text" id="ref-CR35"&gt;Alaluf, E. et al. Heme oxygenase-1 orchestrates the immunosuppressive program of tumor-associated macrophages. &lt;i&gt;JCI Insight&lt;/i&gt; &lt;b&gt;5&lt;/b&gt;, e133929 (2020).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=32369450" aria-label="PubMed reference 35"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308058" aria-label="PubMed Central reference 35"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 35" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Heme%20oxygenase-1%20orchestrates%20the%20immunosuppressive%20program%20of%20tumor-associated%20macrophages.&amp;amp;journal=JCI%20Insight&amp;amp;volume=5&amp;amp;publication_year=2020&amp;amp;author=Alaluf%2CE"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="36."&gt;&lt;p class="c-article-references__text" id="ref-CR36"&gt;Leader, A. M. et al. Single-cell analysis of human non-small cell lung cancer lesions refines tumor classification and patient stratification. &lt;i&gt;Cancer Cell&lt;/i&gt; &lt;b&gt;39&lt;/b&gt;, 1594–1609 (2021).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.ccell.2021.10.009" data-track-item_id="10.1016/j.ccell.2021.10.009" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.ccell.2021.10.009" aria-label="Article reference 36" data-doi="10.1016/j.ccell.2021.10.009"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=34767762" aria-label="PubMed reference 36"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8728963" aria-label="PubMed Central reference 36"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3MXisVyjsLzN" aria-label="CAS reference 36"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 36" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Single-cell%20analysis%20of%20human%20non-small%20cell%20lung%20cancer%20lesions%20refines%20tumor%20classification%20and%20patient%20stratification&amp;amp;journal=Cancer%20Cell&amp;amp;doi=10.1016%2Fj.ccell.2021.10.009&amp;amp;volume=39&amp;amp;pages=1594-1609&amp;amp;publication_year=2021&amp;amp;author=Leader%2CAM"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="37."&gt;&lt;p class="c-article-references__text" id="ref-CR37"&gt;Hu, J. et al. Tumor microenvironment remodeling after neoadjuvant immunotherapy in non-small cell lung cancer revealed by single-cell RNA sequencing. &lt;i&gt;Genome Med.&lt;/i&gt; &lt;b&gt;15&lt;/b&gt;, 14 (2023).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="noopener" data-track-label="10.1186/s13073-023-01164-9" data-track-item_id="10.1186/s13073-023-01164-9" data-track-value="article reference" data-track-action="article reference" href="https://link.springer.com/doi/10.1186/s13073-023-01164-9" aria-label="Article reference 37" data-doi="10.1186/s13073-023-01164-9"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=36869384" aria-label="PubMed reference 37"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985263" aria-label="PubMed Central reference 37"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3sXlsV2ksbc%3D" aria-label="CAS reference 37"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 37" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Tumor%20microenvironment%20remodeling%20after%20neoadjuvant%20immunotherapy%20in%20non-small%20cell%20lung%20cancer%20revealed%20by%20single-cell%20RNA%20sequencing&amp;amp;journal=Genome%20Med.&amp;amp;doi=10.1186%2Fs13073-023-01164-9&amp;amp;volume=15&amp;amp;publication_year=2023&amp;amp;author=Hu%2CJ"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="38."&gt;&lt;p class="c-article-references__text" id="ref-CR38"&gt;Zelenay, S. et al. Cyclooxygenase-dependent tumor growth through evasion of immunity. &lt;i&gt;Cell&lt;/i&gt; &lt;b&gt;162&lt;/b&gt;, 1257–1270 (2015).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.cell.2015.08.015" data-track-item_id="10.1016/j.cell.2015.08.015" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.cell.2015.08.015" aria-label="Article reference 38" data-doi="10.1016/j.cell.2015.08.015"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=26343581" aria-label="PubMed reference 38"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4597191" aria-label="PubMed Central reference 38"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2MXhsVKhu7bL" aria-label="CAS reference 38"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 38" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Cyclooxygenase-dependent%20tumor%20growth%20through%20evasion%20of%20immunity&amp;amp;journal=Cell&amp;amp;doi=10.1016%2Fj.cell.2015.08.015&amp;amp;volume=162&amp;amp;pages=1257-1270&amp;amp;publication_year=2015&amp;amp;author=Zelenay%2CS"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="39."&gt;&lt;p class="c-article-references__text" id="ref-CR39"&gt;Taniguchi, S. et al. In vivo induction of activin A-producing alveolar macrophages supports the progression of lung cell carcinoma. &lt;i&gt;Nat. Commun.&lt;/i&gt; &lt;b&gt;14&lt;/b&gt;, 143 (2023).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41467-022-35701-8" data-track-item_id="10.1038/s41467-022-35701-8" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41467-022-35701-8" aria-label="Article reference 39" data-doi="10.1038/s41467-022-35701-8"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="ads reference" data-track-action="ads reference" href="http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&amp;amp;bibcode=2023NatCo..14..143T" aria-label="ADS reference 39"&gt;ADS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=36650150" aria-label="PubMed reference 39"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845242" aria-label="PubMed Central reference 39"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3sXhvFaqtL8%3D" aria-label="CAS reference 39"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 39" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=In%20vivo%20induction%20of%20activin%20A-producing%20alveolar%20macrophages%20supports%20the%20progression%20of%20lung%20cell%20carcinoma&amp;amp;journal=Nat.%20Commun.&amp;amp;doi=10.1038%2Fs41467-022-35701-8&amp;amp;volume=14&amp;amp;publication_year=2023&amp;amp;author=Taniguchi%2CS"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="40."&gt;&lt;p class="c-article-references__text" id="ref-CR40"&gt;Gomez-Chou, S. B. et al. Lipocalin-2 promotes pancreatic ductal adenocarcinoma by regulating inflammation in the tumor microenvironment. &lt;i&gt;Cancer Res.&lt;/i&gt; &lt;b&gt;77&lt;/b&gt;, 2647–2660 (2017).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1158/0008-5472.CAN-16-1986" data-track-item_id="10.1158/0008-5472.CAN-16-1986" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1158%2F0008-5472.CAN-16-1986" aria-label="Article reference 40" data-doi="10.1158/0008-5472.CAN-16-1986"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=28249896" aria-label="PubMed reference 40"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5441230" aria-label="PubMed Central reference 40"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2sXns1Skt7k%3D" aria-label="CAS reference 40"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 40" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Lipocalin-2%20promotes%20pancreatic%20ductal%20adenocarcinoma%20by%20regulating%20inflammation%20in%20the%20tumor%20microenvironment&amp;amp;journal=Cancer%20Res.&amp;amp;doi=10.1158%2F0008-5472.CAN-16-1986&amp;amp;volume=77&amp;amp;pages=2647-2660&amp;amp;publication_year=2017&amp;amp;author=Gomez-Chou%2CSB"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="41."&gt;&lt;p class="c-article-references__text" id="ref-CR41"&gt;Li, Z. et al. Proinflammatory S100A8 induces PD-L1 expression in macrophages, mediating tumor immune escape. &lt;i&gt;J. Immunol.&lt;/i&gt; &lt;b&gt;204&lt;/b&gt;, 2589–2599 (2020).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.4049/jimmunol.1900753" data-track-item_id="10.4049/jimmunol.1900753" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.4049%2Fjimmunol.1900753" aria-label="Article reference 41" data-doi="10.4049/jimmunol.1900753"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=32198140" aria-label="PubMed reference 41"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXhtVGrur%2FJ" aria-label="CAS reference 41"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 41" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Proinflammatory%20S100A8%20induces%20PD-L1%20expression%20in%20macrophages%2C%20mediating%20tumor%20immune%20escape&amp;amp;journal=J.%20Immunol.&amp;amp;doi=10.4049%2Fjimmunol.1900753&amp;amp;volume=204&amp;amp;pages=2589-2599&amp;amp;publication_year=2020&amp;amp;author=Li%2CZ"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="42."&gt;&lt;p class="c-article-references__text" id="ref-CR42"&gt;Uccellini, M. B. &amp;amp; Garcia-Sastre, A. ISRE-reporter mouse reveals high basal and induced type I IFN responses in inflammatory monocytes. &lt;i&gt;Cell Rep.&lt;/i&gt; &lt;b&gt;25&lt;/b&gt;, 2784–2796 (2018).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.celrep.2018.11.030" data-track-item_id="10.1016/j.celrep.2018.11.030" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.celrep.2018.11.030" aria-label="Article reference 42" data-doi="10.1016/j.celrep.2018.11.030"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=30517866" aria-label="PubMed reference 42"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6317368" aria-label="PubMed Central reference 42"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC1cXisVCit7nO" aria-label="CAS reference 42"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 42" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=ISRE-reporter%20mouse%20reveals%20high%20basal%20and%20induced%20type%20I%20IFN%20responses%20in%20inflammatory%20monocytes&amp;amp;journal=Cell%20Rep.&amp;amp;doi=10.1016%2Fj.celrep.2018.11.030&amp;amp;volume=25&amp;amp;pages=2784-2796&amp;amp;publication_year=2018&amp;amp;author=Uccellini%2CMB&amp;amp;author=Garcia-Sastre%2CA"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="43."&gt;&lt;p class="c-article-references__text" id="ref-CR43"&gt;Singh, A. et al. Small molecule inhibitor of NRF2 selectively intervenes therapeutic resistance in KEAP1-deficient NSCLC tumors. &lt;i&gt;ACS Chem. Biol.&lt;/i&gt; &lt;b&gt;11&lt;/b&gt;, 3214–3225 (2016).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1021/acschembio.6b00651" data-track-item_id="10.1021/acschembio.6b00651" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1021%2Facschembio.6b00651" aria-label="Article reference 43" data-doi="10.1021/acschembio.6b00651"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=27552339" aria-label="PubMed reference 43"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367156" aria-label="PubMed Central reference 43"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC28Xhtlyls7jK" aria-label="CAS reference 43"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 43" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Small%20molecule%20inhibitor%20of%20NRF2%20selectively%20intervenes%20therapeutic%20resistance%20in%20KEAP1-deficient%20NSCLC%20tumors&amp;amp;journal=ACS%20Chem.%20Biol.&amp;amp;doi=10.1021%2Facschembio.6b00651&amp;amp;volume=11&amp;amp;pages=3214-3225&amp;amp;publication_year=2016&amp;amp;author=Singh%2CA"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="44."&gt;&lt;p class="c-article-references__text" id="ref-CR44"&gt;Schaer, D. J. et al. Hemorrhage-activated NRF2 in tumor-associated macrophages drives cancer growth, invasion, and immunotherapy resistance. &lt;i&gt;J. Clin. Invest.&lt;/i&gt; &lt;b&gt;134&lt;/b&gt;, e174528 (2023).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1172/JCI174528" data-track-item_id="10.1172/JCI174528" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1172%2FJCI174528" aria-label="Article reference 44" data-doi="10.1172/JCI174528"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=38060331" aria-label="PubMed reference 44"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 44" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Hemorrhage-activated%20NRF2%20in%20tumor-associated%20macrophages%20drives%20cancer%20growth%2C%20invasion%2C%20and%20immunotherapy%20resistance.&amp;amp;journal=J.%20Clin.%20Invest.&amp;amp;doi=10.1172%2FJCI174528&amp;amp;volume=134&amp;amp;publication_year=2023&amp;amp;author=Schaer%2CDJ"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="45."&gt;&lt;p class="c-article-references__text" id="ref-CR45"&gt;Liu, Z. et al. Fate mapping via Ms4a3-expression history traces monocyte-derived cells. &lt;i&gt;Cell&lt;/i&gt; &lt;b&gt;178&lt;/b&gt;, 1509–1525 (2019).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.cell.2019.08.009" data-track-item_id="10.1016/j.cell.2019.08.009" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.cell.2019.08.009" aria-label="Article reference 45" data-doi="10.1016/j.cell.2019.08.009"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=31491389" aria-label="PubMed reference 45"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC1MXhslCgsb3P" aria-label="CAS reference 45"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 45" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Fate%20mapping%20via%20Ms4a3-expression%20history%20traces%20monocyte-derived%20cells&amp;amp;journal=Cell&amp;amp;doi=10.1016%2Fj.cell.2019.08.009&amp;amp;volume=178&amp;amp;pages=1509-1525&amp;amp;publication_year=2019&amp;amp;author=Liu%2CZ"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="46."&gt;&lt;p class="c-article-references__text" id="ref-CR46"&gt;Ren, D. et al. Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism. &lt;i&gt;Proc. Natl Acad. Sci. USA&lt;/i&gt; &lt;b&gt;108&lt;/b&gt;, 1433–1438 (2011).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1073/pnas.1014275108" data-track-item_id="10.1073/pnas.1014275108" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1073%2Fpnas.1014275108" aria-label="Article reference 46" data-doi="10.1073/pnas.1014275108"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="ads reference" data-track-action="ads reference" href="http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&amp;amp;bibcode=2011PNAS..108.1433R" aria-label="ADS reference 46"&gt;ADS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=21205897" aria-label="PubMed reference 46"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3029730" aria-label="PubMed Central reference 46"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC3MXhs1Smtrs%3D" aria-label="CAS reference 46"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 46" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Brusatol%20enhances%20the%20efficacy%20of%20chemotherapy%20by%20inhibiting%20the%20Nrf2-mediated%20defense%20mechanism&amp;amp;journal=Proc.%20Natl%20Acad.%20Sci.%20USA&amp;amp;doi=10.1073%2Fpnas.1014275108&amp;amp;volume=108&amp;amp;pages=1433-1438&amp;amp;publication_year=2011&amp;amp;author=Ren%2CD"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="47."&gt;&lt;p class="c-article-references__text" id="ref-CR47"&gt;Perrone, M. et al. ATF3 reprograms the bone marrow niche in response to early breast cancer transformation. &lt;i&gt;Cancer Res.&lt;/i&gt; &lt;b&gt;83&lt;/b&gt;, 117–129 (2023).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1158/0008-5472.CAN-22-0651" data-track-item_id="10.1158/0008-5472.CAN-22-0651" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1158%2F0008-5472.CAN-22-0651" aria-label="Article reference 47" data-doi="10.1158/0008-5472.CAN-22-0651"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=36318106" aria-label="PubMed reference 47"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3sXjt1Cmsb0%3D" aria-label="CAS reference 47"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 47" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=ATF3%20reprograms%20the%20bone%20marrow%20niche%20in%20response%20to%20early%20breast%20cancer%20transformation&amp;amp;journal=Cancer%20Res.&amp;amp;doi=10.1158%2F0008-5472.CAN-22-0651&amp;amp;volume=83&amp;amp;pages=117-129&amp;amp;publication_year=2023&amp;amp;author=Perrone%2CM"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="48."&gt;&lt;p class="c-article-references__text" id="ref-CR48"&gt;Zhang, M. et al. Selective activation of STAT3 and STAT5 dictates the fate of myeloid progenitor cells. &lt;i&gt;Cell Death Discov.&lt;/i&gt; &lt;b&gt;9&lt;/b&gt;, 274 (2023).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41420-023-01575-y" data-track-item_id="10.1038/s41420-023-01575-y" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41420-023-01575-y" aria-label="Article reference 48" data-doi="10.1038/s41420-023-01575-y"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=37507383" aria-label="PubMed reference 48"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382539" aria-label="PubMed Central reference 48"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3sXhs1Ohs77N" aria-label="CAS reference 48"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 48" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Selective%20activation%20of%20STAT3%20and%20STAT5%20dictates%20the%20fate%20of%20myeloid%20progenitor%20cells&amp;amp;journal=Cell%20Death%20Discov.&amp;amp;doi=10.1038%2Fs41420-023-01575-y&amp;amp;volume=9&amp;amp;publication_year=2023&amp;amp;author=Zhang%2CM"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="49."&gt;&lt;p class="c-article-references__text" id="ref-CR49"&gt;Laurenti, E. et al. Hematopoietic stem cell function and survival depend on c-Myc and N-Myc activity. &lt;i&gt;Cell Stem Cell&lt;/i&gt; &lt;b&gt;3&lt;/b&gt;, 611–624 (2008).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.stem.2008.09.005" data-track-item_id="10.1016/j.stem.2008.09.005" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.stem.2008.09.005" aria-label="Article reference 49" data-doi="10.1016/j.stem.2008.09.005"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=19041778" aria-label="PubMed reference 49"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2635113" aria-label="PubMed Central reference 49"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD1cXhsFCqsLjJ" aria-label="CAS reference 49"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 49" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Hematopoietic%20stem%20cell%20function%20and%20survival%20depend%20on%20c-Myc%20and%20N-Myc%20activity&amp;amp;journal=Cell%20Stem%20Cell&amp;amp;doi=10.1016%2Fj.stem.2008.09.005&amp;amp;volume=3&amp;amp;pages=611-624&amp;amp;publication_year=2008&amp;amp;author=Laurenti%2CE"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="50."&gt;&lt;p class="c-article-references__text" id="ref-CR50"&gt;Villar, J. et al. ETV3 and ETV6 enable monocyte differentiation into dendritic cells by repressing macrophage fate commitment. &lt;i&gt;Nat. Immunol.&lt;/i&gt; &lt;b&gt;24&lt;/b&gt;, 84–95 (2023).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41590-022-01374-0" data-track-item_id="10.1038/s41590-022-01374-0" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41590-022-01374-0" aria-label="Article reference 50" data-doi="10.1038/s41590-022-01374-0"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=36543959" aria-label="PubMed reference 50"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB38XjtFGqtbzO" aria-label="CAS reference 50"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 50" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=ETV3%20and%20ETV6%20enable%20monocyte%20differentiation%20into%20dendritic%20cells%20by%20repressing%20macrophage%20fate%20commitment&amp;amp;journal=Nat.%20Immunol.&amp;amp;doi=10.1038%2Fs41590-022-01374-0&amp;amp;volume=24&amp;amp;pages=84-95&amp;amp;publication_year=2023&amp;amp;author=Villar%2CJ"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="51."&gt;&lt;p class="c-article-references__text" id="ref-CR51"&gt;Ratajczak, M. Z. &amp;amp; Kucia, M. Hematopoiesis and innate immunity: an inseparable couple for good and bad times, bound together by an hormetic relationship. &lt;i&gt;Leukemia&lt;/i&gt; &lt;b&gt;36&lt;/b&gt;, 23–32 (2022).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41375-021-01482-0" data-track-item_id="10.1038/s41375-021-01482-0" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41375-021-01482-0" aria-label="Article reference 51" data-doi="10.1038/s41375-021-01482-0"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=34853440" aria-label="PubMed reference 51"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB38XntlWjsb8%3D" aria-label="CAS reference 51"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 51" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Hematopoiesis%20and%20innate%20immunity%3A%20an%20inseparable%20couple%20for%20good%20and%20bad%20times%2C%20bound%20together%20by%20an%20hormetic%20relationship&amp;amp;journal=Leukemia&amp;amp;doi=10.1038%2Fs41375-021-01482-0&amp;amp;volume=36&amp;amp;pages=23-32&amp;amp;publication_year=2022&amp;amp;author=Ratajczak%2CMZ&amp;amp;author=Kucia%2CM"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="52."&gt;&lt;p class="c-article-references__text" id="ref-CR52"&gt;Ng, M. S. F. et al. Deterministic reprogramming of neutrophils within tumors. &lt;i&gt;Science&lt;/i&gt; &lt;b&gt;383&lt;/b&gt;, eadf6493 (2024).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1126/science.adf6493" data-track-item_id="10.1126/science.adf6493" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1126%2Fscience.adf6493" aria-label="Article reference 52" data-doi="10.1126/science.adf6493"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=38207030" aria-label="PubMed reference 52"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11087151" aria-label="PubMed Central reference 52"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB2cXht1artbk%3D" aria-label="CAS reference 52"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 52" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Deterministic%20reprogramming%20of%20neutrophils%20within%20tumors&amp;amp;journal=Science&amp;amp;doi=10.1126%2Fscience.adf6493&amp;amp;volume=383&amp;amp;publication_year=2024&amp;amp;author=Ng%2CMSF"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="53."&gt;&lt;p class="c-article-references__text" id="ref-CR53"&gt;Zhao, Y. et al. Neutrophils resist ferroptosis and promote breast cancer metastasis through aconitate decarboxylase 1. &lt;i&gt;Cell Metab.&lt;/i&gt; &lt;b&gt;35&lt;/b&gt;, 1688–1703 (2023).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.cmet.2023.09.004" data-track-item_id="10.1016/j.cmet.2023.09.004" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.cmet.2023.09.004" aria-label="Article reference 53" data-doi="10.1016/j.cmet.2023.09.004"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=37793345" aria-label="PubMed reference 53"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10558089" aria-label="PubMed Central reference 53"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3sXitVGhtrfJ" aria-label="CAS reference 53"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 53" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Neutrophils%20resist%20ferroptosis%20and%20promote%20breast%20cancer%20metastasis%20through%20aconitate%20decarboxylase%201&amp;amp;journal=Cell%20Metab.&amp;amp;doi=10.1016%2Fj.cmet.2023.09.004&amp;amp;volume=35&amp;amp;pages=1688-1703&amp;amp;publication_year=2023&amp;amp;author=Zhao%2CY"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="54."&gt;&lt;p class="c-article-references__text" id="ref-CR54"&gt;Garner, H. et al. Understanding and reversing mammary tumor-driven reprogramming of myelopoiesis to reduce metastatic spread. &lt;i&gt;Cancer Cell&lt;/i&gt; &lt;b&gt;43&lt;/b&gt;, 1279–1295 (2025).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.ccell.2025.04.007" data-track-item_id="10.1016/j.ccell.2025.04.007" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.ccell.2025.04.007" aria-label="Article reference 54" data-doi="10.1016/j.ccell.2025.04.007"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=40345190" aria-label="PubMed reference 54"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12270473" aria-label="PubMed Central reference 54"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB2MXhtVOhtL3P" aria-label="CAS reference 54"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 54" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Understanding%20and%20reversing%20mammary%20tumor-driven%20reprogramming%20of%20myelopoiesis%20to%20reduce%20metastatic%20spread&amp;amp;journal=Cancer%20Cell&amp;amp;doi=10.1016%2Fj.ccell.2025.04.007&amp;amp;volume=43&amp;amp;pages=1279-1295&amp;amp;publication_year=2025&amp;amp;author=Garner%2CH"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="55."&gt;&lt;p class="c-article-references__text" id="ref-CR55"&gt;Daman, A. W. et al. Microbial cancer immunotherapy reprograms hematopoiesis to enhance myeloid-driven anti-tumor immunity. &lt;i&gt;Cancer Cell&lt;/i&gt; &lt;a href="https://doi.org/10.1016/j.ccell.2025.05.002" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1016/j.ccell.2025.05.002"&gt;https://doi.org/10.1016/j.ccell.2025.05.002&lt;/a&gt; (2025).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.ccell.2025.05.002" data-track-item_id="10.1016/j.ccell.2025.05.002" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.ccell.2025.05.002" aria-label="Article reference 55" data-doi="10.1016/j.ccell.2025.05.002"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=40446799" aria-label="PubMed reference 55"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 55" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Microbial%20cancer%20immunotherapy%20reprograms%20hematopoiesis%20to%20enhance%20myeloid-driven%20anti-tumor%20immunity&amp;amp;journal=Cancer%20Cell&amp;amp;doi=10.1016%2Fj.ccell.2025.05.002&amp;amp;publication_year=2025&amp;amp;author=Daman%2CAW"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="56."&gt;&lt;p class="c-article-references__text" id="ref-CR56"&gt;Singh, A. et al. NRF2 activation promotes aggressive lung cancer and associates with poor clinical outcomes. &lt;i&gt;Clin. Cancer Res.&lt;/i&gt; &lt;b&gt;27&lt;/b&gt;, 877–888 (2021).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1158/1078-0432.CCR-20-1985" data-track-item_id="10.1158/1078-0432.CCR-20-1985" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1158%2F1078-0432.CCR-20-1985" aria-label="Article reference 56" data-doi="10.1158/1078-0432.CCR-20-1985"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=33077574" aria-label="PubMed reference 56"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3MXntVSrsbk%3D" aria-label="CAS reference 56"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 56" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=NRF2%20activation%20promotes%20aggressive%20lung%20cancer%20and%20associates%20with%20poor%20clinical%20outcomes&amp;amp;journal=Clin.%20Cancer%20Res.&amp;amp;doi=10.1158%2F1078-0432.CCR-20-1985&amp;amp;volume=27&amp;amp;pages=877-888&amp;amp;publication_year=2021&amp;amp;author=Singh%2CA"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="57."&gt;&lt;p class="c-article-references__text" id="ref-CR57"&gt;Chirnomas, D., Hornberger, K. R. &amp;amp; Crews, C. M. Protein degraders enter the clinic—a new approach to cancer therapy. &lt;i&gt;Nat. Rev. Clin. Oncol.&lt;/i&gt; &lt;b&gt;20&lt;/b&gt;, 265–278 (2023).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41571-023-00736-3" data-track-item_id="10.1038/s41571-023-00736-3" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41571-023-00736-3" aria-label="Article reference 57" data-doi="10.1038/s41571-023-00736-3"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=36781982" aria-label="PubMed reference 57"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11698446" aria-label="PubMed Central reference 57"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3sXjt1Oktr4%3D" aria-label="CAS reference 57"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 57" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Protein%20degraders%20enter%20the%20clinic%E2%80%94a%20new%20approach%20to%20cancer%20therapy&amp;amp;journal=Nat.%20Rev.%20Clin.%20Oncol.&amp;amp;doi=10.1038%2Fs41571-023-00736-3&amp;amp;volume=20&amp;amp;pages=265-278&amp;amp;publication_year=2023&amp;amp;author=Chirnomas%2CD&amp;amp;author=Hornberger%2CKR&amp;amp;author=Crews%2CCM"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="58."&gt;&lt;p class="c-article-references__text" id="ref-CR58"&gt;Mohamed, E. et al. The unfolded protein response mediator PERK governs myeloid cell-driven immunosuppression in tumors through inhibition of STING signaling. &lt;i&gt;Immunity&lt;/i&gt; &lt;b&gt;52&lt;/b&gt;, 668–682 (2020).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.immuni.2020.03.004" data-track-item_id="10.1016/j.immuni.2020.03.004" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.immuni.2020.03.004" aria-label="Article reference 58" data-doi="10.1016/j.immuni.2020.03.004"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=32294407" aria-label="PubMed reference 58"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207019" aria-label="PubMed Central reference 58"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXntFSqsrY%3D" aria-label="CAS reference 58"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 58" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=The%20unfolded%20protein%20response%20mediator%20PERK%20governs%20myeloid%20cell-driven%20immunosuppression%20in%20tumors%20through%20inhibition%20of%20STING%20signaling&amp;amp;journal=Immunity&amp;amp;doi=10.1016%2Fj.immuni.2020.03.004&amp;amp;volume=52&amp;amp;pages=668-682&amp;amp;publication_year=2020&amp;amp;author=Mohamed%2CE"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="59."&gt;&lt;p class="c-article-references__text" id="ref-CR59"&gt;Raines, L. N. et al. PERK is a critical metabolic hub for immunosuppressive function in macrophages. &lt;i&gt;Nat. Immunol.&lt;/i&gt; &lt;b&gt;23&lt;/b&gt;, 431–445 (2022).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41590-022-01145-x" data-track-item_id="10.1038/s41590-022-01145-x" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41590-022-01145-x" aria-label="Article reference 59" data-doi="10.1038/s41590-022-01145-x"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=35228694" aria-label="PubMed reference 59"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112288" aria-label="PubMed Central reference 59"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB38Xlt12lu7o%3D" aria-label="CAS reference 59"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 59" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=PERK%20is%20a%20critical%20metabolic%20hub%20for%20immunosuppressive%20function%20in%20macrophages&amp;amp;journal=Nat.%20Immunol.&amp;amp;doi=10.1038%2Fs41590-022-01145-x&amp;amp;volume=23&amp;amp;pages=431-445&amp;amp;publication_year=2022&amp;amp;author=Raines%2CLN"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="60."&gt;&lt;p class="c-article-references__text" id="ref-CR60"&gt;Kress, J. K. C. et al. The integrated stress response effector ATF4 is an obligatory metabolic activator of NRF2. &lt;i&gt;Cell Rep.&lt;/i&gt; &lt;b&gt;42&lt;/b&gt;, 112724 (2023).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.celrep.2023.112724" data-track-item_id="10.1016/j.celrep.2023.112724" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.celrep.2023.112724" aria-label="Article reference 60" data-doi="10.1016/j.celrep.2023.112724"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=37410595" aria-label="PubMed reference 60"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3sXhtlCjtbbF" aria-label="CAS reference 60"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 60" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=The%20integrated%20stress%20response%20effector%20ATF4%20is%20an%20obligatory%20metabolic%20activator%20of%20NRF2&amp;amp;journal=Cell%20Rep.&amp;amp;doi=10.1016%2Fj.celrep.2023.112724&amp;amp;volume=42&amp;amp;publication_year=2023&amp;amp;author=Kress%2CJKC"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="61."&gt;&lt;p class="c-article-references__text" id="ref-CR61"&gt;Boumelha, J. et al. An immunogenic model of KRAS-mutant lung cancer enables evaluation of targeted therapy and immunotherapy combinations. &lt;i&gt;Cancer Res.&lt;/i&gt; &lt;b&gt;82&lt;/b&gt;, 3435–3448 (2022).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1158/0008-5472.CAN-22-0325" data-track-item_id="10.1158/0008-5472.CAN-22-0325" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1158%2F0008-5472.CAN-22-0325" aria-label="Article reference 61" data-doi="10.1158/0008-5472.CAN-22-0325"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=35930804" aria-label="PubMed reference 61"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7613674" aria-label="PubMed Central reference 61"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB38XjtVGjtbnL" aria-label="CAS reference 61"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 61" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=An%20immunogenic%20model%20of%20KRAS-mutant%20lung%20cancer%20enables%20evaluation%20of%20targeted%20therapy%20and%20immunotherapy%20combinations&amp;amp;journal=Cancer%20Res.&amp;amp;doi=10.1158%2F0008-5472.CAN-22-0325&amp;amp;volume=82&amp;amp;pages=3435-3448&amp;amp;publication_year=2022&amp;amp;author=Boumelha%2CJ"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="62."&gt;&lt;p class="c-article-references__text" id="ref-CR62"&gt;Jackson, E. L. et al. The differential effects of mutant p53 alleles on advanced murine lung cancer. &lt;i&gt;Cancer Res.&lt;/i&gt; &lt;b&gt;65&lt;/b&gt;, 10280–10288 (2005).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1158/0008-5472.CAN-05-2193" data-track-item_id="10.1158/0008-5472.CAN-05-2193" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1158%2F0008-5472.CAN-05-2193" aria-label="Article reference 62" data-doi="10.1158/0008-5472.CAN-05-2193"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=16288016" aria-label="PubMed reference 62"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD2MXht1WgurfO" aria-label="CAS reference 62"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 62" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=The%20differential%20effects%20of%20mutant%20p53%20alleles%20on%20advanced%20murine%20lung%20cancer&amp;amp;journal=Cancer%20Res.&amp;amp;doi=10.1158%2F0008-5472.CAN-05-2193&amp;amp;volume=65&amp;amp;pages=10280-10288&amp;amp;publication_year=2005&amp;amp;author=Jackson%2CEL"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="63."&gt;&lt;p class="c-article-references__text" id="ref-CR63"&gt;Bankhead, P. et al. QuPath: open source software for digital pathology image analysis. &lt;i&gt;Sci. Rep.&lt;/i&gt; &lt;b&gt;7&lt;/b&gt;, 16878 (2017).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41598-017-17204-5" data-track-item_id="10.1038/s41598-017-17204-5" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41598-017-17204-5" aria-label="Article reference 63" data-doi="10.1038/s41598-017-17204-5"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="ads reference" data-track-action="ads reference" href="http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&amp;amp;bibcode=2017NatSR...716878B" aria-label="ADS reference 63"&gt;ADS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=29203879" aria-label="PubMed reference 63"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5715110" aria-label="PubMed Central reference 63"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 63" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=QuPath%3A%20open%20source%20software%20for%20digital%20pathology%20image%20analysis&amp;amp;journal=Sci.%20Rep.&amp;amp;doi=10.1038%2Fs41598-017-17204-5&amp;amp;volume=7&amp;amp;publication_year=2017&amp;amp;author=Bankhead%2CP"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="64."&gt;&lt;p class="c-article-references__text" id="ref-CR64"&gt;Hao, Y. et al. Integrated analysis of multimodal single-cell data. &lt;i&gt;Cell&lt;/i&gt; &lt;b&gt;184&lt;/b&gt;, 3573–3587 (2021).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.cell.2021.04.048" data-track-item_id="10.1016/j.cell.2021.04.048" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.cell.2021.04.048" aria-label="Article reference 64" data-doi="10.1016/j.cell.2021.04.048"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=34062119" aria-label="PubMed reference 64"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238499" aria-label="PubMed Central reference 64"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3MXhtlSrtrvE" aria-label="CAS reference 64"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 64" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Integrated%20analysis%20of%20multimodal%20single-cell%20data&amp;amp;journal=Cell&amp;amp;doi=10.1016%2Fj.cell.2021.04.048&amp;amp;volume=184&amp;amp;pages=3573-3587&amp;amp;publication_year=2021&amp;amp;author=Hao%2CY"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="65."&gt;&lt;p class="c-article-references__text" id="ref-CR65"&gt;Martin, J. C. et al. Single-cell analysis of Crohn’s disease lesions identifies a pathogenic cellular module associated with resistance to anti-TNF therapy. &lt;i&gt;Cell&lt;/i&gt; &lt;b&gt;178&lt;/b&gt;, 1493–1508 (2019).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.cell.2019.08.008" data-track-item_id="10.1016/j.cell.2019.08.008" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.cell.2019.08.008" aria-label="Article reference 65" data-doi="10.1016/j.cell.2019.08.008"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=31474370" aria-label="PubMed reference 65"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7060942" aria-label="PubMed Central reference 65"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC1MXhslSqur7N" aria-label="CAS reference 65"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 65" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Single-cell%20analysis%20of%20Crohn%E2%80%99s%20disease%20lesions%20identifies%20a%20pathogenic%20cellular%20module%20associated%20with%20resistance%20to%20anti-TNF%20therapy&amp;amp;journal=Cell&amp;amp;doi=10.1016%2Fj.cell.2019.08.008&amp;amp;volume=178&amp;amp;pages=1493-1508&amp;amp;publication_year=2019&amp;amp;author=Martin%2CJC"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="66."&gt;&lt;p class="c-article-references__text" id="ref-CR66"&gt;Andreatta, M. &amp;amp; Carmona, S. J. UCell: robust and scalable single-cell gene signature scoring. &lt;i&gt;Comput. Struct. Biotechnol. J.&lt;/i&gt; &lt;b&gt;19&lt;/b&gt;, 3796–3798 (2021).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.csbj.2021.06.043" data-track-item_id="10.1016/j.csbj.2021.06.043" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.csbj.2021.06.043" aria-label="Article reference 66" data-doi="10.1016/j.csbj.2021.06.043"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=34285779" aria-label="PubMed reference 66"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8271111" aria-label="PubMed Central reference 66"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3MXisF2gsr%2FF" aria-label="CAS reference 66"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 66" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=UCell%3A%20robust%20and%20scalable%20single-cell%20gene%20signature%20scoring&amp;amp;journal=Comput.%20Struct.%20Biotechnol.%20J.&amp;amp;doi=10.1016%2Fj.csbj.2021.06.043&amp;amp;volume=19&amp;amp;pages=3796-3798&amp;amp;publication_year=2021&amp;amp;author=Andreatta%2CM&amp;amp;author=Carmona%2CSJ"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="67."&gt;&lt;p class="c-article-references__text" id="ref-CR67"&gt;Calcagno, D. M. et al. The myeloid type I interferon response to myocardial infarction begins in bone marrow and is regulated by Nrf2-activated macrophages. &lt;i&gt;Sci. Immunol.&lt;/i&gt; &lt;b&gt;5&lt;/b&gt;, eaaz1974 (2020).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1126/sciimmunol.aaz1974" data-track-item_id="10.1126/sciimmunol.aaz1974" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1126%2Fsciimmunol.aaz1974" aria-label="Article reference 67" data-doi="10.1126/sciimmunol.aaz1974"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=32978242" aria-label="PubMed reference 67"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808338" aria-label="PubMed Central reference 67"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXhvF2itLrN" aria-label="CAS reference 67"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 67" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=The%20myeloid%20type%20I%20interferon%20response%20to%20myocardial%20infarction%20begins%20in%20bone%20marrow%20and%20is%20regulated%20by%20Nrf2-activated%20macrophages.&amp;amp;journal=Sci.%20Immunol.&amp;amp;doi=10.1126%2Fsciimmunol.aaz1974&amp;amp;volume=5&amp;amp;publication_year=2020&amp;amp;author=Calcagno%2CDM"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="68."&gt;&lt;p class="c-article-references__text" id="ref-CR68"&gt;Agrawal, A. et al. WikiPathways 2024: next generation pathway database. &lt;i&gt;Nucleic Acids Res.&lt;/i&gt; &lt;b&gt;52&lt;/b&gt;, D679–D689 (2024).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1093/nar/gkad960" data-track-item_id="10.1093/nar/gkad960" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1093%2Fnar%2Fgkad960" aria-label="Article reference 68" data-doi="10.1093/nar/gkad960"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=37941138" aria-label="PubMed reference 68"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB2cXivVamsLbP" aria-label="CAS reference 68"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 68" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=WikiPathways%202024%3A%20next%20generation%20pathway%20database&amp;amp;journal=Nucleic%20Acids%20Res.&amp;amp;doi=10.1093%2Fnar%2Fgkad960&amp;amp;volume=52&amp;amp;pages=D679-D689&amp;amp;publication_year=2024&amp;amp;author=Agrawal%2CA"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="69."&gt;&lt;p class="c-article-references__text" id="ref-CR69"&gt;Crowell, H. L. et al. muscat detects subpopulation-specific state transitions from multi-sample multi-condition single-cell transcriptomics data. &lt;i&gt;Nat. Commun.&lt;/i&gt; &lt;b&gt;11&lt;/b&gt;, 6077 (2020).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41467-020-19894-4" data-track-item_id="10.1038/s41467-020-19894-4" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41467-020-19894-4" aria-label="Article reference 69" data-doi="10.1038/s41467-020-19894-4"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="ads reference" data-track-action="ads reference" href="http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&amp;amp;bibcode=2020NatCo..11.6077C" aria-label="ADS reference 69"&gt;ADS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=33257685" aria-label="PubMed reference 69"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705760" aria-label="PubMed Central reference 69"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXisFWlu7nL" aria-label="CAS reference 69"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 69" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=muscat%20detects%20subpopulation-specific%20state%20transitions%20from%20multi-sample%20multi-condition%20single-cell%20transcriptomics%20data&amp;amp;journal=Nat.%20Commun.&amp;amp;doi=10.1038%2Fs41467-020-19894-4&amp;amp;volume=11&amp;amp;publication_year=2020&amp;amp;author=Crowell%2CHL"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="70."&gt;&lt;p class="c-article-references__text" id="ref-CR70"&gt;Granja, J. M. et al. ArchR is a scalable software package for integrative single-cell chromatin accessibility analysis. &lt;i&gt;Nat. Genet.&lt;/i&gt; &lt;b&gt;53&lt;/b&gt;, 403–411 (2021).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41588-021-00790-6" data-track-item_id="10.1038/s41588-021-00790-6" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41588-021-00790-6" aria-label="Article reference 70" data-doi="10.1038/s41588-021-00790-6"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=33633365" aria-label="PubMed reference 70"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8012210" aria-label="PubMed Central reference 70"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3MXls1OgtLk%3D" aria-label="CAS reference 70"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 70" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=ArchR%20is%20a%20scalable%20software%20package%20for%20integrative%20single-cell%20chromatin%20accessibility%20analysis&amp;amp;journal=Nat.%20Genet.&amp;amp;doi=10.1038%2Fs41588-021-00790-6&amp;amp;volume=53&amp;amp;pages=403-411&amp;amp;publication_year=2021&amp;amp;author=Granja%2CJM"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="71."&gt;&lt;p class="c-article-references__text" id="ref-CR71"&gt;Zhang, Y. et al. Model-based analysis of ChIP-Seq (MACS). &lt;i&gt;Genome Biol.&lt;/i&gt; &lt;b&gt;9&lt;/b&gt;, R137 (2008).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="noopener" data-track-label="10.1186/gb-2008-9-9-r137" data-track-item_id="10.1186/gb-2008-9-9-r137" data-track-value="article reference" data-track-action="article reference" href="https://link.springer.com/doi/10.1186/gb-2008-9-9-r137" aria-label="Article reference 71" data-doi="10.1186/gb-2008-9-9-r137"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=18798982" aria-label="PubMed reference 71"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2592715" aria-label="PubMed Central reference 71"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 71" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Model-based%20analysis%20of%20ChIP-Seq%20%28MACS%29&amp;amp;journal=Genome%20Biol.&amp;amp;doi=10.1186%2Fgb-2008-9-9-r137&amp;amp;volume=9&amp;amp;publication_year=2008&amp;amp;author=Zhang%2CY"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="72."&gt;&lt;p class="c-article-references__text" id="ref-CR72"&gt;Schep, A. N., Wu, B., Buenrostro, J. D. &amp;amp; Greenleaf, W. J. chromVAR: inferring transcription-factor-associated accessibility from single-cell epigenomic data. &lt;i&gt;Nat. Methods&lt;/i&gt; &lt;b&gt;14&lt;/b&gt;, 975–978 (2017).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/nmeth.4401" data-track-item_id="10.1038/nmeth.4401" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fnmeth.4401" aria-label="Article reference 72" data-doi="10.1038/nmeth.4401"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=28825706" aria-label="PubMed reference 72"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5623146" aria-label="PubMed Central reference 72"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2sXhtlKjtbbE" aria-label="CAS reference 72"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 72" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=chromVAR%3A%20inferring%20transcription-factor-associated%20accessibility%20from%20single-cell%20epigenomic%20data&amp;amp;journal=Nat.%20Methods&amp;amp;doi=10.1038%2Fnmeth.4401&amp;amp;volume=14&amp;amp;pages=975-978&amp;amp;publication_year=2017&amp;amp;author=Schep%2CAN&amp;amp;author=Wu%2CB&amp;amp;author=Buenrostro%2CJD&amp;amp;author=Greenleaf%2CWJ"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="73."&gt;&lt;p class="c-article-references__text" id="ref-CR73"&gt;Yoshida, H. et al. The &lt;i&gt;cis&lt;/i&gt;-regulatory atlas of the mouse immune system. &lt;i&gt;Cell&lt;/i&gt; &lt;b&gt;176&lt;/b&gt;, 897–912 (2019).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.cell.2018.12.036" data-track-item_id="10.1016/j.cell.2018.12.036" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.cell.2018.12.036" aria-label="Article reference 73" data-doi="10.1016/j.cell.2018.12.036"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=30686579" aria-label="PubMed reference 73"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6785993" aria-label="PubMed Central reference 73"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC1MXhvFSlsrY%3D" aria-label="CAS reference 73"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 73" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=The%20cis-regulatory%20atlas%20of%20the%20mouse%20immune%20system&amp;amp;journal=Cell&amp;amp;doi=10.1016%2Fj.cell.2018.12.036&amp;amp;volume=176&amp;amp;pages=897-912&amp;amp;publication_year=2019&amp;amp;author=Yoshida%2CH"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="74."&gt;&lt;p class="c-article-references__text" id="ref-CR74"&gt;McLean, C. Y. et al. GREAT improves functional interpretation of &lt;i&gt;cis&lt;/i&gt;-regulatory regions. &lt;i&gt;Nat. Biotechnol.&lt;/i&gt; &lt;b&gt;28&lt;/b&gt;, 495–501 (2010).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/nbt.1630" data-track-item_id="10.1038/nbt.1630" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fnbt.1630" aria-label="Article reference 74" data-doi="10.1038/nbt.1630"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=20436461" aria-label="PubMed reference 74"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4840234" aria-label="PubMed Central reference 74"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC3cXlsVyhs7w%3D" aria-label="CAS reference 74"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 74" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=GREAT%20improves%20functional%20interpretation%20of%20cis-regulatory%20regions&amp;amp;journal=Nat.%20Biotechnol.&amp;amp;doi=10.1038%2Fnbt.1630&amp;amp;volume=28&amp;amp;pages=495-501&amp;amp;publication_year=2010&amp;amp;author=McLean%2CCY"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="75."&gt;&lt;p class="c-article-references__text" id="ref-CR75"&gt;Ma, S. et al. Chromatin potential identified by shared single-cell profiling of RNA and chromatin. &lt;i&gt;Cell&lt;/i&gt; &lt;b&gt;183&lt;/b&gt;, 1103–1116 (2020).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.cell.2020.09.056" data-track-item_id="10.1016/j.cell.2020.09.056" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.cell.2020.09.056" aria-label="Article reference 75" data-doi="10.1016/j.cell.2020.09.056"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=33098772" aria-label="PubMed reference 75"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7669735" aria-label="PubMed Central reference 75"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXitFKjsLjL" aria-label="CAS reference 75"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 75" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Chromatin%20potential%20identified%20by%20shared%20single-cell%20profiling%20of%20RNA%20and%20chromatin&amp;amp;journal=Cell&amp;amp;doi=10.1016%2Fj.cell.2020.09.056&amp;amp;volume=183&amp;amp;pages=1103-1116&amp;amp;publication_year=2020&amp;amp;author=Ma%2CS"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="76."&gt;&lt;p class="c-article-references__text" id="ref-CR76"&gt;Kartha, V. K. et al. Functional inference of gene regulation using single-cell multi-omics. &lt;i&gt;Cell Genom.&lt;/i&gt; &lt;b&gt;2&lt;/b&gt;, 100166 (2022).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.xgen.2022.100166" data-track-item_id="10.1016/j.xgen.2022.100166" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.xgen.2022.100166" aria-label="Article reference 76" data-doi="10.1016/j.xgen.2022.100166"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=36204155" aria-label="PubMed reference 76"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9534481" aria-label="PubMed Central reference 76"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB38XitVChu73O" aria-label="CAS reference 76"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 76" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Functional%20inference%20of%20gene%20regulation%20using%20single-cell%20multi-omics.&amp;amp;journal=Cell%20Genom.&amp;amp;doi=10.1016%2Fj.xgen.2022.100166&amp;amp;volume=2&amp;amp;publication_year=2022&amp;amp;author=Kartha%2CVK"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="77."&gt;&lt;p class="c-article-references__text" id="ref-CR77"&gt;Lee, J. J. Early transcriptional effects of inflammatory cytokines reveal highly redundant cytokine networks. &lt;i&gt;J. Exp. Med.&lt;/i&gt; &lt;b&gt;222&lt;/b&gt;, e20241207 (2025).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1084/jem.20241207" data-track-item_id="10.1084/jem.20241207" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1084%2Fjem.20241207" aria-label="Article reference 77" data-doi="10.1084/jem.20241207"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=39873673" aria-label="PubMed reference 77"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB2MXpsVKgur4%3D" aria-label="CAS reference 77"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 77" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Early%20transcriptional%20effects%20of%20inflammatory%20cytokines%20reveal%20highly%20redundant%20cytokine%20networks.&amp;amp;journal=J.%20Exp.%20Med.&amp;amp;doi=10.1084%2Fjem.20241207&amp;amp;volume=222&amp;amp;publication_year=2025&amp;amp;author=Lee%2CJJ"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="78."&gt;&lt;p class="c-article-references__text" id="ref-CR78"&gt;Chen, Y. et al. Spatiotemporal single-cell analysis decodes cellular dynamics underlying different responses to immunotherapy in colorectal cancer. &lt;i&gt;Cancer Cell&lt;/i&gt; &lt;b&gt;42&lt;/b&gt;, 1268–1285 (2024).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.ccell.2024.06.009" data-track-item_id="10.1016/j.ccell.2024.06.009" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.ccell.2024.06.009" aria-label="Article reference 78" data-doi="10.1016/j.ccell.2024.06.009"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=38981439" aria-label="PubMed reference 78"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB2cXhsFSksLvL" aria-label="CAS reference 78"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 78" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Spatiotemporal%20single-cell%20analysis%20decodes%20cellular%20dynamics%20underlying%20different%20responses%20to%20immunotherapy%20in%20colorectal%20cancer&amp;amp;journal=Cancer%20Cell&amp;amp;doi=10.1016%2Fj.ccell.2024.06.009&amp;amp;volume=42&amp;amp;pages=1268-1285&amp;amp;publication_year=2024&amp;amp;author=Chen%2CY"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="79."&gt;&lt;p class="c-article-references__text" id="ref-CR79"&gt;Bassez, A. et al. A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer. &lt;i&gt;Nat. Med.&lt;/i&gt; &lt;b&gt;27&lt;/b&gt;, 820–832 (2021).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41591-021-01323-8" data-track-item_id="10.1038/s41591-021-01323-8" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41591-021-01323-8" aria-label="Article reference 79" data-doi="10.1038/s41591-021-01323-8"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=33958794" aria-label="PubMed reference 79"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3MXhtVCqs7vF" aria-label="CAS reference 79"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 79" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=A%20single-cell%20map%20of%20intratumoral%20changes%20during%20anti-PD1%20treatment%20of%20patients%20with%20breast%20cancer&amp;amp;journal=Nat.%20Med.&amp;amp;doi=10.1038%2Fs41591-021-01323-8&amp;amp;volume=27&amp;amp;pages=820-832&amp;amp;publication_year=2021&amp;amp;author=Bassez%2CA"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="80."&gt;&lt;p class="c-article-references__text" id="ref-CR80"&gt;Wolf, F. A., Angerer, P. &amp;amp; Theis, F. J. SCANPY: large-scale single-cell gene expression data analysis. &lt;i&gt;Genome Biol.&lt;/i&gt; &lt;b&gt;19&lt;/b&gt;, 15 (2018).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="noopener" data-track-label="10.1186/s13059-017-1382-0" data-track-item_id="10.1186/s13059-017-1382-0" data-track-value="article reference" data-track-action="article reference" href="https://link.springer.com/doi/10.1186/s13059-017-1382-0" aria-label="Article reference 80" data-doi="10.1186/s13059-017-1382-0"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=29409532" aria-label="PubMed reference 80"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802054" aria-label="PubMed Central reference 80"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 80" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=SCANPY%3A%20large-scale%20single-cell%20gene%20expression%20data%20analysis&amp;amp;journal=Genome%20Biol.&amp;amp;doi=10.1186%2Fs13059-017-1382-0&amp;amp;volume=19&amp;amp;publication_year=2018&amp;amp;author=Wolf%2CFA&amp;amp;author=Angerer%2CP&amp;amp;author=Theis%2CFJ"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="81."&gt;&lt;p class="c-article-references__text" id="ref-CR81"&gt;Gayoso, A. et al. A Python library for probabilistic analysis of single-cell omics data. &lt;i&gt;Nat. Biotechnol.&lt;/i&gt; &lt;b&gt;40&lt;/b&gt;, 163–166 (2022).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41587-021-01206-w" data-track-item_id="10.1038/s41587-021-01206-w" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41587-021-01206-w" aria-label="Article reference 81" data-doi="10.1038/s41587-021-01206-w"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=35132262" aria-label="PubMed reference 81"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB38XjtFSit78%3D" aria-label="CAS reference 81"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 81" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=A%20Python%20library%20for%20probabilistic%20analysis%20of%20single-cell%20omics%20data&amp;amp;journal=Nat.%20Biotechnol.&amp;amp;doi=10.1038%2Fs41587-021-01206-w&amp;amp;volume=40&amp;amp;pages=163-166&amp;amp;publication_year=2022&amp;amp;author=Gayoso%2CA"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="82."&gt;&lt;p class="c-article-references__text" id="ref-CR82"&gt;Bravo Gonzalez-Blas, C. et al. SCENIC+: single-cell multiomic inference of enhancers and gene regulatory networks. &lt;i&gt;Nat. Methods&lt;/i&gt; &lt;b&gt;20&lt;/b&gt;, 1355–1367 (2023).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41592-023-01938-4" data-track-item_id="10.1038/s41592-023-01938-4" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41592-023-01938-4" aria-label="Article reference 82" data-doi="10.1038/s41592-023-01938-4"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=37443338" aria-label="PubMed reference 82"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10482700" aria-label="PubMed Central reference 82"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3sXhsVOmtbrM" aria-label="CAS reference 82"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 82" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=SCENIC%2B%3A%20single-cell%20multiomic%20inference%20of%20enhancers%20and%20gene%20regulatory%20networks&amp;amp;journal=Nat.%20Methods&amp;amp;doi=10.1038%2Fs41592-023-01938-4&amp;amp;volume=20&amp;amp;pages=1355-1367&amp;amp;publication_year=2023&amp;amp;author=Bravo%20Gonzalez-Blas%2CC"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="83."&gt;&lt;p class="c-article-references__text" id="ref-CR83"&gt;McDavid, A. et al. Data exploration, quality control and testing in single-cell qPCR-based gene expression experiments. &lt;i&gt;Bioinformatics&lt;/i&gt; &lt;b&gt;29&lt;/b&gt;, 461–467 (2013).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1093/bioinformatics/bts714" data-track-item_id="10.1093/bioinformatics/bts714" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1093%2Fbioinformatics%2Fbts714" aria-label="Article reference 83" data-doi="10.1093/bioinformatics/bts714"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=23267174" aria-label="PubMed reference 83"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC3sXis1OjsLs%3D" aria-label="CAS reference 83"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 83" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Data%20exploration%2C%20quality%20control%20and%20testing%20in%20single-cell%20qPCR-based%20gene%20expression%20experiments&amp;amp;journal=Bioinformatics&amp;amp;doi=10.1093%2Fbioinformatics%2Fbts714&amp;amp;volume=29&amp;amp;pages=461-467&amp;amp;publication_year=2013&amp;amp;author=McDavid%2CA"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;/ol&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Nature</author><pubDate>Wed, 10 Sep 2025 15:59:04 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMiX0FVX3lxTFB0VzJiRDNSQXlnOW1NczZ0Z3dIRmxyY3hUSFc2T1A4ckNIZFFmbDlDZTR2ZFdyVzhJSW1qbkdydzhRNWtueS04T1lEVjZHMnpJa2FXaVR5enIwYlBnSjcw</guid></item><item><title>善良的金毛猎犬坚持观察人类新生儿的“整个午睡” - AOL.com</title><link>https://www.aol.com/articles/kindhearted-golden-retriever-insists-watching-140000580.html</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="caas-body"&gt;&lt;p&gt;Golden Retrievers are, like, the family dog. Go look at any list of the&lt;a href="https://paradepets.com/dogs/tenderhearted-dog-breeds" rel="nofollow noopener" target="_blank" data-ylk="slk:best dog breeds for families;elm:context_link;itc:0;sec:content-canvas" class="link rapid-noclick-resp"&gt; best dog breeds for families&lt;/a&gt; ever created, and I bet the Golden Retriever is somewhere in the top five. That's not for nothing, either: they're genuinely great family dogs.&lt;/p&gt;&lt;p&gt;It's a classic combo, and it never gets less awesome to watch. Just look at this video from Tuesday, September 9th, when one Golden retriever refused to let his favorite tiny human nap unattended. He was falling asleep too, but he was not about to let anything slip by:&lt;/p&gt;&lt;p&gt;&lt;a href="https://www.tiktok.com/@marleynyc/" rel="nofollow noopener" target="_blank" data-ylk="slk:Marley the Golden Retriever;elm:context_link;itc:0;sec:content-canvas" class="link rapid-noclick-resp"&gt;Marley the Golden Retriever &lt;/a&gt;is so sweet. I'm sure his mom feels a lot better knowing there's an extra set of eyes on her baby all the time!&lt;/p&gt;&lt;p&gt;&lt;strong&gt;&lt;a href="https://paradepets.com/pet-news/golden-retriever-tiny-kitten-sleep-in-same-position" rel="nofollow noopener" target="_blank" data-ylk="slk:Related: Golden Retriever and Tiny Kitten Sleeping in Exact Same Position Is Sheer Perfection;elm:context_link;itc:0;sec:content-canvas" class="link rapid-noclick-resp"&gt;Related: Golden Retriever and Tiny Kitten Sleeping in Exact Same Position Is Sheer Perfection&lt;/a&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;Marley isn't just a Golden Retriever; he's a city boy, born and raised. He lives in New York City with mom, dad, and their brand new baby. He used to be the only child in the house, which sometimes makes dogs angry. They don't like to share the spotlight.&lt;/p&gt;&lt;p&gt;That wasn't a problem for Marley, though: he was fine with that. Now, he has three siblings! He just wanted a friend, and the new baby was exactly what he needed. As soon as mom let him close to the baby, he was there. He was ready to show her he could be a good boy, and he did an excellent job.&lt;/p&gt;&lt;p&gt;Them meeting was just too cute:&lt;/p&gt;&lt;p&gt;Micro-Gary is an awesome name for a baby. I think I'm going to name my first baby that, too.&lt;/p&gt;&lt;h2&gt;Golden Retrievers Know How to be Gentle&lt;/h2&gt;&lt;p&gt;Part of the reason that Golden Retrievers are so popular in families is that they're like little mirrors. They match energies incredibly well: if you have a baby, they love snuggly naps and lying around while they play. As your baby grows, they love to run, play, and catch the food they drop on the floor.&lt;/p&gt;&lt;p&gt;Though these dogs can definitely be overbearing and very playful, they're also easy to train. They can and will learn how to behave around their new little friend!&lt;/p&gt;&lt;p&gt;&lt;a href="https://emojipedia.org/dog-face" rel="nofollow noopener" target="_blank" data-ylk="slk:🐶;elm:context_link;itc:0;sec:content-canvas" class="link rapid-noclick-resp"&gt;🐶&lt;/a&gt;&lt;strong&gt;&lt;a href="https://parade.com/newsletters/parade-pets" rel="nofollow noopener" target="_blank" data-ylk='slk:SIGN UP to get "pawsitivity" delivered right to your inbox with inspiring &amp;amp; entertaining stories about our furry &amp;amp; feathered friends;elm:context_link;itc:0;sec:content-canvas' class="link rapid-noclick-resp"&gt;SIGN UP to get "pawsitivity" delivered right to your inbox with inspiring &amp;amp; entertaining stories about our furry &amp;amp; feathered friends&lt;/a&gt;&lt;/strong&gt;&lt;a href="https://emojipedia.org/paw-prints" rel="nofollow noopener" target="_blank" data-ylk="slk:🐾🐾;elm:context_link;itc:0;sec:content-canvas" class="link rapid-noclick-resp"&gt;🐾🐾&lt;/a&gt;&lt;/p&gt;&lt;p&gt;&lt;i&gt;This story was originally reported by &lt;a href="https://paradepets.com/pet-news/kindhearted-golden-retriever-insists-on-watching-human-newborn" rel="nofollow noopener" target="_blank" data-ylk="slk:Parade Pets;elm:context_link;itc:0;sec:content-canvas" class="link rapid-noclick-resp"&gt;Parade Pets&lt;/a&gt; on Sep 10, 2025, where it first appeared in the &lt;a href="https://paradepets.com/pet-news" rel="nofollow noopener" target="_blank" data-ylk="slk:Pet News;elm:context_link;itc:0;sec:content-canvas" class="link rapid-noclick-resp"&gt;Pet News&lt;/a&gt; section. Add Parade Pets as a &lt;a href="https://google.com/preferences/source?q=paradepets.com" rel="nofollow noopener" target="_blank" data-ylk="slk:Preferred Source by clicking here.;elm:context_link;itc:0;sec:content-canvas" class="link rapid-noclick-resp"&gt;Preferred Source by clicking here.&lt;/a&gt;&lt;/i&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>AOL.com</author><pubDate>Wed, 10 Sep 2025 15:51:50 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMikwFBVV95cUxNWTdvaE80ejRUbWxnRW5vazROX2V4XzNpSk13Z0p5WFVhZ29TMnF5Q0oxNWRUX2dleWNKV1g3WDVmYnM1LTVrM2Z6cWtpM0lHbXp0bDU4Q2o1aGtfNS16dzlSX25sRnBYemd1NVRjTzRaR3VETUx1a3hDTUpZeldFQXJKOFJHRFkyMU84d3cxdldFdms</guid></item><item><title>“大脑表盘”打开或关闭小鼠的食物消耗-自然</title><link>https://www.nature.com/articles/d41586-025-02871-6</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="article__teaser" data-test="access-teaser"&gt; &lt;figure class="figure"&gt;&lt;picture class="embed intensity--high"&gt;&lt;source type="image/webp" srcset="//media.nature.com/lw767/magazine-assets/d41586-025-02871-6/d41586-025-02871-6_51437210.jpg?as=webp 767w, //media.nature.com/lw319/magazine-assets/d41586-025-02871-6/d41586-025-02871-6_51437210.jpg?as=webp 319w" sizes="(max-width: 319px) 319px, (min-width: 1023px) 100vw,  767px"&gt;&lt;/source&gt;&lt;img class="figure__image" alt="A buffet of many different food dishes on a table in a restaurant with diners sitting in the background" loading="lazy" src="//media.nature.com/lw767/magazine-assets/d41586-025-02871-6/d41586-025-02871-6_51437210.jpg"&gt;&lt;figcaption&gt;&lt;p class="figure__caption u-sans-serif"&gt;&lt;span class="mr10"&gt;Food consumption can be turned off in mice by silencing neurons in a particular brain area. &lt;/span&gt;&lt;span&gt;Credit: Ricardo Ribas/SOPA Images/LightRocket/Getty&lt;/span&gt;&lt;/p&gt;&lt;/figcaption&gt;&lt;/picture&gt;&lt;/figure&gt;&lt;p&gt;Scientists have identified a ‘brain dial’ that can turn food consumption on or off, at least in mice. The effect of this brain region is so powerful that when scientists manipulated it, mice that were already full kept eating — and even gobbled inedible plastic pellets.&lt;/p&gt;&lt;p&gt;The region receives and coordinates multiple streams of information, such as &lt;a href="https://www.nature.com/articles/d41586-017-08478-w" data-track="click" data-label="https://www.nature.com/articles/d41586-017-08478-w" data-track-category="body text link"&gt;hunger levels&lt;/a&gt;, nutritional deficits and &lt;a href="https://www.nature.com/articles/d41586-020-02485-0" data-track="click" data-label="https://www.nature.com/articles/d41586-020-02485-0" data-track-category="body text link"&gt;whether a food is pleasurable to eat&lt;/a&gt;. It is a “key hub” linking the sensory traits of food to &lt;a href="https://www.nature.com/articles/d41586-025-01896-1" data-track="click" data-label="https://www.nature.com/articles/d41586-025-01896-1" data-track-category="body text link"&gt;weight control&lt;/a&gt; — a finding with implications for human health, according to a paper published on 10 September in &lt;i&gt;Cell&lt;/i&gt;&lt;sup&gt;&lt;a href="#ref-CR1" data-track="click" data-action="anchor-link" data-track-label="go to reference" data-track-category="references"&gt;1&lt;/a&gt;&lt;/sup&gt;.&lt;/p&gt;&lt;p&gt;“I am deeply impressed by this study,” says Matthew Carter, a neuroscientist at Williams College in Williamstown, Massachusetts. The work is unusual in separating out how hunger and a food’s sensory qualities affect food consumption, he says, and demonstrates that a single brain region integrates a range of signals to drive consumption.&lt;/p&gt;&lt;h2&gt;The bitter with the sweet&lt;/h2&gt;&lt;p&gt;Food intake is influenced by roughly a dozen brain regions. &lt;a href="https://www.nature.com/articles/508S64a" data-track="click" data-label="https://www.nature.com/articles/508S64a" data-track-category="body text link"&gt;These areas gather information on various factors that together drive our appetite&lt;/a&gt; for something and how likely we are to consume it. A person with salt levels might crave a salty snack, for example, but decline something &lt;a href="https://www.nature.com/articles/d41586-024-01031-6" data-track="click" data-label="https://www.nature.com/articles/d41586-024-01031-6" data-track-category="body text link"&gt;bitter&lt;/a&gt;. In 2019, researchers suggested that all of these stimuli might be funnelled into a brain region called the bed nucleus of the stria terminalis (BNST)&lt;sup&gt;&lt;a href="#ref-CR2" data-track="click" data-action="anchor-link" data-track-label="go to reference" data-track-category="references"&gt;2&lt;/a&gt;&lt;/sup&gt;, but it remained unclear what exactly was happening inside.&lt;/p&gt;&lt;p&gt;Charles Zuker, a neuroscientist at Columbia University in New York City, and his team wanted to trace the brain circuits involved in an animal’s response to tastes. The researchers began by characterizing neurons that become active when a mouse tastes something sweet. In the central amygdala and hypothalamus, they found sweet-detection neurons with branches that link to neurons in the BNST.&lt;/p&gt;&lt;p&gt;&lt;article class="recommended pull pull--left u-sans-serif" data-label="Related"&gt;&lt;a href="https://www.nature.com/articles/d41586-025-01408-1" class="u-link-inherit" data-track="click" data-track-label="recommended article"&gt;&lt;img class="recommended__image" alt="" src="//media.nature.com/w400/magazine-assets/d41586-025-02871-6/d41586-025-02871-6_50956676.jpg"&gt;&lt;p class="recommended__title u-serif"&gt;How we taste sweetness: long-sought structure of human receptor mapped at last&lt;/p&gt;&lt;/a&gt;&lt;/article&gt;&lt;/p&gt;&lt;p&gt;When the scientists silenced those BNST neurons, the animals lost their interest in sugar even when hungry, and &lt;a href="https://www.nature.com/articles/d41586-022-01580-8" data-track="click" data-label="https://www.nature.com/articles/d41586-022-01580-8" data-track-category="body text link"&gt;largely ceased to eat&lt;/a&gt;. The researchers also activated those BNST neurons in mice that had recently been fed and so shouldn’t seek out food. Nevertheless, the activation prompted the mice to ingest all kinds of things: water (a neutral substance they would typically ignore unless thirsty), salt, fat, bitter substances and even plastic pellets.&lt;/p&gt;&lt;p&gt;Collectively, these and other results “tell us that the BNST is functioning as something of a master ‘dial’ with bidirectional control”, Zuker says. “If we can figure out how to turn that dial, it would give us some influence over things like body weight.”&lt;/p&gt;&lt;/div&gt;
                        &lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Nature</author><pubDate>Wed, 10 Sep 2025 15:34:12 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMiX0FVX3lxTE5aMmpWZGZwLXF4TTFUUWw2YTVlRUgxSDFIbkRJaU0tOVE5Q25QMVNFUS16OFdyZjhsUEw5X0pCMXJxUXptbUFyVmlwQk9kX3JLODZqVWtJLTFwYV9lb2Zv</guid></item><item><title>数百万男性可以从更快的15分钟前列腺癌扫描中受益，这为国家筛查计划铺平了道路-每日邮报</title><link>https://www.dailymail.co.uk/health/article-15085049/Millions-men-benefit-faster-15-minute-prostate-cancer-scan.html</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div itemprop="articleBody"&gt;&lt;p class="mol-para-with-font"&gt;Millions of men could benefit from a faster 15-minute prostate &lt;a target="_self" href="/news/cancer/index.html" id="mol-e2b1a530-8e56-11f0-bd1b-3768a5093cbe"&gt;cancer&lt;/a&gt; scan that paves the way to a national screening programme.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;The new MRI scan takes half the time of the current one and costs half as much but was just as accurate at diagnosing the disease in a landmark trial.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;UK researchers say their findings are likely to lead to changes in clinical practice and should make the scans more accessible to men who need one.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;It comes as the Daily Mail is campaigning for a national prostate cancer screening programme, initially targeted at high risk men.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;Prostate cancer is the most common cancer in men, with around 56,000 diagnoses and 12,000 deaths each year in the UK.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;The introduction of MRI scans over the last decade has been the biggest change in how prostate cancer is diagnosed for 30 years.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;Abnormalities seen on the MRI scan allow targeted tissue biopsies to be taken that can improve cancer detection.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;A normal MRI result, which occurs in around a third of patients, is reassuring and allows men to avoid an unnecessary biopsy.&lt;/p&gt;&lt;div class="artSplitter mol-img-group"&gt;  &lt;p class="imageCaption"&gt;The Daily Mail is campaigning for a national prostate cancer screening programme, initially targeted at high risk men&lt;/p&gt;&lt;/div&gt;&lt;p class="mol-para-with-font"&gt;Despite the clear benefits of the MRI scan only 62 per cent of men who needed a prostate MRI in England and Wales received one in 2019, the most recent year for when data is available.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;In the new study, cancer specialists from 22 hospitals in 12 countries recruited 555 patients aged 59 to 70 to see whether a streamlined two-part ‘biparametric’ MRI could detect cancer at the same rate as a full three-part ‘multiparametric’ MRI, which is currently standard of care in the UK and includes a third stage where a dye is injected into the patient.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;All patients underwent the full three-part scan.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;Radiologists then assessed the two-part scan without the dye, and separately assessed the three-part scan with the dye, for every patient.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;A prostate biopsy was done when required to confirm whether or not the diagnosis was correct.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;Researchers from University College London and University College London Hospital confirmed that the two-part scan was just as effective at diagnosing prostate cancer.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;In total, 29 per cent of the patients had important prostate cancer diagnosed by the shorter two-part scan, the same percentage as the longer three-part scan.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;The three-part scan typically takes around 30 to 40 minutes and costs an average of £273 on the NHS.&lt;/p&gt;&lt;div class="artSplitter mol-img-group"&gt;  &lt;p class="imageCaption"&gt;Health secretary Wes Streeting has declared his support for a national prostate cancer screening programme&lt;/p&gt;&lt;/div&gt;&lt;p class="mol-para-with-font"&gt;However, the two-part scan takes just 15 to 20 minutes, reduces the need for a doctor to be present and is 47 per cent cheaper.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;The findings of the Prime trial, funded by the John Black Charitable Foundation and Prostate Cancer UK, are published in JAMA, the Journal of the American Medical Association.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;Associate Professor Veeru Kasivisvanathan, lead researcher and Chief Investigator on the trial from UCL Surgery &amp;amp; Interventional Science and UCLH, said: 'Currently around four million MRI scans are needed each year globally to diagnose prostate cancer.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;‘This demand is set to rise rapidly with a predicted surge in prostate cancer cases over the next 20 years.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;‘Time, cost and staff availability are all limiting factors in how many scans can be offered, which makes the results of the PRIME trial particularly important.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;‘If we can do the scan in up to half the time, with fewer staff and at lower cost, that will make a huge difference in allowing every man who needs a scan to be able to get one in a timely fashion.’&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;The NHS already offers national screening programmes for breast, bowel and cervical cancers - but not for prostate cancer.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;The UK National Screening Committee, which advises the government on which screening programmes to offer, is currently considering recent developments around prostate cancer diagnosis and is due to report its findings later this year.&lt;/p&gt;&lt;div class="artSplitter mol-img-group"&gt;  &lt;p class="imageCaption"&gt; Former prime minister Rishi Sunak has also backed a national prostate cancer screening programme&lt;/p&gt;&lt;/div&gt;&lt;p class="mol-para-with-font"&gt;Associate Professor Francesco Giganti, a lead radiologist on the trial from UCL Surgery &amp;amp; Interventional Science and UCLH, said: ‘The three-part multiparametric MRI scan has been a game-changer for the diagnosis of prostate cancer, sparing thousands of patients unnecessary biopsies and improving cancer detection.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;‘Currently we inject a dye into the patient that highlights the presence of cancer on the MRI scan, but this step requires time and the presence of a clinician, and can on rare occasion cause mild side effects.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;'Being able to make accurate diagnoses without the contrast stage will reduce scan time meaning we can offer scans to more men using the same number of scanners and operators.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;‘However, it is vital that the scans are of optimal diagnostic quality and that they are interpreted by a radiologist with dedicated expertise in prostate MRI.’&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;Separately, Prostate Cancer UK’s Transform trial, the biggest prostate cancer screening trial for 20 years, is due to begin later this year.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;It will find the best way to screen men for prostate cancer, achieving the evidence needed for the introduction of a national screening programme.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;The results of the Prime trial are an important step towards realising this ambition.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;Dr Matthew Hobbs, director of research at Prostate Cancer UK, said: ‘The results from the PRIME trial, showing that a faster, cheaper, type of prostate MRI is just as good as the current standard MRI at detecting prostate cancer, are a hugely important step in the right direction for making MRIs more efficient.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;‘Another trial is already happening in the UK and the results of the two trials together should provide the complete evidence package we need to change practice across the country.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;‘We encourage (health watchdog) NICE to prepare to review their guidelines as soon as that evidence base is complete, so that we can make MRI quicker, cheaper and less onerous for men.’&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;Health secretary Wes Streeting has declared his support for a national prostate cancer screening programme in a major boost for the Mail’s campaign.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;The health secretary told MPs in April that he would like to see the NHS proactively offer men tests for the disease in a move that could prevent thousands of needless deaths.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;He said he is ‘particularly sympathetic’ to the argument that this should initially be targeted at high-risk men.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;The call for targeted screening has also been backed by former prime minister Rishi Sunak, former home secretary Sir James Cleverly and Calvin Bailey, a Labour MP and the chairman of the all-party parliamentary group on prostate cancer.&lt;/p&gt;&lt;/div&gt;
            

            
            
            
            
            &lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Daily Mail</author><pubDate>Wed, 10 Sep 2025 15:28:59 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">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</guid></item></channel></rss>